Top ▲
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| Ligand name | ID | Synonyms | |||||||
| A | Back to top | ||||||||
| 852A |
|
9025 | |||||||
| A011 | 12776 | compound 8d [Zhang et al., 2023] | |||||||
| A1120 |
|
8792 | A 1120, compound 33 [PMID: 24835984] | ||||||
| A-1165442 | 12757 | A1165442, compound 52 [PMID: 25100568] | |||||||
| A-119637 | 490 | A 119637, A119637 | |||||||
| A-123189 | 491 | A 123189, A123189 | |||||||
| A-1262543 | 13181 | A1262543 | |||||||
| A-1331852 | 11102 | A 1331852, A1331852 | |||||||
| A134974 | 5130 | A 134974, A-134974 | |||||||
| A192621 | 1009 | A 192621, A-192621 | |||||||
| A-196 |
|
8949 | |||||||
| A286982 |
|
6592 | A 286982, A-286982 | ||||||
| A-304121 | 1258 | A 304121, A304121 | |||||||
| A317491 |
|
4115 | A 317491, A-317491 | ||||||
| A-317567 | 4116 | A 317567, A317567 | |||||||
| A-317920 | 1216 | A 317920, A317920 | |||||||
| A331440 | 4023 | A 331440, A-331440 | |||||||
| A-349821 | 1217 | A 349821, A-349,821, A349821 | |||||||
| A-366 |
|
8238 | A 366, A366 | ||||||
| A-381393 | 8441 | A 381393, A-381,393 | |||||||
| A-395 | 9525 | ||||||||
| A412997 | 3301 | A-412,997, A-412997 | |||||||
| A425619 | 4117 | A 425619, A-425619 | |||||||
| A438079 |
|
4118 | A 438079, A-438079 | ||||||
| A-582941 | 3995 | A 582941, A582941 | |||||||
| A61603 | 480 | A 61603, A-61603 | |||||||
| A-674563 |
|
5655 | A 674563, A674563 | ||||||
| A68930 | 6077 | A 68930, A 70108, A 70360, A-68930, A-70108, A-70360, A70108, A70360 | |||||||
| A740003 | 4119 | A 740003, A-740003 | |||||||
| A-769662 |
|
10069 | A769662 | ||||||
| A77636 | 9637 | A-77636 | |||||||
| A778317 | 4120 | A 778317, A-778317 | |||||||
| A-794278 | 6354 | A 794278, A794278, compound 1ac [PMID: 16279797] | |||||||
| A-794282 | 6211 | A 794282, A794282, compound 1n [PMID: 16279797] | |||||||
| A-803467 |
|
5734 | A 803467, A803467 | ||||||
| A804598 | 4121 | A 804598, A-804598 | |||||||
| A839977 |
|
4122 | A 839977, A-839977 | ||||||
| A-841720 | 3953 | A 841720, A841720 | |||||||
| A-850002 | 6355 | A 850002, A850002, compound 28b [PMID: 16279797] | |||||||
| A-85380 | 5460 | A 85380, A85380 | |||||||
| A-867744 | 3986 | A 867744, A867744 | |||||||
| A-887826 | 14017 | A887826 | |||||||
| A-908292 | 10669 | ||||||||
| A-910 | 13579 | A910, compound 49 [PMID: 39283694] | |||||||
| A-935142 | 7661 | A 935142, A935142 | |||||||
| A947 | 12308 | ||||||||
| A-967079 | 6280 | A 967079, A967079 | |||||||
| A-971432 | 9496 | ||||||||
| [3H]A317491 |
|
|
|
5407 | [3H]A 317491, [3H]A-317491 | ||||
| [3H]A-585539 |
|
|
3974 | ||||||
| [3H]A778317 |
|
|
4076 | ||||||
| [3H]A804598 |
|
|
5408 | [3H]A 804598 | |||||
| [3H]A81988 |
|
|
3938 | [3H]-A81988 | |||||
| A2315A | 10846 | ||||||||
| AAE-M-PBP-amine | 8289 | acetylaminoethyl-methyl-phenylbutoxyphenyl-amine | |||||||
| AB-343 |
|
13659 | |||||||
| AB928 |
|
|
11154 | AB-928 | |||||
| abacavir |
|
|
11152 | ABC, 1592U89, Ziagen® | |||||
| Abbott 14c | 5871 | 2,4-diaminopyrimidine-based antagonist, 14c | |||||||
| ABBV-318 | 12002 | ABBV318, compound 73 [PMID: 35436748] | |||||||
| ABBV-3221 | 10577 | ABBV/GLPG-3221, compound 19 [PMID: 31749908] | |||||||
| ABBV-744 |
|
10730 | ABBV 744, ABBV744 | ||||||
| ABBV-CLS-484 |
|
11968 | AC484 | ||||||
| ABD-1970 | 11816 | ABD1970 | |||||||
| abediterol |
|
9326 | LAS-100977 | ||||||
| abemaciclib |
|
|
7382 | CS-1230, HY-16297A, LY 2835219, LY-2835219 , LY2835219, Verzenio®, Verzenios® | |||||
| abexinostat | 8366 | CRA-024781, CRA-24781, PCI-24781 | |||||||
| abimtrelvir | 11870 | ||||||||
| abiraterone |
|
6745 | |||||||
| abiraterone acetate |
|
9288 | Yonsa®, Zytiga® | ||||||
| abiraterone-C6 oxime | 13852 | compound 13b [PMID: 29792703] | |||||||
| abivertinib |
|
10044 | AC0010, AC0010MA, avitinib (superceded INN), FUJOVEE® | ||||||
| ABL127 | 8608 | ABL 127, ABL-127, compound 1 [PMID: 21639134] | |||||||
| AB-MECA | 416 | ||||||||
| [125I]AB-MECA |
|
|
436 | [125I]-AB-MECA, [125I]5-[6-[(4-aminophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-oxolane-2-carboxamide, [125I]N(6)-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide | |||||
| AB-NECA | 434 | aminobenzyl-5'-N-ethylcarboxamidoadenosine | |||||||
| abnormal cannabidiol |
|
5526 | Abn-CBD, CAY10429 | ||||||
| [125I]ABOPX |
|
|
452 | [125I]3-(3,4-aminobenzyl)-8-(4-oxyacetate)phenyl-1-propyl-xanthine | |||||
| abrocitinib |
|
|
|
9991 | Cibinqo®, compound 25 [PMID: 29298069], PF-04965842, PF04965842 | ||||
| ABS-752 | 14161 | ABS752, CT-01 | |||||||
| ABT-002 | 14162 | ||||||||
| ABT-239 | 1218 | ABT 239, ABT239 | |||||||
| ABT-288 | 6927 | ABT 288, ABT288 | |||||||
| ABT-299 | 1849 | ABT 299, ABT299 | |||||||
| ABT-384 | 7357 | ABT 384, ABT384 | |||||||
| ABT-491 |
|
1850 | ABT 491, ABT491 | ||||||
| ABT-639 | 7721 | ABT 639, ABT639 | |||||||
| ABT-670 | 8439 | ABT 670, ABT670, compound 6b [PMID 17149874] | |||||||
| ABT702 | 5131 | ABT 702, ABT-702 | |||||||
| ABT-737 |
|
|
8320 | ABT 737, ABT737, compound 2 [PMID 17256834] | |||||
| ABX-1431 | 10062 | ABX1431, compound 28 [PMID: 30067909], compound 9aq [WO2013103973A1], example 82 [WO2013103973A1] | |||||||
| AC1115 | 13927 | ||||||||
| AC-186 | 8897 | AC 186 | |||||||
| AC1903 | 10290 | AC-1903 | |||||||
| AC-260584 | 334 | AC 260584, AC260584 | |||||||
| AC261066 | 4054 | AC 261066, AC-261066 | |||||||
| AC262620 | 4017 | AC 262620, AC-262620 | |||||||
| AC262970 | 4018 | AC 262970, AC-262970 | |||||||
| AC263093 | 4020 | AC 263093, AC-263093 | |||||||
| AC264613 | 9460 | AC-264613, compound 3 [PMID: 18720984] | |||||||
| AC265347 | 3947 | AC 265347, AC-265347 | |||||||
| AC-42 | 289 | AC 42, AC42 | |||||||
| AC430 |
|
9177 | AC-430 | ||||||
| AC45594 | 5422 | 4-(heptyloxy)benzolol, 4-heptoxyphenol | |||||||
| AC-55541 | 9456 | AC55541 | |||||||
| AC55649 | 4055 | AC 55649, AC-55649 | |||||||
| AC710 | 8095 | AC 710, AC-710 | |||||||
| AC-7954 | 2151 | AC 7954, AC7954 | |||||||
| AC-90179 | 174 | AC 90179, AC90179 | |||||||
| AC-98170 | 9457 | AC98170 | |||||||
| ACAA |
|
2443 | ACA | ||||||
| acadesine | 5133 | AICA-riboside, AR-100, SCH-900395 | |||||||
| acalabrutinib |
|
|
|
8912 | ACP-196, Calquence®, Example 6 [US20140155385 A1] | ||||
| acalisib | 10096 | CAL-120, GS-9820 | |||||||
| acamprosate |
|
7106 | Campral® | ||||||
| acarbose |
|
|
6791 | BAY-G 5421, BAY-G-5421, Glucobay®, Precose® | |||||
| 7ACC2 |
|
8818 | compound 19 [PMID: 24095010] | ||||||
| Ac-DEVD-CHO | 6527 | ||||||||
| ACDPP | 3388 | ||||||||
| acebilustat |
|
11984 | CTX-4430, CTX4430 | ||||||
| acebutolol |
|
7107 | IL-17803A, Sectral® | ||||||
| (+)-aceclidine | 286 | S-(+)-aceclidine | |||||||
| (-)-aceclidine | 288 | R-(-)-aceclidine | |||||||
| aceclidine |
|
14102 | ±aceclidine, LINZ-101, LINZ101, racemic aceclidine, VIZZ® | ||||||
| acelarin | 7389 | NUC-1031 | |||||||
| acenocoumarol |
|
9015 | Sinthrome®, Sintrom® | ||||||
| acesulfame |
|
12460 | acetosulfam | ||||||
| ACET |
|
4123 | |||||||
| acetamide |
|
4661 | ethanamide, methylformamide | ||||||
| acetazolamide |
|
|
6792 | Diamox® | |||||
| acetoacetic acid | 4522 | acetoacetate, diacetic acid | |||||||
| acetohexamide |
|
|
6793 | Dymelor® | |||||
| 1'-acetoxychavicol acetate | 6298 | ||||||||
| [3H]acetylcholine |
|
|
|
8593 | |||||
| [14C]acetylCoA |
|
|
4541 | [14C]-acetylCoA | |||||
| acetylcysteine |
|
|
10945 | Ilube® (eye drops), N-A-C Sustain®, N-Acetyl-cysteine, N-Acetyl-L-cysteine, NAC, Parvolex® | |||||
| acetyldigitoxin |
|
6794 | acetyldiginatin, Acylanid®, alpha-acetyldigitoxin | ||||||
| acetyl-podocarpic dimer | 2753 | APD, acetyl podocarpic acid anhydride | |||||||
| AChE reactivator 2 | 10074 | ||||||||
| ACHN-975 |
|
13333 | |||||||
| aciclovir |
|
|
4829 | acyclovir, Zovirax® | |||||
| acifran | 1595 | AY-25712, D02753, reductol | |||||||
| acipimox |
|
1596 | Olbetam® | ||||||
| acitretin |
|
7598 | Ro-101670000, Soriatane® | ||||||
| acivicin |
|
11402 | AT-125, AT125, U 42,126, U-42,126, U-42126 | ||||||
| aclidinium |
|
7449 | LAS W-330, LAS-34273, Tudorza Pressair® | ||||||
| acloproxalap | 12097 | Compound 5 [WO2020223685A1] | |||||||
| acoltremon |
|
|
4343 | AR-15512, AR15512, AVX-012, Tryptyr®, WS 12, WS-12 | |||||
| A101-(CONH2)-B322 | 13122 | ||||||||
| acorafloxacin | 10753 | avarofloxacin (former name), JNJ-Q2, JNJQ2 | |||||||
| acoramidis |
|
|
13628 | AG-10, AG10, Attruby®, Beyonttra® | |||||
| [35S]ACPPB |
|
|
4584 | [35S]-ACPPB | |||||
| ACPT-I | 1408 | 1-aminocyclopentane-1,3,4-tricarboxylic acid | |||||||
| ACQ090 | 2076 | NVP ACQ090 | |||||||
| acrizanib | 12782 | compound 35 [PMID: 29400470], LHA-510, LHA510 | |||||||
| acrolein | 2418 | propenal | |||||||
| acrylamide |
|
4553 | |||||||
| 4-acryloylphenol | 8841 | compound 6 | |||||||
| ACT001 | 13291 | ACT-001 | |||||||
| ACT-1014-6470 |
|
12326 | example 172 [WO2019137927A1], Ic-58 | ||||||
| ACT-1016-0707 | 13337 | compound 49 [PMID: 38349250] | |||||||
| ACT-335827 | 9122 | ACT 335827, compound 9 [PMID: 23589487] | |||||||
| ACT-389949 |
|
9511 | |||||||
| ACT-451840 |
|
10022 | ACT451840, Actelion-451840 | ||||||
| ACT-462206 |
|
9303 | compound 24 [PMID: 25147058] | ||||||
| ACT-660602 |
|
12207 | ACT660602, compound 9j [PMID: 35947786] | ||||||
| ACT-709478 |
|
12647 | ACT709478, compound 66b [PMID: 29116786], NBI-827104, NBI827104 | ||||||
| ACT-777991 |
|
12584 | ACT777991, compound 8a [PMID: 36883854] | ||||||
| acumapimod |
|
9203 | BCT 197, BCT-197, BCT197, compound A [WO2013139809] | ||||||
| Ac-VEID-CHO | 8566 | acetyl-Val-Ile-Asp-aldehyde | |||||||
| ACY-738 | 11120 | example 73 [WO2012068109A2] | |||||||
| AD015 |
|
13835 | |||||||
| AD-5061 | 2663 | AD 5061, AD 7057, AD-7057, AD5061, AD7057 | |||||||
| AD5075 | 2701 | AD 5075, AD-5075 | |||||||
| [3H]AD5075 |
|
|
2702 | [3H]-AD5075 | |||||
| adagrasib |
|
|
10888 | compound 20 [PMID: 32250617], Krazati®, MRTX-849, MRTX849 | |||||
| adapalene |
|
5429 | Differin® | ||||||
| adavosertib |
|
7702 | AZD 1775, AZD-1775, AZD1775, MK-1775, MK1775 | ||||||
| adenophostin A | 4124 | ||||||||
| ADG-207 | 11068 | ||||||||
| ADL5747 | 9003 | ADL 5747, ADL-5747, compound 36 [PMID: 19694468] | |||||||
| ADL5859 |
|
9004 | ADL 5859, ADL-5859, compound 20 [PMID: 18788723] | ||||||
| adomeglivant | 9479 | LY-2409021, LY2409021 | |||||||
| ADPβS |
|
1755 | adenosine 5'-O-(2-thiodiphosphate), ADPbetaS | ||||||
| [35S]ADPβS |
|
|
3408 | ||||||
| adriforant |
|
8985 | PF 3893787, PF-03893787, ZPL-389, ZPL-3893787, ZPL389, ZPL3893787 | ||||||
| adrixetinib | 12375 | example 7 [US2021163448A1] | |||||||
| (+)-ADTN | 932 | (+)-ADTN (aminotetralin-6,7-diol) | |||||||
| ADU-S100 |
|
10192 | dithio-(Rp,Rp)-[cyclic[A(2',5')pA(3',5')p]], MIW815, ML RR-S2 CDA, S100 | ||||||
| ADX-47273 | 1420 | ADX 47273, ADX47273 | |||||||
| ADX71743 | 6217 | ADX 71743, ADX-71743 | |||||||
| ADX88178 |
|
6238 | ADX 88178, ADX-88178 | ||||||
| AE9C90CB | 8586 | ||||||||
| AEE788 |
|
7643 | AEE 788, NVP-AEE788 | ||||||
| 3-AESA | 13325 | 3-(2-aminoethyl)-2-hydroxybenzoic acid | |||||||
| AF353 | 4125 | AF 353, AF-353 | |||||||
| AF-906 | 9538 | compound 128 [PMID: 26686393], Ro-51 | |||||||
| afabicin | 10754 | AFN-1720, Debio 1450, Debio1450 | |||||||
| afatinib |
|
|
5667 | BIBW2992, Gilotrif® | |||||
| AFD(R) | 2937 | ||||||||
| AFDX384 | 3264 | AF-DX 384, AFDX-384 | |||||||
| [3H]AF DX-384 |
|
|
368 | [3H]AF-DX 384 | |||||
| afegostat |
|
7410 | IFM, iso-fagomine, isofagomine | ||||||
| aficamten |
|
11524 | CK-274, CK-3773274, CK3773274 | ||||||
| AFP-07 | 1962 | AFP 07, AFP07 | |||||||
| afuresertib | 7890 | GSK 2110183, GSK-2110183, GSK2110183 | |||||||
| AG-09/1 | 5833 | AG-09/1 [benzimidazole derivative], ST024252 | |||||||
| AG 1024 | 5912 | AG-1024, AG1024, tyrphostin AG 1024 | |||||||
| AG-11/03 | 5832 | AG-11/03 [benzimidazole derivative], STK220090 | |||||||
| AG 112 | 5913 | AG-112, AG112, tyrphostin A48, tyrphostin AG 112 | |||||||
| AG-122018 | 11398 | compound 18 [PMID: 25091930] | |||||||
| AG 1295 | 5914 | AG-1295, AG1295 | |||||||
| AG 1296 | 5915 | AG-1296, AG1296, tyrphostin AG-1296 | |||||||
| AG-14 | 5835 | AG 14, AG14 | |||||||
| AG14361 | 8094 | AG 14361, AG-14361 | |||||||
| AG1478 |
|
4862 | AG 1478, AG-1478, tyrphostin AG1478 | ||||||
| AG-17724 |
|
11400 | AG17724, compound 7 [PMID: 25091930] | ||||||
| AG-26 | 6268 | AG 26, AG26 | |||||||
| AG 490 | 5916 | AG-490, tyrphostin AG490, tyrphostin B42 | |||||||
| AG879 | 4863 | AG 879, AG-879, tyrphostin AG879 | |||||||
| AG 9 | 5917 | AG-9, AG9, tyrphostin 1, tyrphostin A1 | |||||||
| agatolimod |
|
9843 | CpG 7909, CpG7909, PF 3512676, PF-3512676, ProMune, VaxImmune | ||||||
| agerafenib | 7880 | AC013773, CEP 32496, CEP-32496, CEP32496, RXDX-105 | |||||||
| AGI-5198 | 9240 | ||||||||
| AGK2 | 8099 | AGK 2, AGK-2 | |||||||
| AGL 2043 | 5918 | AGL-2043, AGL2043, HMS3229A05 | |||||||
| AGN 191976 | 6071 | AGN-191976, AGN191976 | |||||||
| AGN192093 | 3387 | AGN 192093, AGN-192093 | |||||||
| AGN193109 | 2640 | AGN 193109, AGN-93109 | |||||||
| AGN193836 | 2649 | AGN 193836, AGN-193836 | |||||||
| AGN194204 | 2811 | AGN 194204, AGN-194204 | |||||||
| AGN 211334 | 5455 | AGN-211334, AGN211334 | |||||||
| agomelatine |
|
|
198 | S20098, Thymanax®, Valdoxan® | |||||
| AG-041R | 901 | AG 041R, AG041R, LS-83786 | |||||||
| AGS-499 | 13261 | ||||||||
| AGU654 |
|
13646 | AGU-654, compound 44 [PMID: 39622054] | ||||||
| AH10-7 |
|
9899 | |||||||
| AH 11110 | 8461 | AH-11110, AH11110 | |||||||
| AH13205 | 1928 | AH 13205, AH-13205 | |||||||
| AH23848 | 1949 | (-)-AH23848, (-)AH23848, AH 23848, AH-23848 | |||||||
| AH6809 |
|
1896 | AH 6809, AH-6809 | ||||||
| (S)-4-AHCP |
|
4069 | |||||||
| AHPN | 3431 | CD 437, CD437, Ro 47-2077 | |||||||
| AH23848 (racemic) | 1950 | AH 23848, AH-23848 | |||||||
| AIDA | 1376 | GNF-Pf-1401, UPF 523, UPF523 | |||||||
| AIM-1290 |
|
11823 | |||||||
| ainuovirine |
|
|
13766 | compound 10b [PMID: 20138513], GS-9441, KM-023, KM023 | |||||
| AJ2-30 |
|
13090 | compound 4 [PMID: 38191941] | ||||||
| (+)-AJ76 | 970 | ||||||||
| AK198 |
|
8637 | |||||||
| AK-2292 | 12409 | AK2292 | |||||||
| AKK(thioAc)LM21 | 8816 | ||||||||
| AKN-028 | 7969 | AKN 028, AKN028 | |||||||
| Akt inhibitor IV | 5919 | GNF-PF-254 | |||||||
| Akt inhibitor VIII |
|
5921 | isozyme-selective, Akti-1/2 | ||||||
| Akt inhibitor X |
|
5922 | 10-DEBC, NCGC00167772-01 | ||||||
| AL12180 | 3386 | 5,6-dihydro-4,5-didehydro-11-deoxy-11-oxa-16-(3-chlorophenoxy)-ω-tetranor-PGF2α, AL-12180 | |||||||
| AL-8810 | 1956 | AL 8810, AL8810 | |||||||
| AL-37350A | 160 | AL 37350A, AL37350A | |||||||
| alalevonadifloxacin | 10756 | WCK 2349, WCK-2349, WCK2349 | |||||||
| Ala(1-naph)-Pro-CN | 8607 | ||||||||
| [14C]alanine |
|
|
|
4542 | [14C]-alanine | ||||
| [3H]alanine |
|
|
|
4543 | [3H]-alanine | ||||
| albitiazolium |
|
10407 | SAR97276, SAR97276A, T3 | ||||||
| alcaftadine |
|
|
7587 | Lastacaft®, R-89674 | |||||
| alcudacigib | 14045 | example 9 [WO2021132422A1] | |||||||
| [3H]aldosterone |
|
|
|
3452 | [3H]-aldosterone | ||||
| aldumastat |
|
12778 | GLPG-1972, GLPG1972, S201086 | ||||||
| alectinib |
|
|
7739 | AF802, Alecensa®, CH5424802 | |||||
| aleglitazar |
|
7405 | R-1439, Ro-0728804 | ||||||
| alemcinal | 1444 | ABT 229, ABT-229, ABT229 | |||||||
| alendronate |
|
|
3141 | ABDP, BPH 1, Fosamax®, MK-217 | |||||
| Alexa-488-telenzepine |
|
8600 | |||||||
| alfentanil |
|
7108 | Alfenta®, R-39209, Rapifen® | ||||||
| alfuzosin |
|
7109 | SL-77499-10, SL-7749910, Uroxatral® | ||||||
| ALG-097558 | 12043 | ALG097558, compound 58 [WO2021252491A1] | |||||||
| alimemazine |
|
|
7237 | Nedeltran®, trimeprazine | |||||
| alisertib |
|
7790 | MLN-8237 | ||||||
| aliskiren |
|
|
4812 | CGP-060536B, SPP100, Tekturna® | |||||
| alixorexton | 13879 | ALKS 2680, ALKS-2680, ALKS2680, compound 2 [WO2021108628A1] | |||||||
| alizapride |
|
11141 | Limican®, Litican®, Nausilex®, Plitican®, Superan®, Vergentan® | ||||||
| alkylbenzene sulfonate | 2362 | ||||||||
| alkyl glycerol phosphate 18:1 | 6994 | AGP 18.1 | |||||||
| alkyl OMPT | 2913 | ||||||||
| allitinib | 9912 | ALL-3, AST-1306, AST1306 | |||||||
| allopurinol |
|
|
6795 | Aloprim®, BW-56-158, BW-56158, Zyloprim® | |||||
| allosteric modulator 33 [PMID: 35878399] |
|
12071 | compound 33 [PMID: 35878399] | ||||||
| alloswitch-1 |
|
8543 | trans-alloswitch-1 | ||||||
| alloxazine | 456 | alloxazin, isoalloxazine | |||||||
| all-trans-4-oxo-retinoic acid | 2741 | 4-oxoretinoic acid, Ro 12-4824 | |||||||
| 1-allyl-2-[3-(isopropylamino)propoxy]-9H-carbazole | 3136 | ||||||||
| 1-allyl-2-[3-(isopropylamino)propoxy]-9H-xanthen-9-one | 3135 | ||||||||
| allyl isothiocyanate |
|
2420 | AITC | ||||||
| almorexant | 2886 | ACT-078573 | |||||||
| [3H]-almorexant |
|
|
9465 | ||||||
| almotriptan |
|
7110 | Almogran®, Axert®, LAS-31416, PNU-180638E | ||||||
| alniditan | 120 | R-91274 | |||||||
| [3H]alniditan |
|
|
117 | R-91274 | |||||
| alnodesertib | 13731 | ART-0380, ART0380, compound 6 [PMID: 39630604], example 39b [WO2019014618A1] | |||||||
| alofanib | 11622 | RPT-835, RPT835 | |||||||
| alogliptin |
|
|
6319 | Nesina®, SYR-322, Vipidia® | |||||
| aloisine | 5923 | IN1538, RP106 | |||||||
| aloisine A | 5924 | RP107 | |||||||
| alosetron |
|
|
2296 | GR68755, Lotronex® | |||||
| aloxistatin | 10714 | compound 2b [PMID: 8765519], E-64d, E64d, EP453, loxistatin | |||||||
| alpelisib |
|
|
7955 | BYL 719, BYL-719, NVP-BYL719, Piqray®, Vijoice® | |||||
| 3 alpha-aminocholestane |
|
9564 | 3AC, 3 α-aminocholestane | ||||||
| alpha-D-pentagalloylglucose | 11820 | α-PGG, αPGG, 1,2,3,4,6-penta-O-galloyl-a-D-glucopyranose, aPGG | |||||||
| alpha-ketothiazole analogue 36 | 6549 | ||||||||
| alpha-methyltyrosine |
|
6956 | Demser®, metyrosine, MK-781 | ||||||
| alphaxalone |
|
5461 | 5α-alphaxalone, alfadione, alfaxalone, GR 2/234 | ||||||
| alpibectir | 12957 | BVL-GSK098 | |||||||
| alprazolam |
|
|
7111 | Niravam®, U-31889, Xanax® | |||||
| alprenolol |
|
563 | Atenenol® | ||||||
| ALRT 1550 |
|
2740 | |||||||
| alsterpaullone |
|
5925 | 9-nitropaullone, NSC-705701 | ||||||
| alsterpaullone 2-cyanoethyl | 5926 | alsterpaullone derivative7 | |||||||
| [18F]altanserin |
|
|
3242 | [18F]altanserin (PET ligand) | |||||
| altiratinib |
|
|
9174 | DCC-270, DCC-2701, DP-5164 | |||||
| altretamine |
|
7112 | Hexalen® | ||||||
| alvelestat |
|
6476 | AZD 9668, AZD-9668, AZD9668, KB-105160 | ||||||
| alverine |
|
14185 | Meteospasmyl®, phenopropamine, Profenil® | ||||||
| alvespimycin |
|
9828 | 17-DMAG | ||||||
| alvimopan |
|
|
7471 | ADL 8-2698, Entereg® | |||||
| alvocidib |
|
5680 | flavopiridol, HL 275, HMR 1275, L 86-8275, L 868275, MDL-107826A, NSC-649890 | ||||||
| ALX 1393 | 4622 | ALX-1393, ALX1393, O-[2-benzyloxyphenyl-3-flurophenyl]methyl-L-serine | |||||||
| ALX 1405 | 4767 | ALX-1405, ALX1405 | |||||||
| AM-0883 |
|
12528 | |||||||
| AM-0902 | 10276 | AM0902, compound 27 [PMID: 26942860] | |||||||
| AM095 | 6988 | AM 095, AM-095 | |||||||
| AM10257 | 10177 | AM-10257 | |||||||
| AM11542 |
|
9612 | |||||||
| AM12 | 10292 | 3,5,7-trihydroxy-2-(2-bromophenyl)-4H-chromen-4-one, AM-12 | |||||||
| AM1241 | 3316 | AM 1241, AM-1241 | |||||||
| AM-1473 | 12532 | AM1473 | |||||||
| AM1476 | 13189 | ||||||||
| AM1710 | 10202 | AM-1710, analog 4b [PMID: 18038967] | |||||||
| AM2201 | 9705 | AM-2201 | |||||||
| AM237 | 10421 | Example 319 [WO2014143799] | |||||||
| AM251 |
|
3317 | AM 251, AM-251 | ||||||
| AM281 | 741 | AM 281, AM-281 | |||||||
| AM-37 | 11262 | ||||||||
| AM404 | 12556 | AM-404, N-arachidonoylaminophenol | |||||||
| AM-461 |
|
10170 | AM461, Compound 1 [WO2011085033] | ||||||
| AM-630 | 750 | 6-iodopravadoline, AM 630, AM630 | |||||||
| AM-6494 |
|
10520 | compound 20 [PMID: 31589043] | ||||||
| AM6538 |
|
9338 | 4-(4-(1-(2,4-dichlorophenyl)-4-methyl-3-(piperidin-1-ylcarbamoyl)-1 H-pyrazol-5- yl)phenyl)but-3-ynyl nitrate, compound 10 [WO2010104488], Example 2 [WO2010104488] | ||||||
| AM6545 | 10029 | AM 6545, AM-6545 | |||||||
| AM7 |
|
8292 | AM 7, AM-7, pyrimidone, 22 | ||||||
| AM7499 | 9257 | compound 3b [PMID: 27367336] | |||||||
| AM841 |
|
9613 | AM-841 | ||||||
| AM966 | 2905 | AM 966, AM-966 | |||||||
| [123I]AM251 |
|
|
744 | ||||||
| AMA | 5134 | S-(5'-deoxy-5'-adenosyl)-methylthioethyl-hydroxylamine | |||||||
| amantadine |
|
4128 | ADS-5102, Gocovri®, Symadine®, Symmetrel® | ||||||
| 4-AMBA |
|
4702 | |||||||
| ambrisentan |
|
|
3951 | Letairis® | |||||
| ambroxol |
|
10692 | |||||||
| amcasertib | 9924 | BBI-503, BBI503 | |||||||
| amcenestrant |
|
10566 | compound 43d [PMID: 31721572], SAR-439859, SAR439859 | ||||||
| amcinonide |
|
|
7060 | CL-34699, Cyclocort® | |||||
| amdizalisib | 11699 | compound 28 [PMID: 30582813], compound 4 [WO2016045591A1] | |||||||
| amelenodor |
|
13384 | example 2 [WO2020010132A1], NX-13, NX13 | ||||||
| amelubant |
|
8463 | BIIL 284, BIIL-284 | ||||||
| amesergide | 199 | LY-237733, LY237733 | |||||||
| amfenac |
|
7565 | AHR-5850D, Fenazox® (Japan) | ||||||
| amg-1 |
|
8227 | |||||||
| AMG28 |
|
12186 | example 240 [WO2009158011A1], inhibitor 3 [PMID: 33944571] | ||||||
| AMG319 |
|
|
8917 | AMG 319, AMG-319 | |||||
| AMG-337 |
|
8913 | AMG 337, compound 24 [PMID: 19819693] | ||||||
| AMG-35 | 14140 | AMG35, Amgen Compound 35 | |||||||
| AMG410 | 14131 | AMG 410, AMG-410, example 99 [WO2024107686] | |||||||
| AMG487 |
|
13071 | AMG 487, AMG-487, compound 47 [PMID: 17448658] | ||||||
| AMG517 | 4129 | AMG 517, AMG-517 | |||||||
| AMG628 | 4130 | AMG 628, AMG-628 | |||||||
| AMG650 | 11949 | AMG 650, AMG-650, example 11-52 [US20200239441A1] | |||||||
| AMG7703 |
|
5803 | AMG 7703, AMG-7703, CFMB, phenylacetamide 1 [PMID: 18818303] | ||||||
| AMG-7905 | 12756 | AMG7905 | |||||||
| AMG-837 | 6485 | AMG 837, AMG837 | |||||||
| AMG-8718 |
|
9639 | |||||||
| AMG-900 | 8060 | AMG 900, AMG900 | |||||||
| AMG 9810 | 6347 | AMG-9810, AMG9810 | |||||||
| AMI-1 | 7028 | AMI 1, AMI1 | |||||||
| amibegron | 568 | SR 58611, SR-58,611A, SR-58611A, SR58611A | |||||||
| amidephrine | 514 | ||||||||
| amifampridine |
|
|
8032 | 3,4-DAP, 3,4-diaminopyridine, Firdapse®, Ruzurgi®, Zenas® | |||||
| amifloxacin | 10758 | compound 7 [PMID: 2834557], WIN 49, 375, WIN 49,375-3, WIN-49375, WIN49375 | |||||||
| amikacin |
|
|
10894 | Amikin®, AMK, Arikayce liposomal®, BB-K8 | |||||
| amiloride |
|
|
2421 | amiloride HCl, Midamor® | |||||
| aminobenzovesamicol | 4768 | compound 11 [PMID: :7702637], M-iodobenzyltrozamicol | |||||||
| 2(S)-amino-6-boronohexanoic acid | 5107 | ABH | |||||||
| 6-aminocaproic acid |
|
|
6574 | ε-aminocaproic acid, Amicar®, EACA | |||||
| aminoethoxyvinylglycine | 8860 | AVG, aviglycine | |||||||
| aminoglutethimide |
|
7054 | Cytadren® | ||||||
| 2-amino-4-methylpyridine |
|
5111 | |||||||
| aminopurvalanol A | 5927 | NG-97 | |||||||
| aminopyridine 2 |
|
10051 | |||||||
| 5-aminosalicylate | 4655 | 5-ASA | |||||||
| 2-amino-3-sulfinopropanoic acid | 4695 | 3-sulfinoalanine, cysteine sulfinate | |||||||
| 2-amino-uridine-5'-monophosphate |
|
6201 | compound 13g [PMID: 21417463], iso-CMP | ||||||
| amiodarone |
|
|
2566 | amiodarone hydrochloride, Cordarone® | |||||
| amiselimod |
|
9319 | Example 1 [US20090137530], MT-1303, MT1303 | ||||||
| amiselimod phosphate |
|
9491 | amiselimod-P, MT-1303-P | ||||||
| amisulpride |
|
963 | (±)-amisulpride, Barhemsys® | ||||||
| amitriptyline |
|
|
200 | amitryptiline, Elavil®, Endep® | |||||
| amlexanox |
|
|
|
7113 | AA-673, Amlexanox®, Aphthasol®, CHX-3673 | ||||
| amlodipine |
|
6981 | amlodipine besylate, amlodipine maleate, Copalia® (amlodipine + valsartan), Katerzia® (amlodipine oral suspension, 1 mg/mL), Norvasc®, UK-4834011 | ||||||
| ammonium carbonate | 4509 | ||||||||
| AMMTC | 3385 | ||||||||
| AMN082 | 1441 | AMN 082, AMN-082 | |||||||
| amodiaquine |
|
|
|
10018 | Alphaquine®, Amdaquine®, Amoquin®, Camoquin®, Flavoquine® | ||||
| amorolfine |
|
14013 | Curanail®, Loceryl® | ||||||
| amoxapine |
|
201 | amoxipine, Asendin® | ||||||
| amoxicillin |
|
10895 | Amoxil®, BRL-2333, co-amoxiclav (amoxicillin + clavulanic acid), Moxatag®, NSC-277174, Trimox® | ||||||
| AMPA | 4131 | ||||||||
| [3H]AMPA |
|
|
4077 | ||||||
| amphetamine |
|
4804 | (±)-amphetamine, Amphetamine Sulfate®, DL-amphetamine | ||||||
| ampicillin |
|
|
10896 | aminobenzylpenicillin, KS-R1, Penbritin®, Polycillin, Principen® | |||||
| AMP-PNP |
|
2456 | |||||||
| amprenavir |
|
|
12681 | Agenerase®, AMV, Prozei®, VX-478, VX478 | |||||
| amredobresib |
|
11866 | example III-13 [US9266891B2] | ||||||
| AMTB |
|
4132 | |||||||
| amthamine |
|
4025 | |||||||
| amuvatinib | 7932 | MP 470, MP-470, MP470 | |||||||
| AN0128 | 10983 | AN 0128, AN-0128, compound 2g [PMID: 16997550] | |||||||
| AN13762 |
|
10085 | AN762 | ||||||
| AN3661 |
|
10084 | |||||||
| anacetrapib | 8400 | MK-0859 | |||||||
| anagliptin |
|
|
11582 | compound 4a [PMID: 22019046], CWP-403, SK-0403, SK0403, Suiny® | |||||
| anagrelide |
|
|
7114 | Agrylin®, BL-4162a, Xagrid® | |||||
| analog 18 [PMID: 28696697] |
|
11567 | |||||||
| analog 3 [Vlattas et al., 1996] | 7994 | ||||||||
| anamorelin |
|
|
14127 | ONO-7643, RC-1291 | |||||
| anastrozole |
|
5137 | Arimidex® | ||||||
| anatibant | 679 | LF 16-0687, LF160687 | |||||||
| ANAVEX 3-71 | 13166 | AF710B | |||||||
| ancremonam | 13161 | BOS-228, LYS228 | |||||||
| ancriviroc |
|
804 | SCH 351125, SCH-351125, SCH-C | ||||||
| [3H]ancriviroc |
|
|
802 | [3H]SCH 351125, [3H]Sch-351125 | |||||
| andamertinib | 13732 | compound 206 [WO2018228446A1], PLB-1004, PLB1004 | |||||||
| andarine |
|
7849 | GTX-007, GTX007 | ||||||
| andrographolide |
|
9675 | |||||||
| androstanol | 2760 | 5α-androstan-3α-ol | |||||||
| 4,9-anhydro-tetrodotoxin | 5730 | 4,9-ah-TTX, 4,9-anhydro-TTX | |||||||
| Ani9 | 11276 | ||||||||
| anileridine |
|
7115 | Leritine® | ||||||
| aniracetam |
|
|
4133 | ||||||
| anisindione |
|
6960 | Miradon® | ||||||
| anizatrectinib | 12087 | BLN64892, hTrkA-IN-1 | |||||||
| ANP-230 | 14014 | DSP-2230 | |||||||
| ansornitinib | 12086 | ANG-3070, ANG3070, Example 1 [WO2013112959A1] | |||||||
| ANT3310 | 12795 | ||||||||
| antalarmin | 3489 | ||||||||
| ANTAQ | 8671 | compound 5 | |||||||
| ANTA XV |
|
10334 | |||||||
| antazoline |
|
7116 | |||||||
| 9-anthroic acid | 4113 | 9-AC, anthracene-10-carboxylic acid | |||||||
| anti-BrP-LPA | 6987 | ||||||||
| ANXA3 degrader 18a5 | 13778 | compound 18a5 [PMID: 40013713] | |||||||
| ANXA3 degrader (R)-SL18 | 13779 | (+)-SL18 | |||||||
| AO/854 | 13024 | AO/854/43447428, o-Cresolphthalein | |||||||
| A1P | 8806 | compound 10 [PMID: 20441173] | |||||||
| AP1189 | 11292 | AP-1189, example 19 [WO2007141343A1] | |||||||
| AP14145 | 13990 | AP-14145 | |||||||
| AP18 | 4134 | AP 18, AP-18 | |||||||
| AP30663 | 14034 | AP-30663 | |||||||
| [3H]AP4 |
|
|
|
1412 | |||||
| Ap3a |
|
5454 | diadenosine triphosphate | ||||||
| Ap5a | 5453 | diadenosine pentaphosphate | |||||||
| APA |
|
5139 | 1-aminooxy-3-aminopropane | ||||||
| apabetalone |
|
7034 | QC-216, RVX 208, RVX-000222, RVX-208 | ||||||
| apadenoson | 3290 | ATL-146e, BMS-068645 | |||||||
| apafant |
|
1860 | WEB 2086 BS, WEB-2086 | ||||||
| [3H]apafant |
|
|
1859 | [3H]WEB 2086 | |||||
| apalcillin | 10759 | PC-904, PC904, WY-44,417, WY-44417 | |||||||
| apalutamide |
|
9043 | ARN-509, ARN509, Erleada®, JNJ-56021927 | ||||||
| apararenone | 12039 | compound 39 [PMID: 35652647], MT-3995, MT3995 | |||||||
| 2-APB |
|
2433 | 2-aminoethoxydiphenyl borate, 2-aminoethoxydiphenylborane | ||||||
| APC148 | 13418 | ZN148 | |||||||
| APD668 |
|
12151 | APD-668, compound 3k [PMID: 21444206], compound A129 [WO2005007658A2], JNJ-28630368, JNJ28630368 | ||||||
| APG-1252-M1 | 13070 | APG-1244, BM-1244 | |||||||
| API-32 | 13697 | ||||||||
| apilimod |
|
9859 | LAM-002A (apilimod dimesylate), LAM002A, STA 5326, STA-5326, STA5326 | ||||||
| apitolisib |
|
7888 | GDC-0980, GDC0980, RG-7422, RG7422 | ||||||
| apixaban |
|
|
6390 | BMS-562247, Eliquis® | |||||
| APL-2301 | 13957 | ASN-1733, MET-102 | |||||||
| aplaviroc | 805 | AK-602, GW 873140, GW873140A | |||||||
| 3-APMPA |
|
1080 | CGP 35024, CGP35024, SK&F 97541, SKF 97541, SKF-97,541 | ||||||
| APNEA | 417 | N6-2-(4-aminophenyl)ethyladenosine | |||||||
| [125I]APNEA |
|
|
462 | [3H]N6-2-(4-aminophenyl)ethyladenosine | |||||
| apomorphine |
|
|
33 | Apokyn®, Ixense®, Kynmobi® (sublingual film), Onapgo® (apomorphine hydrochloride for continuous subcutaneous release), Uprima® | |||||
| 3-APPA | 1081 | 3-aminopropanephosphinic acid, APPA, CGP-27492 | |||||||
| 4-APPES | 6258 | ||||||||
| APR19 | 8662 | ||||||||
| apraclonidine |
|
7117 | AL-02145, Iopidine®, para-amino clonidine | ||||||
| apratastat |
|
6482 | compound 5h [PMID: 16426848], TMI-05, TMI005 | ||||||
| apremilast |
|
|
|
7372 | CC-10004, Otezla® | ||||
| aprepitant |
|
|
3490 | Aponvie®, Emend® | |||||
| apricitabine | 12677 | AVX-754, AVX754, BCH 10618, BCH10618, SPD-754, SPD754 | |||||||
| aprocitentan |
|
10070 | ACT-132577, ACT132577, Tryvio® | ||||||
| APS03118 | 14205 | APS-03118, compound 5 [PMID: 40920215] | |||||||
| apstatin | 8803 | ||||||||
| APV206690A | 12538 | example 2 [WO2008024364A2] | |||||||
| APV207010A | 12539 | example 3 [WO2008024364A2] | |||||||
| APV207094A | 12540 | example 1 [WO2008024364A2] | |||||||
| APV207095A | 12541 | ||||||||
| AQ-13 |
|
10391 | Ro 47-0543 | ||||||
| AQ-RA 741 | 8584 | ||||||||
| AQW051 | 7371 | AQW-051, VQW 765, VQW-765, VQW765 | |||||||
| AR231453 |
|
5653 | AR 231453, AR-231,453, AR-231453 | ||||||
| AR234958 | 11279 | ||||||||
| AR234960 | 7039 | AR 234960, AR-234960 | |||||||
| AR244555 | 7042 | AR 244555, AR-244555 | |||||||
| AR291903 | 11280 | ||||||||
| AR-67 | 8919 | AR67, compound 14 [PMID:11052802], DB-67, DB67, silatecan | |||||||
| AR-9281 |
|
13112 | AR9281, compound 14a [PMID: 21211973] | ||||||
| arachidonyl-2-chloroethylamide | 738 | ACEA | |||||||
| arachidonylcyclopropylamide | 739 | ACPA, arachidonyl cyclopropylamide | |||||||
| arachidonyl trifluoromethyl ketone | 5142 | ATFMK, arachidonoyltrifluoromethylketone, arachidonyltrifluoromethyl ketone | |||||||
| aranidipine |
|
11744 | MPC-1304, MPC1304, Sapresta® | ||||||
| arbekacin |
|
|
7345 | arbekacin sulfate, habekacin, ME1100, NPC-14 | |||||
| AR-C126313 | 1738 | compound 52 [PMID: 18600475], compound 71a [PMID: 15078212] | |||||||
| ARC-239 | 524 | AR-C239, ARC239 | |||||||
| AR-C67085 | 1756 | AR-C67085MX, ARC-67085, ARC67085, PSB-0413 | |||||||
| AR-C118925XX | 5907 | AR-C118925 | |||||||
| ARD-1676 | 13248 | ARD1676, compound 39 [PMID: 37683104] | |||||||
| ARD-2585 |
|
11755 | ARD2585, compound 43 [PMID: 34473519] | ||||||
| ARD-266 | 10579 | compound 11 [PMID: 31804827] | |||||||
| ARD-69 | 10182 | ARD69, compound 34 [PMID: 30629437] | |||||||
| arecaidine | 9487 | methylguvacine, N-methylguvacine | |||||||
| arecaidine propargyl ester | 295 | ||||||||
| arformoterol |
|
|
|
7479 | (-)-Formoterol, (R,R)-Formoterol, Brovana®, YM-08316 | ||||
| argatroban |
|
6385 | DK-7419, GN-1600, Gn1600, MCI-9038, MD-805 | ||||||
| AR-H067637 | 7688 | ||||||||
| ARI-3099 | 8563 | compound 226 [PMID: 24997602], compound 6 [PMID: 23594271], Py(D)AlaboroPro | |||||||
| ARI-3531 | 8564 | compound 22 [PMID: 23594271] | |||||||
| arimoclomol |
|
8271 | BRX-220, BRX220, Miplyffa® | ||||||
| aripiprazole |
|
|
34 | Abilify®, Aripiprex®, Aristada® (aripiprazole lauroxil), OPC 14597, OPC-14597 | |||||
| aristolochic acid |
|
12438 | |||||||
| arketamine |
|
9153 | (S) Ketamine | ||||||
| ARL66096 | 3384 | 2-propylthio-βγ-difluoromethylene ATP, ARL 66096, FPL66096 | |||||||
| ARL 67156 |
|
9030 | 6-N,N-diethyl-beta,gamma-dibromomethylene-D-ATP, ARL-67156, FPL 67156, FPL-67156 | ||||||
| AR-M1000390 | 9005 | AR-M390, ARM-390 | |||||||
| ARN19702 |
|
|
10120 | ARN-19702, compound 8 [PMID: 27404798] | |||||
| ARN19874 | 11055 | CS-0078339, HY-118994 | |||||||
| ARN-3236 | 9581 | example 86 [WO2014093383] | |||||||
| ARN726 |
|
9178 | ARN-726, compound 6 [PMID: 25874594] | ||||||
| (R)-ARN2508 |
|
9000 | compound (-)-10r [PMID: 26774927], example 19 [WO2014023643] | ||||||
| (S)-ARN2508 |
|
|
8999 | compound (+)-10r [PMID: 26774927], example 20 [WO2014023643] | |||||
| ARP100 |
|
5140 | ARP 100, ARP-100 | ||||||
| arpromidine |
|
1221 | ARP | ||||||
| ARRY-371797 |
|
11095 | ARRY-797, ARRY371797, ARRY797, compound 7 [PMID: 19950901] | ||||||
| ARRY-382 |
|
9108 | ARRY 382, ARRY382, c-Fms-IN-12, PF-07265804, PF07265804 | ||||||
| ARRY-502 |
|
10179 | ARRY502, example 237, enantiomer 1 [WO2009158426A1] | ||||||
| ARS-1620 |
|
10383 | ARS1620, example 227 [US9840516B2] | ||||||
| ART558 |
|
12657 | ART-558, compound 22 [PMID: 36200480] | ||||||
| ART812 | 12658 | ART-812, compound 43 [PMID: 36200480] | |||||||
| artefenomel |
|
9971 | OZ439 | ||||||
| arteflene |
|
10397 | Ro 42-1611 | ||||||
| artemether |
|
|
|
9955 | β-artemether, beta-artemether, Coartem® (artemether + lumefantrine) | ||||
| artemotil |
|
9958 | β-arteether | ||||||
| artesunate |
|
|
|
9956 | |||||
| ARV-766 | 12624 | ARV766 | |||||||
| ARV-771 | 10564 | ARV771 | |||||||
| arvanil | 2485 | N-vanillylarachidonamide | |||||||
| 1-arylmethylpyrrolidin-2-yl ethanol amine | 711 | compound 26a [PMID: 16216508] | |||||||
| 4-arylphthalazin-1(2H)-3,4-Di-F | 7753 | ||||||||
| AS100 | 381 | AS 100, AS-100 | |||||||
| AS101 |
|
437 | ammonium tri-chloro(dioxoethylene-O,O'-)tellurate, AS 101, AS-101 | ||||||
| AS1269574 | 4027 | AS 1269574, AS-1269574 | |||||||
| AS1535907 | 5722 | AS 1535907, AS-1535907 | |||||||
| AS16 | 438 | AS 16, AS-16 | |||||||
| AS-19 | 8433 | AS 19, AS19 | |||||||
| AS1907417 | 5723 | AS 1907417, AS-1907417 | |||||||
| AS1949490 | 8878 | AS 1949490, AS-1949490 | |||||||
| AS-252424 |
|
10578 | AS252424, compound 26 [PMID: 16789742] | ||||||
| AS2717638 | 10230 | ||||||||
| AS3334034 | 11075 | ||||||||
| AS408 |
|
11074 | |||||||
| AS604872 | 3424 | AS 604872, AS-604872 | |||||||
| AS70 | 382 | AS 70, AS-70 | |||||||
| AS74 | 439 | AS 74, AS-74 | |||||||
| AS94 | 440 | AS 94, AS-94 | |||||||
| AS95 | 441 | AS 95, AS-95 | |||||||
| AS96 | 442 | AS 96, AS-96 | |||||||
| AS99 | 383 | AS 99, AS-99 | |||||||
| (R)-AS-1 | 12135 | (R)-7 | |||||||
| asandeutertinib | 13201 | Embodiment 3A [US10414756] | |||||||
| ASAP-0017445 | 13895 | AS-0017445, example 1 [WO2025125695] | |||||||
| asapiprant |
|
11951 | BGE-175, BGE175, example II-74 [US8153793B2], S-555739 | ||||||
| asciminib |
|
|
8962 | ABL-001, ABL001, compound 1 [PMID: 30137981], Example 9, Scemblix® | |||||
| [14C]ascorbic acid |
|
|
|
4532 | [14C]-ascorbic acid | ||||
| asenapine |
|
22 | ORG-5222, ORG5222, Saphris®, Secuado® (transdermal asenapine), Sycrest® | ||||||
| asengeprast | 13202 | example 27 [WO2018144620], FT-011, FT011, SHP-627 | |||||||
| asimadoline |
|
9279 | EMD 61 753, EMD 61753, EMD-61753 | ||||||
| asivatrep |
|
9621 | Example 230 [US7858621], PAC-14028 | ||||||
| ASN02563583 | 5517 | ASN 02563583, ASN-02563583 | |||||||
| ASN04421891 | 5518 | ASN 04421891, ASN-04421891 | |||||||
| ASN04450772 | 5519 | ASN 04450772, ASN-04450772 | |||||||
| ASN04885796 | 5520 | ASN 04885796, ASN-04885796 | |||||||
| ASN06917370 | 5524 | ASN 06917370, ASN-06917370 | |||||||
| asnuciclib | 12074 | CDKI-73, compound 12e [PMID: 23301767], LS-007 | |||||||
| asoprisnil |
|
2883 | J-867, J867 | ||||||
| ASP-0819 | 12646 | ASP0819, Example 10 [WO2014196644A1] | |||||||
| ASP2453 | 11839 | ||||||||
| ASP2535 | 11296 | ASP 2535, ASP-2535 | |||||||
| ASP-3026 |
|
7740 | ASP 3026, ASP3026 | ||||||
| ASP4058 |
|
9569 | ASP-4058 | ||||||
| ASP5878 | 11934 | ASP-5878, compound 27 [PMID: 35219181] | |||||||
| ASP7663 | 10274 | ASP 7663, ASP-7663 | |||||||
| ASP8477 | 10248 | ||||||||
| aspirin |
|
|
|
4139 | Acetophen®, acetylsalicylic acid, Aspirin® | ||||
| aspoxicillin |
|
12293 | Doyle®, TA-058 | ||||||
| ASS234 | 7369 | ||||||||
| AST-487 | 5661 | AST 487, NVP-AST 487, NVP-AST487 | |||||||
| astemizole |
|
|
2603 | Hismanal® | |||||
| asunaprevir |
|
|
10882 | BMS-650032, BMS650032, compound 24 [PMID: 24564672], Sunvepra™ | |||||
| asundexian |
|
11710 | BAY 2433334, BAY2433334, example 235 [WO2017005725A1] | ||||||
| AT-076 | 8870 | ||||||||
| AT-121 | 14128 | AT121, compound 5 [PMID: 30158150] | |||||||
| AT38 |
|
9020 | [3-(aminocarbonyl)furoxan-4-yl]methyl salicylate | ||||||
| AT-403 | 9747 | ||||||||
| AT-56 | 10261 | AT56 | |||||||
| AT-7519 |
|
5662 | AT 7519, AT7519 | ||||||
| AT-9283 | 7949 | AT 9283, AT9283 | |||||||
| atabecestat |
|
9963 | JNJ-54861911, JNJ-54861911-AAA, RSC-385896 | ||||||
| ataciguat | 5141 | ||||||||
| ataluren |
|
|
7341 | PTC124 | |||||
| atamparib |
|
13118 | RBN-2397, RBN2397 | ||||||
| atazanavir |
|
|
11138 | ATV, BMS-232632, CGP 73547, latazanavir, Reyataz®, zrivada | |||||
| ATC0065 | 1304 | ATC 0065, ATC-0065 | |||||||
| ATC0175 | 1305 | ATC 0175, ATC-0175 | |||||||
| atebimetinib | 13733 | compound 9 [US20230119327A1] | |||||||
| atecegatran metoxil | 7682 | atecegatran fexenetil, AZD 0837, AZD-0837, AZD0837 | |||||||
| atenolol |
|
548 | Myocord®, Normiten®, Tenormin® | ||||||
| ATF936 | 9475 | ATF-936, compound 10a [PMID: 20158186] | |||||||
| atglistatin | 12995 | compound 4 [PMID: 24096302] | |||||||
| ATI-50001 |
|
12317 | ATI-501, ATI50001, ATI501, example 103 [WO2007070872A1] | ||||||
| aticaprant | 9194 | CERC-501, CERC501, JNJ-67953964, JNJ67953964, LY-2456302, LY2456302 | |||||||
| atipamezole | 12576 | MPV-1248 | |||||||
| atirmociclib |
|
13485 | example A94 (US20200354350), PF-07220060, PF07220060 | ||||||
| ATL802 | 5616 | ||||||||
| ATLa2 | 3383 | ATL analog [15-epi-16-(para-fluoro)-phenoxy-LXA4] | |||||||
| ATM/ATR kinase inhibitor | 5929 | CGK733 | |||||||
| atogepant |
|
9730 | AGN-241689, Aquipta®, example 4 [US20120122911], MK-8031, Qulipta® | ||||||
| atomoxetine |
|
|
7118 | LY-139603, Strattera® | |||||
| atopaxar | 4048 | E 5555, E5555, ER 172594-00 | |||||||
| atorvastatin |
|
|
2949 | Lipitor® | |||||
| atorvastatin lactone | 2957 | ||||||||
| atovaquone |
|
|
|
9695 | 566C80, Mepron®, Wellvone® | ||||
| atoxifent | 13395 | compound 2 [PMID: 38810170] | |||||||
| ATPA | 4140 | ||||||||
| ATPO | 4141 | ||||||||
| ATPγS | 1714 | adenosine 5'-(3-thio)triphosphate, ATPgammaS | |||||||
| [35S]ATPγS |
|
|
5406 | [35S]-ATPgammaS | |||||
| atracurium |
|
|
9537 | atracurium besilate, atracurium dibesylate, BW 33A, Tracrium® | |||||
| atrasentan |
|
3487 | A-127722, A-147627, ABT-627 | ||||||
| atuveciclib | 11687 | BAY 1143572, BAY-1143572, BAY1143572 | |||||||
| atuzabrutinib | 11666 | compound 11 [PMID: 35302767], PRN-473, PRN473, SAR-444727, SAR444727 | |||||||
| aumolertinib |
|
11136 | almonertinib, Ameile, Egfr T790M inhibitor HS-10296, example 26 [WO2016054987A1], HS10296 | ||||||
| auranofin |
|
|
6306 | MMV688978, Ridaura®, SK&F-39162, SK-39162 | |||||
| auriclosene | 13417 | NVC-422 | |||||||
| aurora kinase inhibitor II | 5930 | quinazoline deriv. 1 | |||||||
| aurora kinase inhibitor III |
|
5931 | 2np8 | ||||||
| AUY954 | 2925 | AUY 954 | |||||||
| avacopan |
|
|
|
9450 | CCX-168, CCX168, Tavneos® | ||||
| avadomide |
|
10522 | CC-122, CC122, Compound A [WO2014039960A1] | ||||||
| avagacestat |
|
6489 | BMS-708163 | ||||||
| avanafil |
|
|
7448 | Spedra®, Stendra®, TA-1790 | |||||
| avapritinib |
|
|
|
10368 | Ayvakit®, Ayvakyt®, BLU-285, BLU285 | ||||
| avatrombopag |
|
9953 | AKR-501, Doptelet®, E5501, YM477 | ||||||
| AVE 0991 |
|
5579 | AVE-0991, AVE0991 | ||||||
| AVE1231 | 11206 | A-293, A293, AVE-1231 | |||||||
| avibactam |
|
|
10761 | AVI, Emblaveo® (aztreonam and avibactam), NXL 104, NXL-104, NXL104 | |||||
| avibactam tomilopil | 12949 | ARX-1796, AV-006, PF-07338233 | |||||||
| avitriptan | 10446 | BMS-180,048, BMS-180048, BMS180048 | |||||||
| avoralstat |
|
11584 | BCX-4161, BCX4161 | ||||||
| avosentan | 8260 | Ro 67-0565, SPP-301 | |||||||
| avutometinib |
|
|
11867 | Avmapki Fakzynja (avutometinib + defactinib co-pack), CH-5126766, CH5126766, compound 1 [PMID: 24900832], RG-7304, RO-5126766, RO5126766, VS-6766 | |||||
| AX-024 |
|
11253 | AX-24, AX024 | ||||||
| AX15836 | 11980 | AX-15836, compound A10 [PMID: 27679845] | |||||||
| axitinib |
|
|
5659 | AG 013736, AG-013736, AG013736, Inlyta® | |||||
| AXT914 | 10696 | AXT-914, PD127836 | |||||||
| AZ1 |
|
13348 | |||||||
| AZ10417808 | 5143 | AZ 10417808, AZ-10417808 | |||||||
| AZ10606120 | 9021 | AZ 10606120, AZ-10606120, compound 43 [PMID: 19191585], compound-17 [PMID: 18071294] | |||||||
| AZ11645373 | 4142 | AZ 11645373, AZ-11645373 | |||||||
| AZ12216052 | 6216 | AZ 12216052, AZ-12216052 | |||||||
| AZ12260493 | 7725 | AZ 12260493, AZ-12260493 | |||||||
| AZ12419304 | 7734 | AZ 12419304, AZ-12419304 | |||||||
| AZ12971554 | 7727 | AZ 12971554, AZ-12971554 | |||||||
| AZ13102909 |
|
9577 | AZ909 | ||||||
| AZ13483342 | 7735 | AZ 13483342, AZ-13483342 | |||||||
| AZ1366 | 10676 | AZ-1366, compound 9 [PMID: 25815142] | |||||||
| AZ13824374 |
|
11939 | AZ-13824374, compound 5 [ PMID: 35133824] | ||||||
| AZ14117230 | 11784 | AZ-14117230, compound 2 [PMID: 31786184], EED PROTAC 1 | |||||||
| AZ191 |
|
9268 | AZ-191, Compound 19 [PMID25738750] | ||||||
| AZ2 |
|
|
10233 | ||||||
| AZ20 |
|
8477 | AZ 20, AZ-20, compound 6 [PMID: 46244454] | ||||||
| AZ2158 | 14148 | AZ-2158 | |||||||
| AZ2429 | 12490 | ||||||||
| AZ3146 |
|
9400 | |||||||
| AZ3246 |
|
|
13722 | AZ-3246, compound 24 [PMID: 39928839] | |||||
| AZ3451 |
|
|
9560 | ||||||
| AZ3971 | 7804 | AZ 3971, AZ-3971 | |||||||
| AZ-4217 |
|
6939 | AZ 4217, AZ4217 | ||||||
| AZ4800 | 7805 | AZ 4800, AZ-4800 | |||||||
| AZ505 |
|
7021 | AZ 505, AZ-505 | ||||||
| AZ5104 |
|
11580 | AZ-5104 | ||||||
| AZ6102 | 11779 | AZ-6102, compound 25 [PMID: 25815142] | |||||||
| AZ628 |
|
8475 | AZ 628, AZ-628 | ||||||
| AZ7188 |
|
9586 | |||||||
| AZ8838 |
|
|
9585 | ||||||
| AZ960 | 8476 | AZ 960, AZ-960 | |||||||
| [11C]AZ10419369 |
|
|
3926 | [11C]AZ10419369 (PET ligand) | |||||
| [3H]AZ11637326 |
|
|
3971 | ||||||
| [3H]AZ12464237 |
|
|
14167 | [3H]AZ12464237 | |||||
| azacitidine |
|
|
|
6796 | 5-AZAC, 5-azacytidine, ladakamycin, Onureg®, Onureg® (CC-486; oral azacitidine), U-18496, Vidaza® | ||||
| 3-azageranylgeranyl diphosphate |
|
3199 | |||||||
| 1-azakenpaullone | 8018 | azakenpaullone | |||||||
| azalanstat | 8799 | compound 1 [PMID: 8340925], RS-21607197 | |||||||
| azasetron |
|
2285 | Y-25130 | ||||||
| azatadine |
|
|
7119 | Optimine®, SCH-10649 | |||||
| azathioprine |
|
|
7120 | Azasan®, BW-57-322, Imuran®, Jayempi® | |||||
| aza-THIP | 4143 | ||||||||
| AZD0156 | 9942 | compound 64 [PMID: 29683659] | |||||||
| AZD0233 | 14193 | AZD-0233, example 46 (isomer 2) [WO2024083933] | |||||||
| AZD0284 |
|
|
11711 | AZD-0284, compound 20 [PMID: 34464130] | |||||
| AZD0328 | 7697 | AZD 0328, AZD-0328 | |||||||
| AZD1080 | 7819 | AZD 1080, AZD-1080, KB-160506 | |||||||
| AZD1208 | 7698 | AZD 1208, AZD-1208 | |||||||
| AZD1236 |
|
7844 | AZD 1236, AZD-1236 | ||||||
| AZD1283 |
|
7360 | AZD 1283, AZD-1283 | ||||||
| AZD1332 | 7700 | AZD 1332, AZD-1332 | |||||||
| AZD1386 | 7820 | AZ12457709, AZD 1386, AZD-1386, KB-270807 | |||||||
| AZD1390 | 11277 | ||||||||
| AZD1480 |
|
5933 | AZD 1480, AZD-1480 | ||||||
| AZD1656 | 7701 | AZD 1656, AZD-1656 | |||||||
| AZD1678 |
|
9679 | AZD-1678, compound 49 [PMID: 28947948] | ||||||
| AZD1940 | 12754 | AZD-1940 | |||||||
| AZD1981 |
|
7680 | AZD 1981, AZD-1981 | ||||||
| AZD2098 |
|
9678 | AZD-2098, compound 47 [PMID: 28947948] | ||||||
| AZD2389 | 13842 | AZD-2389, example 67 [WO2022130270A1] | |||||||
| AZD2423 |
|
7825 | AZD 2423, AZD-2423 | ||||||
| AZD2461 | 8472 | AZD 2461, AZD-2461 | |||||||
| AZD2858 |
|
8478 | AZD 2858, AZD-2858, compound 18 [PMID: 22489897] | ||||||
| AZD2906 |
|
11780 | AZD-2906, compound 4 [PMID: 29424542] | ||||||
| AZD2927 | 7704 | AZD 2927, AZD-2927 | |||||||
| AZD3409 | 8027 | AZD 3409, AZD-3409 | |||||||
| AZD3458 |
|
9997 | AZD-3458, compound 15 [PMID: 29852070] | ||||||
| AZD3463 | 7706 | AZD-3463, CS-1382, HY-15609, KB-154896 | |||||||
| AZD3778 | 7679 | AZD 3778, AZD-3778 | |||||||
| AZD3839 | 6931 | AZD 3839, AZD-3839 | |||||||
| AZD3965 |
|
10605 | AZD-3965 | ||||||
| AZD4017 |
|
7695 | AZD 4017, AZD-4017 | ||||||
| AZD4320 | 11781 | AZD-4320, Example 3 [US9248140B2] | |||||||
| AZD4619 | 7821 | AZ11942571, AZD 4619, AZD-4619 | |||||||
| AZD4625 |
|
11978 | AZD-4625, compound 21 [PMID: 35471939] | ||||||
| AZD4877 | 7708 | AZD 4877, AZD-4877, cc-722 | |||||||
| AZD5069 |
|
8948 | AZD-5069 | ||||||
| AZD5423 |
|
|
13017 | AZD-5423, compound 1b [PMID: 28937774] | |||||
| AZD5438 |
|
8473 | AZD 5438, AZD-5438 | ||||||
| AZD5462 | 13273 | AZD-5462, compound 6 [PMID: 38502782] | |||||||
| AZD5582 | 7710 | AZD 5582, AZD-5582 | |||||||
| AZD5672 |
|
7686 | AZD 5672, AZD-5672 | ||||||
| AZD5718 |
|
10352 | compound 12 [PMID: 30869888] | ||||||
| AZD5904 |
|
7728 | AZD 5904, AZD-5904 | ||||||
| AZD5991 |
|
11783 | AZD-5991 | ||||||
| AZD6088 | 7822 | AZ 12677524, AZ-12677524, AZ12677524, AZD 6088, AZD-6088 | |||||||
| AZD6482 |
|
8059 | AZD 6482, AZD-6482 | ||||||
| AZD6495 | 7711 | AZD 6495, AZD-6495 | |||||||
| AZD6538 | 6440 | AZD 6538, AZD-6538 | |||||||
| AZD6605 |
|
7823 | AZ 11920155, AZ-11920155, AZ11920155, AZD 6605, AZD-6605 | ||||||
| AZD6703 |
|
|
7687 | AZ 12012199, AZ-12012199, AZ12012199, AZD 6703, AZD-6703 | |||||
| AZD7268 | 7824 | AZ 12488024, AZ-12488024, AZ12488024, AZD 7268, AZD-7268 | |||||||
| AZD7325 | 7712 | AZD 7325, AZD-7325 | |||||||
| AZD7545 |
|
9362 | AZD-7545 | ||||||
| AZD7624 |
|
11714 | AZD-7624, Example 259 [WO2009001132] | ||||||
| AZD7648 |
|
10601 | AZD-7648, compound 16 [PMID: 31851518] | ||||||
| AZD7687 | 7827 | AZD 7687, AZD-7687 | |||||||
| AZD7762 |
|
7713 | AZD 7762, AZD-7762 | ||||||
| AZD8055 | 7714 | AZD 8055, AZD-8055 | |||||||
| AZD8154 |
|
|
11204 | AZD-8154, Example 1 [WO2018055040A1] | |||||
| AZD8165 | 7726 | AZD 8165, AZD-8165 | |||||||
| AZD8186 | 8527 | AZD 8186, AZD-8186 | |||||||
| AZD8329 | 7715 | AZD 8329, AZD-8329 | |||||||
| AZD8330 | 8474 | ARRY-424704, ARRY-704, AZD-8330 | |||||||
| AZD8421 | 13385 | AZD-8421 | |||||||
| AZD8529 | 7678 | AZD 8529, AZD-8529 | |||||||
| AZD8542 | 7716 | AZD 8542, AZD-8542 | |||||||
| AZD8835 | 8915 | AZD 8835, AZD-8835, compound 25 [PMID: 26475521] | |||||||
| AZD8848 |
|
9256 | DSP-3025 | ||||||
| AZD9056 |
|
7826 | AZD 9056, AZD-9056 | ||||||
| AZD9272 | 6439 | AZD 9272, AZD-9272 | |||||||
| AZD9567 |
|
|
9812 | AZD 9567, AZD-9567, compound 15 [PMID: 29424542], example 1 [WO2016046260A1] | |||||
| AZD9898 |
|
|
10479 | AZD-9898, example 62 [WO2016177845A1] | |||||
| azelaic acid |
|
|
|
7484 | Azelex®, Finacea®, ZK-62498 | ||||
| azelaoyl-PAF | 5428 | azelaoyl PAF | |||||||
| azelaprag | 10061 | AMG 986, AMG-986, AMG986, example 263 [WO2016187308A1] | |||||||
| azelastine |
|
7121 | A-5610, Astelin®, E-0659, Rhinolast®, W-2979M | ||||||
| azeliragon | 8317 | TTP488 | |||||||
| azenosertib |
|
11731 | compound 16 [PMID: 34423975], ZN-c3, ZNc3 | ||||||
| azidamfenicol |
|
12397 | azidamphenicol, azidoamfenicol, azidoamphenicol, Thilocof® | ||||||
| azidocillin | 12291 | BRL 2534, SPC 297 D | |||||||
| [125I]7-azido-8-iodoketanserine |
|
|
4763 | [125I]-7-azido-8-iodoketanserine (photoaffinity ligand), [125I]azidoiodoketanserin, [125I]AZIK | |||||
| azidopine | 6980 | ||||||||
| [3H]azietomidate |
|
|
5404 | ||||||
| azilsartan | 6901 | TAK 536, TAK-536, TAK536 | |||||||
| azilsartan medoxomil |
|
6900 | Edarbi®, TAK 491 | ||||||
| azimilide | 2588 | ||||||||
| azithromycin |
|
|
|
|
6510 | ||||
| azlocillin |
|
12260 | Azlin®, BAY-E-6905 | ||||||
| AZ-PRMT5i-1 |
|
13638 | AZPRMT5i-1, compound 28 [PMID: 39080842] | ||||||
| AZ11657312 (salt free) |
|
7722 | |||||||
| aztreonam |
|
10763 | Azactam®, Cayston®, Emblaveo® (aztreonam and avibactam), SQ 26776, SQ-26776, SQ26776 | ||||||
| azvudine | 13479 | RO-0622 | |||||||
| B | Back to top | ||||||||
| bacampicillin |
|
12292 | Penglobe®, Spectrobid® | ||||||
| (-)-baclofen |
|
1064 | (R)-(-)-baclofen, p-chlorophenyl GABA | ||||||
| baclofen |
|
1084 | Baclon®, Kemstro®, Lioresal® | ||||||
| [3H](R)-(-)-baclofen |
|
|
|
3428 | |||||
| BADGE | 2708 | ||||||||
| bafetinib |
|
|
7906 | INNO-406, Lyn-IN-1, NS-187 | |||||
| bag-1 | 6188 | AK120413 | |||||||
| bag-2 | 6189 | ||||||||
| [3H]bag-2 |
|
|
8506 | ||||||
| BAL19403 | 10981 | BAL 19403, BAL-19403 | |||||||
| BAL30072 | 11004 | BAL-30072 | |||||||
| balamapimod |
|
9925 | MKI-833, MKI833 | ||||||
| balcinrenone |
|
11281 | (S)-1 [PMID: 30596500], AZD-9977 | ||||||
| balicatib | 7861 | AAE581 | |||||||
| balinatunfib |
|
13583 | SAR-441566, SAR441566 | ||||||
| balofloxacin |
|
13105 | Q-35, Q-Roxin® | ||||||
| balomenib | 13734 | ZE63-0302 | |||||||
| balovaptan |
|
10615 | compound 1 [PMID: 31951127], RG7314, RO5285119 | ||||||
| baloxavir marboxil |
|
11748 | S-033188, S033188, Xofluza® | ||||||
| balsalazide |
|
11569 | Colazal®, Colazide®, Giazo® | ||||||
| bambuterol |
|
6601 | Bambec®, Oxeol® | ||||||
| bamocaftor | 10553 | compound 1 [WO2018064632A1], VX-659, VX659 | |||||||
| bantag-1 | 6176 | ||||||||
| [125I]bantag-1 |
|
|
11435 | ||||||
| banyu (I) | 796 | Banyu Compound 1b | |||||||
| [3H]banyu (I) |
|
|
795 | ||||||
| barasertib | 7332 | AZD1152 | |||||||
| barasertib-hQPA |
|
5663 | AZD-1152HQPA, AZD2811, INH 34 | ||||||
| bardoxolone |
|
2717 | CDDO, RTA-401 | ||||||
| baricitinib |
|
|
|
7792 | INCB-028050, INCB028050, LY-3009104, LY3009104, Olumiant® | ||||
| BAS-118 | 10976 | BAS118, compound 7n [PMID: 11728192] | |||||||
| basimglurant | 9309 | compound 2 [PMID: 25565255], RG-7090, RO-4917523, Ro4917523 | |||||||
| basmisanil |
|
10427 | example 112 [WO2009071476], RG-1662, RG1662 | ||||||
| basroparib | 12611 | STP-1002, STP1002 | |||||||
| batimastat |
|
5145 | BB 94, BB-94, BB94 | ||||||
| batoprotafib |
|
12068 | compound 1 [PMID: 32910655], TNO-155, TNO155 | ||||||
| bavarostat |
|
11119 | compound 4 [PMID: 30118224] | ||||||
| bavdegalutamide | 11512 | ARV-110, ARV110, compound 406 [WO2018071606A1] | |||||||
| baxdrostat | 12362 | CIN-107, CIN107, RO6836191 | |||||||
| BAY-069 | 12232 | BAY069, compound 36a [PMID: 36261130] | |||||||
| BAY-091 |
|
11793 | BAY091, compound 60 [PMID: 34699202] | ||||||
| BAY1125976 | 10908 | BAY-1125976, Example 5 [WO2012136776A1] | |||||||
| BAY 11-7082 |
|
5934 | (E)-3-tosylacrylonitrile, BAY-117082, BAY117082 | ||||||
| BAY1214784 | 12784 | BAY 1214784, BAY-1214784, BAY-784, compound 5a [PMID: 32960053], ent-5a | |||||||
| BAY1217389 |
|
12705 | BAY 1217389, BAY-1217389, compound 35 [PMID: 31121430] | ||||||
| BAY1238097 | 9119 | BAY 1238097, BAY-1238097 | |||||||
| BAY1316957 | 12783 | BAY 1316957, BAY-1316957, compound 32 [PMID: 30707023] | |||||||
| BAY-1797 |
|
12567 | BAY1797 | ||||||
| BAY1830839 |
|
|
13101 | BAY-1830839, example 11 [WO2016083433A1] | |||||
| BAY2413555 | 13637 | BAY 2413555, BAY-2413555, compound 27 [PMID: 39463278] | |||||||
| BAY-277 | 13974 | BAY277 | |||||||
| BAY27-9955 | 3491 | Bay 27-9955, BAY 27-9955, BAY-279955 | |||||||
| BAY-293 |
|
10480 | BAY293, compound 23 [PMID: 30683722] | ||||||
| BAY-297 |
|
11794 | BAY297, compound 58 [PMID: 34699202] | ||||||
| BAY-299 |
|
9524 | |||||||
| BAY-320 | 9126 | ||||||||
| BAY 3389934 |
|
13845 | BAY-3389934, BAY3389934, example 1 [US20230391761A1] | ||||||
| BAY 367620 | 1381 | BAY 36-7620, BAY-367620, BAY36-7620 | |||||||
| BAY412272 |
|
5146 | BAY 41-2272, BAY-412272 | ||||||
| BAY 41-8543 | 13801 | BAY 418543, BAY-41-8543, BAY-418543, BAY418543 | |||||||
| BAY-439 | 13972 | ||||||||
| BAY-524 | 9127 | ||||||||
| BAY-545 | 11224 | BAY545, compound 8 [PMID: 30576906] | |||||||
| BAY-593 | 13298 | BAY593 | |||||||
| BAY-593074 | 10348 | BAY 59-3074, BAY-59-3074, BAY593074 | |||||||
| BAY-598 |
|
8953 | |||||||
| BAY-6035 | 13977 | BAY6035 | |||||||
| BAY 60-6583 |
|
3289 | BAY-60-6583, BAY60-6583 | ||||||
| BAY607550 |
|
5147 | BAY 60-7550, BAY-607550 | ||||||
| BAY 61-3606 | 9693 | BAY-61-3606, BAY-613606, BAY61-3606, Syk inhibitor IV | |||||||
| BAY-6672 | 11283 | BAY6672, compound 46 [PMID: 32969660] | |||||||
| BAY-678 | 8956 | ||||||||
| BAY-73-1449 | 5851 | ||||||||
| BAY-747 | 12763 | BAY 1165747, BAY747, compound 28 [PMID: 37040336] | |||||||
| BAY-7598 | 13973 | BAY7598 | |||||||
| BAY-8002 |
|
10405 | BAY8002 | ||||||
| BAY-805 | 12479 | BAY805, compound 21 [PMID: 36802665] | |||||||
| BAY-8400 | 11732 | BAY8400, compound 25 [PMID: 34428039] | |||||||
| BAY-850 | 13975 | BAY850 | |||||||
| BAY-885 | 10183 | BAY885, compound 41 [PMID: 30563338] | |||||||
| BAY-9835 | 13168 | BAY9835, compound 32 [PMID: 38348661] | |||||||
| BAY-985 |
|
10597 | BAY985, compound 34 [PMID: 31859507] | ||||||
| BayCysLT2 | 6196 | CysLT2cpd | |||||||
| BAYK 8644 | 2511 | ||||||||
| (-)-(S)-BayK8644 |
|
4065 | |||||||
| BAYu9773 |
|
3381 | BAY u9773, BAY-u 9773 | ||||||
| BAY-X1005 |
|
5148 | BAY X 1005, DG-031, veliflapon | ||||||
| bazedoxifene |
|
|
7355 | Conbriza®, TSE-424, Viviant®, WAY-140424 | |||||
| BAZ2-ICR |
|
8571 | inhibitor 13 [PMID: 25719566] | ||||||
| BBC0403 | 13230 | BBC-0403 | |||||||
| BB2-50F |
|
13072 | |||||||
| BBO-10203 | 13703 | compound 508 [WO2023154282A1] | |||||||
| B3C | 7859 | compound 23 [PMID: 18752942] | |||||||
| BC11-38 | 6559 | ||||||||
| BC-1215 |
|
12671 | BC 1215, BC1215 | ||||||
| BC-3205 | 10998 | ||||||||
| BC5 | 14023 | ||||||||
| BC-7013 | 11034 | BC7013 | |||||||
| 4‐BCCA | 11309 | trans‐4‐butylcyclohexane carboxylic acid | |||||||
| BCH | 4700 | ||||||||
| BCH070 |
|
10614 | |||||||
| BCL3 inhibitor JS6 | 12672 | compound 1a [WO2015014972] | |||||||
| BCL6 PROTAC 15 | 11778 | compound 15 [PMID: 30335946] | |||||||
| Bcr-abl inhibitor GNF-2 |
|
5935 | GNF 2, GNF-2 | ||||||
| BCTC | 2460 | ||||||||
| BD-1047 | 6680 | BD 1047, BD1047 | |||||||
| BD-1063 | 12125 | BD1063 | |||||||
| 5-BDBD | 9541 | ||||||||
| [125I]-BDZ2 |
|
|
6667 | ||||||
| beclometasone |
|
|
|
7059 | beclomethasone, SCH-18020W | ||||
| beclometasone dipropionate |
|
|
5894 | beclomethasone dipropionate, Beconase®, Qnasl®, Vancenase® | |||||
| becondogrel | 13802 | (4S)-2-Oxoclopidogrel, compound IV-1 [EP3290423B1], compound of formula I [US2022028976] | |||||||
| BED | 8438 | ||||||||
| bedaquiline |
|
|
11171 | BDQ, compound 1a [PMID: 17496888], R-207910, Sirturo®, TMC-207, TMC207 | |||||
| bederocin |
|
10764 | REP-8839, REP8839 | ||||||
| befetupitant | 5759 | Ro 67-5930, Ro-675930 | |||||||
| befloxatone | 6637 | MD370503 | |||||||
| befotertinib |
|
12951 | compound 4 [WO2019218987A1], D-0316, D0316, Surmana® | ||||||
| begacestat | 6979 | GSI-953 | |||||||
| belinostat |
|
|
7496 | Beleodaq®, PXD-101, PXD101 | |||||
| belizatinib |
|
10474 | compound 36 [PMID: 22734674], TSR-011, TSR011 | ||||||
| belnacasan |
|
9035 | HMR3480, VX-765 | ||||||
| beloranib | 8445 | CKD-732, O-(4-(2-Dimethylaminoethoxy)-trans-cinnamoyl)fumagillol, ZGN 440, ZGN-440 | |||||||
| belumosudil |
|
|
|
9558 | KD-025, KD025, Rezurock®, SLx 2119, SLx2119 | ||||
| belvarafenib |
|
11544 | Example 116 [WO2013100632A1], GDC-5573, HM95573, RG6185 | ||||||
| belzutifan |
|
|
11251 | compound 2 [PMID: 31282155], MK-6482, MK6482, PT2977, Welireg® | |||||
| bemcentinib |
|
10478 | BGB-324, BGB324, R-428, R428 | ||||||
| bemnifosbuvir | 11295 | AT-527, AT527, RO-7496998, RO7496998 | |||||||
| bempedoic acid |
|
8321 | ESP-55016, ETC-1002, Nexletol®, Nilemdo® | ||||||
| BEN-28010 | 13893 | BEN28010, clinical candidate 38 [PMID: 40273287] | |||||||
| benapenem | 12793 | ||||||||
| benazepril |
|
6374 | CGS-14824A, Lotensin® | ||||||
| benazeprilat |
|
6375 | CGS-14831 | ||||||
| bendamustine |
|
7478 | Levact®, SDX-105, Treanda® | ||||||
| bendroflumethiazide |
|
7122 | Aprinox®, Naturetin® | ||||||
| benfluorex |
|
14184 | benfluramate, Mediator® | ||||||
| benidipine |
|
10159 | Coniel® | ||||||
| benperidol |
|
9215 | Anquil®, MCN-JR-4584, R-4584 | ||||||
| benserazide |
|
5150 | Madopar®, Ro 4-4602, serazide | ||||||
| bentamapimod |
|
9926 | AS-602801, AS602801, PGL-5001, PGL5001 | ||||||
| benzamidine |
|
7566 | |||||||
| benzamil | 4145 | ||||||||
| benzatropine |
|
|
7601 | benztropine, benztropine mesylate, Cogentin® | |||||
| benzbromarone |
|
14007 | GsMTx-4 | ||||||
| 1,2,3-benzenetricarboxylic acid |
|
4701 | 1,2,3-benzenetricarboxylate | ||||||
| benzgalantamine |
|
13477 | alpha-1062, galantamine benzoate, Gln-1062, memogain, Zunveyl® | ||||||
| benzimidazole 991 |
|
14098 | |||||||
| benzodrocortisone |
|
9731 | compound 1 [WO2013071010], hydrocortisone 17-benzoate | ||||||
| benzolamide |
|
6920 | |||||||
| benzonatate |
|
7611 | Tessalon®, Zonatuss® | ||||||
| benzoquinazolinone 12 | 8549 | compound A [PMID: 26582730], compound C [PMID: 29025977], T662 | |||||||
| benzoquinone |
|
6307 | p-BQ, p-benzoquinone | ||||||
| benzquinamide |
|
7124 | P-2647, Quantril® | ||||||
| benzthiazide |
|
7125 | Aquatag®, Fovane® | ||||||
| 1-benzyl-APDC | 1436 | ||||||||
| benzyl bromide | 6294 | ||||||||
| benzylcysteine |
|
4501 | S-benzyl-L-cysteine | ||||||
| 5-benzyloxytryptamine | 265 | 5-BT | |||||||
| benzylserine |
|
4500 | O-benzyl-L-serine | ||||||
| bepafant | 6078 | WEB-2170, WEB2170 | |||||||
| bepotastine |
|
7466 | Talion®, TAU-284 | ||||||
| bepridil |
|
2337 | CERM-1978, Vascor® | ||||||
| beraprost | 1967 | MDL 201229, MDL-201229, ML 1229, ML-1229 | |||||||
| beroterkib |
|
11727 | ASTX-029, ASTX029, compound 15 [PMID: 34387469] | ||||||
| berotralstat |
|
|
11347 | BCX-7353, BCX7353, Orladeyo® | |||||
| berzosertib |
|
8003 | M6620, VE 822, VE-822, VX-970, VX970 | ||||||
| besifloxacin |
|
12877 | Besivance®, BOL-303224-A, ISV-403, SS734 | ||||||
| bestatin | 5151 | ubenimex | |||||||
| beta-carboline |
|
8222 | carbazoline, norharmane | ||||||
| beta-ergocriptine | 988 | ||||||||
| betahistine |
|
11937 | OBE101, SERC®, Vasomotal® | ||||||
| 3beta-Hydroxy-20(29)-lupene |
|
9028 | Fagarasterol, Lupeol | ||||||
| betanidine |
|
7618 | bethanidine, BW-467-C-60, Tenathan® | ||||||
| beta ph61 | 13135 | ||||||||
| betaxolol |
|
549 | betaxolol HCl, Betoptic®, Kerlone®, SL-75212-10 | ||||||
| betazole |
|
7126 | ametazole, Histalog® | ||||||
| bethanechol |
|
297 | Duvoid®, Urecholine® | ||||||
| BETP | 7585 | ||||||||
| betrixaban |
|
9602 | Bevyxxa®, compound 11 [PMID: 19297154], PRT-054021, PRT054021 | ||||||
| bexagliflozin |
|
12335 | Brenzavvy®, compound 29 [PMID: 21737266], EGT-0001442, EGT-1442, EGT1442, THR-1442 | ||||||
| bexarotene |
|
|
2807 | LGD1069, Targretin®, Targrexin® | |||||
| bexobrutideg |
|
12898 | compound 195 [WO2021113557A1], NX-5948, NX5948 | ||||||
| bexotegrast | 12108 | PLN-74809, PLN74809 | |||||||
| bezafibrate |
|
|
2668 | Bezalip® | |||||
| bezisterim |
|
13988 | 17-ethynyl-5-androstene-3,7,17-triol, HE-3286, HE3286, NE-3107, NE3107 | ||||||
| bezuclastinib |
|
11868 | CGT-9486, CGT9486, PLX-9486, PLX9486 | ||||||
| BF-1 | 8424 | ||||||||
| BGC201531 | 3380 | BGC20-1531 | |||||||
| BGT-226 | 7951 | BGT 226, BGT-226 free base, BGT226, NPV-BGT226 | |||||||
| BHF-177 | 5503 | BHF 177, BHF177 | |||||||
| (+)-BHFF |
|
5504 | |||||||
| BHQ | 5486 | ||||||||
| BI01383298 | 11242 | BI-01383298 | |||||||
| BI-0474 |
|
12279 | BI 0474, BI0474, compound 23 [PMID: 36300829] | ||||||
| BI1265162 | 11717 | BI-1265162, example 2.04 [WO2017028927A1] | |||||||
| BI-167107 | 12065 | BI167107, compound 6b [PMID: 19875286] | |||||||
| BI-1935 |
|
9717 | BI 1935, example 3 [WO2007067836] | ||||||
| BI-1950 |
|
9719 | |||||||
| BI-2493 |
|
12764 | BI2493 | ||||||
| BI-2536 |
|
5666 | BI 2536, BI2536 | ||||||
| BI-2545 |
|
|
9791 | BI2545, compound 19 [PMID: 29259743] | |||||
| BI-3231 | 12478 | BI3231, compound 45 [PMID: 36727857] | |||||||
| BI-3406 |
|
12061 | BI3406 | ||||||
| BI-3802 |
|
11338 | BI3802 | ||||||
| BI-4020 |
|
12984 | BI4020 | ||||||
| BI-4142 | 12164 | BI4142, compound 8 [PMID: 35883003], example L-1 [WO2021156178A1] | |||||||
| BI-43 | 13398 | ||||||||
| BI6015 | 6695 | BI 6015, BI-6015 | |||||||
| BI605906 |
|
9357 | 3-Amino-4-(1,1-difluoro- propyl)-6-(4-methanesulfonyl- piperidin-1-yl)-thieno[2,3- b]pyridine-2-carboxylic acid amide, compound 115 [US20070293533] | ||||||
| BI 653048 |
|
9715 | (R)-39, BI 653048 BS H3PO4, BI-653048, BI653048 | ||||||
| BI 665915 |
|
9716 | BI-665915, compound 69 [PMID: 25671290] | ||||||
| BI-6901 |
|
9714 | BI 6901, BI 6901, BI6901, eut-22 | ||||||
| BI-7273 |
|
9146 | |||||||
| BI 749327 | 12530 | BI-749327, BI749327 | |||||||
| BI-847325 |
|
12661 | BI 847325, BI847325 | ||||||
| BI-9564 |
|
8950 | |||||||
| 7-BIA | 10109 | compound 14 [PMID: 30348770] | |||||||
| BIA 10-2474 | 9001 | BIA-10-2474, BIA-102474, compound 8 l [PubMed: 30113139], example 362 [WO2010074588] | |||||||
| BIA 10-2639 | 9603 | ||||||||
| biapenem |
|
12022 | L-627, LJC10,627, Omegacin®, RPX2003 | ||||||
| BIBF-1202 | 8096 | BIBF 1202 | |||||||
| BIBO3304 | 1528 | ||||||||
| BIBP3226 | 1485 | BIBP 3226 | |||||||
| [3H]BIBP3226 |
|
|
3474 | [3H]-BIBP3226 | |||||
| BIC1 |
|
7510 | |||||||
| bicalutamide |
|
2863 | Calutide®, Casodex® | ||||||
| bictegravir |
|
|
11575 | GS-9883, GS9883 | |||||
| 3-bicyclo[2.2.1]hept-2-yl-benzene-1,2-diol | 2569 | ||||||||
| BI-D1870 | 8038 | ||||||||
| bifemelane |
|
11742 | Alnert®, BP-N-methylbutylamine, Celeport®, MCI-2016, MCI2016 | ||||||
| BIIB021 |
|
9258 | |||||||
| BIIB068 |
|
|
11178 | BIIB-068, compound 1 [PMID: 32696648] | |||||
| BIIB091 |
|
11791 | BIIB-091, compound 51 [PMID: 34734694] | ||||||
| BIIB129 | 13420 | BIIB-129, compound 25 [PMID: 38712838] | |||||||
| BIIE0246 | 1547 | BIIE 0246, BIIE-0246 | |||||||
| BIIL 260 |
|
6154 | BIIL-260, BIIL260 | ||||||
| biKEAP1 | 13066 | compound 3 [PMID: 38157852] | |||||||
| bilastine |
|
11579 | Bilaxten®, Ilaxten® | ||||||
| bilorphin | 10518 | peptide 3c [PMID: 31611414] | |||||||
| bimatoprost |
|
|
1958 | AGN 192024, LS-181817, Lumigan® | |||||
| bimatoprost (free acid form) | 1959 | 17-phenyl-ω-trinor-PGF2α | |||||||
| bimiralisib |
|
8383 | PQR-309, PQR309 | ||||||
| bimosiamose |
|
9049 | compound 15e [PMID: 9544210], TBC 1269, TBC-1269, TBC1269 | ||||||
| BIMU 1 | 233 | BIMU-1, BIMU1 | |||||||
| BIMU 8 | 234 | BIMU-8, BIMU8 | |||||||
| bindarit |
|
11124 | AF-2838, AF2838 | ||||||
| binimetinib |
|
|
7921 | ARRY 162, ARRY-162, ARRY-438162, MEK-162, MEK162, Mektovi® | |||||
| binodenoson | 5595 | WRC-0470 | |||||||
| BIO-32546 | 11590 | BIO32546, example 12a [WO2014018881A1] | |||||||
| BIO-7488 |
|
13341 | BIO7488 | ||||||
| BIO-8169 |
|
13355 | BIO8169, compound 2 [PMID: 38695469] | ||||||
| biperiden |
|
7128 | Akineton®, biperiden HCl, biperiden lactate | ||||||
| biphenylindanone A | 3954 | BINA, LS-193,571 | |||||||
| birabresib |
|
8359 | MK-8628, OTX-015, OTX015 | ||||||
| birelentinib | 13735 | compound 14 [WO2021136219A1], DZD-8586, DZD8586 | |||||||
| biricodar | 11741 | Incel®, VX-710, VX710 | |||||||
| birinapant |
|
7432 | TL 32711, TL-32711, TL32711 | ||||||
| BIRT 377 |
|
9720 | BIRT-377 | ||||||
| bisindolylmaleimide IV | 5937 | arcyriarubin A, BIM IV, Ro-31-6233, RO-316233 | |||||||
| bisoprolol |
|
7129 | CL-297939, EMD-33512, Zebeta® | ||||||
| bisphenol A |
|
7865 | BPA | ||||||
| bis-triazole derivative 10 | 6537 | ||||||||
| bithionol |
|
2338 | Inh 2 [PMID: 32284327] | ||||||
| bitopertin | 7546 | paliflutine, RG1678, RO-4917838 | |||||||
| BIX-01294 |
|
7014 | BIX 01294, BIX01294 | ||||||
| BIX02188 | 8064 | BIX 02188, BIX-02188 | |||||||
| BIX02189 | 9380 | BIX 02189, BIX-02189 | |||||||
| BIX 02565 | 8039 | BIX-02565, BIX02565 | |||||||
| BJG-05-039 | 12266 | ||||||||
| BL-1249 | 10336 | BL1249 | |||||||
| blarcamesine | 11586 | AE-37, AE37, Anavex 2-73, Anavex2-73, THD-DP-FM | |||||||
| bleximenib | 12866 | Compound A [WO2022237720], JNJ-75276617, JNJ75276617 | |||||||
| BLI-489 free acid | 10995 | BLI489 | |||||||
| blonanserin |
|
7670 | AD 5423, AD-5423, Lonasen® | ||||||
| blovacitinib | 14046 | compound 36 [PMID: 36512734], TUL-01101, TUL01101 | |||||||
| BLU-9931 |
|
8862 | BLU9931 | ||||||
| bluensomycin | 10765 | bluensin, U-12898, U12898 | |||||||
| BML-281 |
|
9664 | compound 3 [PMID: 18642892] | ||||||
| BMS-1001 |
|
10191 | BMS1001, Example 1001 [WO2015160641A2] | ||||||
| BMS-1166 |
|
9608 | compound 2c [PMID: 28613862], Example 1166 [WO2015160641A2] | ||||||
| BMS 181,101 | 108 | BMS 181101, BMS-181,101, BMS-181101, BMS181,101, BMS181101 | |||||||
| BMS-189532 | 11955 | AGN-193491, BMS189532, compound 2 [PMID: 24040487] | |||||||
| BMS-191011 | 14022 | BMS 191011, Bms-a, BMS191011 | |||||||
| BMS-193884 | 13016 | BMS 193884, BMS193884, compound 3 [PMID: 10956219] | |||||||
| BMS-193885 |
|
14160 | BMS 193885, BMS193885 | ||||||
| BMS-202 |
|
|
9607 | compound 1c [PMID: 28613862], PD1-PDL1 inhibitor 2 | |||||
| BMS-214662 |
|
8026 | BMS 214662, BMS214662, BVM | ||||||
| BMS-265246 | 8051 | BMS 265246, BMS265246 | |||||||
| BMS270394 |
|
2653 | BMS 270394, BMS 961, BMS-270394 | ||||||
| BMS-303141 | 12855 | BMS303141 | |||||||
| BMS309403 |
|
6735 | BMS 309403, BMS-309403 | ||||||
| BMS-345541 |
|
5669 | BMS 345541, BMS345541 | ||||||
| BMS-387032 |
|
5670 | BMS 387032, BMS387032, compound 21 [PMID: 15027863], SNS 032, SNS-032, SNS032 | ||||||
| BMS493 |
|
2641 | BMS 493, BMS-493 | ||||||
| BMS-502 | 13006 | BMS502, compound 22 [PMID: 37465293] | |||||||
| BMS-509744 |
|
9994 | BMS 509744, BMS509744, compound 3 [PMID:16682193] | ||||||
| BMS-536924 | 9386 | BMS 536924, BMS536924, compound 1 [PMID: 18763755], compound 3 [PMID: 16134929] | |||||||
| BMS-561392 |
|
6509 | BMS 561392, BMS561392, DPC-333 | ||||||
| BMS-582949 |
|
|
7838 | BMS 582949, BMS582949, PS 540446, PS-540446, PS540446 | |||||
| BMS-599626 | 7647 | AC1480 (free base), AC480, BMS 599626, BMS599626 | |||||||
| BMS614 | 2643 | BMS 614, BMS-614 | |||||||
| BMS641 |
|
2651 | BMS 641, BMS-641 | ||||||
| BMS-681 |
|
|
9430 | compound 13d [PMID: 25893046] | |||||
| BMS-684 | 13007 | BMS684, compound 1 [PMID: 37465293] | |||||||
| BMS-690514 | 7879 | BMS 690514, BMS690514 | |||||||
| BMS-741672 | 11598 | BMS741672, compound 1a [PMID: 34141082], compound 7 [PMID: 30891130] | |||||||
| BMS753 | 2650 | BMS 753, BMS-753 | |||||||
| BMS-753426 | 11597 | BMS753426, compound 2d [PMID: 34141082] | |||||||
| BMS-754807 |
|
7952 | BMS 754807, BMS754807 | ||||||
| BMS-777607 |
|
7953 | BMS 777607, BMS777607 | ||||||
| BMS-817399 |
|
|
9497 | compound 29 [PMID: 25101488] | |||||
| BMS-820132 |
|
11932 | BMS820132, compound 31 [PMID: 35179904] | ||||||
| BMS-823778 |
|
10158 | compound 2 [Li et al., 2018] | ||||||
| BMS-833923 | 8202 | BMS 833923, BMS833923, XL 139, XL-139, XL139 | |||||||
| BMS-852927 |
|
|
14079 | BMS852927, compound 15 [PMID: 27994765], XL-041, XL041 | |||||
| BMS-908662 | 7968 | BMS 908662, BMS908662, XL281 | |||||||
| BMS-911172 |
|
11688 | BMS911172, compound 59 [PMID: 34270254] | ||||||
| BMS-911543 |
|
7954 | BMS 911543, BMS911543 | ||||||
| BMS-962212 | 9884 | BMS962212, compound 55 [PMID: 29077405] | |||||||
| BMS-963272 | 12738 | BMS963272, compound 21s [PMID: 34613725] | |||||||
| BMS-986020 | 9498 | am-152, AM152, AP-3152 free acid | |||||||
| BMS-986120 | 10269 | BMS986120, compound 43 [PMID: 35729784] | |||||||
| BMS-986121 | 9156 | ||||||||
| BMS-986122 | 9157 | ||||||||
| BMS-986123 | 9159 | ||||||||
| BMS-986124 | 9160 | ||||||||
| BMS-986141 | 12038 | BMS986141, compound 49 [PMID: 35729784] | |||||||
| BMS-986142 |
|
|
9857 | BMS986142, compound 14f [PMID: 27583770] | |||||
| BMS-986158 |
|
11757 | BMS986158, compound 18 [PMID: 34543572] | ||||||
| BMS-986166 |
|
11493 | BMS986166, compound 14a [PMID: 30785748] | ||||||
| BMS-986172 | 12971 | BMS986172, compound 12 [PMID: 37724542] | |||||||
| BMS-986187 | 9748 | ||||||||
| BMS-986202 | 12723 | BMS986202, compound 7 [PMID: 33370104] | |||||||
| BMS-986224 | 11838 | BMS986224 | |||||||
| BMS-986235 |
|
11024 | BMS986235, compound 13c [PMID: 32407089], LAR-1219, LAR1219 | ||||||
| BMS-986260 |
|
|
10662 | BMS986260, compound 10 [Velaparthi et al., 2020], Example 32' [WO2016140884A1] | |||||
| BMS-986278 | 11798 | BMS986278, compound 33 [PMID: 34709814] | |||||||
| BMS-986299 | 11509 | BMS986299, compound 112 [WO2018152396A1] | |||||||
| BMS-986318 | 11728 | BMS986318, compound 1 [PMID: 34531950] | |||||||
| BMS-986339 | 12109 | BMS986339, compound 32 [PMID: 35704802] | |||||||
| BMS-986449 | 13941 | ||||||||
| BMS-986458 | 13838 | ||||||||
| BMS-986463 | 14190 | BMS986463, example S131 [WO2024006881] | |||||||
| BMS-986470 | 14200 | BMS986470, compound No. 32 [WO2024097932] | |||||||
| BMS compound 87b | 3492 | ||||||||
| BMS compound 4c | 5901 | ||||||||
| BMS compound 16 [PMID:23368907] |
|
5808 | BPTU | ||||||
| BMS-986104 derivative 12 |
|
11494 | compound 12 [PMID: 33492963] | ||||||
| BMS-986104 derivative 24 |
|
11495 | compound 24 [PMID: 33492963] | ||||||
| BMS pyrazole inhibitor 7f | 7030 | ||||||||
| BMX-IN-1 | 9269 | Example 1-14 [ WO2014063054] | |||||||
| BMY-14802 | 8 | BMY 14802, BMY14802 | |||||||
| BMY-21950 | 2981 | BMY 21950, BMY21950, compound 4 [PMID: 1992149] | |||||||
| BMY 22089 | 2973 | BMY-22089, BMY22089, compound 4a [PMID: 2231596] | |||||||
| BMY 45778 | 1963 | BMY-45778, BMY45778 | |||||||
| BMY-7378 | 9 | BMY 7378, BMY7378 | |||||||
| BN 50739 | 1851 | BN-50739, BN50739 | |||||||
| BN-81,644 | 2070 | BN 81,644, BN 81644, BN-81644, BN81,644, BN81644 | |||||||
| BN-81,674 | 2071 | BN 81,674, BN 81674, BN-81674, BN81,674, BN81674 | |||||||
| BNC375 | 10693 | CS-0095916, HY-128575 | |||||||
| BNTX | 1634 | 7-benzylidenenaltrexone, Bntx-7 | |||||||
| BO1 | 8963 | Bcr-abl Inhibitor II | |||||||
| boceprevir |
|
7876 | EBP-520, EBP520, SCH-503034, SCH503034, Victrelis® | ||||||
| BODIPY FL-prazosin |
|
13134 | QAPB | ||||||
| BODIPY-pirenzepine |
|
8604 | Bodipy[558/568]Pirenzepine, BoPz | ||||||
| boditrectinib | 12368 | AUM-601, AUM601, CHC 2014, CHC2014, Chemical Compound 50 [US20160168156A1], HL 5101, HL5101, NOV 1601, NOV-1601 | |||||||
| 5-BODMT | 8422 | 5-N-butyryloxy-N,N-dimethyltryptamine, compound 10 [PMID 21422162] | |||||||
| bofutrelvir |
|
11070 | compound 11a [PMID: 32321856], DC-402234, DC402234, FB-2001, FB2001 | ||||||
| bohemine | 5938 | ||||||||
| BOMA | 1421 | ||||||||
| BOMPPA | 7924 | benzyloxy-methoxyphenyl-propylamide, compound 10 [PMID: 23228808] | |||||||
| [125I]BOP |
|
|
1973 | [125I]-I-BOP | |||||
| bortezomib |
|
|
|
|
6391 | peptide boronate, PS-341, Velcade® | |||
| BOS172722 |
|
12706 | BOS-172722, compound 36 [PMID: 30199249] | ||||||
| bosentan |
|
|
3494 | RO 47-0203, Tracleer® | |||||
| bosmolisib | 13486 | BR-101801, BR101801, example 1 [WO2019139399A1], example 10 [WO2016204429] | |||||||
| bosutinib |
|
|
|
5710 | Bosulif®, SK 606, SK-606, SKI 606 | ||||
| BP 897 | 7625 | BP-897, BP897 | |||||||
| BPAM344 |
|
13392 | |||||||
| BPH-252 | 3198 | BPH 252, BPH252 | |||||||
| BPH-608 |
|
7977 | BPH 608, BPH608 | ||||||
| BPH-628 |
|
3188 | B28, BPH 628, BPH628 | ||||||
| BPH-629 |
|
7976 | BPH 629, BPH629 | ||||||
| BPH-675 |
|
7975 | BPH 675, BPH675 | ||||||
| BPH-676 |
|
7978 | BPH 676, BPH676 | ||||||
| BPH-715 | 3196 | BPH 715, BPH715 | |||||||
| BPH-742 | 3189 | bisphosphonate, 9, BPH 742, BPH742 | |||||||
| BPH-830 | 3121 | BPH 830, BPH830 | |||||||
| BPIQ-I | 5939 | ||||||||
| BPKDi | 9370 | bipyridyl PKD inhibitor | |||||||
| BPN14770 |
|
10451 | BPN-14770, compound 28 [PMID: 31013090] | ||||||
| (R)-BPO-27 |
|
14077 | |||||||
| BPR1R024 | 11747 | BPR1R-024, compound 12 [PMID: 34606263] | |||||||
| 4BP-TQS | 3962 | ||||||||
| BQ788 | 1010 | BQ 788, BQ-788 | |||||||
| BQCA | 5436 | benzyl quinolone carboxylic acid | |||||||
| bradanicline | 3969 | ATA-101, ATA101, compound 7a [PMID 23126648], TC-5619, TC5619 | |||||||
| bradyzide | 680 | ||||||||
| branebrutinib |
|
9869 | BMS-986195, BMS986195, Example 223 [US20160115126A1] | ||||||
| Br-BTHIQ | 14000 | compound 1 [PMID: 31933369] | |||||||
| BRD1158 | 13360 | BRD 1158, BRD-1158, exmple 47 [WO2021050700] | |||||||
| BRD3444 |
|
9648 | |||||||
| BRD4770 | 7016 | BRD 4770, BRD-4770 | |||||||
| BRD7929 |
|
|
11723 | ||||||
| BRD9185 |
|
11469 | compound 27 [PMID: 28435533] | ||||||
| BRD9539 | 7375 | BRD 9539, BRD-9539 | |||||||
| (-)-bremazocine | 1603 | ||||||||
| brensocatib |
|
|
9412 | AZD7986, Brinsupri®, compound 30, INS 1007, INS1007 | |||||
| brepocitinib |
|
|
10459 | compound 23 [PMID: 30113844], PF-06700841, PF06700841 | |||||
| brequinar |
|
7406 | DUP-785, DUP785, NSC 368390, NSC-368390, NSC368390 | ||||||
| bretazenil |
|
4146 | Ro 16-6028 | ||||||
| bretylium |
|
7130 | ASL-603, bretylium tosylate, Bretylol® | ||||||
| brexpiprazole |
|
7672 | OPC 34712, OPC-34712, Rxulti® | ||||||
| brigatinib |
|
|
7741 | Alunbrig®, AP-26113, AP26113, compound 11q [PMID: 27144831] | |||||
| brigimadlin |
|
12627 | BI 907828, BI-907828, BI907828, example Ia-34 [WO2017060431A1] | ||||||
| brilacidin |
|
13807 | MMV1634402, PMX30063 | ||||||
| brilliant blue G | 4147 | ||||||||
| brimarafenib | 13203 | BGB-3245, BGB3245, compound 1.49 [WO2014206343] | |||||||
| brimonidine (UK14304) |
|
|
|
520 | Alphagan®, Lumify®, Mirvaso®, UK14,304, UK14304 | ||||
| [3H]brimonidine (UK14304) |
|
|
|
5386 | [3H]-UK14304 | ||||
| brincidofovir |
|
11556 | CMX-001, CMX001, HDP-CDV, hexadecyloxypropyl cidofovir, Tembexa® | ||||||
| brinzolamide |
|
|
6797 | AL-4862, Azopt® | |||||
| brivanib | 5671 | BMS 540215, BMS-540215 | |||||||
| brivanib alinate | 8097 | BMS-582664, BMS582664 | |||||||
| brivaracetam |
|
|
9041 | 2-(2-oxo-4-propylpyrrolidin-1-yl)butanamide, Briviact®, compound 83α, UCB 34714, UCB-34714, UCB34714 | |||||
| BRL-15572 |
|
10 | BRL 15572, BRL-15,572, BRL15572 | ||||||
| BRL35135 | 13194 | BRL 35135, BRL-35135 | |||||||
| BRL 37344 | 567 | BRL-37344, BRL37344 | |||||||
| BRL-42715 | 10993 | C6-(N1-Methyl-1,2,3-trazolylmethylene)penem, LS-186900 (sodium salt), LS-187554 | |||||||
| BRL-44154 | 11036 | analogue 4f [Brown et al., 1991], BRL44154 | |||||||
| BRL 44408 | 525 | BRL-44408, BRL44408 | |||||||
| BRL50481 | 5154 | BRL 50481, BRL-50481 | |||||||
| BRL-54443 |
|
3927 | BRL 54443, BRL54443 | ||||||
| Br-5MPEPy | 6397 | ||||||||
| brodimoprim | 12325 | Ro 10-5970 | |||||||
| brolamfetamine | 163 | DOB, 2,5-dimethoxy-4-bromoamphetamine | |||||||
| bromfenac |
|
|
|
7131 | AHR-10282B, Bromday®, Prolensa®, Xibrom® | ||||
| bromhexine |
|
11218 | Bisolvon®, NA-274, NA274 | ||||||
| bromoacetone | 6293 | acetonyl bromide, martonite, monobromoacetone | |||||||
| bromocresol green | 4530 | ||||||||
| bromocriptine |
|
|
35 | 2-bromoergocryptine, bromocryptine, CB-154, Parlodel® | |||||
| bromo-deaza-SAH |
|
7018 | |||||||
| bromodiphenhydramine |
|
7132 | Ambodryl® | ||||||
| bromoenol lactone | 5149 | BEL, bromoenolactone | |||||||
| 2-bromo-LSD |
|
272 | 2-br-LSD, 2-bromolysergic acid diethylamide, bromolysergide | ||||||
| 3-bromo-7NI |
|
5113 | 3-Br-7NI, 3-bromo-7-nitroindazole | ||||||
| 2-(3-bromophenyl)histamine | 1194 | ||||||||
| 3-bromopyruvate | 4517 | bromopyruvic acid | |||||||
| [1-bromo-(3S)-hydrox-4-(palmitoyloxy)butyl]phosphate | 6991 | ||||||||
| bromosporine |
|
8234 | |||||||
| (+)-5-(5-bromothiophen-3-yl)-5-methyl-4-oxo-4,5-dihydro-furan-2-carboxylic acid | 1589 | ||||||||
| brompheniramine |
|
7133 | Bromfed®, brompheniramine maleate, Dimetapp® | ||||||
| bromsulphthalein | 4506 | BSP, bromosulfophthalein, BSP, sulfobromophthalein | |||||||
| brophenexin | 13601 | compound 8 [PMID: 33033186], NMDAR/TRPM4 inhibitor 8 | |||||||
| brorphine | 12956 | compound 21 [PMID: 30199635] | |||||||
| BrP-LPA | 6985 | α-bromomethylene phosphonate | |||||||
| brucine N-oxide | 343 | ||||||||
| 5BrUTP |
|
1731 | 5-bromo-UTP, 5-bromouridine triphosphate, bromouridine 5'-triphosphate | ||||||
| BS-181 |
|
9405 | |||||||
| BS-194 |
|
8176 | BS 194, BS194, compound 4k [PMID 21080703] | ||||||
| BSJ-03-123 | 10532 | ||||||||
| BSJ-03-204 | 10530 | ||||||||
| BSJ-04-132 | 10531 | ||||||||
| [3H]BSP |
|
|
4505 | [3H]-BSP, bromosulfophthalein | |||||
| BT-33 |
|
13822 | |||||||
| BTB07018 | 9669 | ||||||||
| BTD | 10289 | K261-1567 | |||||||
| BTDM |
|
12531 | |||||||
| BTK inhibitor 16 [PMID: 30122225] | 10076 | example 90 [US20160264548] | |||||||
| BTP2 |
|
2438 | YM-58483 | ||||||
| B-TPMF | 9315 | (-)-B-TPMF | |||||||
| BTT-3033 | 11489 | BTT 3033, BTT3033 | |||||||
| BTZ-043 | 13034 | BTZ-10526043, MMV676603 | |||||||
| BU08028 | 9294 | compound 1b [PMID: 21866885] | |||||||
| BU10038 | 14129 | ||||||||
| BU72 |
|
9363 | compound 10 (Husbands and Lewis, 1995) | ||||||
| bucindolol | 13193 | MJ 13105, MJ-13105 | |||||||
| bucladesine | 5485 | actosin, cyclic AMP dibutyrate, dbcAMP, dibutyryl cAMP | |||||||
| buclizine |
|
7134 | UCB-4445 | ||||||
| budesonide |
|
|
7434 | Entocort®, Eohilia® (budesonide oral suspension), Jorveza®, Pulmicort®, S-1320, Uceris® | |||||
| BU-E 47 | 1219 | ||||||||
| bufexamac |
|
|
7498 | CP-1044-J3, Paraderm®, Parfenac® | |||||
| bufuralol | 9834 | ||||||||
| bulaquine |
|
10414 | CDRI-80/53, elubaquine | ||||||
| bumetanide |
|
|
4837 | Bumex®, Burinex®, PF 1593, Ro 10-6338 | |||||
| bunolol |
|
570 | (+/-)-bunolol, BRN 1887243, racemic bunolol, W-6421A | ||||||
| buparlisib |
|
7878 | BKM 120, BKM-120, BKM120, NVP-BKM120 | ||||||
| bupivacaine |
|
2397 | DL-Bupivacaine, Exparel®, Marcain®, Posimir®, Sensorcaine®, W-7, Xaracoll® | ||||||
| bupranolol |
|
550 | Betadrenol®, BRN 2272923, Ophtorenin®, SK&F 16805-A | ||||||
| buprenorphine |
|
1670 | Buprenex®, Buvidal®, CAM2038, Sixmo® (buprenorphine hydrochloride), Subutex®, Temgesic® | ||||||
| bupropion |
|
7135 | amfebutamone, BW-323, Wellbutrin®, Zyban® | ||||||
| burimamide | 1229 | ||||||||
| buspirone |
|
|
36 | Buspar®, MJ-9022-1 | |||||
| busulfan |
|
7136 | Busulfex IV®, Myleran® | ||||||
| butabarbital |
|
7137 | Butisol® | ||||||
| (+)-butaclamol | 62 | ||||||||
| butalbital |
|
7138 | alisobumal, allylbarbituric acid, itobarbital, tetrallobarbital | ||||||
| butaprost | 3379 | ||||||||
| butaprost (free acid form) | 1892 | butaprost acid | |||||||
| butikacin | 10766 | UK-18,892, UK-18892, UK18892 | |||||||
| butorphanol |
|
7591 | butorphanol tartrate, LEVO-BC-2627 | ||||||
| butoxamine | 9809 | ||||||||
| 5-butyl-1H-pyrazole-3-carboxylic acid |
|
1591 | |||||||
| 5-butyl-methyl immidazole carboxylate 30 | 6917 | compound 30 [PMID: 22889560] | |||||||
| [11C]butylthio-TZTP |
|
|
3268 | [11C]butylthio-TZTP (PET ligand) | |||||
| 2-Butynoic acid | 12862 | compound 15 [PMID: 21220428], SCA15, small carboxylic acid 15, tetrolic acid | |||||||
| γ-butyrolactone |
|
5462 | 2-oxolanone, 4-butanolide, gamma-butyrolactone | ||||||
| BV-6 | 7914 | BV6 | |||||||
| BVT173187 | 5825 | BVT 173187 | |||||||
| BW-A1433 | 443 | BWA1433 | |||||||
| BWA-522 | 12912 | BWA522, compound 28 [PMID: 37556600] | |||||||
| BWA868C | 1897 | BWA 868C, BWA-868C | |||||||
| [3H]BWA868C |
|
|
1899 | ||||||
| BW B70C | 11393 | BW-B70C, BWB-70C, BWB70C | |||||||
| BW 245C | 1878 | BW-245C, BW245C | |||||||
| BW284C51 |
|
6600 | |||||||
| BW723C86 | 161 | BW-72386 | |||||||
| BWC0977 | 12809 | ||||||||
| BW373U86 | 9002 | BW 373U86, BW-373U86, SNC-86 | |||||||
| BX 048 | 1766 | BX-048, BX048 | |||||||
| BX-430 |
|
9543 | BX430 | ||||||
| BX 471 |
|
767 | BX-471, BX-741 | ||||||
| BX 667 | 1767 | BX-667, BX667 | |||||||
| BX-795 |
|
|
8006 | BX 795, BX795 | |||||
| BX-912 | 8007 | BX 912, BX912 | |||||||
| BY13 | 13933 | ||||||||
| BzATP |
|
1757 | |||||||
| BzT-7 |
|
7515 | |||||||
| C | Back to top | ||||||||
| C004019 | 12146 | ||||||||
| C108297 |
|
9180 | Compound 52 [PMID:18226897] | ||||||
| C1-27 |
|
|
10719 | GSTO1-IN-1 | |||||
| C-176 |
|
13136 | C-176 STING inhibitor | ||||||
| C2230 | 14011 | ||||||||
| C391 |
|
9570 | compound 5 [PMID: 27994760] | ||||||
| C646 |
|
7004 | |||||||
| CAA0225 |
|
6532 | |||||||
| cabazitaxel |
|
6798 | Jevanta®, taxoid XRP6258, TXD 258, XRP-6258 | ||||||
| cabergoline |
|
37 | Cabaser®, Caberlin® | ||||||
| cabotegravir |
|
11386 | Apretude®, CAB, Cabenuva® (cabotegravir + rilpivirine), GSK-1265744, GSK1265744, GSK744, Vocabria® | ||||||
| cabozantinib |
|
5887 | BMS907351, Cabometyx®, Cometriq®, XL-184, XL184 | ||||||
| CACA | 4148 | 4-aminocrotonic acid, cis-aminocrotonic acid | |||||||
| CaCCinh-A01 | 12257 | CaCCinh-A01 | |||||||
| cadazolid |
|
10767 | ACT-179811, ACT179811 | ||||||
| cadefrecitinib | 14047 | compound 9 [PMID: 38805213], GLPG-3667, GLPG3667 | |||||||
| calcipotriol |
|
|
2778 | calcipotriene, Calcitrene®, Dovonex®, MC903 | |||||
| calhex 231 | 714 | calhex-231 | |||||||
| calindol | 719 | ||||||||
| cambritaxestat |
|
|
13506 | compound 9v [PMID: 27780639], CRT-0273750, CRT0273750, IOA-289 | |||||
| camicinal | 4035 | GSK 962040, GSK962040 | |||||||
| camizestrant | 12716 | AZ-14066724, AZ14066724, AZD-9833, AZD9833, compound 28 PMID: 32910656] | |||||||
| camlipixant |
|
11232 | BLU-5937, BLU5937, NEO5937, P2X3 antagonist 34 | ||||||
| camonagrel | 5157 | ||||||||
| camonsertib | 12073 | RP-3500, RP3500 | |||||||
| camostat |
|
6432 | ONO-3403 | ||||||
| [3H]cAMP |
|
|
|
5096 | [3H]-cAMP | ||||
| canagliflozin |
|
|
4582 | Invokana®, JNJ-28431754, TA-7284 | |||||
| candesartan |
|
587 | CV-11974, TCV-116 (prodrug) | ||||||
| [3H]candesartan |
|
|
6907 | ||||||
| candesartan cilexetil | 8352 | ||||||||
| candoxatril | 6492 | ||||||||
| candoxatrilat | 6491 | UK-69578 | |||||||
| canertinib |
|
5675 | CI 1033, CI-1033, PD 183805 dihydrochloride | ||||||
| cangrelor |
|
1776 | AR-C69931MX, ARL69931, Kengreal®, Kengrexal® | ||||||
| canlitinib | 12865 | CX-1003, CX1003, Kanitinib | |||||||
| cannabidiol-dimethylheptyl (-)-CBD-DMH | 10012 | (-)-5'-CBD-DMH, (-)-5'-DMH-CBD, 1"',1'"-Dimethylheptylcannabidiol, 5-(1,1-Dimethylheptyl)cannabidiol, DMH-CBD | |||||||
| cannabidiolic acid | 10600 | cannabidiol acid, CBDA | |||||||
| cannabinol | 740 | ||||||||
| cannabinor | 12752 | PRS-211,375, PRS-211375 | |||||||
| canrenone |
|
13963 | aldadiene, Luvion®, Phanurane®, SC-9376, SC9376 | ||||||
| canverixin | 14179 | ACT-1004-1239, compound 28f [PMID: 33314938] | |||||||
| capadenoson | 11221 | BAY 68-4986, BAY-68-4986, BAY684986 | |||||||
| capecitabine |
|
6799 | Ro-09-1978-000, Ro-091978000, Xeloda® | ||||||
| capeserod | 29 | SL65.0155 | |||||||
| capivasertib |
|
|
7709 | AZD 5363, AZD-5363, AZD5363, cc-638, Truqap® | |||||
| capmatinib |
|
7904 | INC280, INCB28060, Tabrecta® | ||||||
| capsazepine |
|
2461 | |||||||
| captopril |
|
|
5158 | Capoten®, SQ-14225 | |||||
| carazolol |
|
569 | BM-51052, conducton, corazolol | ||||||
| carbachol |
|
|
298 | Carbastat®, Carboptic® | |||||
| carbacyclin | 1893 | carboprostacyclin | |||||||
| carbamazepine |
|
|
5339 | calepsin, Carnexiv®, Tegretol® | |||||
| carbenicillin |
|
10768 | BRL-2064, BRL2064, carboxybenzylpenicillin, CBPC, CP 15639-2, CP-156392, Pyopen® | ||||||
| carbenoxolone |
|
4151 | |||||||
| carbidopa |
|
|
5159 | Duodopa®, Lodosyn®, MK 486 | |||||
| carbinoxamine |
|
7139 | carbinoxamine maleate, Clistin® | ||||||
| carbocyclic thromboxane A2 | 1970 | CTA2, 9α,11α,11a-dicarba-TXA2, CTA-2 | |||||||
| C3a receptor agonist | 11252 | compound 7 [PMID: 17459702] | |||||||
| carfecillin |
|
12288 | BRL 3475, carbenicillin phenyl, Uticillin® | ||||||
| carfentanil |
|
10040 | (4-methoxycarbonyl)fentanyl, carfentanyl, R 33,799, R-31833, R31833, Wildnil® | ||||||
| carfilzomib |
|
7420 | Kyprolis®, PR-171 | ||||||
| carglumic acid |
|
7458 | N-carbamylglutamate, Carbaglu®, OE-312 | ||||||
| carindacillin |
|
12276 | carbenicillin indanyl, CP-15,464-2, CP-15464-2, Geocillin® | ||||||
| cariprazine |
|
|
7671 | Reagila®, RGH 188, RGH-188, Vraylar® | |||||
| carisoprodol |
|
7610 | Soma® | ||||||
| carmoterol |
|
7582 | |||||||
| carmustine |
|
6800 | BiCNU®, Carustine® | ||||||
| carotegrast |
|
10511 | HCA2969 | ||||||
| carotegrast methyl |
|
|
10510 | AJM-300, AJM300, Carogra® | |||||
| carphenazine |
|
7140 | Proketazine®, WY-2445 | ||||||
| carprofen |
|
|
7141 | Ro-205720000 | |||||
| carteolol |
|
7142 | ABBOTT-43326, Cartrol®, Ocupress®, OPC-1085 | ||||||
| carumonam |
|
12296 | AMA-1080, Ro 17-2301 | ||||||
| carvedilol |
|
551 | Coreg®, DQ 2466, Eucardic®, SKF 105517 | ||||||
| CAS-010 | 14186 | ||||||||
| casdatifan | 13981 | ||||||||
| casein kinase II inhibitor III | 5941 | TBCA, tetrabromocinnamic acid | |||||||
| casopitant | 5758 | GW679769, Rezonic (proposed trade name), Zunrisa (proposed trade name) | |||||||
| casp 4 inhib | 8635 | 1-methyl-5-nitro-isatin, 5-nitro-isatin 1 [PMID: 11384246] | |||||||
| catadegbrutinib | 13736 | BGB-116673, BGB116673, compound 14 [WO2021219070A1] | |||||||
| catequentinib |
|
9601 | AL-3818, AL3818, anlotinib | ||||||
| CATPB | 6487 | ||||||||
| CAY10441 | 1969 | CAY-10441, Ro-1138452, RO1138452 | |||||||
| CAY10499 | 12994 | CAY-10499 | |||||||
| CAY10583 | 6161 | CAY 10583, CAY-10583, compound A [PMID:15866883] | |||||||
| 2C-B | 13549 | BDMPEA | |||||||
| CB-103 | 10517 | CB103 | |||||||
| CBA | 10038 | compound 5 [PMID: 29579323] | |||||||
| CBDMB | 4593 | CB-DMB | |||||||
| CBiPES | 3372 | LY-566332, LY566332 | |||||||
| CBIQ | 4152 | ||||||||
| CBOBNEA | 7778 | carboxybiphenyloxy-butoxy-naphthalen-ethylacetamide | |||||||
| C1-BODIPY-C12 | 5496 | C1-Bodipy-C12 | |||||||
| CBPD-268 | 13245 | CBPD268, compound 33 [PMID: 38477974] | |||||||
| CBPD-409 | 13301 | CBPD409, compound 25 [PMID: 38530938] | |||||||
| (S)-(+)-CBPG | 3421 | ||||||||
| CBS-3595 |
|
9610 | |||||||
| CC-401 | 11457 | CC401 | |||||||
| CC-885 |
|
9224 | |||||||
| CC-90005 | 11659 | CC90005, compound 57 [PMID: 34355886] | |||||||
| CC-90009 | 11424 | Cereblon modulator 1, Compound 1 [WO2019006299A1], compound 16 [PMID: 33591756] | |||||||
| CC-90011 |
|
11284 | CC90011, compound 11 [PMID: 33034194] | ||||||
| CCF981 |
|
11658 | CCF0058981, compound 41 [PMID: 34347470] | ||||||
| CCG-100602 | 6764 | CCG 100602, CCG100602, compound 4g [PMID: 19963382] | |||||||
| CCG-1423 | 6761 | CCG 1423, CCG1423 | |||||||
| CCG-203920 | 8034 | CCG203920, RGS4 inhibitor 13 | |||||||
| CCG-203971 | 6763 | CCG 203971, CCG203971, compound 8a [PMID: 23707258] | |||||||
| CCG258747 |
|
10946 | |||||||
| CCG-4986 | 8721 | compound 1 | |||||||
| CCG-50014 | 7784 | CCG 50014, CCG50014, compound 1a | |||||||
| CCG-63802 | 8724 | ||||||||
| CCG-63808 | 8725 | ||||||||
| CCG-977 | 6762 | CCG 977, CCG977 | |||||||
| CCP | 5161 | ||||||||
| CCPA | 374 | 2-chloro-N(6)cyclopentyladenosine, 2-chloro-N6-cyclopentyladenosine (2-Cl-CPA) | |||||||
| [3H]CCPA |
|
|
379 | [3H]-CCPA | |||||
| CCR5 antagonist 34 |
|
10106 | |||||||
| CCR2-RA-[R] |
|
|
9431 | analog 49 (Dasse et al., 2007) | |||||
| CCT129957 | 8820 | ||||||||
| CCT196969 | 9815 | ||||||||
| CCT241161 | 9814 | ||||||||
| CCT241533 | 8044 | CCT-241533 | |||||||
| CCT244747 | 8215 | compound 26 [PMID: 23082860] | |||||||
| CCT245737 | 9187 | compound 4 [PMID: 27167172] | |||||||
| CCT251545 |
|
8945 | |||||||
| CCT365623 | 10485 | compound 9f [PMID: 31070916] | |||||||
| CCX354 |
|
10164 | CCX 354, CCX-354, CCX-354-C | ||||||
| CD2314 | 8906 | CD 2314, CD-2314 | |||||||
| CD2665 | 2654 | CD 2665, CD-2665 | |||||||
| CD3254 |
|
2810 | CD 3254, CD-3254 | ||||||
| CD666 | 2652 | CD 666, CD-666 | |||||||
| CDC | 5162 | cinnamyl-3,4-dihydroxy-α-cyanocinnamate | |||||||
| Cdc2-like kinase inhibitor |
|
5942 | Clk inhibitor, TG 003, TG-003, TG003 | ||||||
| CDD-1976 | 11702 | CDD1976 | |||||||
| CDDO-Me | 3443 | 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid methyl ester | |||||||
| Cdk/Crk inhibitor | 5943 | pyrazolopyrimidone analog, RGB-286147 | |||||||
| CDK12 inhibitor 2 | 10063 | ||||||||
| Cdk1/5 inhibitor | 5947 | quinoxaline1 | |||||||
| Cdk1 inhibitor | 5944 | ||||||||
| Cdk4 inhibitor | 5950 | indolocarbazole deriv. 4(d), K00024 | |||||||
| CDK inhibitor 4.35 |
|
10357 | LGR4455 | ||||||
| CDK9 inhibitor 1-7a-B1 | 13916 | ||||||||
| Cdk4 inhibitor II | 5951 | NSC 625987, NSC-625987, NSC625987 | |||||||
| Cdk1/2 inhibitor III |
|
5946 | |||||||
| Cdk2 inhibitor III |
|
5948 | AC1OCFD4, CVT-313, NG 26 | ||||||
| Cdk4 inhibitor III | 5952 | ryuvidine | |||||||
| Cdk2 inhibitor IV |
|
5949 | NU6140 | ||||||
| CDK9 PROTAC C3 | 13713 | ||||||||
| CDN1163 | 12968 | ||||||||
| CDP840 |
|
9330 | CDP 840, CDP-840 | ||||||
| CDPPB |
|
1422 | |||||||
| CDRI-97/78 |
|
10399 | |||||||
| CE-326597 | 9055 | compound 4a [PMID: 20851601] | |||||||
| cebranopadol | 8866 | GRT 6005, GRT-6005, GRT6005 | |||||||
| cedazuridine |
|
11101 | (4R)-2'-deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine, ASTX727 (cedazuridine + decitabine), compound 7a [PMID: 24520856] | ||||||
| cediranib | 5664 | AZD 2171, AZD2171, ZD 2171 | |||||||
| CEE321 |
|
12350 | CEE-321, compound 1e [PMID: 36657024] | ||||||
| CE3F4 | 10624 | ||||||||
| cefacetrile | 12192 | Celospor®, cephacetrile | |||||||
| cefaclor |
|
10897 | Ceclor®, Lilly 99638, Raniclor® | ||||||
| cefadroxil |
|
|
4831 | Duricef® | |||||
| cefaloglycin |
|
12193 | cephaloglycin, Kafocin® | ||||||
| cefalonium | 13609 | cephalonium, Cepravin® (veterinary) | |||||||
| cefaloridine | 12189 | cephaloridine, ceporin | |||||||
| cefalotin |
|
|
8798 | cephalothin, cephalotin, Keflin® | |||||
| cefamandole |
|
|
12210 | cephamandole | |||||
| cefapirin |
|
12191 | Cefadyl®, cephapirin | ||||||
| cefatrizine | 12204 | BL-S640 | |||||||
| cefazaflur | 10770 | SK&F 59962 | |||||||
| cefazedone | 12203 | EMD-30087, Refosporen® | |||||||
| cefazolin |
|
|
10935 | Ancef®, cephazolin, CEZ, Kefzol®, SK&F-41558 | |||||
| cefbuperazone | 12253 | ||||||||
| cefcapene |
|
12053 | Flomox® (cefcapene pivoxil), S-1006 | ||||||
| cefclidin | 10771 | cefclidine, E-1040, E1040 | |||||||
| cefdinir |
|
12023 | FK 482, Omnicef® | ||||||
| cefditoren |
|
12030 | ME 1206, Spectracef® (cefditoren pivoxil) | ||||||
| cefepime |
|
10772 | BMY-28142, BMY28142, CFPM, Maxipime®, Renapime® | ||||||
| cefetamet | 12416 | Ro 15-8074 | |||||||
| cefetecol | 10775 | GR-69153, GR-69153X, GR69153 | |||||||
| cefiderocol |
|
10776 | compound 3 [PMID: 29960205], Fetcroja®, Fetroja®, GSK-2696266, GSK2696266, RSC 649266, RSC-649266, RSC649266, S-649266 | ||||||
| cefixime |
|
|
10898 | (E)-Cefixime, Cefspan®, CFIX, FK-027, FR-17027, Suprax® | |||||
| cefluprenam | 10777 | E-1077, E1077 | |||||||
| cefmatilen | 10778 | S-1090, S1090 | |||||||
| cefmenoxime |
|
12024 | A-50912, Abbott 50192, Bestron®, Cefmax®, SCE-1365 | ||||||
| cefmetazole |
|
|
12215 | CS-1170, U-72791, Zefazone® | |||||
| cefminox | 12255 | MT 141 | |||||||
| cefodizime | 12032 | HR 221 | |||||||
| cefonicid |
|
12217 | Monocid®, SK&F 75073 | ||||||
| cefoperazone |
|
12025 | Cefobid®, T-1551 | ||||||
| ceforanide |
|
12218 | BL-S786, Precef® | ||||||
| cefoselis |
|
12034 | FK-037, Wincef® | ||||||
| cefotaxime |
|
|
10893 | Claforan®, Ru-24756 | |||||
| cefotetan |
|
10936 | Apatef®, Cefotan®, ICI-156834, ICI156834 | ||||||
| cefotiam | 12254 | SCE 963 | |||||||
| cefovecin | 13654 | Convenia® (veterinary) | |||||||
| cefoxitin |
|
|
10937 | Cenomycin®, CFX, Mefoxin®, MK-306, MK306 | |||||
| cefozopran |
|
12054 | SCE-2787 | ||||||
| cefpimizole | 10779 | CPIZ, U 63196E, U-63,196, U-63196E | |||||||
| cefpiramide |
|
12027 | SM-1652, WY-44635 | ||||||
| cefpirome |
|
12033 | HR 810, Romecef® | ||||||
| cefpodoxime |
|
10780 | RU-51746, Vantin® | ||||||
| cefprozil |
|
12219 | BMY-28100, Cefzil® | ||||||
| cefquinome | 13622 | Cobactan® (veterinary), HR 111V | |||||||
| cefroxadine |
|
13619 | CGP 9000, CGP-9000, Oraspor® | ||||||
| cefsulodin | 10783 | Cefonomil®, CGP-7174-E, CGP7174/E | |||||||
| ceftaroline fosamil |
|
10899 | PPI-0903, TAK-599, Teflaro®, Zinforo® | ||||||
| ceftazidime |
|
10762 | CAZ, Fortaz®, Fortum®, GR 20263, GR-20263, GR20263, LY-139381, LY139381, Pentacef®, Tazicef® | ||||||
| cefteram |
|
11051 | cefterame, ceftetrame, CFTM, Ro 19-5247, T-2525 | ||||||
| ceftezole | 12259 | ceftezol, FR10123 | |||||||
| ceftibuten |
|
12029 | 7432-S, Cedax®, SCH 39720 | ||||||
| ceftiofur | 13653 | Naxcel® (veterinary) | |||||||
| ceftiolene | 10784 | 42980RP, cefatiolene, RP 42,980, RP 42980, RP-42980, RP42980 | |||||||
| ceftizoxime |
|
10785 | Cefizox®, compound 22 {PMID: 2342058], Epocelin®, FK-749, FK749, FR-13749, FR13749, SK&F 88373-Z | ||||||
| ceftizoxime alapivoxil | 10786 | AS-924, AS924, KY-020, KY020 | |||||||
| ceftobiprole |
|
10787 | BAL-9141, BAL9141, BAL9141-000, BAL9141000, Ro-63-9141, Ro-639141, Zeftera®, Zevtera® | ||||||
| ceftolozane |
|
10788 | CXA-101, CXA101, FR-264205, FR264205, Zerbaxa® (ceftolozane + tazobactam) | ||||||
| ceftriaxone |
|
5326 | Rocephin® | ||||||
| cefuroxime |
|
|
10900 | Ceftin®, CXM, Kefurox®, Zinacef® | |||||
| celecoxib |
|
|
|
2892 | Celecox®, Elyxyb® (DFN-15; oral solution), Onsenal®, SC-58635, SC58635 | ||||
| celiprolol |
|
9064 | Celectol®, REV 5320, Selectol®, ST-1396, ST1396 | ||||||
| cemdomespib | 13726 | BIIB-143, BIIB143, compound 13b [PMID: 22702513], compound 3 [PMID: 35905686], KU-596, KU596, RTA 901, RTA-901 | |||||||
| cenacitinib | 13487 | compound 5 [US20210139486] | |||||||
| cenerimod |
|
|
9824 | ACT-334441 | |||||
| cenicriviroc |
|
801 | TAK 652, TAK-652, TAK652, TBR-652 | ||||||
| cenisertib | 9927 | AS-703569, AS703569, compound 2 [PMID: 22695126], compound 60a [WO2005118544A2], enantiomer E1 [WO2005118544A2], R-763, R763 | |||||||
| cenobamate |
|
10773 | Ontozry®, Xcopri®, YKP-3089, YKP3089 | ||||||
| centrinone B | 13844 | Centrinone-B, LCR-323, LCR323 | |||||||
| CEP-11981 | 8189 | CEP 11981, CEP11981, compound 11b [PMID 22148921] | |||||||
| CEP-1347 | 8173 | CEP 1347, CEP1347, KT-7515, KT7515 | |||||||
| CEP-33779 | 9387 | CEP33779, compound 29 [PMID: 22594690] | |||||||
| CEP-37440 | 9698 | CEP37440, compound 27b [PMID: 27527804] | |||||||
| ceperognastat |
|
11953 | LY-3372689, LY3372689 | ||||||
| cephalexin |
|
4832 | cefalexin, Ceporex®, Keflex® | ||||||
| cephradine |
|
4830 | cefradine, Infexin®, Velocef® | ||||||
| ceralasertib | 9390 | AZD-6738, AZD6738 | |||||||
| cerdulatinib |
|
|
8957 | PRT 062070, PRT-062070, PRT-2070, PRT062070 | |||||
| ceritinib |
|
|
7397 | compound 15b [PMID 23742252], LDK378, NVP-LDK378-NX, Zykadia® | |||||
| cerivastatin |
|
2950 | Baycol®, Lipobay® | ||||||
| cerlapirdine | 7356 | PF-05212365, SAM-531, WAY-262531 | |||||||
| ceruletide |
|
7589 | caerulein, cerulein, ceruletide diethylamine, Tymtran® | ||||||
| CES2 inhibitor 9d | 13920 | ||||||||
| cetagliptin |
|
13952 | CGT-8012, CGT8012, compound 8 [CN101899047A] | ||||||
| cetefloxacin | 10790 | compound 43f [PMID: 7990118], E-4868, E4868 | |||||||
| cethromycin |
|
10791 | A-195773, Abbott-195773, ABT-773, ABT773, Restanza® | ||||||
| cetilistat |
|
11433 | ATL-962, ATL962, Oblean® | ||||||
| cetirizine |
|
|
1222 | Reactine®, Zyrtec® | |||||
| (R)-cetirizine |
|
|
1214 | Vozet®, Xyzal® | |||||
| (S)-cetirizine |
|
1215 | |||||||
| cetocycline | 10792 | A-40728, Abbott 40728, chelocardin, compound 1 [PMID: 379332] | |||||||
| cevimeline |
|
9658 | Evoxac® | ||||||
| CFMMC | 6340 | ||||||||
| CFMTI | 6341 | ||||||||
| CFT1946 | 12623 | CFT-1946 | |||||||
| CFT7455 | 11961 | ||||||||
| CFT8634 | 11965 | CFT-8634 | |||||||
| CFTRinh-172 | 4153 | ||||||||
| CG200745 |
|
10055 | CG-2, CG-200745, HDCG-0745 | ||||||
| CGI1746 |
|
|
8066 | CGI 1746, CGI-1746 | |||||
| CGI560 |
|
9264 | CGI-560 | ||||||
| CGP 12177 | 532 | CGP 12177A, CGP12177A | |||||||
| CGP13501 | 7848 | CGP 13501, CGP-13501 | |||||||
| CGP-31608 | 10963 | CGP 31608, CGP31608 | |||||||
| CGP35348 |
|
1069 | CGP 35348, CGP-35348 | ||||||
| CGP 36742 |
|
1085 | CGP-36742, CGP36742 | ||||||
| CGP-37157 | 11611 | CGP37157 | |||||||
| CGP37849 | 4154 | CGP 37849, CGP-37849 | |||||||
| CGP44532 | 1082 | CGP 44532, CGP-44532 | |||||||
| CGP 46381 |
|
1086 | CGP-46381, CGP46381 | ||||||
| CGP 47656 | 1066 | CGP-47656, CGP47656 | |||||||
| CGP53353 | 5163 | CGP 53353, CGP-53353, PKCbII/EGFR Inhibitor | |||||||
| CGP55845 |
|
1088 | CGP 55845, CGP-55845, CGP-55845A | ||||||
| CGP61594 | 5474 | CGP 61594, CGP-61594 | |||||||
| CGP62349 | 1072 | CGP 62349, CGP-62349 | |||||||
| CGP 64213 | 1073 | CGP-64213, CGP64213 | |||||||
| CGP 71872 | 1074 | CGP-71872, CGP71872 | |||||||
| CGP7930 | 1079 | CGP 7930, CGP-7930 | |||||||
| [125I]CGP64213 |
|
|
1076 | ||||||
| [125I]CGP71872 |
|
|
1077 | CGP 71872 | |||||
| [3H](-)CGP 12177 |
|
|
531 | ||||||
| [3H]CGP12177 |
|
|
5387 | [3H]-CGP12177, [3H]CGP 12177 | |||||
| [3H]CGP27492 |
|
|
5381 | [3H]-3-APPA, [3H]-CGP27492, [3H]3-APPA | |||||
| [3H]CGP39653 |
|
|
4078 | ||||||
| [3H]CGP54626 |
|
|
|
1090 | |||||
| [3H]CGP61594 |
|
|
4079 | [3H]CGP 61594 | |||||
| [3H]CGP62349 |
|
|
3429 | [3H]-CGP 62349 | |||||
| CGP 20712A | 541 | CGP-20712A, CGP20712A | |||||||
| CGP 54626A |
|
1070 | CGP-54626, CGP54626 | ||||||
| CGP 56999A | 1071 | CGP-56999A, CGP56999A | |||||||
| CGP 71683A | 1562 | CGP-71683A, CGP71683A, GNF-Pf-1864, TCMDC-124251 | |||||||
| CGP74514A |
|
5945 | CGP 74514A, CGP-74514A | ||||||
| CGS-12066 | 109 | CGS 12066, CGS 12066B, CGS-12066A, CGS-12066B, CGS12066 | |||||||
| CGS 15943 |
|
384 | CGS 15943A, CGS-15943, CGS15943 | ||||||
| CGS 21680 |
|
375 | CGS-21680, CGS21680 | ||||||
| CGS 24012 | 418 | CGS-24012, CGS24012, DPMA | |||||||
| CGS8216 | 4156 | CGS 8216, CGS-8216 | |||||||
| [3H]CGS19755 |
|
|
4080 | ||||||
| [3H]CGS 21680 |
|
|
|
424 | [3H]-CGS21680 | ||||
| [3H]CGS23131 |
|
|
3415 | [3H]CGS 23131, [3H]-CGS23131, LY223982 | |||||
| [3H]CGS8216 |
|
|
4366 | ||||||
| CGS-27023A |
|
8846 | CGS 27023A, CGS27023A, MMI270 | ||||||
| CH-4051 |
|
9844 | Formula (10) [WO2012078708A1] | ||||||
| CH4987655 |
|
9910 | compound 24 [PMID: 21316218], RO4987655 | ||||||
| CH7057288 |
|
12237 | CH-7057288, compound 7 [PMID: 36066182] | ||||||
| CH7233163 |
|
12985 | CH-7233163 | ||||||
| chenodeoxycholyl-Nε-nitrobenzoxadiazol-lysine |
|
4770 | |||||||
| CHF-5074 |
|
7339 | CHF 5074, CHF5074 | ||||||
| CHF-6366 | 12165 | CHF6366, compound 29 [PMID: 35901125] | |||||||
| CHF-6523 |
|
13639 | CHF 6523, CHF6523, example 1a [WO2020200918] | ||||||
| chiglitazar |
|
12287 | Bilessglu®, CS-038, CS038 | ||||||
| chinfloxacin | 11017 | ||||||||
| CHIR-124 | 9365 | CHIR124, compound 11 [PMID: 6603354] | |||||||
| CHIR-265 |
|
5674 | CHIR 265, CHIR265, RAF 265, RAF-265, RAF265 | ||||||
| CHIR-98014 | 8016 | CHIR 98014, CHIR98014 | |||||||
| Chk2 inhibitor II |
|
5954 | |||||||
| chlophedianol |
|
7324 | SL-501, Ulone® | ||||||
| chlorambucil |
|
|
7143 | chlorbutin, Leukeran® | |||||
| chloramphenicol |
|
|
10901 | Brolene®, chloromycetin | |||||
| chlordane | 2831 | chlordan | |||||||
| chlordiazepoxide |
|
3370 | chlordiazepoxide HCl, Librium®, Lygen® | ||||||
| chlorhexidine |
|
14052 | |||||||
| chlormezanone |
|
7323 | chlormethazanone, Fenaprim®, Trancopa® | ||||||
| 2-chloroadenosine | 372 | 2Cl-Ado, CADO | |||||||
| 2-chloroadenosine-5-triphosphate | 1716 | 2-ClATP, 2-chloro-ATP | |||||||
| chlorobenzylidene malononitrile | 4158 | 2-chlorobenzylidene malononitrile, alonitrile, CS gas (lacrimator) | |||||||
| chloroform |
|
2503 | |||||||
| 5-(6-chloro-2-hexyl-1H-indol-1-yl)-5-oxo-valeric acid | 6174 | compound 39 [PMID: 23581530] | |||||||
| 2-(3-chlorophenyl)histamine | 1195 | ||||||||
| chloropicrin | 6292 | nitrotrichloromethane, trichloronitromethane | |||||||
| chloroprocaine |
|
7145 | chloroprocaine hydrochloride, Nesacaine® | ||||||
| chloroquine |
|
|
|
|
5535 | Aralen®, chloraquine, Malaquin® | |||
| (S)-chlorosuccinic acid | 9634 | (S)-2-chlorosuccinic acid | |||||||
| chlorothiazide |
|
4835 | Diuril® | ||||||
| chlorotrianisene |
|
7146 | chlortrianisestrol, Tace® | ||||||
| 3-chlorotyrosine | 5114 | ||||||||
| (+)-chlorpheniramine | 1210 | chlorphenamine | |||||||
| (-)-chlorpheniramine | 1213 | ||||||||
| chlorpheniramine |
|
6976 | chlorprophenpyridamine maleate, Phenetron®, Teldrin® | ||||||
| chlorpromazine |
|
|
83 | chlorpromazine HCl, Largactil®, Thorazine® | |||||
| chlorpropamide |
|
|
6801 | Diabenese®, Glucamide® | |||||
| chlorprothixene |
|
11976 | N-714, Ro-4-0403, Taractan®, Truxal® | ||||||
| chlorthalidone |
|
7147 | G-33182, Hygroton® | ||||||
| chlorzoxazone |
|
|
2322 | Paraflex® | |||||
| CHMFL-BTK-11 |
|
9516 | |||||||
| CHMFL-KIT-64 | 10420 | compound 18 [PMID: 31250638] | |||||||
| CHMFL-KIT-8140 | 9301 | ||||||||
| CHMFL-PI4K-127 |
|
11285 | |||||||
| C10 (homobivalent 4-aminoquinoline) | 13180 | ||||||||
| CHPG | 1417 | 2-chloro-5-hydroxyphenylglycine | |||||||
| (S)-4C3HPG | 1374 | ||||||||
| CHR-3996 | 8391 | CHR 3996, CHR3996, compound 21r [PMID 21080647] | |||||||
| chroman 28 | 664 | ||||||||
| CI-1015 | 872 | CI 1015, CI1015, PD 144598 | |||||||
| CI-1040 | 5676 | CI 1040, CI1040, PD-184352, PD184352 | |||||||
| CI-966 | 4612 | CI 966, CI966 | |||||||
| CI-988 | 873 | CI 988, CI988, PD 134308, PD-134,308, PD-134308 | |||||||
| CIAC001 | 12913 | ||||||||
| cicaprost |
|
1917 | ZK 96480, ZK-96480 | ||||||
| ciclesonide |
|
|
7469 | Alvesco®, Omnaris®, RPR-251526 | |||||
| ciclopirox |
|
|
11349 | Ciclodan®, HOE-296, HOE-296b, Loprox® | |||||
| cicloprolol | 552 | SL 75-177-10 | |||||||
| CID1172084 | 5564 | CID 1172084 | |||||||
| CID16020046 | 6577 | CID 16020046 | |||||||
| CID16197121 | 8579 | ||||||||
| CID1792197 | 5563 | CID 1792197 | |||||||
| CID2440433 |
|
5565 | CID 2440433 | ||||||
| CID2745687 | 9741 | AC1MCK4S, compound 13 [PMID: 23888932] | |||||||
| CIFEA | 7780 | cyclohexylmethyl-indenofurane-ethylacetamide | |||||||
| ciforadenant |
|
10190 | CPI-444, CPI444, V-81444, V81444 | ||||||
| ciglitazone | 2711 | ||||||||
| cilansetron | 2297 | ||||||||
| cilastatin |
|
5166 | MK 0791, MK-791, MK791, Primaxin® | ||||||
| cilazapril |
|
6459 | Inhibace®, Ro 31-2848006, Vascace® | ||||||
| cilazaprilat |
|
6461 | Ro 31-3113 | ||||||
| cilnidipine |
|
7767 | FRC-8653 | ||||||
| cilobradine |
|
2355 | DK-AH269 | ||||||
| cilofexor |
|
10644 | example 13/9 [US10485795B2], GS-9674, GS9674 | ||||||
| cilomilast |
|
|
7407 | SB-207499 | |||||
| cilostamide | 5167 | OPC 3689 | |||||||
| cilostazol |
|
7148 | OPC-13013, OPC-21, Pletal® | ||||||
| CIM0216 | 10297 | CIM-0216 | |||||||
| cimadronate | 3174 | cimadronic acid, icandronate, incadronic acid, YM-175 | |||||||
| cimaterol | 12578 | AB-A 663, ABA-663, cimatrol, CL-263,780 | |||||||
| cimetidine |
|
|
1231 | cimetidine HCl, Tagamet® | |||||
| cimpuciclib | 11409 | example 63 [WO2018045956A1] | |||||||
| cinacalcet |
|
|
3308 | AMG-073, Mimpara®, Sensipar® | |||||
| cinaciguat |
|
5168 | BAY 58-2667 | ||||||
| cinnamaldehyde |
|
2423 | cinnamic aldehyde | ||||||
| cinnamic acid |
|
3203 | |||||||
| cinnarizine |
|
|
9072 | R-1575, Stugeron® | |||||
| cinoxacin |
|
12401 | Cinobac®, Lilly 64716 | ||||||
| cinromide | 10256 | 3-bromo-N-ethylcinnamamide | |||||||
| cinsebrutinib | 12867 | 5-6 enantiomer A [WO2021207549A1], example 5-6 [WO2021207549A1] | |||||||
| cintirorgon |
|
10045 | compound 32J [WO2016201225A1], LYC-55716, LYC55716 | ||||||
| cipargamin |
|
9721 | KAE609, NITD609 | ||||||
| cipemastat |
|
6466 | Ro 28-2653 | ||||||
| cipralisant | 1244 | GT-2331 | |||||||
| ciprofibrate |
|
3438 | Lipanor®, Modalim®, WIN-35833 | ||||||
| ciprofloxacin |
|
|
10902 | BAY-O-9867, BAY-O9867, Cetraxal®, Ciloxan®, Cipro®, CPFX, Proquin XR | |||||
| ciproxifan | 1265 | FUB-359, FUB359 | |||||||
| cirazoline | 515 | ||||||||
| cirtociclib | 13297 | BLU-222, BLU222 | |||||||
| cirtuvivint | 12620 | example 545 [WO2020150552], SM-08502, SM08502 | |||||||
| cis-3-ACPBPA | 4096 | 3-amino-cyclopentenylbutylphosphonic acid | |||||||
| cisapride |
|
240 | Prepulsid®, Propulsid® | ||||||
| (±)-cis-2-CAMP | 4067 | ||||||||
| cis-1,2-cyclopropanedicarboxylic acid | 9632 | ||||||||
| [3H](+)-cis-diltiazem |
|
|
2512 | [3H]-(+)-cis-diltiazem | |||||
| cis-epoxysuccinic acid |
|
9631 | |||||||
| (+)-cis-H2-PAT | 1208 | ||||||||
| (±)-cis-H2-PAT | 1206 | ||||||||
| cis-JB253 | 7787 | ||||||||
| cis-10 [PMID: 15771457] | 6474 | ||||||||
| [3H]9-cis-retinoic acid |
|
|
|
5383 | [3H]-9-cis-retinoic acid | ||||
| citalopram |
|
7547 | Celexa®, Cipramil®, LU-10171B | ||||||
| [3H]citalopram |
|
|
4621 | [3H]-citalopram | |||||
| citarinostat |
|
9426 | ACY-241, Compound (I) [WO2016200919], HDAC-IN-2 | ||||||
| CITCO |
|
2758 | |||||||
| citronellal | 6300 | 3,7-dimethyl-6-octenal, rhodinal | |||||||
| civorebrutinib |
|
12868 | |||||||
| CJ-042794 | 5857 | ANW-61958, CJ 42794, CJ- 42794, RQ-00015986, RQ-15986 | |||||||
| CJ13610 | 5169 | CJ-13,610, CJ-13610 | |||||||
| CK-586 | 13526 | CK-4021586, CK586, compound 4 [WO2022187501A1] | |||||||
| CL316243 | 3462 | CL-316243, CL316,243 | |||||||
| CL82198 | 5170 | CL 82198, CL-82198 | |||||||
| 2-Cl-ADP(α-BH3) | 8447 | ||||||||
| cladribine |
|
|
4799 | Leustatin®, Litak®, Mavenclad® | |||||
| Cl-amidine | 8685 | ||||||||
| clamikalant | 13270 | HMR-1883, HMR1883 | |||||||
| clarithromycin |
|
|
10903 | 6-O-methylerythromycin, A-56268, ABBOTT-56268, Biaxin®, Klaricid®, TE-031 | |||||
| clascoterone |
|
11215 | CB-03-01, CB-0301, cortexolone 17α-propionate, Winlevi® | ||||||
| claturafenib |
|
13808 | ARRY-440, ARRY440, PF-07799933, PF07799933 | ||||||
| clazosentan |
|
12286 | AXV-034343, AXV034343, compound 22 [PMID: 9703472], Pivlaz® | ||||||
| CLB073 | 13980 | mCLB073, TBD11 | |||||||
| 5-Cl-5-deoxy-(±)-ENBA | 6560 | ||||||||
| clemastine |
|
|
6063 | HS-592, meclastin, Tavegil®, Tavist® | |||||
| clemizole |
|
|
10285 | ||||||
| clenbuterol | 12582 | NAB 365, NAB-365, Planipart®, Spiropent® | |||||||
| clesacostat | 12242 | PF-05221304, PF05221304 | |||||||
| clevidipine |
|
7468 | Cleviprex® | ||||||
| Cl-IB-MECA |
|
457 | 2Cl-IB-MECA | ||||||
| clidinium |
|
366 | Quarzan® | ||||||
| [3H]clidinium |
|
|
351 | (-)MQNB, [3H](-)N-methyl-3-quinuclidinyl benzilate, Ro-23773 | |||||
| cligosiban | 13229 | PF-3274167, PF3274167 | |||||||
| clinafloxacin | 10793 | AM 1091, CI-960, PD-127321 | |||||||
| clindamycin |
|
|
|
10607 | |||||
| 6-Cl-MLT | 1346 | 6-chloromelatonin, 6-Cl-melatonin | |||||||
| clobazam |
|
7149 | Frisium®, H-4723, HR-376, LM-2717, Onfi®, Urbanol® | ||||||
| clobenpropit |
|
|
1223 | VUF 9153, VUF-9153 | |||||
| clobetasol propionate |
|
|
|
7062 | CCI-4725, Clobex®, Dermovate®, GR 2/925, Temovate® | ||||
| clobetasone |
|
|
9088 | Eumovate® | |||||
| clodronic acid |
|
|
9605 | Bonefos®, Clasteon ®, clodronate, Loron® | |||||
| clofarabine |
|
|
6802 | CAFdA, Cl-F-araA, Clolar®, Evoltra® | |||||
| clofazimine |
|
|
9184 | Lamprene® | |||||
| clofibrate |
|
2667 | Atromid-S®, AY-61123, ICI-28257 | ||||||
| clofilium | 2507 | ||||||||
| clofoctol |
|
12926 | Gramplus®, Octofene® | ||||||
| clometocillin | 12294 | clometacillin, clomethacillin | |||||||
| clomiphene |
|
4159 | Androxal®, Clomid®, clomifene, MER-41, MRL-41, Omifin®, RMI-16289 | ||||||
| clomipramine |
|
|
2398 | Anafranil®, G-34586 | |||||
| clomocycline |
|
13541 | chlormethylenecycline, Megaclor® | ||||||
| clonazepam |
|
6963 | Klonopin®, Ro-5-4023, Ro-54023 | ||||||
| clonidine |
|
|
516 | Catapres®, Kapvay® | |||||
| [3H]clonidine |
|
|
|
13162 | |||||
| clopidogrel |
|
|
7150 | Iscover®, Plavix®, SR-25990C | |||||
| clopidogrel (active metabolite) |
|
1772 | |||||||
| cloprostenol |
|
1894 | ICI 80996 | ||||||
| clorazepate |
|
7548 | 4306 CB, Tranxene® | ||||||
| clorgiline |
|
6636 | chlorgyline, clorgyline | ||||||
| clotrimazole |
|
|
2330 | Canesten®, Lotrimin® | |||||
| cloxacillin |
|
|
11126 | BRL-1621, BRL1621, chloroxacillin, Methocillin S, Syntarpen®, Tegopen® | |||||
| clozapine |
|
|
38 | Clorazil®, HF-1854 | |||||
| 3CL protease (Mpro) inhibitor M3 | 12831 | ||||||||
| CM-272 | 13289 | CM272 | |||||||
| CM-352 | 8259 | compound 2 [PMID 25686022] | |||||||
| CMF-019 |
|
9448 | |||||||
| CMPD-1 | 1179 | furan-1 | |||||||
| cmp5 [PMID: 25742700] | 8288 | ChemBridge ID 9033823 | |||||||
| 4-CMTB | 5500 | ||||||||
| (S)-4-CMTB | 3420 | phenylacetamide 2 [PMID: 18818303] | |||||||
| CM-TPMF | 9314 | (-)-CM-TPMF | |||||||
| CMX990 | 13169 | CMX-990 | |||||||
| CNQX |
|
5475 | 6-cyano-2,3-dihydroxy-7-nitroquinoxaline, 6-cyano-7-nitroquinoxaline-2,3-dione, FG 9065 | ||||||
| [3H]CNQX |
|
|
|
4081 | |||||
| CNX-774 |
|
9266 | |||||||
| cobalt protoporphyrin IX | 8902 | CoPP, protoporphyrin IX containing Co | |||||||
| cobicistat |
|
|
7535 | GS-9350 | |||||
| cobimetinib |
|
|
7626 | cobimetinib butyrate, cobimetinib fumarate, cometinib, Cotellic®, GDC-0973, XL-518, XL518 | |||||
| cofrogliptin |
|
13765 | compound 2 [PMID: 32452679], Haisco HSK7653, HSK-7653, HSK7653 | ||||||
| colchicine |
|
|
|
2367 | Colcrys®, methoxylated analogue of XD1, XD25 | ||||
| combretastatin A4 |
|
8854 | CA-4, combretastatin A-4, NSC-613729 | ||||||
| comp-43 | 13995 | compound 43 [PMID: 33185430] | |||||||
| compound 48/80 |
|
|
5531 | ||||||
| compound 5128535 | 13992 | compound 8535, lead compound I [PMID: 38060818] | |||||||
| compound 6641 | 12503 | ||||||||
| compound 15a | 10557 | ||||||||
| Compound 245A | 13558 | example 10 [WO2005077950] | |||||||
| Compound 780A | 13559 | example 49 [WO2007017262A1] | |||||||
| compound 3a [Badolato et al., 2019] | 10345 | ||||||||
| compound 5ab [PMID: 8246233] | 2994 | ||||||||
| compound 13ac [PMID: 33256400] | 11565 | ||||||||
| compound 4a [Marquart et al., 1994] | 6707 | ||||||||
| compound 6a [Patil et al., 1989] | 2963 | ||||||||
| compound 9a [Patil et al., 1989] | 2958 | ||||||||
| compound 3a [Pipionne et al, 2018] |
|
9965 | |||||||
| compound 10a [PMID: 1447738] | 8753 | ||||||||
| compound 10a [PMID: 31283223] |
|
10435 | |||||||
| compound 11a [PMID: 14697765] | 6426 | ||||||||
| compound 12a [PMID: 29031075] |
|
9684 | |||||||
| compound 13a [PMID: 23639540] | 8155 | ||||||||
| compound 14a [PMID: 18812259] | 6254 | ||||||||
| compound 14a [PMID: 34795866] | 11837 | ||||||||
| compound 15a [PMID: 16242323] | 6724 | ||||||||
| compound 15a [PMID: 22464687] |
|
7578 | |||||||
| compound 15a [PMID: 32069401] | 10702 | ||||||||
| compound 15a [PMID: 36642961] | 12352 | ||||||||
| compound 16a [PMID: 14697765] | 6427 | ||||||||
| compound 16a [PMID: 38522114] | 13947 | ||||||||
| compound (+)17a [PMID: 20363624] | 5790 | ||||||||
| compound 18a [PMID: 16242323] | 6727 | ||||||||
| compound 19a [PMID: 21855335] | 8186 | ||||||||
| compound 19a [PMID: 24359159] | 6977 | ||||||||
| compound 19a [PMID: 26506089] |
|
9842 | |||||||
| compound 19a [PMID: 30503936] | 10181 | ||||||||
| compound 1a [PMID: 15055993] | 6514 | ||||||||
| compound 1a [PMID: 17556356] |
|
2833 | |||||||
| compound 1a [PMID: 18573659] | 8872 | ||||||||
| compound 1a [PMID: 2153213] | 2987 | ||||||||
| compound 1a [PMID: 23597791] |
|
8881 | |||||||
| compound 1a [PMID: 24900311] | 7799 | ||||||||
| compound 1a [PMID: 24900749] |
|
8128 | |||||||
| compound 1a [PMID: 25692029] |
|
9091 | |||||||
| compound 1a [PMID: 27184081] | 13994 | ||||||||
| compound 22a [PMID: 21688779] | 6231 | ||||||||
| compound 23a [PMID: 33417443] | 11404 | ||||||||
| compound 26a [PMID: 16242323] | 6732 | ||||||||
| compound 29a [PMID: 21444206] | 5741 | ||||||||
| compound 2a [PMID: 34213885] | 11596 | ||||||||
| compound 2a (+) [PMID: 8709131] | 3102 | ||||||||
| compound 33a [PMID: 35944901] | 12126 | ||||||||
| compound 38a [PMID: 15634016] | 8755 | ||||||||
| compound 39a [PMID: 15634016] |
|
8754 | |||||||
| compound 3a [PMID: 12238936] | 3085 | ||||||||
| compound 3a [PMID: 16099654] | 6205 | ||||||||
| compound 3a [PMID: 18606542] | 9872 | ||||||||
| compound 3a [PMID: 21444206] | 5737 | ||||||||
| compound 3a [PMID: 22873688] | 5911 | ||||||||
| Compound 4a [PMID: 17452318] | 13557 | 3-methyl-5-carboxyl-isoxazole | |||||||
| compound 5a [PMID: 20690647] | 8615 | Cbz-Leu-D,L-Phe-CONH-(CH(2))(3)-adenin-9-yl | |||||||
| compound 5a [PMID: 27536893] | 9300 | ||||||||
| compound 5a [PMID: 31287314] | 10433 | ||||||||
| compound 6a [PMID: 18942826] |
|
8744 | lutidinic acid | ||||||
| compound 74a [PMID: 27077528] | 9145 | ||||||||
| compound 77A [PMID: 37639383] | 12906 | BDM-71589, BDM71589 | |||||||
| compound 7a [PMID: 24884590] | 8840 | ||||||||
| compound 7a [PMID: 33730669] | 11917 | ||||||||
| compound 8a [PMID: 22861813] |
|
7891 | |||||||
| compound 8a [PMID: 23713581] |
|
8856 | |||||||
| compound 8a [PMID: 24900283] | 8503 | ||||||||
| compound 8a [PMID: 35500474] | 13121 | ||||||||
| compound 9a [PMID: 22266036] | 6356 | ||||||||
| compound A34 [PMID: 35635004] | 12018 | ||||||||
| compound A [PMID 24997608] | 8418 | ||||||||
| compound A [PMID: 28324017] | 11261 | ||||||||
| compound A [PMID: 40037063] | 14173 | ||||||||
| compound 25ap [PMID: 37796543] | 12932 | ||||||||
| compound 16a [Sharratt et al., 1994] | 3107 | ||||||||
| compound 8 [Avgoustou et al., 2020] | 11148 | ||||||||
| compound A127 [WO2013110309] | 8169 | A-127 | |||||||
| compound 14a [WO2021155612A1] |
|
11958 | |||||||
| compound 1a [WO2021204952A1] |
|
11928 | |||||||
| compound 8ay [PMID: 29589443] | 11156 | ||||||||
| compound 4 [Balasubramanian et al., 1992] | 2962 | ||||||||
| compound 20 [Bergeron et al., 2016] |
|
9171 | |||||||
| compound 7b [Haftchenary et al., 2013] | 8850 | ||||||||
| compound 15 [Biller et al., 1993] | 3131 | ||||||||
| compound 6 [Biller et al., 1991] | 3132 | ||||||||
| compound 4b [Marquart et al., 1994] | 6708 | ||||||||
| compound 10b [PMID: 26222319] |
|
8731 | |||||||
| compound 11b [PMID: 32321856] | 11071 | ||||||||
| compound 12b [PMID: 31465220] | 10489 | ||||||||
| compound 13b [PMID: 18412317] | 2988 | ||||||||
| compound 13b [PMID: 19101153] | 8808 | ||||||||
| compound 13b [PMID: 2153213] | 3005 | ||||||||
| compound 13b [PMID: 32198291] |
|
10720 | |||||||
| compound 13B [PMID: 32506913] | 11077 | ||||||||
| compound 14b [PMID: 25742366] | 8684 | ||||||||
| compound 15b [PMID: 16242323] | 6725 | ||||||||
| compound 15b [PMID: 16539403] | 8194 | ||||||||
| compound 15b [PMID: 18334293] | 8157 | Scios-15b | |||||||
| compound 15b [PMID: 31811124] | 10582 | ||||||||
| compound 17b [PMID: 19639995] | 14146 | ||||||||
| compound 17b [PMID: 35286086] | 11941 | ||||||||
| compound 18b [PMID: 16242323] | 6728 | ||||||||
| compound 19b [PMID: 37058391] | 12610 | ||||||||
| compound 1b [PMID: 16290936] | 8613 | ||||||||
| compound 1b [PMID: 18078750] | 8627 | ||||||||
| compound 1b [PMID: 37562607] | 13028 | ||||||||
| compound 1b [PMID: 9871762] | 8794 | ||||||||
| compound 21b [PMID: 12723954] | 630 | ||||||||
| compound 21b [PMID: 31136173] |
|
10403 | |||||||
| compound 21b [PMID: 31430136] | 10486 | ||||||||
| compound 21b [PMID: 31944697] | 10640 | ||||||||
| compound 25b [PMID: 22564207] | 8139 | ||||||||
| compound 26b [PMID: 16242323] | 6733 | ||||||||
| compound 29b [PMID: 20809633] | 6430 | ||||||||
| compound 2b-1 [PMID: 12614873] | 3696 | ||||||||
| compound 3b [PMID: 23454515] | 8127 | ||||||||
| compound 3b [PMID: 24946214] | 8618 | ||||||||
| compound 3b [PMID:28943244] | 9825 | ||||||||
| compound 3b [PMID: 34097384] | 14118 | ||||||||
| compound 4b [PMID: 16099654] | 6206 | ||||||||
| compound 4b [PMID: 19683441] | 7755 | ||||||||
| compound 4b [PMID: 20690647] | 8614 | Cbz-Leu-D,L-Abu-CONH-(CH(2))(3)-2-methoxyadenin-9-yl | |||||||
| compound 4b [PMID: 40259683] | 13929 | ||||||||
| compound 5b [PMID: 17358052] | 1598 | ethyl analogue of acifran | |||||||
| compound 5b [PMID: 24900464] | 8171 | ||||||||
| compound 5B [PMID: 25349648] | 7831 | ||||||||
| compound 5b [PMID: 25974655] | 11471 | ||||||||
| compound 5b [PMID: 29457898] |
|
9835 | |||||||
| compound 5b [PMID: 31287314] |
|
10434 | |||||||
| compound 6b [PMID: 22749870] | 8814 | ||||||||
| compound 7b [PMID: 17583500] | 8828 | ||||||||
| compound 8b [PMID: 1992138] | 2966 | ||||||||
| compound 8b [PMID: 22408719] | 9113 | ||||||||
| compound 8b [PMID: 38522114] | 13946 | ||||||||
| compound 9b [PMID: 18986805] | 8160 | ||||||||
| compound B [PMID:18477808] | 3367 | cpd B, Cpd-B | |||||||
| compound 4b [Ramsey et al., 2023] | 13022 | ||||||||
| compound 4 [Brinkman et al., 1996] | 3097 | ||||||||
| compound 7 [Brinkman et al., 1996] | 3067 | ||||||||
| compound 8 [Brinkman et al., 1996] | 3066 | ||||||||
| compound 1c [Brown et al., 1997] | 3105 | ||||||||
| compound 13 [Chen et al., 2016] | 9205 | ||||||||
| compound 10c [PMID: 35638577] |
|
12016 | |||||||
| compound 10c [PMID: 39813204] | 13672 | ||||||||
| compound 11c [PMID: 17929793] | 6343 | ||||||||
| compound 11c [PMID: 30613327] |
|
|
11263 | ||||||
| compound 12c [PMID: 16516466] | 8663 | ||||||||
| compound 13c [PMID: 20684591] | 9681 | ||||||||
| compound 13c [PMID: 30457869] | 13014 | ||||||||
| compound 14c [PMID: 18812259] | 6255 | ||||||||
| compound 15c [PMID: 21536437] | 8553 | ||||||||
| compound 15c [PMID: 34865476] | 11834 | ||||||||
| compound 17c [PMID: 25497965] | 8507 | ||||||||
| compound 18c [PMID:19143533] | 10589 | BMS compound 1 | |||||||
| compound 18c [PMID: 25901531] |
|
9227 | |||||||
| compound 20c [PMID: 34181850] | 11589 | ||||||||
| compound 22c [PMID: 16242323] | 6730 | ||||||||
| compound 2-2c [PMID: 32003560] |
|
10689 | |||||||
| compound 23c [PMID: 17929793] | 6345 | ||||||||
| compound 25c [PMID: 36649216] | 12334 | ||||||||
| compound 26c [PMID: 16242323] | 6734 | ||||||||
| compound 2c [PMID: 2153213] | 3004 | ||||||||
| compound 2c [PMID: 22115617] |
|
8140 | |||||||
| compound 2c [PMID: 24900538] | 8138 | ||||||||
| compound 2c [PMID: 38953866] | 13438 | ||||||||
| compound 34c [PMID: 24641010] |
|
|
9647 | ||||||
| compound 46c [PMID: 29350534] | 9883 | ||||||||
| compound 49c [PMID: 29074775] |
|
10418 | |||||||
| compound 4c [PMID: 21571530] | 14143 | ||||||||
| compound 5c [PMID: 27894870] | 9495 | ||||||||
| compound 6c [PMID: 34435786] | 11706 | ||||||||
| compound 6c [PMID: 7966163] | 3083 | ||||||||
| compound 7c [PMID: 22041175] |
|
9931 | |||||||
| compound 7c [PMID: 36414390] | 14083 | ||||||||
| compound 8c [PMID: 28760529] |
|
9671 | |||||||
| compound C10 [PMID: 24297249] | 9162 | ||||||||
| compound C2 [PMID: 29990428] | 10273 | Ec2la | |||||||
| compound 51 [Crosignani et al., 2011] | 8777 | ||||||||
| compound 1 [Cruz-López et al., 2019] | 10574 | ||||||||
| compound 11d [DOI: 10.1039/c0md00194e] | 8197 | ||||||||
| compound 11dd [PMID: 1656041] | 3017 | ||||||||
| compound 24dd [PMID: 20684603] | 8550 | ||||||||
| Compound 9 [doi:10.26434/chemrxiv.7072592.v1] |
|
10083 | |||||||
| compound 10d [PMID: 34855388] | 11906 | ||||||||
| compound 11d [PMID: 23981898] |
|
6946 | |||||||
| compound 11d [PMID: 34406006] | 11697 | ||||||||
| compound 12d [PMID: 33821636] |
|
11505 | |||||||
| compound 13d [PMID: 23639540] | 8120 | ||||||||
| compound 16d [PMID: 36573286] | 12337 | ||||||||
| compound 17d [PMID: 23099093] |
|
8196 | |||||||
| compound 1d [PMID: 21493067] | 8123 | ||||||||
| compound 22d [PMID: 16242323] | 6731 | ||||||||
| compound 24d [PMID: 23357634] | 6366 | ||||||||
| compound 25d [PMID: 19502059] | 2997 | ||||||||
| compound 27d [PMID: 28231433] | 10218 | ||||||||
| compound 2d [PMID: 2153213] | 3003 | ||||||||
| compound 2d [PMID: 7629799] | 3060 | ||||||||
| compound 3d [PMID: 38953866] | 13439 | ||||||||
| compound 3d [PMID: 3941405] | 8622 | ||||||||
| compound 4d [PMID: 20655626] | 8852 | ||||||||
| compound 4d [PMID: 21851057] | 7516 | ||||||||
| compound 4d [PMID: 2296036] | 2969 | ||||||||
| compound 4d [PMID: 25489658] | 8483 | ||||||||
| compound 4d [PMID: 38746883] | 13365 | ||||||||
| compound 5d [PMID: 31335136] |
|
10441 | Example 59 [WO2018121550] | ||||||
| compound 5d [PMID: 7966163] | 3091 | ||||||||
| compound 5d [PMID: 7966163] | 3082 | ||||||||
| compound 6d [PMID: 7966163] | 3086 | ||||||||
| compound 7d [PMID: 19111466] | 7056 | ||||||||
| compound 7d [PMID: 25703523] |
|
8304 | |||||||
| compound 7d [PMID: 29672049] |
|
9937 | |||||||
| compound 7d [PMID: 34528437] | 11767 | ||||||||
| compound 8d [PMID: 15027864] | 8659 | ||||||||
| compound D24 [PMID: 24374347] | 8834 | ||||||||
| compound (R)-4d [PMID: 16766089] | 5489 | ||||||||
| compound 2 [Dreyer et al., 1991] | 7991 | ||||||||
| compound 3 [Dreyer et al., 1991] | 7993 | ||||||||
| compound 16d [Tao et al., 2009] | 9988 | example 19 [US8084472] | |||||||
| compound E3 |
|
14091 | |||||||
| compound 1e [Brown et al., 1997] | 3089 | ||||||||
| compound 6ee [PMID: 22364528] | 8796 | ||||||||
| compound 12e [PMID: 18605714] | 8787 | ||||||||
| compound 12e [PMID: 22266036] | 6357 | ||||||||
| compound 13e [PMID: 16759857] | 8786 | ||||||||
| compound 13e [PMID: 31811124] | 10581 | ||||||||
| compound 18e [PMID: 31670517] |
|
|
10549 | ||||||
| compound 1e [PMID: 2153213] | 2991 | ||||||||
| compound 1e [PMID: 27285276] | 9550 | ||||||||
| compound 22e [PMID: 20167483] | 8504 | ||||||||
| compound 23e [PMID: 17929793] | 6346 | ||||||||
| compound 25e [PMID: 25875054] | 9443 | (5-Bromo-1-methyl-1H-pyrrolo[2,3-c]pyridin-2-yl){6-[(dimethylamino)methyl]-(+)-4-methyl-3,4-dihydroisoquinolin-2(1H)-yl}methanone | |||||||
| compound 25e [PMID: 38217503] | 13102 | ||||||||
| compound 29e [PMID: 23631440] | 8578 | ||||||||
| compound 2e [PMID: 19013076] | 8830 | L-VNIO, vinyl-L-NIO | |||||||
| compound 2e [PMID: 31900320] | 10670 | ||||||||
| compound 2e [PMID: 7629799] | 3064 | ||||||||
| compound 4e [PMID: 35546685] |
|
12122 | CHF-6297, CHF6297, CHI 91040, CHI91040, p38α MAPK-IN-5 | ||||||
| compound 4e [PMID: 7966163] | 3090 | ||||||||
| compound 5e [PMID: 17975902] | 3169 | ||||||||
| compound 5e [PMID: 28580438] |
|
9712 | |||||||
| compound 6e [PMID: 25614116 ] | 8262 | ||||||||
| compound 6e [PMID: 32747425] | 11216 | ||||||||
| compound 7e [PMID: 21571530] | 5515 | ||||||||
| compound 8e [PMID: 23044371] | 8780 | ||||||||
| compound 8e [PMID: 24432909] | 8137 | ||||||||
| compound E22 [PMID: 31298542] | 10437 | ||||||||
| compound 3f [Festa et al., 2019] | 10187 | ||||||||
| compound 11ff [PMID: 1656041] | 3016 | ||||||||
| compound 4ff [PMID: 1656041] | 2970 | ||||||||
| compound 2f [Jiang et al., 2018] | 9810 | dual GSK-3β/AChE inhibitor | |||||||
| compound 10f [PMID: 24556381] | 8602 | ||||||||
| compound 14f [PMID: 35063894] |
|
11936 | |||||||
| compound 16f [PMID: 18155906] | 3011 | ||||||||
| compound 17f [PMID: 19632837] | 7031 | benzo[d]imidazole inhibitors of PRMT4 from BMS | |||||||
| compound 1f [PMID: 2153213] | 2990 | ||||||||
| compound 20f [PMID: 21536438] | 5750 | ||||||||
| compound 20f [PMID: 28520415] |
|
9961 | |||||||
| compound 27f [PMID: 25625617] | 9238 | ||||||||
| compound 28f [PMID: 40400488] | 13921 | ||||||||
| compound 29f [PMID: 17560788] | 2959 | ||||||||
| compound 2f [PMID: 17532216] | 6342 | ||||||||
| compound 2f [PMID: 2153213] | 3007 | ||||||||
| compound 34f [PMID: 37535845] | 12911 | ||||||||
| compound 3f [PMID: 12238936] | 3111 | ||||||||
| compound 3f [PMID: 7966163] | 3116 | ||||||||
| compound 4f [PMID: 34328319] |
|
11733 | |||||||
| compound 6f [PMID: 35476936] | 11979 | ||||||||
| compound 7f [PMID: 29191554] |
|
|
9794 | example 32 [WO2011078413] | |||||
| compound 7f [PMID: 29283260] |
|
9780 | |||||||
| compound 7f [PMID: 31251063] | 10523 | ||||||||
| compound 8f [PMID: 20615702] | 5793 | ||||||||
| compound 9f [PMID: 24412111] | 8508 | ||||||||
| compound 1 [Gotteland et al., 1997] | 6722 | ||||||||
| compound 13g [PMID: 2153213] | 3002 | ||||||||
| compound 15g {PMID: 34242027] | 12821 | ||||||||
| compound 16g [PMID: 35507418] | 12028 | ||||||||
| compound 2g [PMID: 19309152] | 5791 | ||||||||
| compound 2g [PMID: 2296036] | 2971 | ||||||||
| compound 2g [PMID: 27390066] |
|
9682 | |||||||
| compound 4g [PMID: 17709461] | 3077 | ||||||||
| compound 4g [PMID: 21316219] | 8211 | ||||||||
| compound 4g [PMID: 22220592] |
|
9236 | Example XCII [US20160175314] | ||||||
| compound 4g [PMID: 22595175] | 8626 | ||||||||
| compound 4g [PMID: 2680437] |
|
9198 | |||||||
| compound 4g [PMID: 30893553] | 12734 | ||||||||
| compound 5g [PMID: 20483621] | 8207 | ||||||||
| compound 5g [PMID: 21571530] | 5514 | ||||||||
| compound 5g [PMID: 36385925] | 12277 | ||||||||
| compound 6g [PMID: 30633509] | 10194 | ||||||||
| compound 6g [PMID: 7966163] | 3118 | ||||||||
| compound 8g [PMID: 21444206] | 5739 | ||||||||
| compound 9g [PMID: 24412111] | 8509 | ||||||||
| compound G1 [PMID: 36689364] |
|
12354 | |||||||
| compound 15 [Hay et al., 2013] | 7528 | ||||||||
| compound 28 [Heitel et al., 2019] | 10186 | ||||||||
| compound 10h [PMID: 20832306] | 8779 | ||||||||
| compound 11h [PMID: 29808961] | 9970 | ||||||||
| compound 23h [PMID: 17929793] | 6338 | ||||||||
| compound 2h [PMID: 30664827] |
|
10604 | |||||||
| compound 34h [PMID: 27055065] | 9169 | example 77 [WO2014037750] | |||||||
| compound 3h [PMID: 8246234] | 2956 | ||||||||
| compound 8h [PMID: 21561767] | 8170 | ||||||||
| compound 8h [PMID: 22765894] | 8175 | ||||||||
| compound 9h [PMID: 32697083] | 13040 | ||||||||
| compound (R)-10h [PMID: 22490048] | 7754 | ||||||||
| compound (S)-3h [PMID: 15686947] | 712 | 2-benzylpyrridine-substituted aryloxypropanol analogue | |||||||
| compound 8ic [PMID: 19081254] |
|
9478 | CCR4 Antagonist | ||||||
| compound III [PMID: 24045148] |
|
9709 | |||||||
| compound III [PMID: 24080463] | 8825 | ||||||||
| compound III [PMID: 29351497] | 11560 | ||||||||
| compound II [PMID: 21329883] |
|
9579 | |||||||
| compound II [PMID: 29351497] | 11559 | ||||||||
| compound 10i [PMID: 23084894] | 6365 | ||||||||
| compound 14i [PMID: 37204466] | 12746 | ||||||||
| compound 16i [PMID: 31525963] |
|
10502 | |||||||
| compound 23i [PMID: 17929793] | 6348 | ||||||||
| compound 2i [PMID: 23245752] |
|
11630 | |||||||
| compound 4i [PMID: 2296036] | 2968 | ||||||||
| compound 5i [PMID: 36542759] |
|
12336 | |||||||
| compound 8i [PMID: 22765894] | 9905 | ||||||||
| compound I3 [PMID: 23428964] | 8565 | ||||||||
| compound I [PMID: 29351497] | 11558 | ||||||||
| compound IV [PMID: 29351497] | 11561 | ||||||||
| compound 11jj [PMID: 1656041] | 3015 | compound 10jj [PMID: 1656041], compound 4jj [PMID: 1656041] | |||||||
| compound 11j [PMID: 23021994] |
|
8827 | |||||||
| compound 14j [PMID: 27050842] |
|
9147 | |||||||
| compound 18j [PMID: 35446588] | 12987 | ||||||||
| compound 1j [PMID: 26314925] | 8835 | ||||||||
| compound 20j [PMID: 38564512] | 13310 | compound I-10 [WO2020233716A1] | |||||||
| compound 36j [PMID: 21536438] | 5755 | ||||||||
| compound 3j [PMID: 21444206] | 5738 | ||||||||
| compound 3j [PMID: 2231594] | 2979 | ||||||||
| compound 3j [PMID: 33975947] |
|
11553 | |||||||
| compound 5j [PMID: 9216829] | 3099 | ||||||||
| compound 6j [PMID: 27219676] | 9230 | ||||||||
| compound 6j [PMID: 32747425] | 11217 | ||||||||
| compound J [PMID: 21907142] |
|
7854 | Example 1 (WO2011029803) | ||||||
| compound 13k [PMID: 22390415] |
|
7579 | |||||||
| compound 14k [PMID: 21982499] | 8214 | ||||||||
| compound 1k [PMID: 35912476] | 12104 | ||||||||
| compound 21k [PMID: 34985886] | 11833 | ||||||||
| compound 38k [PMID: 34351741] | 11660 | ||||||||
| compound 3k [PMID: 2231594] | 2978 | ||||||||
| compound 3k [PMID: 24568342] |
|
10748 | |||||||
| compound 3k [PMID: 28688274] | 13523 | ||||||||
| compound 4k [PMID: 39232360] | 13555 | ||||||||
| compound 5k [PMID: 23528296] | 8801 | ||||||||
| compound 7k [PMID: 23521020] | 8164 | ||||||||
| compound 9 [Kumar et al., 2019] |
|
10448 | |||||||
| compound 6li [Chan et al., 2022] | 12249 | ||||||||
| compound 9 [Lin et al., 2023] | 12806 | ||||||||
| compound 1 [Lolli et al., 2019] | 10344 | ||||||||
| compound 10l [PMID: 24556381] | 8603 | ||||||||
| compound 15l [PMID: 34242027] |
|
11606 | |||||||
| compound 17l [PMID: 26288691] |
|
10035 | |||||||
| compound 1l [PMID: 16644217] | 8810 | ||||||||
| compound 3l [PMID: 30637955] | 10394 | ||||||||
| compound 58l [PMID: 30843696] | 10340 | ||||||||
| compound 8l [PMID: 36053746] | 12171 | ||||||||
| compound M1 |
|
13669 | phenylisoxazole 4 | ||||||
| compound 51 [Mallinger et al., 2016] | 9170 | ||||||||
| compound 2 [Maurer et al., 2012] | 8823 | ||||||||
| compound 29 [Moslin et al., 2017] |
|
9992 | |||||||
| compound 15m [PMID: 34242027] | 12829 | ||||||||
| compound 16m [PMID: 19931453] | 6429 | ||||||||
| compound 22m [PMID: 19831390] | 8153 | ||||||||
| compound 35m [PMID: 36073117] | 12179 | ||||||||
| compound 3m [PMID: 32603117] | 11099 | ||||||||
| compound 5m [PMID: 20483621] | 8206 | ||||||||
| compound 5m [PMID: 9216829] | 3098 | ||||||||
| compound 7 [Nguyen et al., 2023] | 12485 | ||||||||
| compound 11nn [PMID: 1656041] | 3014 | ||||||||
| compound 5 [Noble et al., 1992] | 8844 | myo-inositol 1-phosphate 4,5-bisphosphorothioate | |||||||
| compound 14n [PMID: 25589934] | 9423 | Sanofi-14n | |||||||
| compound 18n [PMID: 34382802] | 11735 | ||||||||
| compound 21n [PMID: 17656086] | 8750 | ||||||||
| compound 23n [PMID: 24900877] | 7832 | ||||||||
| compound 5n [PMID: 20483621] | 8208 | ||||||||
| compound 6N [PMID: 31419141] | 10483 | ||||||||
| compound 9n [PMID: 18752940] |
|
5795 | |||||||
| compound 9n [PMID: 23084894] | 6362 | ||||||||
| compound NRA 4 [PMID: 25262941] | 9010 | ||||||||
| compound 10 [O'Mahony et al., 2022] |
|
11974 | |||||||
| compound 1o [PMID: 24210504] | 8143 | ||||||||
| compound 20o [PMID: 22984835] | 5906 | ||||||||
| compound 6o [PMID: 19524438] | 5800 | ||||||||
| compound 1 [Overhand et al., 1997] | 3065 | ||||||||
| compound 1 [Patel et al., 1991] | 3009 | ||||||||
| compound 12p [Larson et al., 2017] |
|
9690 | |||||||
| compound 101 [PMID: 21596927] |
|
8437 | cmpd101, Takeda compound 101 | ||||||
| compound 108 [PMID: 37918435] | 12998 | ||||||||
| compound 10 [PMID: 15482906] | 6450 | ||||||||
| compound 10 [PMID: 15482908] | 6449 | ||||||||
| compound 10 [PMID: 18754614] | 3075 | ||||||||
| compound 10 [PMID: 18759424] | 8838 | 3-Cl-AHPC analogue 10 | |||||||
| compound 10 [PMID: 18790648] | 8665 | ||||||||
| compound 10 [PMID: 19402633] | 8466 | 2,4-Bisanilinopyrimidine, 10, Aurora A inhibitor I | |||||||
| compound 10 [PMID: 22533316] | 6717 | ||||||||
| compound 10 [PMID: 23147077] |
|
8133 | TC ASK 10 | ||||||
| compound 10 [PMID: 31306001] | 10443 | ||||||||
| compound 10 [PMID: 31411465] |
|
10488 | example 8 (cis racemate) [WO2017060855A1] | ||||||
| compound 10 [PMID: 31663733] |
|
10548 | |||||||
| compound 10 [PMID: 34279934] | 11689 | ||||||||
| compound 10 [PMID: 34704759] | 11802 | ||||||||
| compound 10 [PMID: 34989568] | 11832 | ||||||||
| compound 10 [PMID: 39952925] | 13749 | ||||||||
| compound 111 [PMID: 37918435] | 12997 | ||||||||
| compound 11 [PMID: 12812482] | 665 | ||||||||
| compound 11 [PMID: 15261275] | 9415 | ||||||||
| compound 11 [PMID: 16413183] | 8493 | ||||||||
| compound 11 [PMID: 18800762] |
|
3191 | bisphosphonate, 11 | ||||||
| compound 11 [PMID: 20638279] | 6235 | ||||||||
| compound 11 [PMID: 26431428] |
|
9989 | |||||||
| compound 11 [PMID: 29442501] |
|
9819 | |||||||
| compound 11 [PMID: 35653642] |
|
12047 | |||||||
| compound 11 [PMID: 37449845] | 12803 | NUCC-0226543 | |||||||
| compound 11 [PMID: 7473541] | 3096 | ||||||||
| compound 12 [PMID: 12014956] | 3192 | AC1NV8HB | |||||||
| compound 12 [PMID: 12723943] | 666 | ||||||||
| compound 12 [PMID: 19800804] | 6989 | ||||||||
| compound 12 [PMID: 20299227] | 3134 | ||||||||
| compound 12 [PMID: 22521646] | 8125 | ||||||||
| compound 12 [PMID: 26238322] | 13151 | ||||||||
| compound 12 [PMID: 27448772] |
|
|
9453 | ||||||
| Compound 12 [PMID:28626832] |
|
9823 | |||||||
| compound 12 [PMID: 31990537] | 10664 | example 24 [WO2014042939A1] | |||||||
| compound 12 [PMID: 38150587] | 13284 | ||||||||
| compound 130 [PMID: 29157600] | 10294 | (5-(4-Fluorophenyl)furan-2-carbonyl)-L-aspartic acid | |||||||
| compound 13 [PMID: 15686941] | 6447 | ||||||||
| compound 13 [PMID: 15925511] | 8188 | ||||||||
| compound 13 [PMID: 17502136] | 8797 | ||||||||
| compound 13 [PMID: 19456099] | 3127 | compound 1d [PMID: 19456099] | |||||||
| compound 13 [PMID: 1992149] | 2983 | ||||||||
| compound 13 [PMID: 23098072] | 8888 | ||||||||
| compound 13 [PMID: 23412139] | 8399 | ||||||||
| compound 13 [PMID: 33984473] | 12839 | ||||||||
| compound 13 [PMID: 34333981] | 11895 | ||||||||
| compound 13 [PMID: 35653642] | 12048 | ||||||||
| compound 13 [PMID: 37465299] |
|
12815 | |||||||
| compound 14 [PMID: 18800762] | 3194 | bisphosphonate, 14 | |||||||
| compound 14 [PMID: 19191557] | 3125 | ||||||||
| compound 14 [PMID: 19831390] | 8151 | ||||||||
| compound 14 [PMID: 21155570] | 6323 | ||||||||
| compound 14 [PMID: 23634668] | 8557 | ||||||||
| compound 14 [PMID: 24900428] | 8154 | ||||||||
| compound 14 [PMID: 25050158] | 8539 | ||||||||
| compound 14 [PMID: 30925062] | 10372 | ||||||||
| compound 14 [PMID: 33786375] |
|
12840 | |||||||
| compound 14 [PMID: 34333981] | 11896 | ||||||||
| compound 14 [PMID: 9871507] | 3106 | ||||||||
| compound 15 [PMID: 18178086] | 6993 | ||||||||
| compound 15 [PMID: 19456099] | 3120 | compound 1j [PMID:19456099] | |||||||
| compound 15 [PMID: 22017539] |
|
8636 | 4UF | ||||||
| compound 15 [PMID: 24900237] | 8220 | ||||||||
| compound 15 [PMID: 25313322] | 7803 | ||||||||
| compound 15 [PMID: 25411721] |
|
9078 | example 252 [WO2007110237] | ||||||
| compound 15 [PMID: 25699151] | 9982 | example 385 [US8883782] | |||||||
| compound 15 [PMID: 32045236] |
|
10706 | |||||||
| compound 15 [PMID: 33738061] | 12573 | ||||||||
| compound 15 [PMID: 34438124] | 12841 | ||||||||
| compound 15 [PMID: 35034442] | 12115 | ||||||||
| compound 15 [PMID: 35450354] | 11989 | ||||||||
| compound 15 [PMID: 8709131] | 3092 | ||||||||
| compound 16 [PMID: 16242323] | 6726 | ||||||||
| compound 16 [PMID: 17480064] |
|
8177 | |||||||
| compound 16 [PMID: 17585909] |
|
12977 | |||||||
| compound 16 [PMID: 18800762] | 3195 | bisphosphonate, 16 | |||||||
| compound 16 [PMID: 18945615] | 8178 | ||||||||
| compound 16 [PMID: 19097778] | 8837 | ||||||||
| compound 16 [PMID: 20947351] | 7057 | ||||||||
| compound 16 [PMID: 23412139] |
|
8698 | 0V6 | ||||||
| compound 16 [PMID: 26794040] |
|
9223 | |||||||
| compound 16 [PMID: 31498617] |
|
10482 | |||||||
| compound 16 [PMID: 31525966] |
|
10501 | |||||||
| compound 16 [PMID: 31653597] |
|
10713 | |||||||
| compound 16 [PMID: 31955138] | 10881 | ||||||||
| compound 16 [PMID: 31977207] | 10650 | ||||||||
| compound 16 [PMID: 34408808] | 12835 | ||||||||
| compound 16 [PMID: 38385364] | 13259 | ||||||||
| compound 16 [PMID: 38526960] | 13292 | ||||||||
| compound 16 [PMID: 40916365] | 14197 | example 23 [US20240051958] | |||||||
| compound 1754-31 [PMID: 23788657] | 6263 | ||||||||
| compound 17 [PMID: 15300839] | 715 | ||||||||
| compound 17 [PMID: 15686906] | 3000 | ||||||||
| compound 17 [PMID: 17125263] | 1306 | ||||||||
| compound 17 [PMID: 18754614] | 3076 | ||||||||
| compound 17 [PMID: 23570514] | 8778 | ||||||||
| compound 17 [PMID: 23642479] | 8161 | ||||||||
| compound 17 [PMID: 23888693] | 7494 | ||||||||
| compound 17 [PMID: 23916253] | 8666 | ||||||||
| compound 17 [PMID: 24257095] | 9449 | ||||||||
| compound 17 [PMID: 29741897] |
|
10005 | |||||||
| compound 17 [PMID: 33655614] | 11520 | ||||||||
| compound 17 [PMID: 34176264] | 11588 | ||||||||
| compound 17 [PMID: 34408808] | 12834 | ||||||||
| compound 17 [PMID: 36111834] | 12185 | ||||||||
| compound 17 [PMID: 3701793] | 2974 | ||||||||
| compound 17 [PMID: 38325398] |
|
13347 | |||||||
| compound 17 [PMID: 38477582] | 13346 | ||||||||
| compound 17 [PMID: 8709131] | 3093 | ||||||||
| compound 182 [PMID: 37500611] |
|
|
13005 | compound XI [PMID: 37500611] | |||||
| compound 18 [PMID: 15664838] | 6536 | ||||||||
| compound 18 [PMID: 17723296] | 6443 | ||||||||
| compound 18 [PMID: 17888661] | 3212 | ||||||||
| compound 18 [PMID: 1875346] | 3028 | ||||||||
| compound 18 [PMID: 18754614] | 3071 | ||||||||
| compound 18 [PMID: 20873740] | 8191 | ||||||||
| compound 18 [PMID: 21927650] | 6442 | ||||||||
| compound 18 [PMID: 32330443] | 11157 | ||||||||
| compound 18 [PMID: 34212719] | 11595 | ||||||||
| compound 18 [PMID: 38090813] | 13109 | ||||||||
| compound 18 [PMID: 40773370] | 14114 | compound 102 [WO2022265577] | |||||||
| compound 18 [PMID: 8426367] | 2961 | ||||||||
| compound 19 [PMID: 17888661] | 3211 | ||||||||
| compound 19 [PMID: 18754614] | 3074 | ||||||||
| compound 19 [PMID: 18800762] | 3193 | ||||||||
| compound 19 [PMID: 18812259] | 6256 | ||||||||
| compound 19 [PMID: 19191557] | 3124 | ||||||||
| compound 19 [PMID: 22142545] |
|
8758 | |||||||
| compound 19 [PMID: 33786375] |
|
11615 | |||||||
| compound 19 [PMID: 33979649] | 11543 | ||||||||
| compound 19 [PMID: 34347470] |
|
12838 | |||||||
| compound 19 [PMID: 35142215] | 11903 | ||||||||
| compound 19 [PMID: 35925768] |
|
12105 | |||||||
| compound 19 [PMID: 7473541] | 3112 | ||||||||
| compound 19 [PMID: 7707314] | 8892 | ||||||||
| compound 19 [PMID: 8831774] | 8569 | Z-Leu-Abu-CONH-CH2-CHOH-Ph | |||||||
| compound 1 [PMID: 10498202] |
|
6541 | |||||||
| compound 1 [PMID: 11425539] | 6542 | ||||||||
| compound 1 [PMID: 15724976] | 7507 | ||||||||
| compound 1 [PMID: 16650987] | 6552 | ||||||||
| compound 1 [PMID: 16821802] | 8873 | imidazole-dioxolane 1 | |||||||
| compound 1 [PMID: 17935984] |
|
6526 | |||||||
| compound 1 [PMID: 18507370] | 8673 | ||||||||
| compound 1 [PMID: 1895299] | 2975 | ||||||||
| compound 1 [PMID: 20005102] |
|
8181 | |||||||
| compound 1 [PMID: 20080612] | 5819 | BAS 00486818 | |||||||
| compound 1 [PMID: 21273063] | 5745 | ||||||||
| compound 1 [PMID: 21742770] | 8190 | ||||||||
| compound 1 [PMID: 21882820] |
|
8831 | |||||||
| compound 1 [PMID: 21939274] | 5743 | ||||||||
| compound 1 [PMID: 22465637] | 6236 | ||||||||
| compound 1 [PMID: 22533316] | 6709 | ||||||||
| compound 1 [PMID: 22795084] |
|
7032 | compound 1 (allosteric) | ||||||
| compound 1 [PMID: 23113556] | 13041 | TC AQP1 1 | |||||||
| compound 1 [PMID: 23589301] | 6488 | ||||||||
| compound 1 [PMID: 24793884] | 8218 | ||||||||
| compound 1 [PMID: 24900526] | 7870 | ||||||||
| compound 1 [PMID: 24900608] | 7800 | ||||||||
| compound 1 [PMID: 24930776] |
|
9092 | DB36 | ||||||
| compound 1 [PMID: 25408830] |
|
7809 | BAS 08314227 | ||||||
| compound 1 [PMID: 25719566] |
|
8302 | |||||||
| compound 1 [PMID: 26055709] | 12222 | PDE12-IN-1 | |||||||
| compound 1 [PMID: 28379944] |
|
11930 | compound 13 [Glinka et al., 1994), L-161,638, L-161638 | ||||||
| compound 1 [PMID: 28611375] |
|
9673 | |||||||
| compound 1 [PMID: 31465224] | 10493 | ||||||||
| compound 1 [PMID: 31477924] |
|
10481 | |||||||
| compound 1 [PMID: 33547286] |
|
11447 | |||||||
| compound 1 [PMID: 33929818] |
|
11709 | |||||||
| compound 1 [PMID: 34210738] | 11835 | ||||||||
| compound 1 [PMID: 34917254] | 11845 | ||||||||
| compound 1 [PMID: 37741852] |
|
12948 | |||||||
| compound 1 [PMID: 40415551] | 13928 | ||||||||
| compound 1 [PMID: 8496942] | 3109 | ||||||||
| compound 20 [PMID:12127536] | 8650 | ||||||||
| compound 20 [PMID: 12372533] | 8555 | ||||||||
| compound 20 [PMID: 16439120] | 6371 | ||||||||
| compound 20 [PMID: 20299227] | 3133 | ||||||||
| compound 20 [PMID: 22136433] | 8156 | ||||||||
| compound 20 [PMID: 22153340] | 6568 | ||||||||
| compound 20 [PMID: 23489211] | 8124 | PCM126 | |||||||
| compound 20 [PMID: 23692593] | 8486 | Ahx-FSQn(boro)Bpg | |||||||
| compound 20 [PMID: 25091930] | 11399 | ||||||||
| compound 20 [PMID: 30998356] |
|
10371 | |||||||
| compound 20 [PMID: 34432979] | 11726 | ||||||||
| compound 20 [PMID: 35584373] | 12118 | ||||||||
| compound 20 [PMID: 37522273] | 14104 | ||||||||
| compound 20 [PMID: 37666112] |
|
13077 | C20 [PMID: 37666112], Y041-1875 | ||||||
| compound 20 [PMID: 7473541] | 3114 | ||||||||
| compound 2-1-1 [PMID: 24900824] | 8109 | ||||||||
| compound 2-13-1 [PMID: 24900824] | 8112 | ||||||||
| compound 21 [PMID: 19191557] | 3119 | ||||||||
| compound 21 [PMID: 21185185] | 5789 | ||||||||
| compound 21 [PMID: 22802221] |
|
6918 | 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt, C21 | ||||||
| compound 21 [PMID: 23312943] | 8135 | ||||||||
| compound 21 [PMID: 23981033] | 8884 | ||||||||
| compound 21 [PMID: 24900635] |
|
8187 | |||||||
| compound 21 [PMID: 25259874] | 8381 | ||||||||
| compound 21 [PMID: 33786375] |
|
12832 | |||||||
| compound 21 [PMID: 34141085] | 11600 | ||||||||
| compound 21 [PMID: 34347470] |
|
12836 | |||||||
| compound 21 [PMID: 34408808] | 11616 | ||||||||
| compound 21 [PMID: 34855405] | 11836 | ||||||||
| compound 21 [PMID: 36459756] | 13025 | ||||||||
| compound 21 [PMID: 7473541] |
|
3115 | |||||||
| compound 22 [PMID: 17276684] | 6358 | ||||||||
| compound 22 [PMID: 19289283] | 6349 | ||||||||
| compound 22 [PMID: 19899765] | 6562 | ||||||||
| compound 22 [PMID: 20462760] | 8205 | ||||||||
| compound 22 [PMID: 21823616] | 8116 | ||||||||
| compound 22 [PMID: 24754609] |
|
10234 | |||||||
| compound 22 [PMID: 30457869] | 13013 | ||||||||
| compound 22 [PMID: 38085679] | 13061 | ||||||||
| compound 2-3-1 [PMID: 24900824] | 8111 | ||||||||
| compound 2-3-2 [PMID: 24900824] | 8110 | ||||||||
| compound 23 [PMID: 17125252] | 8756 | ||||||||
| compound 23 [PMID: 17590335] | 6444 | ||||||||
| compound 23 [PMID: 17600705] | 8146 | ||||||||
| compound 23 [PMID: 21444206] | 5740 | ||||||||
| compound 23 [PMID: 31398032] | 10445 | ||||||||
| compound 23 [PMID: 33786375] |
|
12833 | compound 18 [PMID: 34408808] | ||||||
| compound 23 [PMID: 35767390] |
|
12046 | IL-17 modulator 4 | ||||||
| compound 23 [PMID: 35816678] | 12059 | ||||||||
| compound 23 [PMID: 35944849] | 12208 | ||||||||
| compound 23 [PMID: 8709131] | 3095 | ||||||||
| compound 24 [PMID: 15955699] | 8131 | ||||||||
| compound 24 [PMID: 16451050] |
|
7361 | Banyu Compound-24, C-24 | ||||||
| compound 24 [PMID: 20346665] | 6209 | ||||||||
| compound 24 [PMID: 23374867] | 6419 | ||||||||
| compound 24 [PMID: 23441572] | 8147 | ||||||||
| compound 24 [PMID: 26987013 ] |
|
9252 | |||||||
| compound 24 [PMID: 31343176] | 10438 | ||||||||
| compound 24 [PMID: 32959656] |
|
11319 | |||||||
| compound 24 [PMID: 35286090] | 12005 | ||||||||
| compound 24 [PMID: 36723914] | 12399 | ||||||||
| compound 25 [PMID: 17935989] | 8122 | ||||||||
| compound 25 [PMID: 18068976] | 8568 | ||||||||
| compound 25 [PMID: 20855207] | 8159 | ||||||||
| compound 25 [PMID: 2296027] | 2965 | ||||||||
| compound 25 [PMID: 28038940] |
|
9700 | |||||||
| compound 25 [PMID: 31260299] |
|
10428 | |||||||
| compound 25 [PMID: 32023060] | 10677 | ||||||||
| compound 25 [PMID: 32105470] |
|
10718 | |||||||
| compound 25 [PMID: 32687365] |
|
11130 | |||||||
| compound 25 [PMID: 35439007] | 11971 | ||||||||
| compound 26 [PMID: 16190743] | 2929 | 1,2,4-oxadiazole_based compound 26, Merck SIP agonist | |||||||
| compound 26 [PMID: 16439120] | 6372 | ||||||||
| compound 26 [PMID: 21733693] | 8783 | Example 23 [WO2010104899A1] | |||||||
| compound 26 [PMID: 24673130] | 8134 | ||||||||
| compound 26 [PMID: 31710475] |
|
10602 | |||||||
| compound 26 [PMID: 34543009] |
|
12810 | CASK chemical probe 18 | ||||||
| compound 26 [PMID: 39453309] | 13580 | ||||||||
| compound 27 [PMID: 18337095] | 8158 | ||||||||
| compound 27 [PMID: 19854648] | 8168 | ||||||||
| compound 27 [PMID: 20346665] | 6210 | ||||||||
| compound 27 [PMID: 20598884] | 6437 | ||||||||
| compound 27 [PMID: 21123062] | 8210 | ||||||||
| compound 27 [PMID: 22142545] | 8757 | SCH-1518291 | |||||||
| compound 27 [PMID: 24900635] |
|
10133 | |||||||
| compound 27 [PMID: 26938474] |
|
9084 | |||||||
| compound 27 [PMID: 29775310] |
|
9973 | |||||||
| compound 27 [PMID: 32551645] | 11112 | ||||||||
| compound 27 [PMID: 32945666] |
|
11294 | |||||||
| compound 27 [PMID: 35834807] | 12062 | ||||||||
| compound 27 [PMID: 36449304] |
|
12314 | inhibitor T35 | ||||||
| compound 28.1 [PMID: 36847646] |
|
13326 | TAS2R14 agonist 28.1, TAS2R14 agonist-2 | ||||||
| compound 28 [PMID: 16460935] | 8619 | ||||||||
| compound 28 [PMID: 18324760] | 6555 | ||||||||
| compound 28 [PMID: 28671460] |
|
9670 | |||||||
| compound 28 [PMID: 30624936] |
|
10195 | |||||||
| compound 28 [PMID: 31188540] |
|
10617 | |||||||
| compound 28 [PMID: 35439002] | 11970 | ||||||||
| compound 28 [PMID: 7473541] | 3113 | ||||||||
| compound 28 [PMID: 8246233] | 2985 | ||||||||
| compound 29 [PMID: 1527791] | 3029 | ||||||||
| compound 29 [PMID: 15686906] | 2995 | ||||||||
| compound 29 [PMID: 17064898] | 6208 | ||||||||
| compound 29 [PMID: 2296027] | 2964 | ||||||||
| compound 29 [PMID: 31934767] |
|
10596 | |||||||
| compound 29 [PMID: 36356320] | 12313 | ||||||||
| compound 2 [PMID: 11934595] |
|
8562 | |||||||
| compound 2 [PMID: 15546730] | 8136 | ||||||||
| compound 2 [PMID: 18295483] | 3156 | ||||||||
| compound 2 [PMID: 19097784] | 8646 | ||||||||
| compound 2 [PMID: 19230660] | 5530 | ||||||||
| compound 2 [PMID: 21105727] | 6222 | ||||||||
| compound 2 [PMID: 21627121] | 8149 | ||||||||
| compound 2 [PMID: 21939274] | 5744 | ||||||||
| compound 2 [PMID: 22380603] | 8829 | ||||||||
| compound 2 [PMID: 22560567] | 8115 | ||||||||
| compound 2 [PMID: 22911925] |
|
6950 | compound 37 [PMID: 22468684] | ||||||
| compound 2 [PMID: 24486398] | 8467 | ||||||||
| compound 2 [PMID: 24793972] |
|
7798 | (1R,2R)-2-PCCA | ||||||
| compound 2 [PMID: 25408830] | 7810 | ||||||||
| compound 2 [PMID: 26061392] | 8548 | caged vemurafenib prodrug | |||||||
| compound 2 [PMID: 28379944] |
|
11931 | |||||||
| compound 2 [PMID: 28621538] |
|
|
11282 | example 727 [WO2012093101A1] | |||||
| compound 2 [PMID: 31932225] | 11197 | AZ2 | |||||||
| compound 2 [PMID: 33085774] |
|
11322 | |||||||
| compound 2 [PMID: 33647232] |
|
13027 | |||||||
| compound 2 [PMID: 8410973] | 6566 | ||||||||
| compound 30 [PMID: 15953724] |
|
8812 | |||||||
| compound 30 [PMID: 16455256] | 8813 | ||||||||
| compound 30 [PMID: 17280833] | 8193 | ||||||||
| compound 30 [PMID: 21757343] | 6407 | ||||||||
| compound 30 [PMID: 22239545] | 8749 | ||||||||
| compound 30 [PMID: 22468970] | 8885 | ||||||||
| compound 30 [PMID: 22902653] | 8118 | ||||||||
| compound 30 [PMID: 23414845] |
|
7864 | |||||||
| compound 30 [PMID: 37057760] | 12609 | ||||||||
| compound 31 [PMID: 17963374] | 3152 | ||||||||
| compound 31 [PMID: 20936789] | 8180 | ||||||||
| compound 31 [PMID: 22902653] | 8117 | ||||||||
| compound 31 [PMID: 23374866] |
|
8174 | |||||||
| compound 31 [PMID: 24809814] |
|
8465 | |||||||
| compound 31 [PMID: 24915291] | 8148 | ||||||||
| compound 31 [PMID: 29968758] | 10296 | Trifluoromethoxy)phenyl)picolinoyl)-L-aspartic acid | |||||||
| compound 31 [PMID: 31259550] |
|
10417 | |||||||
| compound 32 [PMID: 19191557] | 3123 | ||||||||
| compound 32 [PMID: 19289283] | 6351 | ||||||||
| compound 32 [PMID: 20471253] | 8184 | ||||||||
| compound 32 [PMID: 30006177] | 13120 | ||||||||
| compound 32 [PMID: 31638797] |
|
10528 | example 69 [WO2016179460A1] | ||||||
| compound 32 [PMID: 31675166] |
|
10576 | |||||||
| compound 32 [PMID: 38047891] |
|
13050 | |||||||
| compound 33 [PMID: 17574412] | 3010 | ||||||||
| compound 33 [PMID: 19364658] | 8163 | ||||||||
| compound 33 [PMID: 19908842] | 8874 | ||||||||
| compound 33 [PMID: 26230603] |
|
8732 | |||||||
| compound 33 [PMID: 32003991] |
|
10680 | |||||||
| compound 33 [PMID: 40529071] | 13976 | ||||||||
| compound 34 [PMID: 20189382] | 8743 | ||||||||
| compound 34 [PMID: 20409708] | 6321 | ||||||||
| compound 34 [PMID: 20866075] | 8751 | ||||||||
| compound 34 [PMID: 24749861] | 8129 | ||||||||
| compound 34 [PMID: 25974391] |
|
8396 | |||||||
| compound 35 [PMID: 19191557] | 3122 | ||||||||
| compound 35 [PMID: 20684608] | 8209 | ||||||||
| compound 35 [PMID: 22902653] | 8119 | ||||||||
| compound 35 [PMID: 23916259] | 8842 | ||||||||
| compound 35 [PMID: 24157366] | 8554 | ||||||||
| compound 35 [PMID: 8246233] | 2999 | ||||||||
| compound 36 [PMID: 17936624] | 6445 | ||||||||
| compound 36 [PMID: 21273063] | 5747 | ||||||||
| compound 36 [PMID: 21958547] |
|
9391 | |||||||
| compound 36 [PMID: 24000170] | 7521 | ||||||||
| compound 36 [PMID: 32429662] | 11083 | ||||||||
| compound 36 [PMID: 34843241] | 12713 | example 48 [WO2012056478] | |||||||
| compound 37 [PMID: 16250654] | 2239 | ||||||||
| compound 37 [PMID: 24418773] | 8612 | ||||||||
| compound 37 [PMID: 29193967] |
|
9797 | |||||||
| compound 37 [PMID: 36384290] | 12256 | ||||||||
| compound 38 [PMID: 20817473] | 8768 | ||||||||
| compound 38 [PMID: 22123324] | 7757 | ||||||||
| compound 38 [PMID: 24000170] | 7522 | ||||||||
| compound 38 [PMID: 24915291] | 8145 | ||||||||
| compound 39 [PMID: 23623673] | 8875 | ||||||||
| compound 39 [PMID: 31742400] |
|
10585 | |||||||
| compound 39 [PMID: 34982553] | 11852 | H2N-c[X-R-L-S-X]-K-G-P-(D-1Nal) | |||||||
| compound 39 [PMID: 36127295] | 12236 | ||||||||
| compound 39 [PMID: 36402081] | 12537 | ||||||||
| compound 39 [PMID: 40643363] | 13986 | ||||||||
| compound 3 [PMID: 12470711] | 6364 | ||||||||
| compound 3 [PMID: 14640538] | 8675 | 2-mercaptomethyl-3-guanidinoethylthiopropanoic acid, 2-Mmgetpa, DL-2-mercaptomethyl-3-guanidinoethyl-thiopropanoic acid, mergepta, MGTA | |||||||
| compound 3 [PMID: 17942791] | 8556 | ||||||||
| compound 3 [PMID: 18255300] | 8747 | ||||||||
| compound 3 [PMID: 19097791] | 8185 | ||||||||
| compound 3 [PMID: 19191557] | 3126 | ||||||||
| compound 3 [PMID: 21105727] | 6223 | ||||||||
| compound 3 [PMID: 21310611] | 5724 | ||||||||
| compound 3 [PMID: 21650226] | 8745 | ||||||||
| compound 3 [PMID: 22533316] | 6711 | ||||||||
| compound 3 [PMID: 23134120] | 9190 | HS6666 | |||||||
| compound 3 [PMID: 23849879] | 8488 | ||||||||
| compound 3 [PMID: 24440480] | 8682 | ||||||||
| compound 3 [PMID: 24900526] | 7868 | ||||||||
| compound 3 [PMID: 25408830] |
|
7811 | |||||||
| compound 3 [PMID: 26055709] |
|
12221 | GSK3036342A, PDE12-IN-3 | ||||||
| compound 3 [PMID: 26191365] | 8936 | ||||||||
| compound 3 [PMID: 27347366] | 9337 | Compound 6412 from US9096541 | |||||||
| compound 3 [PMID: 28603634] |
|
9628 | |||||||
| compound 3 [PMID: 29633584] |
|
9960 | |||||||
| compound 3 [PMID: 31804822] | 10606 | ||||||||
| compound 3 [PMID: 32258933] |
|
11214 | |||||||
| compound 3 [PMID: 32636746] | 11159 | example 6 [WO2019101906] | |||||||
| compound 3 [PMID: 8410973] | 8634 | ||||||||
| compound 3 [PMID: 9003518] | 6720 | ||||||||
| compound 40 [PMID: 10602705] | 8630 | H(3)N(+)CH(CH(2)CH(2)SO(3)(-))CH(SH)CO-Ile-(3-COOH)Pro | |||||||
| compound 40 [PMID: 33470814] | 11397 | ||||||||
| compound 40 [PMID: 34347470] | 12837 | ||||||||
| compound 40 [PMID: 34982553] | 11853 | H2N-c[X-R-L-S-X]-K-G-P-(D-2Nal) | |||||||
| compound 41 [PMID: 15026062] | 6702 | ||||||||
| compound 41 [PMID: 17574411] | 3006 | 2q6b | |||||||
| compound 41 [PMID: 23434029] | 6420 | ||||||||
| compound 41 [PMID: 25000588] |
|
9349 | |||||||
| compound 41 [PMID: 31855425] |
|
|
10598 | ||||||
| compound 41 [PMID: 35436124] | 11999 | ||||||||
| compound 41 [PMID: 36630177] | 12331 | ||||||||
| compound 42 [PMID: 17189691] | 6446 | ||||||||
| compound 42 [PMID: 17574411] | 3001 | ||||||||
| compound 42 [PMID: 22420767] | 5794 | ||||||||
| compound 42 [PMID: 22545772] | 5735 | ||||||||
| compound 42 [PMID: 26938474] | 9085 | ||||||||
| compound 42 [PMID: 37721854] | 12942 | ||||||||
| compound 43 [PMID: 21173551] |
|
5831 | compound 43 [PMID:16697190], compound 43 [PMID:23160941], pyrazolone, 1 | ||||||
| compound 43 [PMID: 26751273] |
|
9492 | |||||||
| compound 4-3 [PMID: 34027661] | 11548 | ||||||||
| compound 43 [PMID: 34781683] |
|
13359 | compound 4 [PMID: 38713486] | ||||||
| compound 43 [PMID: 37812884] | 14039 | ||||||||
| compound 44 [PMID: 19748780] | 8761 | ||||||||
| compound 45 [PMID: 8709105] | 8809 | ||||||||
| compound 46 [PMID: 16451062] | 8355 | ||||||||
| compound 46 [PMID: 25268943] | 11235 | ||||||||
| compound 47 [PMID: 18800762] | 3197 | bisphosphonate, 47 | |||||||
| compound 47 [PMID: 21295468] | 6406 | ||||||||
| compound 47 [PMID: 28737909] |
|
9646 | |||||||
| compound 47 [PMID: 35640059] | 12017 | ||||||||
| compound 48 [PMID: 22364337] | 6320 | ||||||||
| compound 48 [PMID: 25815140] | 8485 | ||||||||
| compound 49 [PMID: 24405707] | 8992 | ||||||||
| compound 49 [PMID: 30889352] | 11144 | ||||||||
| compound 49 [PMID: 36529947] |
|
12355 | |||||||
| compound 4 [PMID: 12408711] | 8628 | ||||||||
| compound 4 [PMID: 16495056] | 8832 | ||||||||
| compound 4 [PMID: 18163548] |
|
6545 | |||||||
| compound 4 [PMID: 18754614] | 3080 | ||||||||
| compound 4 [PMID: 19954973] | 8623 | ||||||||
| compound 4 [PMID: 21105727] | 6224 | ||||||||
| compound 4 [PMID: 22533316] | 6712 | ||||||||
| compound 4 [PMID: 22984835] | 5905 | ||||||||
| compound 4 [PMID: 23083103] | 6148 | ||||||||
| compound 4 [PMID: 24432870] | 8941 | ||||||||
| compound 4 [PMID: 25259874] | 8384 | ||||||||
| compound 4 [PMID: 26191369] |
|
8733 | |||||||
| compound 4 [PMID: 26218264] | 8734 | ||||||||
| compound 4 [PMID: 27074625] | 9148 | ||||||||
| compound 4 [PMID: 30824200] | 11460 | ||||||||
| compound 4 [PMID: 32677155] | 11225 | [18F]4 | |||||||
| compound 4 [PMID: 33531496] | 11408 | ||||||||
| compound 4 [PMID: 8576905] | 3129 | ||||||||
| compound 4 [PMID: 8709131] | 3094 | ||||||||
| compound 4 [PMID: 9003518] | 6721 | ||||||||
| compound 50 [PMID: 18072721] | 3008 | 2r4f | |||||||
| compound 50 [PMID: 24313754] | 8824 | ||||||||
| compound 51 [PMID: 18800762] | 3186 | bisphosphonate, 51 | |||||||
| compound 51 [PMID: 19743866] | 8653 | Ac-RLTbaLAR-H | |||||||
| compound 52 [PMID: 28541707] |
|
10001 | |||||||
| compound 52 [PMID: 32902255] |
|
13913 | IL-4 inhibitor 4 | ||||||
| compound 52 [PMID: 36749735] | 12412 | ||||||||
| compound 52 [PMID: 9677190] |
|
5955 | |||||||
| compound 53 [PMID: 19631533] | 8811 | ||||||||
| compound 53 [PMID: 23434029] | 6451 | ||||||||
| compound 53 [PMID: 33038794] |
|
11960 | |||||||
| compound 55 [PMID: 29889526] |
|
10016 | |||||||
| compound 55 [PMID: 30889352] | 11145 | ||||||||
| compound 56 {PMID: 25583879] | 12509 | SORA1 | |||||||
| compound 56 [PMID: 36136378] | 12194 | ||||||||
| compound 56 [PMID: 8568816] | 5956 | PD153035 Analog 56 | |||||||
| compound 57 [PMID: 16610804] | 8771 | ||||||||
| compound 57 [PMID: 20121197] | 6550 | ||||||||
| compound 57 [PMID: 26155854] | 8640 | ||||||||
| compound 58 [PMID: 21273063] | 5748 | ||||||||
| compound 58 [PMID: 25037917] | 8520 | ||||||||
| compound 59 [PMID: 30889352] | 11146 | ||||||||
| compound 5 [PMID: 17618114] | 9348 | Tie2 kinase inhibitor | |||||||
| compound 5 [PMID: 18754614] | 3081 | ||||||||
| compound 5 [PMID: 19338355] |
|
11407 | |||||||
| compound 5 [PMID: 21741839] |
|
8670 | |||||||
| compound 5 [PMID: 21838328] | 8790 | ||||||||
| compound 5 [PMID: 22533316] | 6715 | ||||||||
| compound 5 [PMID: 23232060] | 8192 | ||||||||
| compound 5 {PMID: 24900446] | 8655 | ||||||||
| compound 5 [PMID: 24900526] | 7869 | ||||||||
| compound 5 [PMID: 28038940] |
|
9699 | |||||||
| compound 5 [PMID: 30894487] |
|
|
10398 | ||||||
| compound 5 [PMID: 34779204] |
|
11843 | |||||||
| compound 5 [PMID: 40393772] | 13917 | ||||||||
| compound 60 [PMID: 26155854] |
|
8641 | |||||||
| compound 60 [PMID: 30889352] | 11147 | ||||||||
| compound 61 [PMID: 36221183] | 12224 | ||||||||
| compound 65 [PMID: 36126387] | 12523 | LPA5 antagonist 2 | |||||||
| compound 66 [PMID: 19788238] |
|
8141 | |||||||
| compound 66 [PMID: 21802293] | 8212 | ||||||||
| compound 66 [PMID: 36126387] | 12524 | LPA5 antagonist 1 | |||||||
| compound 68 [PMID: 24900699] | 8165 | ||||||||
| compound 69 [PMID: 19136975] | 8782 | ||||||||
| compound 6 [PMID: 10395480] | 8632 | ||||||||
| compound 6 [PMID: 17948018] | 8660 | ||||||||
| compound 6 [PMID: 22533316] | 6714 | ||||||||
| compound 6 [PMID: 29769246] | 13195 | Cmpd-6 [PMID: 34580163] | |||||||
| compound 6 [PMID: 30125504] | 10073 | ||||||||
| compound 6 [PMID: 34333981] | 11893 | ||||||||
| compound 6 [PMID: 34553947] |
|
11775 | |||||||
| compound 6 [PMID: 38134034] | 13023 | ||||||||
| compound 6 [PMID: 7629799] | 3063 | compound 3 [PMID: 8576905] | |||||||
| compound 70 [PMID: 26161824] | 8706 | ||||||||
| compound 73 [PMID: 40167442] | 13834 | ||||||||
| compound 74 [PMID: 1656041] | 2982 | ||||||||
| compound 74 [PMID: 24793884] | 8219 | ||||||||
| compound 76 [PMID: 28657314] |
|
9609 | |||||||
| compound 77 [PMID: 24793884] | 8217 | ||||||||
| compound 7 [PMID: 18754614] | 3079 | ||||||||
| compound 7 [PMID: 20638279] | 6232 | compound 7 [PMID: 20180624] | |||||||
| compound 7 [PMID: 21334791] | 8785 | ||||||||
| compound 7 [PMID: 22464456] |
|
8172 | thienopyrazolylindole inhibitor 477 | ||||||
| compound 7 [PMID: 22533316] | 6713 | ||||||||
| compound 7 [PMID: 24825313] | 7531 | ||||||||
| compound 7 [PMID: 25719566] |
|
8306 | |||||||
| compound 7 [PMID: 2909732] | 3020 | ||||||||
| compound 7 [PMID: 31381331] |
|
10450 | |||||||
| compound 7 [PMID: 31955578] | 10649 | ||||||||
| compound 7 [PMID: 32302132] | 11374 | 8-[(1H-1,2,3-Benzotriazol-1-yl)amino]octanoic Acid | |||||||
| compound 7 [PMID: 34333981] | 11894 | ||||||||
| compound 7 [PMID: 37428122] | 12852 | ||||||||
| compound 7 [PMID: 8496919] | 3100 | ||||||||
| compound 82 [PMID: 21332118] |
|
8805 | |||||||
| compound 83 [PMID: 23888932] | 9742 | ||||||||
| compound 84 [PMID: 38753594] | 13378 | ||||||||
| compound 86 [PMID: 26982234] | 9251 | ||||||||
| compound 87 [PMID: 20942471] | 9934 | ||||||||
| compound 8 [PMID: 15482908] | 6448 | ||||||||
| compound 8 [PMID: 17480064] |
|
8763 | PHA-767491 | ||||||
| compound 8 [PMID: 17562362} | 8886 | ||||||||
| compound 8 [PMID: 18754614] | 3078 | ||||||||
| compound 8 [PMID: 19191557] | 3128 | ||||||||
| compound 8 [PMID: 20598884] | 6436 | ||||||||
| compound 8 [PMID: 21692504] | 8491 | ||||||||
| compound 8 [PMID: 22533316] | 6716 | ||||||||
| compound 8 [PMID: 24044867] | 8195 | ||||||||
| compound 8 [PMID: 25898023] |
|
10498 | |||||||
| compound 8 [PMID: 33655614] | 11519 | ||||||||
| compound 9 [PMID: 11606127] | 8833 | ||||||||
| compound 9 [PMID: 15615544] | 8890 | ||||||||
| compound 9 [PMID: 1738140] | 8677 | ||||||||
| compound 9 [PMID: 18754614] | 3072 | ||||||||
| compound 9 [PMID: 1992149] | 2984 | compound 10b [PMID: 1597859] | |||||||
| compound 9 [PMID: 20718420] | 9893 | ||||||||
| compound 9 [PMID: 22533316] | 6718 | ||||||||
| compound 9 [PMID: 23472952] | 9017 | arginase inhibitor 1 | |||||||
| compound 9 [PMID: 23517011] | 7517 | ||||||||
| compound 9 [PMID: 23788254] | 7492 | ||||||||
| compound 9 [PMID: 26006010] |
|
9761 | |||||||
| compound 9 [PMID: 26937601] |
|
9197 | Mbi-4 | ||||||
| compound 9 [PMID: 32140747] | 13566 | ||||||||
| compound 9 [PMID: 3514912] | 8559 | ||||||||
| compound 9 [PMID: 7932551] | 3030 | (3α,5β,12α,17xi)-3-hydroxy-21-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]pregnan-12-yl (2S)-2-methylbutanoate | |||||||
| compound (R)-26 [PMID: 22686657] | 6535 | ||||||||
| compound (S)-29 [PMID: 37606563] |
|
12904 | |||||||
| compound 4p [PMID: 1895299] | 3019 | ||||||||
| compound 7p [PMID: 7861416] | 8795 | ||||||||
| compound 11q [PMID: 19433355] | 6214 | ||||||||
| compound 1q [PMID: 18029181] | 5792 | ||||||||
| compound 2q [PMID: 30986068] |
|
|
10365 | example 2-8 [US20150353552] | |||||
| compound 3q [PMID: 2231594] | 2977 | ||||||||
| compound 4q [PMID: 7650673] | 3108 | ||||||||
| compound rac-16 [PMID: 15603962] | 2333 | ||||||||
| compound R-(-)-5f [PMID: 22607879] | 5834 | ||||||||
| compound 11r [PMID: 32045235] | 10705 | Cinnamoyl-cyclopropylalanine-GlnLactam-CO-CO-NH-benzyl | |||||||
| compound 13r [PMID: 23639540] | 8144 | ||||||||
| compound 7r [PMID: 26080733] | 8639 | ||||||||
| compound R-16 [PMID: 21967808] | 8213 | ||||||||
| compound 4rr [PMID: 1656041] | 2967 | ||||||||
| compound 14 [Schnute et al., 2023] |
|
12351 | |||||||
| compound 17 [Shechter et al., 1996] | 3061 | ||||||||
| compound 20 [Shechter et al., 1996] | 3062 | ||||||||
| compound 11s [PMID: 19433355] | 6215 | ||||||||
| compound 89S [PMID: 19115845] |
|
8114 | |||||||
| compound 5 [Stecula et al., 2020] | 11155 | MCULE-2879769428 | |||||||
| compound T.14 |
|
10385 | |||||||
| compound 33 [Toda et al., 2013] | 8791 | ||||||||
| compound 5 [Tomassi et al., 2020] | 10672 | ||||||||
| compound 18t [PMID: 8246237] | 2996 | ||||||||
| compound 2t [PMID: 2296036] | 2972 | ||||||||
| compound 3 [Tuttle et al., 2013] | 8815 | ||||||||
| compound 3 [Uddin et al., 2020] |
|
10701 | |||||||
| compound 1u [PMID: 30245402] |
|
10258 | |||||||
| compound 3u [PMID: 2231594] | 2976 | ||||||||
| compound 7u [PMID: 24775305] | 8633 | ||||||||
| compound 8u [PMID: 31999451] |
|
10682 | |||||||
| compound 35 [US12091406] | 14090 | ||||||||
| compound 1 [Vakkeel et al., 2018] | 9895 | ||||||||
| compound 29 [Vietor, et al., 2023] | 12651 | ||||||||
| compound VII [WO2021149692A1] |
|
11926 | |||||||
| compound 3v [PMID: 27390066] |
|
9683 | |||||||
| compound 6v [PMID: 1895299] | 3018 | ||||||||
| compound V [PMID: 29351497] | 11562 | ||||||||
| compound 12 [Wattanasin et al.,1997] | 3130 | ||||||||
| compound 104 [WO2023245166] | 13564 | ||||||||
| compound 17 [WO2024240153] | 14132 | ||||||||
| compound 1 [WO2012007375] |
|
8084 | |||||||
| compound 1 [WO2014017936] | 8990 | ||||||||
| compound 27 [WO2016008433] | 13919 | clifutinib, compound 9e [PMID: 40213868] | |||||||
| compound 6 [WO2022133588] | 12593 | compound 15h [PMID: 34242027] | |||||||
| compound 72 [WO2013026806] | 8166 | compound 8c [PMID 25264830], EHT 5372 | |||||||
| compound 7 [WO2012007375] |
|
8085 | |||||||
| compound 22 [WO2019141694A1] | 12181 | ||||||||
| compound 27 [WO2019226977A1] | 11977 | ||||||||
| compound 451 [WO2021252644A1] | 11892 | ||||||||
| compound 4 [WO2022008639A1] |
|
11933 | |||||||
| compound 669 [WO2021055376A1] |
|
13911 | |||||||
| compound 71 [WO2018191577A1] |
|
11203 | |||||||
| compound 1 [Xiao et al. 2014] |
|
8301 | indole sufonamide 1 | ||||||
| compound 28xvii [PMID: 8809154] | 8764 | ||||||||
| compound XVI [PMID: 38863440] |
|
13423 | |||||||
| compound 19y [Kiss et al., 2011] | 9013 | ||||||||
| compound 25 [Zhang et al., 2020] |
|
|
10643 | example 6B [WO2014028600A2] | |||||
| compound 5 [Zhang et al., 2021] |
|
11443 | |||||||
| compound 15z [PMID: 38029358] |
|
13044 | NLRP3 inhibitor 15z | ||||||
| compound 16z [PMID: 35609303] | 13172 | 2-16z | |||||||
| compound 5z [PMID: 8410981] | 8893 | 10,11-Methylenedioxy-20S-camptothecin | |||||||
| conivaptan |
|
2203 | Vaprisol®, YM-087, YM087 | ||||||
| conteltinib | 9763 | CT-707, CT707, example 96 [WO2012092880], US9428508, 96 | |||||||
| contezolid |
|
|
10795 | MRX-1, MRX-I, Youxitai® | |||||
| contezolid acefosamil (parent) | 10796 | MRX-4 | |||||||
| COOH | 2715 | LS-191838 | |||||||
| cooling agent 10 | 2463 | (-)-menthoxypropane-1,2-diol | |||||||
| copanlisib |
|
|
7875 | Aliqopa®, BAY 80-6946, BAY80-6946 | |||||
| corbadrine |
|
508 | α-Me-NE, α-methylnoradrenaline, α-methylnorepinephrine, levonordefrin, Neo-Cobefrin®, Nordefrin® | ||||||
| CORM-2 |
|
9535 | |||||||
| [3H] corticosterone |
|
|
13966 | 1,2,6,7-(3H) corticosterone | |||||
| [3H] cortisol |
|
|
13965 | 1,2,6,7-(3H)Cortisol | |||||
| coumamycin |
|
10879 | coumermycin A1, notomycin | ||||||
| CoV 3CLpro PROTAC 1 | 13632 | PROTAC 1 [PMID: 38352832] | |||||||
| CoV Mpro CRBN PROTAC 9 [US11530195] | 12594 | ||||||||
| CoV Mpro VHL PROTAC 9 [US11518759] | 12595 | example 9 [US11518759] | |||||||
| CoV nsp16 inhibitor 2a [PMID: 34257831] | 13634 | ||||||||
| Cp-1 | 10280 | ||||||||
| CP-10 | 11662 | ||||||||
| CP105696 |
|
3368 | CP 105696, CP-105,696, CP-105696 | ||||||
| CP-122288 | 110 | CP 122288, CP-122,288, CP122288 | |||||||
| CP 154,526 | 3495 | CP-154526, CP154,526, CP154526 | |||||||
| CP-195543 |
|
6155 | CP 195543, CP-195,543, CP195543 | ||||||
| CP-226269 | 973 | CP 226269, CP-226,269, CP226269 | |||||||
| CP-293019 | 977 | CP 293019, CP293019 | |||||||
| CP-294838 | 3058 | CP 294838, CP294838 | |||||||
| CP-316,311 | 10377 | compound 2 [PMID: 18260619], CP-316311, CP316311 | |||||||
| CP-339818 | 2558 | CP 339818, CP339818 | |||||||
| CP 376,395 |
|
3496 | compound 3a [PMID: 18288792], CP 376395, CP-376,395, CP-376395, CP376395 | ||||||
| CP-412,245 |
|
11809 | |||||||
| CP-424,174 |
|
11810 | CP-424174 | ||||||
| CP466722 | 9359 | CP-466722 | |||||||
| CP-481,715 | 3497 | CP 481715, CP-481715, CP481715 | |||||||
| CP-547632 |
|
7881 | CP 547,632, CP 547632, CP-547,632, CP547632 | ||||||
| CP55,244 | 5568 | CP 55,244, CP 55244, CP-55,244, CP-55244, CP55244 | |||||||
| CP55,667 | 5570 | CP 55,667, CP-55,667 | |||||||
| CP55940 |
|
730 | CP-55,940, CP-55940, CP55,940 | ||||||
| CP-601927 | 9056 | CP 601927, CP-601,927 | |||||||
| CP608,039 | 5598 | CP-608,039 | |||||||
| CP-628006 | 11800 | CP628006 | |||||||
| CP-640186 |
|
12243 | compound 1 [PMID: 16973360], CP 640,186, CP640186 | ||||||
| CP-673451 |
|
8069 | CP-673,451, CP673451 | ||||||
| CP-724714 | 7883 | CP 724714, CP724714 | |||||||
| CP734432 | 4039 | CP 734432, CP-734432 | |||||||
| CP-775146 | 6691 | CP775146 | |||||||
| CP 93129 | 11 | CP-93,129, CP-93129, CP93129 | |||||||
| CP94253 | 3221 | CP-94,253, CP-94253 | |||||||
| CP 99994 |
|
2102 | CP-99994, CP99994 | ||||||
| [3H]Cp-1 |
|
|
9466 | ||||||
| [3H]CP55940 |
|
|
|
734 | |||||
| CPCCOEt | 1382 | ||||||||
| CpdA (parent molecule) |
|
11317 | |||||||
| Cpd8l [PMID: 40040241] | 14096 | ||||||||
| CPFPX | 5603 | ||||||||
| (S)-4CPG | 1418 | (S)-4-carboxyphenylglycine | |||||||
| C7/3-phth | 7634 | heptane-1,7-bis(dimethyl-3'-phthalimidopropylammonium) | |||||||
| CPI-1205 | 9115 | compound 13 [PMID: 27739677], CPI 1205, CPI1205 | |||||||
| CPI-203 | 7513 | CPI 203, CPI203 | |||||||
| CPK20 | 14038 | ||||||||
| CPP-115 | 8284 | compound 12 [PMID 25616005] | |||||||
| [3H]CPP |
|
|
4082 | ||||||
| CPPG | 1413 | cyclopropyl-4-phosphonophenylglycine | |||||||
| CPPHA | 1423 | ||||||||
| CPPZ | 6416 | ||||||||
| CPS125 | 6369 | ||||||||
| CPTB | 12861 | compound 58 [PMID: 20005104] | |||||||
| cPTIO | 10621 | carboxy-PTIO | |||||||
| CPUY192018 |
|
9710 | compound 18e [PMID: 26258437], compound 2 [PMID: 24512214] | ||||||
| CpX | 11313 | ||||||||
| CPX | 427 | 1,3-dipropylxanthine | |||||||
| CpY |
|
11314 | |||||||
| CPZEN-45 | 13508 | ||||||||
| C6-Quino | 13817 | ||||||||
| CR4056 | 10453 | CR-4056, US8633208, 1 | |||||||
| CR6086 |
|
9845 | |||||||
| (R)-CR8 |
|
11065 | |||||||
| (S)-CR8 |
|
11064 | |||||||
| CRA1000 | 3498 | CRA-1000 | |||||||
| CRAC channel inhibitor 5b [PMID: 26256403] |
|
10042 | |||||||
| CRAC channel inhibitor 1 [PMID: 26256403] |
|
10041 | |||||||
| crenigacestat |
|
11359 | LY-3039478, LY3039478 | ||||||
| crenolanib |
|
|
7882 | ARO-002, CP 868596, CP-868,596, CP-868596 | |||||
| cresomycin |
|
13428 | |||||||
| crinecerfont |
|
3533 | Crenessity®, SSR-125543A, SSR125543 | ||||||
| crisaborole |
|
|
9151 | AN 2728, AN2728, compound 5b [PMID: 19303290], Eucrisa®, Staquis® | |||||
| crisdesalazine | 13254 | AAD-2004, AAD2004 | |||||||
| crisugabalin |
|
13764 | HSK-16149, HSK16149 | ||||||
| crizotinib |
|
|
|
4903 | (R)-crizotinib, PF 2341066, PF-02341066, PF-2341066, PF2341066, Xalkori® | ||||
| (S)-crizotinib |
|
7581 | ent-crizotinib | ||||||
| CRN04894 | 13339 | compound 17h [PMID: 38628803], CRN-0489 | |||||||
| cromakalim | 2413 | cromakalin | |||||||
| cromoglicic acid |
|
|
7608 | cromoglycate, cromolyn, cromolyn sodium, FPL-670, Intal®, Opticrom®, sodium cromoglicate | |||||
| Crotamiton |
|
11165 | Eurax® | ||||||
| crotylaldehyde |
|
6288 | 2-butenal, crotonal, trans-crotonaldehyde | ||||||
| crozbaciclib | 12076 | ||||||||
| CRS3123 |
|
10991 | CRS-3123, REP-3123, REP3123 | ||||||
| CRT 0066101 | 8048 | ||||||||
| CRV431 | 11612 | CPI-431, CPI-431-32, CPI431, CRV-431 | |||||||
| CRX-555 |
|
10091 | CRX555, N-[(3R)-3-(Octanoyloxy)myristoyl]-O-[2-[[(3R)-3-(octanoyloxy)myristoyl]amino]-3-O-[(3R)-3-(octanoyloxy)myristoyl]-4-O-phosphono-2-deoxy-beta-D-glucopyranosyl]-L-serine | ||||||
| CSC | 5609 | ||||||||
| CSTI-300 |
|
10699 | |||||||
| 5-CT |
|
4 | 5-carboxamidotryptamine | ||||||
| CT1113 | 14188 | compound I-85 [WO2020224652], CT-1113 | |||||||
| CT1812 | 13335 | compiund 7 [PMID: 34531947], CT-1812, Elayta | |||||||
| [3H]5-CT |
|
|
262 | [3H]5-carboxamidotryptamine, tritiated 5-carbamidotryptamine | |||||
| CTA091 | 8819 | compound 3a [PMID: 15615534], MK-24(S)-S(O)(NH)Ph | |||||||
| C3TD879 | 13171 | C3TD-879, compound 58 [PMID: 38330278] | |||||||
| CTEP | 6409 | compound 3 [PMID: 25565255] | |||||||
| [3H]CTEP |
|
|
6408 | ||||||
| CTPI-2 | 12853 | ||||||||
| CU-CPT8m |
|
|
9795 | 7-(m-Tolyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide, compound 5 [PMID: 29155428] | |||||
| CUDC-101 | 8894 | compound 8 [PMID: 20143778], CUDC101 | |||||||
| culmerciclib | 12077 | ||||||||
| CV-1674 | 419 | 2-(4-methoxyphenyl)adenosine, CV 1674, CV1674, NSC 310669 | |||||||
| CV-1808 | 420 | 2-phenylaminoadenosine, CV 1808, CV1808 | |||||||
| CV-3988 | 6079 | CV 3988, CV3988 | |||||||
| CV-6209 | 1852 | CV 6209, CV6209 | |||||||
| CVN293 |
|
13373 | CVN-293 | ||||||
| CVN45502 | 12604 | CVN-45502 | |||||||
| CVN766 | 13165 | CVN-766 | |||||||
| CVT-6883 | 5615 | CVT 6883, CVT6883 | |||||||
| CW85319 | 12791 | CW-85319 | |||||||
| CWHM12 | 10495 | CWHM 12, CWHM-12 | |||||||
| CX4 | 7663 | ||||||||
| CX-5011 | 9373 | ||||||||
| CX516 |
|
4165 | BDP-12, CX 516, CX-516 | ||||||
| CX-5279 | 9374 | ||||||||
| CX546 | 4166 | CX 546, CX-546 | |||||||
| CX549 |
|
9701 | compound 63 [WO2016048861], CX-549 | ||||||
| CX614 | 7842 | BDP 37, CX 614, CX-614 | |||||||
| CX-6258 |
|
9368 | compound 13 [PMID: 24900437], CX6258 | ||||||
| CXCR4 antagonist 22 |
|
10146 | |||||||
| CY-09 |
|
10057 | |||||||
| cyamemazine | 84 | cyamepromazine, RP-7204 | |||||||
| α-cyanocinnamate | 11299 | (2E)-2-cyano-3-phenylacrylic acid, alpha-cyanocinnamate, alpha-Cyanocinnamic acid | |||||||
| α-cyano-4-hydroxycinnamate | 11300 | 2-cyano-4-hydroxycinnamate, alpha-cyano-4-hydroxycinnamate, alpha-cyano-4-hydroxycinnamic acid | |||||||
| β-Cyano-L-alanine |
|
8859 | 3-Cyano-L-alanine, L-beta-Cyanoalanine | ||||||
| α-Cyano-5-phenyl-2,4-pentadienic acid | 11301 | Alpha-Cyano-5-phenyl-2,4-pentadienic acid, ααcyano-5-phenyl-2,4-pentadienoate | |||||||
| cyanopindolol | 132 | ||||||||
| cyanotriphenylborate | 2368 | ||||||||
| Cy3B-telenzepine |
|
8598 | |||||||
| cyclacillin |
|
4817 | ciclacillin, Cyclapen®, Vastcillin®, Wy-4508 | ||||||
| cyclamate | 12470 | cyclamic acid, Cyclohexanesulfamic acid, Hexamic acid | |||||||
| (-)-cyclazocine | 1604 | ||||||||
| (+)-cyclazosin |
|
486 | |||||||
| cyclic CMP |
|
6261 | cCMP, cytidine, cyclic 3',5'-(hydrogen phosphate) | ||||||
| cyclic di-GMP |
|
|
13137 | Bis-(3'-5')-cyclic dimeric guanosine monophosphate, c-di-GMP, cGpGp, dyclic diguanylate monophosphate | |||||
| cyclizine |
|
7151 | Marezine® | ||||||
| cyclobenzaprine |
|
7152 | Amrix®, Fexmid, MK-130 | ||||||
| cyclocreatine | 5491 | AM 285 | |||||||
| cycloguanil |
|
|
10027 | ||||||
| cycloheximide |
|
5433 | FT 3422-2, naramycin A, NM-MCD 80, NSC 185 | ||||||
| cyclohexylamine | 5507 | ||||||||
| cyclopamine-KAAD | 10329 | 3-keto, N-aminoethyl aminocaproyl dihydrocinnamoyl cyclopamine, KAAD-cyclopamine | |||||||
| cyclopenthiazide |
|
7899 | cyclomethiazide, SU-8341 | ||||||
| cyclopentolate |
|
7153 | Cyclogyl®, Mydrilate® | ||||||
| cyclopentyladenosine |
|
380 | CPA, N(6)-cyclopentyladenosine, N6-cyclopentyladenosine | ||||||
| 8-cyclopentyltheophylline | 385 | CPT | |||||||
| cyclophosphamide |
|
7154 | cytophosphane, Cytoxan®, Endoxan® | ||||||
| cyclothiazide |
|
4167 | Anhydron®, Aquirel® | ||||||
| CYD0618 | 12139 | compound 28 [PMID: 27344488], CYD-0618 | |||||||
| CYM2503 | 8547 | CYM-2503 | |||||||
| CYM-50308 | 10311 | CYM 50308, CYM50308 | |||||||
| CYM-50358 | 10312 | CYM 50358, CYM50358 | |||||||
| CYM5181 | 2927 | CYM-5181 | |||||||
| CYM5442 | 2928 | CYM-5442 | |||||||
| CYM-5478 | 13459 | CYM5478 | |||||||
| CYM5520 | 11312 | CYM-5520 | |||||||
| CYM-5541 |
|
9494 | CYM5541, ML249 | ||||||
| CYP3A4 fluorescent probe 4-OH F8 | 12660 | ||||||||
| CYP3A4 fluorogenic substrate F8 | 12659 | compound F8 [PMID: 37145039] | |||||||
| CyPPA | 2323 | ||||||||
| cyPPTS | 6257 | ||||||||
| cyproheptadine |
|
|
277 | cyproheptidine, Periactin®, Peritol® | |||||
| cyproterone acetate |
|
|
2865 | Androcur®, Cyprostat®, SH-714 | |||||
| cytarabine |
|
|
4827 | Cytosar®, DepoCyte®, U-19920 | |||||
| [3H]cytisine |
|
|
3979 | ||||||
| cytosporone B |
|
5424 | dothiorelone G | ||||||
| CZ415 |
|
9837 | compound 3 [PMID: 27563401], CZ-415 | ||||||
| CZC 24832 | 6653 | CZC-24832, CZC24832 | |||||||
| C34 [Zhu et al., 2023] | 12981 | ||||||||
| CZS-241 | 12396 | compound B43 [PMID: 36734825], CZS241 | |||||||
| D | Back to top | ||||||||
| D4476 |
|
5940 | casein kinase I inhibitor, CK1 inhibitor, D 4476 | ||||||
| D5261 | 12213 | D-5261 | |||||||
| D6-3 | 13572 | ||||||||
| D6808 |
|
12248 | compound 14 [PMID: 36355693], D-6808 | ||||||
| DABCO | 2577 | ||||||||
| DABCO-C16 | 2572 | C16-1,4-Diazabicyclo[2.2.2]octane, TA279 | |||||||
| dabigatran |
|
6380 | |||||||
| dabigatran etexilate |
|
6379 | BIBR 1048, Pradaxa® | ||||||
| dabogratinib |
|
13809 | compound 22 [PMID: 39258897], TYRA-300, TYRA300 | ||||||
| dabrafenib |
|
|
6494 | GSK2118436, GSK2118436A, Tafinlar® | |||||
| dabuzalgron | 3469 | R 450, Ro-115-1240, Ro-1151240190 | |||||||
| dacarbazine |
|
9075 | DTIC-Dome® | ||||||
| dacinostat | 7497 | LAQ-824, NVP-LAQ824 | |||||||
| daclatasvir |
|
11266 | BMS-790052, BMS790052, Daklinza® | ||||||
| dacomitinib |
|
|
7422 | PF-00299804, PF00299804, Vizimpro® | |||||
| dactolisib | 7950 | BEZ235, NVP-BEZ235, RTB-101, RTB101 | |||||||
| daglutril | 6506 | SLV 306, SLV-306, SLV306 | |||||||
| dagrocorat |
|
9650 | PF-00251802 | ||||||
| dalbavancin |
|
10876 | BI-397, BI397, Dalvance®, Xydalba® | ||||||
| dalcetrapib | 12972 | JTT-705, JTT705, RO-4607381, RO4607381 | |||||||
| dalfopristin |
|
|
10797 | RP-54476, RP54476, Synercid® (dalfopristin + quinupristin) | |||||
| dalmelitinib | 12088 | compound 4d [PMID: 27288183] | |||||||
| dalosirvat | 11188 | compound 1 [WO2012024404A1] | |||||||
| dalpiciclib |
|
11189 | Example 1 [WO2014183520A1], SHR-6390, SHR6390 | ||||||
| dalteparin |
|
6803 | dalteparin sodium, Fragmin® | ||||||
| daltroban |
|
1986 | BM-13505, daltrobanum, SK&F 96148, SKF 96148 | ||||||
| dalvastatin | 3036 | RG 12561 | |||||||
| daminozide |
|
7025 | B 995, DMASA, SADH | ||||||
| 4-DAMP | 307 | 4-diphenylacetoxy-1,1-dimethylpiperidinium | |||||||
| [3H]4-DAMP |
|
|
11497 | ||||||
| danaparoid |
|
6804 | ORG-10172, Orgaran® | ||||||
| danavorexton |
|
11448 | Example 5 [US10287305], TAK-925, TAK925 | ||||||
| danazol |
|
|
6942 | Danocrine® | |||||
| danicopan |
|
11988 | ACH-4471, ACH4471, Voydeya® | ||||||
| danirixin |
|
8500 | GSK-1325756B, GSK1325756, GSK1325756B | ||||||
| danofloxacin | 13667 | Advocid® (veterinary), Advocin® (veterinary), CP-76,136 | |||||||
| dantrolene |
|
4172 | Agilus®, Dantrium®, F-368, F-440, Ryanodex® | ||||||
| danuglipron |
|
12064 | PF-06882961, PF06882961 | ||||||
| danusertib |
|
7937 | PHA 739358, PHA-739358 | ||||||
| D-AP4 | 1443 | ||||||||
| d-AP5 | 4168 | D-aminophosphonovaleric acid, D-AP-5 | |||||||
| dapagliflozin |
|
|
4594 | BMS-512148, Farxiga®, Forxiga® | |||||
| dapansutrile |
|
10056 | OLT-1177, OLT1177 | ||||||
| DAPI |
|
5498 | 4',6-diamidino-2-phenylindole, antifade | ||||||
| dapiprazole |
|
7155 | AF-2139, Rev-Eyes® | ||||||
| DAPK inhibitor 13 | 9422 | compound 13 [PMID: 20206532], i-13 | |||||||
| dapolsertib | 13204 | Example 26A [WO2014096388], MEN1703, SEL-24, SEL24 | |||||||
| daporinad |
|
7745 | APO-866, FK-866, FK866 | ||||||
| dapoxetine |
|
7901 | LY 210448, LY-210448 | ||||||
| daprodustat |
|
8455 | Duvroq®, GSK-1278863, GSK1278863, Jesduvroq® | ||||||
| dapsone |
|
|
10934 | Aczone®, NSC-6091 | |||||
| DAPT | 11363 | gamma-Secretase Inhibitor IX, GSI-IX, LY-374973 | |||||||
| daptomycin |
|
10904 | Cubicin®, LY-146032, LY146032 | ||||||
| darapladib |
|
|
6696 | SB 480848, SB-480848 | |||||
| daraxonrasib | 13368 | RAS Inhibitor A122, RMC-6236, RMC6236 | |||||||
| daridorexant |
|
|
11648 | ACT-541468, ACT541468, nemorexant (former name), Quviviq® | |||||
| darifenacin |
|
321 | Emselex®, Enablex®, UK-88525 | ||||||
| [3H]darifenacin |
|
|
319 | ||||||
| darigabat | 9798 | example 4 [WO2014091368], PF-06372865, PF06372865 | |||||||
| darizmetinib | 12376 | example 63 [WO2019149738A1] | |||||||
| darlifarnib | 13803 | compound (S)-058 [US20230322711], KO-2806, KO2806 | |||||||
| darolutamide |
|
10439 | BAY-1841788), BAY1841788, example 56 [US9657003], Nubeqa®, ODM-201, ODM201 | ||||||
| darovasertib |
|
11186 | Example 9 [WO2016020864A1], IDE-196, IDE196, LXS-196, LXS196, NVP-LXS196 | ||||||
| darunavir |
|
|
11243 | DRV, Prezista®, TMC114, UIC-94017 | |||||
| darusentan | 3508 | HMR-4005, LU-135252 | |||||||
| DA-302168S | 13870 | compound 29 [PMID: 40257122] | |||||||
| DASA-58 |
|
10556 | compound 1 [PMID: 21958545], DASA58, ML-203, ML203 | ||||||
| dasabuvir |
|
11270 | ABT-333, ABT333, Exviera® | ||||||
| dasatinib |
|
|
|
5678 | BMS 345825, BMS 354825, BMS 35482513, Sprycel® | ||||
| dasotraline | 8308 | (1R,4S)-trans-norsertraline, SEP-225,289, SEP-225289 | |||||||
| [3H]D-aspartic acid |
|
|
|
4698 | [3H]-D-aspartate, [3H]-D-aspartic acid | ||||
| dATPαS | 1715 | dATPalphaS | |||||||
| [35S]dATPαS |
|
|
3406 | [35S]-dATPαS | |||||
| DAU 6285 | 246 | ||||||||
| DAV-CRI-14a23e73-1 | 11174 | ||||||||
| davelizomib | 12887 | ||||||||
| DAX | 444 | 1,3-diallyl-8-cyclohexylxanthine | |||||||
| dazoxiben | 5175 | ||||||||
| dazucorilant | 13264 | compound 1 [PMID: 28368581], CORT-113176, CORT113176 | |||||||
| dBET6 | 10534 | ||||||||
| dBRD9 | 10545 | Naphthiridinone degrader 6 | |||||||
| dBRD9-A | 10546 | ||||||||
| DC 128.1 | 12726 | compound 18 [PMID: 36234992], DC-01-0128.1 | |||||||
| DC-1-76.1 | 12729 | compound 9 [PMID: 36234992], DC-01-0076.1 | |||||||
| DC-1-76.2 | 12727 | copmound 8 [PMID: 36234992], DC-01-0076.2 | |||||||
| DC-1-90.2 | 12728 | compound 17 [PMID: 36234992], DC-01-0090.2 | |||||||
| DC591053 |
|
12505 | |||||||
| DC-159a | 10982 | ||||||||
| d-CCPene | 4170 | ||||||||
| DCDPC | 4173 | dichloro-diphenylamine 2-carboxylic acid | |||||||
| DC-EBIO | 2324 | dichloro-EBIO | |||||||
| DCG-IV |
|
1377 | |||||||
| DCLK1-IN-1 |
|
11114 | compound 4 [PMID: 32251410] | ||||||
| (S)-3,4-DCPG |
|
1407 | (S)-3,4-dicarboxylphenylglycine | ||||||
| DCPIB | 4174 | 4-(2-butyl-6,7-dichlor-2-cyclopentyl-indan-1-on-5-yl) oxybutyric acid | |||||||
| D-cycloserine |
|
|
9489 | Seromycin® | |||||
| DD-03-171 | 10535 | ||||||||
| DDD85646 |
|
|
11455 | compound 1a [PMID: 24451586], IMP-366 | |||||
| DDO-3055 | 12785 | compound 17 [PMID: 32787144], DDO3055 | |||||||
| DDR-IN-1 |
|
9354 | |||||||
| DDR1/2 inhibitor 5n |
|
|
10105 | ||||||
| DDR1 inhibitor 7rh | 14107 | ||||||||
| DDTPA | 12967 | compound 74 [PMID: 33540044] | |||||||
| 3-deazaadenosine |
|
5115 | 3-deaza-adenosine | ||||||
| DEBIO 1452 | 10755 | afabicin desphosphono, AFN-1252, AFN-12520000, DEBIO-1452, DEBIO1452 | |||||||
| decanoyl-RVKR-chloromethylketone | 11258 | decanoyl-Arg-Val-Lys-Arg-CMK, Decanoyl-RVKR-CMK | |||||||
| decaplanin | 10968 | M 861410, M86-1410, MM-47761 | |||||||
| decernotinib |
|
|
8309 | adelatinib, VRT-831509, VX-509 | |||||
| decitabine |
|
6805 | 5-azadeoxycytidine, ASTX-727, ASTX727 (decitabine + cedazuridine), azadC, DAC, Dacogen®, Inqovi® (decitabine + cedazuridine) | ||||||
| decyl dihydrogen phosphate | 4030 | decanol phosphate, decyl phosphate, FAP-10, FAP10, n-decyl phosphoric acid | |||||||
| decynium 22 | 8482 | 1,1'-diethyl-2,2'-cyanine, D-22, decynium-22, Dy22, GNF-Pf-1919, GNF-Pf-4440, NSC-97374, pseudoisocyanine | |||||||
| defactinib |
|
|
7910 | Avmapki Fakzynja (avutometinib + defactinib co-pack), PF-04554878, VS-6063 | |||||
| deferiprone |
|
7456 | APO-66, CP20, Ferriprox® | ||||||
| deflazacort |
|
|
9477 | Emflaza®, MDL 458 | |||||
| defoslimod |
|
9024 | OM 174, OM-174 | ||||||
| [3H]dehydroepiandrosterone sulphate |
|
|
5577 | [3H]DHEAS, [3H]dehydroepiandrosterone sulfate | |||||
| delafloxacin |
|
|
10799 | Abbott 492, ABT-492, ABT492, Baxdela®, Quofenix® | |||||
| delamanid |
|
12876 | Deltyba®, OPC-67683 | ||||||
| delavirdine |
|
|
12674 | DLV, Rescriptor®, U-90152, U90152 | |||||
| delgocitinib |
|
|
|
9619 | Anzupgo®, Corectim®, ent-60, JTE-052, JTE052 | ||||
| delpazolid | 10999 | LCB-01,0371, LCB-01-0371, LCB01-0371 | |||||||
| D-e-MAPP | 8817 | D-erythro-MAPP | |||||||
| demeclocycline |
|
10905 | Declomycin®, Ledermycin® | ||||||
| denatonium |
|
12433 | |||||||
| denfivontinib | 8108 | G-749, G749 | |||||||
| denifanstat |
|
14123 | ASC-40, ASC40, compound 152 [US8871790], TVB-2640, TVB2640 | ||||||
| denopamine | 534 | TA 064, TA-064 | |||||||
| denufosol | 1737 | dCp4U, INS37217, Up4dC | |||||||
| [3H]2-deoxyglucose |
|
|
4643 | 2-deoxy-D-glucose, 2-DG, [3H]-2-deoxyglucose | |||||
| 8-deoxy-neodysiherbaine | 4112 | 8-deoxy-neoDH | |||||||
| 1-deoxynojirimycin-1-sulfonic acid | 4744 | ||||||||
| 11-deoxy-PGE2 | 1945 | ||||||||
| 15-deoxy-Δ12,14-PGJ2 | 1877 | 15d-Δ12,14-PGJ2, 15deoxy-delta-12,14-PGJ2, LS-125843 | |||||||
| 15-deoxy-TIC | 5865 | ||||||||
| DEPX | 445 | 1,3-diethyl-8-phenylxanthine, DPX | |||||||
| dequalinium |
|
2313 | |||||||
| deramciclane | 5490 | EGIS-3886, EGYT 3886, EGYT-3886, EGYT3886 | |||||||
| derazantinib | 9785 | ARQ-087, ARQ087 | |||||||
| derenofylline | 3281 | SLV 320, SLV-320, SLV320 | |||||||
| derivative 17 [Nakahata et al., 2018] |
|
9804 | example 65 [WO2011078360] | ||||||
| desflurane |
|
7156 | I-653, Suprane® | ||||||
| desidustat | 12285 | EXAMPLE 2 [WO2014102818A1], Oxemia®, ZYAN-1, ZYAN1 | |||||||
| desipramine |
|
|
2399 | EX-4355, JB-8181, Norpramin®, Pertrofane®, Treyzafagit® | |||||
| deslanoside |
|
6806 | Cedilanide®, desacetyl-lanatoside C | ||||||
| desloratadine |
|
|
|
7157 | Clarinex®, SCH-34117 | ||||
| desogestrel |
|
7065 | ORG-2969 | ||||||
| desonide |
|
|
7066 | D-2083, Desowen® | |||||
| desvenlafaxine |
|
7158 | O-desmethylvenlafaxine (ODV), Pristiq®, WY-45233 | ||||||
| deucravacitinib |
|
|
10432 | BMS-986165, BMS986165, compound 11 [PMID: 31318208}, Sotyktu®, Tyk2-IN-4 | |||||
| deucrictibant | 12421 | PHA-022121, PHA-121, PHA022121 | |||||||
| deulorlatinib | 13488 | compound of formula A [US20220024908A1], TGRX-326, TGRX326 | |||||||
| deupirfenidone | 12890 | LYT-100 | |||||||
| deuruxolitinib |
|
|
11410 | CTP-543, CTP543, D8-ruxolitinib, Leqselvi® | |||||
| Deuterium-substituted L-DOPA | 8611 | D3 L-DOPA, DP-102 | |||||||
| deutetrabenazine |
|
8707 | Austedo®, SD-809, SD809, tetrabenazine D6 | ||||||
| deutivacaftor |
|
13695 | Ivacaftor-D9, VX-561, VX561 | ||||||
| (-)-devapamil | 2517 | (-)-D888, (-)-desmethoxyverapamil, 4-desmethoxyverapamil (4-DMV) | |||||||
| [3H](-)devapamil |
|
|
2515 | ||||||
| devazepide | 878 | BRN 5156082, L-364,718, L-364718, MK-329 | |||||||
| [3H]devazepide |
|
|
3476 | [3H]-devazepide | |||||
| dexamethasone |
|
|
|
2768 | Decadron®, desametasone, fluormethylprednisolone | ||||
| [3H]dexamethasone |
|
|
|
3447 | [3H]-dexamethasone | ||||
| dexamfetamine |
|
|
2147 | (+)-alpha-methylphenylethylamine, d-amphetamine, Dexadrine®, dextroamphetamine, Dextrostat®, S(+)amphetamine | |||||
| dexbrompheniramine |
|
7588 | D-brompheniramine, Disomer® | ||||||
| dexetimide |
|
354 | (+)-benzetimide, R 16470, Tremblex® | ||||||
| dexfadrostat |
|
13884 | (+)-fadrozole, (R)-fadrozole, DP-13, DP13 | ||||||
| dexlansoprazole |
|
5487 | (+)-lansoprazol, (R)-lansoprazole, Dexilant SoluTab®, Dexilant®, Kapidex®, T 168390, TAK 390 | ||||||
| dexloxiglumide | 889 | CR-2017 | |||||||
| dexmedetomidine |
|
|
521 | Dexdor®, Igalmi® (dexmedetomidine sublingual film), MPV 1440, Precedex® | |||||
| dexmethylphenidate |
|
|
7554 | Attenade®, D-TMP, Focalin® | |||||
| dexniguldipine | 463 | (R)-(-)-niguldipine, (R)-niguldipine | |||||||
| dexrazoxane |
|
7330 | ADR-529, Cardioxane®, ICRF-187, Savene®, Zinecard® | ||||||
| dextromethorphan |
|
6953 | d-methorphan | ||||||
| dextropropoxyphene |
|
7593 | (+)-alpha-propoxyphene, Darvon®, propoxyphene | ||||||
| dextrorphan | 9052 | ||||||||
| dextrothyroxine |
|
6951 | Choloxin®, D-T4, D-thyroxine | ||||||
| dezapelisib |
|
9728 | compound 67 [PMID: 22924688], example 15 [WO2011008487], INCB 40093, INCB40093 | ||||||
| DF2726 | 12231 | DF2726 (acid form), DF2726A (sodium salt) | |||||||
| DF2593A | 9451 | ||||||||
| DF2755A | 12230 | DF 2755A, DF-2755A | |||||||
| DF3016A | 14177 | DF-3016A | |||||||
| DF3966A | 12515 | ||||||||
| (R)-DFV890 |
|
|
13782 | compound (R)-1 [PMID: 40036600], DFV-890, IFM-2427, IFM2427 | |||||
| DG-041 | 5822 | DTSI | |||||||
| DG-051 | 6548 | compound 20 [PMID: 19950900] | |||||||
| DH376 | 10244 | DH-376, inhibitor 38 | |||||||
| DH97 | 3366 | ||||||||
| DHβE |
|
4006 | dihydro-β-erythroidine | ||||||
| DHP-103 | 14035 | ||||||||
| 3,5-DHPG | 1367 | 3,5-dihydroxyphenylglycine | |||||||
| diABZI-4 | 11555 | Example 39 [WO2017175147A1] | |||||||
| diacerein |
|
10800 | Artrodar®, Fisiodar® | ||||||
| diacylglycerol kinase inhibitor II | 5957 | R 59 949, R59949 | |||||||
| diamide 7 | 5830 | ||||||||
| diamorphine |
|
9082 | acetomorphine, diacetylmorphine, heroin | ||||||
| diarylpropionitrile | 2825 | DPN | |||||||
| diazepam |
|
|
3364 | Diastat®, LA-III, Valium®, WY-3467 | |||||
| diazoxide |
|
|
2409 | Proglycem®, SCH-6783, SRG-95213 | |||||
| diBA-(5)-C4 | 4176 | bis-(1,3-dibutylbarbituric acid)pentamethine oxanol, oxalon dye | |||||||
| dibekacin |
|
|
12134 | 3',4'-dideoxykanamycin B, debecacin | |||||
| dibenamine | 13154 | dibenzylchlorethamine | |||||||
| dibenzoxazepine | 6472 | CR gas | |||||||
| dibucaine |
|
7159 | Cincain ®, cincaine chloride, Nupercaine ® | ||||||
| dibutyl phthalate |
|
6295 | di-n-butyl phthalate, n-butyl phthalate, nutyl phthalate | ||||||
| dichloroacetate | 4518 | DCA, dichloroacetic acid | |||||||
| 3,4-dichlorobenzamil | 4597 | 3',4'-dichlorobenzamil , GNF-Pf-1778 | |||||||
| 5,7-dichlorokynurenic acid |
|
2361 | |||||||
| diclofenac |
|
|
|
2714 | Cataflam®, CGP-45840B, GP-45840, Voltaren®, Voltarol® | ||||
| diclofenamide |
|
|
6807 | Daranide®, dichlofenamide, dichlorphenamide, glauconide, Keveyis® | |||||
| dicloxacillin |
|
12261 | BRL-1702, Diclocil®, Dynapen® | ||||||
| dicumarol |
|
6808 | bishydroxycoumarin, Melitoxin® | ||||||
| dicyclomine |
|
355 | Bentyl®, Byclomine® | ||||||
| didanosine |
|
|
4833 | dideoxyinosine, Videx EC® | |||||
| DIDS | 4177 | 4,4'-diisothiocyanostilbene-2,2'-disulphonic acid, ABC inhibitor 2 | |||||||
| dienestrol |
|
7160 | Estraguard® | ||||||
| dienogest |
|
7654 | dienogestrel, STS-557 | ||||||
| diethylpropion |
|
7161 | diethylpropion hydrochloride, Prefamone, Regenon® | ||||||
| diethylstilbestrol |
|
|
2801 | stilboestrol | |||||
| difamilast |
|
|
9776 | example 352 [WO2007058338], MM36, Moizerto®, OPA-15406 | |||||
| difenoxin |
|
7592 | difenoxin hydrochloride, MCN-JR-15,403-11, Motofen®, R-15403 | ||||||
| diflapolin |
|
10080 | |||||||
| diflorasone diacetate |
|
|
7068 | Psorcon®, U-34865 | |||||
| difloxacin | 10801 | A 56619, A-56619, Dicural® | |||||||
| diflunisal |
|
|
|
7162 | Dolobid® | ||||
| difluoroagomelatine | 7776 | ||||||||
| 3,3'-difluorobenzaldazine | 1424 | DFB | |||||||
| α,β-difluoromethylene-UDP | 14169 | compound 12 [PMID: 19902968], Up-CF2-p | |||||||
| 2,2-difluoromevalonate 5-diphosphate | 3213 | ||||||||
| 10,10-difluoro TXA2 | 6069 | ||||||||
| difluprednate |
|
|
7474 | DFBA, Durezol®, W-6309 | |||||
| digeranyl bisphosphonate |
|
3187 | |||||||
| digitoxin |
|
|
6782 | digitoxoside, unidigin | |||||
| [3H]digoxin |
|
|
|
4725 | [3H]-digoxin | ||||
| dihydrexidine | 9267 | DAR 0100A, DAR-0100A, DAR0100A | |||||||
| [3H]dihydroalprenolol |
|
|
5388 | [3H]-dihydroalprenolol | |||||
| dihydrocarveol | 6415 | neodihydrocarveol | |||||||
| dihydrocodeine |
|
7594 | DF-118, Dicogesic®, dihydrocodeine bitartrate, Drocode, Paracodeine® | ||||||
| 2,3-dihydro-1,4-dithiin-1,1,4,4-tetroxide | 3486 | ||||||||
| dihydroergocryptine | 282 | DHC, dihydroergokryptine | |||||||
| dihydroergotamine |
|
|
121 | Brekiya® (dihydroergotamine mesylate auto-injector), D.H.E. 45®, Migranal® | |||||
| dihydrokainate | 4571 | ||||||||
| 13,14-dihydro-15-keto-PGD2 | 1900 | 13,14-dihydro-15-keto-prostaglandin D2, 13,14-dihydro-15-ketoprostaglandin D2, 13,14-dihydro-15-oxo PGD2, DK-PGD2 | |||||||
| dihydrolipoic acid | 6738 | ||||||||
| 13,14-dihydro-16-m-chlorophenoxy-w-tetranor-PGF1α | 1955 | ||||||||
| dihydromorphine | 1616 | paramorphan | |||||||
| dihydrostreptomycin |
|
|
12163 | ||||||
| [3H]dihydrotestosterone |
|
|
|
3455 | [3H]-dihydrotestosterone | ||||
| dihydroxybenzofuran | 10992 | 2,3-Benzofurandiol | |||||||
| 3,5-dihydroxybenzoic acid |
|
5783 | α-resorcylic acid, 5-carboxyresorcinol, NSC 22948 | ||||||
| 3,5-diiodo-L-tyrosine |
|
6651 | 3,5-diiodotyrosine, diotyrosine | ||||||
| dilazep |
|
4717 | |||||||
| dilmapimod |
|
7815 | SB-681323 | ||||||
| diltiazem |
|
|
2298 | (+)-cis-diltiazem, Cardizem®, CRD-401, D-(cis)-diltiazem, Dilacor-XR®, RG-83606 | |||||
| DIM | 11208 | ||||||||
| dimaprit | 1248 | ||||||||
| dimdazenil | 13435 | EVT-201, EVT201, Junoenil® | |||||||
| dimethyl fumarate |
|
|
|
7045 | BG-12, BG00012, fumaric acid, Tecfidera® | ||||
| dimethylhistaprodifen | 1203 | ||||||||
| dimethyl itaconate |
|
9939 | dimethylitaconate, itaconic acid dimethyl ester | ||||||
| 16,16-dimethyl-PGE2 | 1926 | 16,16-dimethylprostaglandin E2 | |||||||
| 3,5-dimethyl PPP | 3397 | 3,5-DMPPP | |||||||
| dimethyl shikonin oxime 5a | 14059 | DSO-5a | |||||||
| dimethyl-W84 | 365 | ||||||||
| [3H]dimethyl-W84 |
|
|
364 | ||||||
| dimetindene |
|
|
10101 | (+/-)-dimethindene, dimethindene, dimethpyrindene, Fenistil®, Vibrocil® | |||||
| (S)-dimetindene |
|
10104 | (+)-dimethindene, (+)-dimetindene, (S)-dimethindene | ||||||
| diminazene |
|
|
10307 | Azidin®, Berenil®, Pirocide® | |||||
| dinaciclib |
|
7379 | SCH727965 | ||||||
| DIOA | 4589 | dihydroindenyl-oxyalkanoic acid | |||||||
| dioctanoylglycerol pyrophosphate |
|
2916 | DGPP, DGPP 8:0 | ||||||
| dioscin | 840 | ||||||||
| diosuxentan | 13748 | SC-0062, WX-013, WX013 | |||||||
| [3H]-di-o-tolylguanidine |
|
|
6685 | [3H]DOTG | |||||
| diphenhydramine |
|
|
1224 | Benadryl®, benzhydramine, dimehydrinate | |||||
| diphenidol |
|
7163 | K-478-A, SK&F-478-J, SK&F-478A, SK-478, Vontrol® | ||||||
| diphenoxylate |
|
7164 | Co-phenotrope, diphenoxylate HCl, Lomotil® | ||||||
| diphenylamine-2-carboxylic acid |
|
4182 | DPC, fenamic acid, N-phenylanthranilic acid, NPA | ||||||
| diphenylboronic anhydride | 2494 | diphenylborinic anhydride | |||||||
| diphenyleneiodonium chloride | 7802 | ||||||||
| diphenylpyraline |
|
|
7165 | Hispril® | |||||
| diphenyltetrahydrofuran | 2498 | ||||||||
| diphosphoglycolyl proline | 3206 | DPGP, (R,S)-diphosphoglycolyl proline, diphosphoglycolyproline | |||||||
| diphosphoric acid |
|
3151 | phosphonooxyphosphonic acid, pyrophosphoric acid | ||||||
| dipipanone |
|
9081 | Diconal tablets (dipipanone+cyclizine), pipadone | ||||||
| dipivefrine |
|
7166 | Propine® | ||||||
| dipraglurant | 6452 | ADX48621 | |||||||
| diprenorphine | 1617 | ||||||||
| [3H]diprenorphine |
|
|
1612 | [15,16-3H]diprenorphine | |||||
| dipropyl-5-CT | 122 | DP-5-CT, DP5CT, N,N-dipropylcarboxamidotryptamine | |||||||
| diprovocim-1 |
|
|
10341 | compound 3 [PMID: 30272974] | |||||
| dipyridamole |
|
|
4807 | Persantine® | |||||
| diquafosol | 1736 | INS-365, INS365 | |||||||
| dirithromycin |
|
|
12928 | AS-E 136, Dynabac®, LY237216 | |||||
| diroleuton |
|
|
9775 | 8,11,14-Eicosatrienoic acid, DGLA, dihomo-gamma-linolenic acid, DS107, Homo-gamma-linolenic acid | |||||
| diroximel fumarate |
|
|
10525 | ALKS-8700, ALKS8700, BIIB098, Vumerity® | |||||
| dirozalkib | 13811 | compound 3 [WO2016050171A1], XZP-3621, XZP3621 | |||||||
| disopyramide |
|
7167 | Norpace®, Rythmodan®, SC-13957, SC-7031 | ||||||
| disprocynium24 | 8826 | 1,1'-Diisopropyl-2,4'-cyanine | |||||||
| disulfiram |
|
7168 | Antabuse®, NSC-25953 | ||||||
| dithiipin-1,1,4,4-tetroxide analogue 7 | 6124 | ||||||||
| 1,3-ditolylguanidine | 6684 | 1,3-Di-o-tolylguanidine, Di-o-tolylguanidine, DOTG | |||||||
| [125I]DIV880 |
|
|
7771 | ||||||
| divarasib | 11963 | GDC-6036, GDC6036, RG-6330, RG6330 | |||||||
| dizocilpine |
|
2403 | MK-801 | ||||||
| [3H]dizocilpine |
|
|
4089 | [3H]MK-801 | |||||
| DKFZ‐251 | 10575 | compound 11 [PMID: 30212625] | |||||||
| DK-507k | 11037 | ||||||||
| D-kynurenine | 5799 | ||||||||
| DL-175 | 11213 | ||||||||
| DL5055 | 13871 | compound 6k [PMID: 40145447], DL-5055 | |||||||
| DL-TBOA |
|
4631 | dl-threo-β-benzyloxyaspartate | ||||||
| DL-threo-β-hydroxyaspartate |
|
4497 | |||||||
| DM-1451 | 267 | DM 1451 | |||||||
| DMAMCL | 9936 | compound 21 [PMID: 22985027], dimethylaminomicheliolide | |||||||
| DMAT |
|
|
9323 | 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole, CK2 Inhibitor II | |||||
| DMBI | 5958 | 3-(4-dimethylaminobenzylidenyl)-2-indolinone | |||||||
| DM-CHX | 11484 | N-(N′,N′-Dimethylcarboxamidomethyl)cycloheximide | |||||||
| DMCM |
|
4179 | |||||||
| DMP696 | 3499 | DMP-696 | |||||||
| DMPP | 3967 | ||||||||
| DM-PPP | 1383 | ||||||||
| DNA-PK inhibitor III | 5960 | IC86621 | |||||||
| DNA-PK inhibitor V | 5961 | AMA37, arylmorpholine analog 37 | |||||||
| DNDI-6510 |
|
13989 | (S)-x38 DNDI-6510, DNDI6510, MAT-POS-e48723dc-2, Mpro-P3038 | ||||||
| β-D-N4-hydroxycytidine |
|
10735 | EIDD-1931, NHC | ||||||
| DO264 |
|
10250 | compound 46, DO-264 | ||||||
| DO34 | 10243 | DO-34 | |||||||
| [3H](+)DOB |
|
|
155 | 4-bromo-2,5-dimethoxyphenylisopropylamine, brolamfetamine | |||||
| dobutamine |
|
535 | dobutamine hydrochloride, Dobutrex®, Inotrex® | ||||||
| docetaxel |
|
|
6809 | Docecad®, docetaxel anhydrous, EmDOC, Taxotere® | |||||
| dodecylphosphate | 4031 | dodecanol phosphate, FAP-12, FAP12, lauryl phosphate | |||||||
| dodecyl-thiophosphate | 6990 | ||||||||
| dofetilide |
|
2604 | Tikosyn®, UK-68798 | ||||||
| (+)-DOI | 153 | ||||||||
| DOI | 147 | 4-DOI | |||||||
| (R)-DOI | 157 | (-)-DOI | |||||||
| [125I]DOI |
|
|
169 | ||||||
| dolutegravir |
|
|
7365 | GSK 1349572, GSK-1349572, GSK1349572, S-349572, Tivicay® | |||||
| DOM | 164 | (RS)-DOM, STP | |||||||
| domitroban | 1979 | (+)-S-145, S-145 | |||||||
| domperidone |
|
|
965 | Motilium®, Nauzelin®, R-33812 | |||||
| donafenib | 11830 | CM-4307, CM4307, Sorafenib-d3, Zepsun® | |||||||
| donecopride | 10584 | compound 1 [PMID: 25793650], MR31147 | |||||||
| donepezil |
|
6599 | Aricept®, E-2020 | ||||||
| donitriptan | 39 | F 11356 | |||||||
| Dooku1 | 10112 | Dooku 1, Dooku-1 | |||||||
| doramapimod |
|
|
5668 | BIRB 796BS, BIRB-796, BIRB796 | |||||
| doravirine |
|
|
12679 | MK-1439, MK1439, Pifeltro® | |||||
| dordaviprone |
|
|
9978 | Modeyso®, ONC-201, ONC201, TIC-10, TIC10 | |||||
| doripenem |
|
|
12183 | compound 1m [PMID: 8621362], Doribax®, S-4661 | |||||
| dorsomorphin |
|
4907 | AMPK Inhibitor, Compound C | ||||||
| dorzagliatin |
|
12124 | HMS-5552, HMS5552, RO-5305552, RO5305552, Sinogliatin | ||||||
| dorzolamide |
|
|
6810 | Trusopt® | |||||
| dosimertinib | 12710 | compound 2h [PMID: 33459024] | |||||||
| dosulepin |
|
7549 | Dothep®, dothiepin, Prothiaden® | ||||||
| DOTA | 5538 | NSC 681107 | |||||||
| dotinurad |
|
|
11389 | FYU-981, FYU981, Urece® | |||||
| dovitinib | 5962 | Chir 258, CHIR-258, TKI 258, TKI-258 | |||||||
| dovramilast | 13581 | AMG-634, CC-11050 | |||||||
| doxapram |
|
7169 | AHR-619, Dopram® | ||||||
| doxazosin |
|
7170 | Cardura®, UK-3327427 | ||||||
| doxepin |
|
|
1225 | Deptran®, P-3693A, Sinequan® | |||||
| [11C]doxepin |
|
|
|
3958 | [11C]-doxepin | ||||
| doxycycline |
|
|
|
|
6464 | BMY-28689, Monodox®, Vibramycin® | |||
| doxylamine |
|
7171 | Unisom® | ||||||
| DPCPX | 386 | 1,3-DPCPX, 8-cyclopentyl-1,3-dipropylxanthine, GNF-Pf-2224 | |||||||
| [3H]DPCPX |
|
|
406 | [3H]-DPCPX | |||||
| DPO-1 | 11207 | diphenyl phosphine oxide-1, DPO1 | |||||||
| DQP-1105 | 7843 | KB-272091 | |||||||
| DR-4004 | 8431 | compound 7 [PMID 10052959] | |||||||
| draflazine | 4590 | ||||||||
| DRB |
|
5178 | 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole | ||||||
| DRF 2519 | 2671 | ||||||||
| (S)-DRF-1042 | 8261 | 5(S)-(2'-hydroxyethoxy)-20(S)-camptothecin, 5(S)-(2'-hydroxyethoxy)-20(S)-CPT | |||||||
| DRL-17822 | 10721 | DRL 17822, DRL17822, Example 57 [US20070015758A1] | |||||||
| dromostanolone propionate |
|
6947 | drostanolone, Masteron® | ||||||
| dronedarone |
|
7465 | Multaq®, SR-33598B | ||||||
| droperidol |
|
|
7172 | Droleptan®, Inapsine®, McN-JR-4749, R-4749 | |||||
| drospirenone |
|
2874 | dihydrospirorenone, Slynd®, Yasmin®, ZK30595 | ||||||
| droxidopa |
|
7391 | L-DOPS, Northera®, SM-5688 | ||||||
| droxinostat |
|
8464 | NS-41080, NS41080 | ||||||
| DS1 | 4183 | ||||||||
| DS2 | 4184 | delta selective compound 2 | |||||||
| DS21360717 | 10367 | compound 21 [Taniguchi et al., 2019] | |||||||
| DS37001789 | 11438 | ||||||||
| DS-437 | 8395 | DS437 | |||||||
| DS69910557 | 12004 | Compound 19e [PMID: 35487102], DS-69910557 | |||||||
| DS-7423 | 12616 | DS7423 | |||||||
| DS-8587 | 10955 | DS8587 | |||||||
| DS88790512 | 12534 | ||||||||
| DS96432529 | 11842 | compound 9o [PMID: 34742889], DS-96432529 | |||||||
| DS-1971a | 11023 | compound 6o [PMID: 32392056] | |||||||
| DS-8500a |
|
10082 | |||||||
| DS-2969b | 10985 | DS 11960558 (DS-2969b prodrug), DS-2969, example 2 [WO2017/056012A1] | |||||||
| DS-3801b free base |
|
11902 | compound 12 [PMID: 35051575] | ||||||
| DSM265 |
|
|
9644 | ||||||
| DSM421 |
|
|
10020 | ||||||
| DSM502 |
|
11219 | |||||||
| DSM705 |
|
|
11554 | compound 79 | |||||
| DT2216 | 11722 | DT-2216 | |||||||
| dTAG-13 | 10533 | ||||||||
| [11C]DTBZ |
|
|
4608 | [11C]-DTBZ , [11C]-DTBZ (PET ligand), dihydrotetrabenazine | |||||
| dTRIM24 | 10536 | ||||||||
| D-tryptophan |
|
5798 | |||||||
| [d-Tyr-14C]TAK-448 |
|
|
10223 | ||||||
| DU172 |
|
9530 | |||||||
| dual BRD4/PLK1 inhibitor 23 | 10072 | compound 23 [PMID: 30125504] | |||||||
| dual sEH/FAAH inhibitor 11 |
|
10124 | compound B-11 [WO2017160861], example 28 [WO2017160861] | ||||||
| dual VEGFR/PARP inhibitor 14b | 12905 | compound 14b [PMID: 37616488] | |||||||
| dubermatinib |
|
8863 | compound 13, TP 0903, TP-0903, TP0903 | ||||||
| duloxetine |
|
|
202 | Cymbalta®, LY248686 | |||||
| Duo3 | 7635 | DUO3 | |||||||
| Dup-105 | 10950 | DuP 105, DuP105 | |||||||
| Dup-714 |
|
8760 | acetylphenylalanyl-prolyl-boroarginine, Dup 714 | ||||||
| DuP-721 | 10960 | DuP 721 | |||||||
| durlobactam |
|
12693 | ETX-2514, EXT2514, Xacduro® (sulbactam and durlobactam) | ||||||
| dutasteride |
|
7457 | Avodart®, GG-745, GI-198745 | ||||||
| duvelisib |
|
|
7795 | compound 4904 [Patent US8193182], Copiktra®, INK-1197, IPI-145 | |||||
| dWIZ-1 | 13440 | compound C [PMID: 38963839] | |||||||
| DX-619 | 11039 | compound 4 [PMID: 19736016], DX619 | |||||||
| DX-9065a |
|
11365 | DX9065A | ||||||
| DY131 | 2834 | DY-131, GSK9089 | |||||||
| DY268 | 14078 | compound 4j [PMID: 24775917], DY-268 | |||||||
| dyclonine |
|
|
7173 | dyclocaine | |||||
| dydrogesterone |
|
2878 | Duphaston® | ||||||
| DZNep | 8392 | 3-deazaneplanocin A | |||||||
| E | Back to top | ||||||||
| 6E11 |
|
9749 | |||||||
| E-0702 | 11056 | ||||||||
| E2012 |
|
7358 | E 2012, E-2012 | ||||||
| E209 |
|
10465 | |||||||
| E4031 |
|
2605 | E 4031, E-4031 | ||||||
| E-52862 |
|
|
10431 | compound 28 [PMID: 22784008], E52862, MR309, sigma 1 receptor antagonist (S1RA) | |||||
| E55888 | 3929 | E 55888, E-55888 | |||||||
| E5700 | 3104 | E 5700, E-5700 | |||||||
| E6201 |
|
|
7836 | E 6201, E-6201 | |||||
| E6801 | 3217 | E 6801, E-6801 | |||||||
| E913 | 3500 | E 913, E-913 | |||||||
| Eact | 13562 | Eact | |||||||
| EAI045 | 9222 | ||||||||
| eAmSPC 2593 | 13565 | ||||||||
| EB-42168 | 13903 | EB42168, LRRK2 inhibitor 30 [PMID: 33197196] | |||||||
| EB-42486 | 11566 | compound 31 [PMID: 33197196] | |||||||
| ebaresdax | 12149 | ACP-044, ACP044, compound 1 [WO2020159643A1] | |||||||
| EBI-2511 | 9881 | compound 34 [PMID: 29456795], EBI2511 | |||||||
| EBIO |
|
2314 | |||||||
| ebselen | 10583 | DR 3305, PZ51, SPI-1005 | |||||||
| EC18 | 6262 | ||||||||
| EC5026 | 12750 | BPN-19186, BPN19186, EC-5026 | |||||||
| ecenofloxacin | 10802 | CFC-222, CFC222 | |||||||
| eCF309 | 9571 | compound 12 [Fraser et al., 2016], eCF-309 | |||||||
| eCF506 |
|
9186 | derivative 11a [PMID: 27115835], NXP-900, NXP900 | ||||||
| echothiophate |
|
9074 | ecostigmine iodide, phospholine iodide | ||||||
| eclitasertib |
|
11308 | DNL-758, DNL758, example 42 [WO2017136727A2], SAR443122 | ||||||
| econazole |
|
2446 | R-14827, Spectazole® | ||||||
| ecopipam | 3304 | EBS-101, PSYRX-101, SCH 39166, SCH-39166, SCH39166 | |||||||
| E339-3D6 | 6187 | ||||||||
| edaglitazone |
|
8907 | BM 131258, BM13.1258, R 483 | ||||||
| edaravone |
|
11994 | MCI-186, MCI186, Radicava®, Radicut® | ||||||
| edaxeterkib | 11411 | Example 104 [WO2015051341A1] | |||||||
| edecesertib | 12080 | ||||||||
| edicotinib |
|
8942 | JNJ-40346527, JNJ40346527, US8497376, 15 | ||||||
| edonentan | 13015 | BMS-207940, BMS207940, compound 16a [PMID: 12502366] | |||||||
| edoxaban |
|
7575 | DU-176, DU-176b, edoxaban tosylate, Lixiana®, Savaysa® | ||||||
| edrophonium |
|
|
9073 | Enlon®, Tensilon® | |||||
| EDT001 | 14040 | compound 30h [PMID: 39561495], EDT-001 | |||||||
| (2E, 6E)-farnesylbisphosphonate | 3200 | ||||||||
| (R)-EF-1520 | 6512 | ||||||||
| (S)-EF-1520 | 6513 | ||||||||
| efavirenz |
|
|
11287 | DMP-266, DMP266, EFV, L-743,726, L-743726, Stocrin®, Sustiva® | |||||
| eflornithine |
|
5176 | 2-(difluoromethyl)ornithine (DMFO), difluoromethylornithine, Iwilfin®, Ornidyl®, Vaniqa® | ||||||
| (5E)-1-(4-fluorophenyl)-5-[(5-methylthiophen-2-yl)methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione | 8728 | ||||||||
| efonidipine |
|
12565 | Landel®, NZ-105 (efonidipine HCl) | ||||||
| (-)-(R)-efonidipine |
|
2519 | |||||||
| EFPPEA | 7774 | ethyl-furo-pyrazolo-pyridine-ethyl-acetamide, N-[2-(2-Ethyl-8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridin-1-yl)ethyl]acetamide | |||||||
| E-1010 free base | 11050 | E1010, ER-35786 | |||||||
| efsevin | 10648 | ||||||||
| EG00229 |
|
11335 | compound 2 [PMID: 20151671], EG-00229 | ||||||
| EG-011 | 12315 | ||||||||
| EG01377 |
|
|
9904 | (3-((5-(4-(aminomethyl)phenyl)-2,3-dihydrobenzofuran)-7-sulfonamido)thiophene- 2-carbonyl)-L-arginine, compound 1 [PMID: 29648813] | |||||
| EG-1-203 | 12732 | compound 12 [PMID: 33479684] | |||||||
| EG-1-230 | 12733 | compound 13 [PMID: 33479684] | |||||||
| EG-2184 | 13604 | compound 1 [WO2023283743], EG2184 | |||||||
| eganelisib |
|
|
9563 | compound 26 [PMID: 27660692], IPI-549, IPI549 | |||||
| EGFR/ErbB-2/ErbB-4 inhibitor | 5965 | HDS 029 | |||||||
| EGFR/ErbB-2 inhibitor | 5964 | 4557W | |||||||
| EGFR inhibitor |
|
5963 | |||||||
| EGFR inhibitor 57 | 12278 | ||||||||
| EGIS-11150 | 11959 | EGIS11150, S 36549, S-36549, S36549 | |||||||
| EGIS-7625 | 176 | ||||||||
| eGlu | 1400 | (s)-α-ethylglutamate, EGLU | |||||||
| eglumegad |
|
1393 | LY354740 | ||||||
| [3H]eglumegad |
|
|
|
1396 | [3H]LY354740 | ||||
| EHNA | 5179 | erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride | |||||||
| EHop 016 | 11061 | EHop-016, EHop016 | |||||||
| EHT 1864 | 11059 | EHT-1864, EHT1864 | |||||||
| EI1 | 7013 | KB-145943 | |||||||
| elacestrant |
|
|
12339 | ER-306323, ER306323, Orserdu®, RAD-1901, RAD1901 | |||||
| elacridar |
|
13578 | GF-120918, GF120918, GG918, GW-120918, GW120918 | ||||||
| elafibranor |
|
|
11135 | GFT-505, GFT505, Iqirvo® | |||||
| elagolix |
|
|
8362 | compound 10b [PMID 19006286], NBI-56418, NBI56418, Orilissa® | |||||
| eldecalcitol |
|
|
2783 | 1α,25-dihydroxy-2β-(3-hydroxypropoxy)vitamin D3, 2β-(3-hydroxypropoxy)calcitriol, ED-71 | |||||
| eleclazine | 8413 | GS-6615, GS6615 | |||||||
| elenbecestat | 9818 | E 2609, E-2609, E2609 | |||||||
| elenestinib |
|
12357 | BLU-263, BLU263, exampl4 4 [WO2020210293A1] | ||||||
| eletriptan |
|
40 | Relpax®, UK 116044 | ||||||
| [3H]eletriptan |
|
|
118 | ||||||
| elexacaftor |
|
|
10552 | Compound 1 [WO2018107100A1], VX-445 | |||||
| eliapixant | 11969 | BAY-1817080, BAY1817080 | |||||||
| eliglustat |
|
7536 | GENZ-112638 | ||||||
| elimusertib | 10354 | BAY-1895344, BAY1895344 | |||||||
| elinzanetant | 12691 | BAY-3427080, BAY3427080, Compound A [WO2021094247A1], Example 34 [WO2007028654A1], NT-814, NT814 | |||||||
| elironrasib | 12622 | RMC-6291, RMC6291 | |||||||
| elismetrep | 9774 | example 104 [WO2012124825] | |||||||
| ELND006 | 7337 | ||||||||
| elobixibat |
|
9996 | 2-[[(2R)-2-[[2-[(3,3-dibutyl-7-methylsulfanyl-1,1-dioxo-5-phenyl-2,4-dihydro-1λ6,5-benzothiazepin-8-yl)oxy]acetyl]amino]-2-phenylacetyl]amino]acetic acid, A3309, AJG533, AZD-7806, AZD7806, Goofice® | ||||||
| elocalcitol | 2785 | 1α-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3, BXL 628, BXL628, Ro-26-9228 | |||||||
| ELQ-300 |
|
|
10021 | ELQ300 | |||||
| elraglusib | 11412 | 9-ING-41, compound 26 [PMID: 19338355] | |||||||
| elsubrutinib |
|
10464 | example #30 (S) [WO2014210255A1] | ||||||
| eltanexor | 10037 | KPT-8602, KPT8602 | |||||||
| eltrombopag |
|
6961 | AMG531, Promacta®, Revolade®, SB-497115-GR | ||||||
| elubirixin |
|
8499 | SB 656933, SB-656933, SB656933 | ||||||
| elunetirom | 12973 | ABX-002, ABX002, compound 1 [WO2022236133A1], MA-JD-21, MA-JD21 | |||||||
| elunonavir | 11667 | ||||||||
| eluxadoline |
|
7691 | JNJ-27018966, Truberzi® | ||||||
| elvitegravir |
|
|
11574 | compound 2 [PMID: 18281931], EVG, GS-9137, GS9137, JTK-303, JTK303, Vitekta® | |||||
| ELX-02 | 10944 | CS-0095334, ELX-02 (disulfate), HY-114231B | |||||||
| elzovantinib |
|
11869 | compound 5 [WO2019023417A1], CSF1R-IN-2, TPX-0022, TPX002 | ||||||
| EM127 |
|
13979 | compound 11C [PMID: 36116234], EM-127 | ||||||
| EM-523 | 1445 | N-ethyl,N-methyl EM-A enolether, erythromycin analogue (523) | |||||||
| emapunil | 8704 | AC-5216, XBD-173, XBD173 | |||||||
| emavusertib |
|
|
10152 | AU-4948, AU4948, CA4948, compound 24 [PMID: 33335659] | |||||
| EMD-386088 | 8428 | compound 18 [PMID 16055331], EMD 386088, EMD386088 | |||||||
| EMD638683 | 9407 | ||||||||
| EMDT | 12 | ||||||||
| emedastine |
|
7174 | AL-3432A, Emadine® | ||||||
| emilumenib |
|
13617 | DS-1594a, DS-1594b | ||||||
| emlenoflast |
|
12172 | Inzomelid, MCC-7840, MCC7840 | ||||||
| EMPA |
|
4037 | |||||||
| [3H]EMPA |
|
|
9467 | ||||||
| empagliflozin |
|
|
4754 | BI 10773, Jardiance® | |||||
| empesertib |
|
9427 | BAY-1161909, BAY1161909, Mps1-IN-5 | ||||||
| emraclidine | 13626 | compound 21 [PMID: 38888621], CVL-231, CVL231, PF-06852231, PF06885190 | |||||||
| emricasan | 6508 | IDN-6556, PF-03491390 | |||||||
| α-Emtbl | 2363 | alpha-Emtbl | |||||||
| EM-TBPC | 3363 | ||||||||
| [3H]EM-TBPC |
|
|
1390 | ||||||
| emtricitabine |
|
|
11244 | FTC, 524W91, BW-524W91, Coviracil®, Emtriva® | |||||
| emupertinib | 13742 | example 37 [WO2020166680A1] | |||||||
| emvistegrast | 14189 | example 356 [WO2020092375], GS-1427, GS1427 | |||||||
| emvododstat | 11421 | PTC-299, PTC299 | |||||||
| emzeltrectinib | 12377 | example 36 [WO2018077246A1] | |||||||
| EN450 | 12636 | EN-450 | |||||||
| EN67 | 12637 | EN-67 | |||||||
| enadoline | 1646 | CI 977, CI-977, CI977 | |||||||
| [3H]enadoline |
|
|
3475 | [3H]-CI977, [3H]-enadoline, [3H]CI-977, [3H]CI977 | |||||
| enalapril |
|
6322 | Enaladex®, Vasotec® | ||||||
| enalaprilat |
|
|
6332 | MK-422 | |||||
| (+)-4 enantiomer [PMID: 39046805] | 13529 | ||||||||
| enantio PAF C-16 | 1834 | enantio platelet-activating factor C-16 | |||||||
| enarodustat |
|
|
11828 | compound 14 [PMID: 29259755], Enaroy®, JTZ-951, JTZ951 | |||||
| enasidenib |
|
|
8960 | AG-221, CC-90007, Idhifa® | |||||
| enavogliflozin |
|
11905 | compound 14g [PMID: 34813882], DWP-16001, DWP16001, Envlo®, GCC-5694A, GCC5694A | ||||||
| enbezotinib | 11873 | ||||||||
| encaleret | 9474 | CLTX-305, CLTX305, JTT-305, MK5442 | |||||||
| encenicline |
|
6926 | EVP 6124, EVP-6124, EVP6124 | ||||||
| encequidar |
|
12787 | HM-30181, HM30181, Oratecan (encequidar methanesulfonate + irinotecan), Oraxol (encequidar methanesulfonate + paclitaxel) | ||||||
| enclomiphene |
|
7619 | Androxal®, enclomiphene citrate | ||||||
| encorafenib |
|
7908 | Braftovi®, LGX-818, LGX818 | ||||||
| encukalner | 12650 | 1OP2198, Example 11 [WO2008024398A2], VRX621698, XEN-1101, XEN1101 | |||||||
| endoxifen |
|
10203 | N-Desmethyl-4-hydroxytamoxifen, Z-Endoxifen | ||||||
| Enduracidin | 10989 | ||||||||
| enerisant | 11293 | ||||||||
| enflurane |
|
7175 | Forane® | ||||||
| engasertib | 13743 | ALM301, VAD-044, VAD044 | |||||||
| (-)-englerin A |
|
8372 | |||||||
| enitociclib | 11686 | BAY 1251152, BAY-1251152, BAY1251152, VIP-152, VIP152 | |||||||
| ENMD-2076 |
|
7885 | ENMD 2076, ENMD2076 | ||||||
| enmetazobactam |
|
12188 | AAI101, Exblifep® (cefepime + enmetazobactam), OCID-5090 | ||||||
| enoxacin |
|
8882 | AT-2266, CI-919, Penetrex® | ||||||
| enoxaparin |
|
6811 | Clexane®, enoxaparin sodium, Lovenox®, PK-10169, RP-54563 | ||||||
| enoximone |
|
9063 | fenoximone, MDL 17,043, MDL-17,043, MDL-17043, Perfan® | ||||||
| enoxolone |
|
11264 | 18β-Glycyrrhetinic acid, glycyrrhetic acid, glycyrrhetinic acid | ||||||
| enozertinib | 13744 | example 57 [US11466000B2] | |||||||
| enpatoran |
|
|
11307 | compound 73 [WO2017106607A1], M-5049, M5049 | |||||
| ENPP1 inhibitor 27 |
|
13937 | |||||||
| ENPP1 inhibitor 29f | 13938 | ||||||||
| enprostil | 1918 | gardrin, RS 84135-004, RS-84135 | |||||||
| enrofloxacin | 13668 | BAY Vp 2674, Baytril® (veterinary) | |||||||
| enrupatinib | 13489 | compound 54 [WO2018071348] | |||||||
| ensartinib |
|
8959 | Ensacove®, Example 18 [WO2012048259], X-396 | ||||||
| ensifentrine |
|
|
11865 | Ohtuvayre®, RPL554, VMX 554, VMX-554, VMX554 | |||||
| ensitrelvir |
|
|
11871 | compound 3 [PMID: 35352927], compound I-0006 [WO2022138987], S-217622, S217622, Xocova® | |||||
| entacapone |
|
|
6647 | Comtan®, Comtess®, OR-611 | |||||
| enteromycin carboxamide | 11063 | BRN 2416858, BRN-2416858, BRN2416858, LS-14645 | |||||||
| entinostat |
|
7007 | BAY 86-5274, MS-275, SNDX-275, ZK 244894 | ||||||
| entospletinib |
|
7889 | GS-9973 | ||||||
| entrectinib |
|
|
8290 | NMS-E628, Rozlytrek®, RXDX-101 | |||||
| envometinib | 14073 | example 274 [WO2023133472], IMM-6-415 | |||||||
| envonalkib |
|
11874 | example 27 [WO2014117718A1], TQ-B3139 | ||||||
| envudeucitinib | 13205 | ||||||||
| enzalutamide |
|
6812 | MDV-3100, MDV3100, Xtandi® | ||||||
| enzastaurin | 5693 | LY-317615, LY317615 | |||||||
| enzomenib | 13620 | DSP-5336, DSP5336 | |||||||
| EOS-984 | 13932 | compound 10 [US20230203058A1], EOS301984, EOS984 | |||||||
| EP 157 | 5853 | EP-157, EP157 | |||||||
| EP 171 | 1971 | EP-171, EP171 | |||||||
| EP26 | 13364 | ||||||||
| EP-7041 | 11990 | EP7041 | |||||||
| epacadostat |
|
|
8221 | IDO inhibitor 1, INCB 24360, INCB-24360, INCB024360 | |||||
| epalrestat |
|
11371 | Kinedak®, ONO-2235, ONO2235 | ||||||
| 16,17-EpDPE | 14019 | 16(17)-EpDoPE, 16(17)-EpDPE, 16,17-EDP, 16,17-epoxydocosapentaenoic acid | |||||||
| eperezolid | 10803 | comound 2 [PMID: 23584544], PNU-100592, PNU100592, U-100592, U100592 | |||||||
| epetraborole | 13079 | AN3365, BRII-658, GSK2251052 | |||||||
| ephedrine |
|
556 | Emerphed® (ephedrine sulfate injection) | ||||||
| EPI-589 | 13272 | EPI589 | |||||||
| [125I]epibatidine |
|
|
3976 | ||||||
| [3H]epibatidine |
|
|
3977 | ||||||
| epicillin | 10804 | Dexacillin®, SQ 11302, SQ-11302, SQ11302 | |||||||
| epinastine |
|
|
7176 | Elestat®, epinastine hydrochloride | |||||
| 2,4-epi-neodysiherbaine | 4102 | 2,4-epi-neoDH | |||||||
| epiroprim | 12327 | Ro 11-8958, TCMDC-137295 | |||||||
| epitinib | 11608 | compound 68 [WO2010002845A2], HMPL-813, HMPL813 | |||||||
| eplerenone |
|
|
2876 | Inspra®, SC-66110 | |||||
| EPPTB | 5457 | Ro 5212773, Ro-5212773, Ro5212773 | |||||||
| eprosartan |
|
588 | Eprozar®, SK-108566, Teveten® | ||||||
| [3H]eprosartan |
|
|
3940 | [3H]-eprosartan, [3H]SK&F 108566 | |||||
| eptifibatide |
|
6585 | C68-22, Eptifibatide Accord (generic), Integrelin® | ||||||
| EPZ004777 |
|
7377 | EPZ 004777, EPZ-004777 | ||||||
| EPZ005687 | 8387 | EPZ 005687, EPZ-005687 | |||||||
| EPZ011989 | 9273 | ||||||||
| EPZ015666 |
|
8287 | EPZ 015666, EPZ-015666 | ||||||
| EPZ020411 | 9243 | ||||||||
| EPZ031686 | 13978 | EPZ-031686 | |||||||
| ER-27319 |
|
9611 | |||||||
| ER819762 | 4040 | ER 819762, ER-819762 | |||||||
| ERAS-5024 | 12988 | compound 14 [PMID: 37849557], ERAS5024 | |||||||
| eratrectinib | 14070 | Example 1 [WO2019233461], VC-004, VC004 | |||||||
| eravacycline |
|
|
10805 | compound 17j [PMID: 2148514], TP-434, TP434, Xerava® | |||||
| ERD-308 | 10565 | compound 32 [PMID: 30990042], ERD308 | |||||||
| ERD-3111 | 13249 | compound 44 [PMID: 37647546], ERD3111 | |||||||
| erdafitinib |
|
|
9039 | Balversa®, compound 4 [WO2011135376], JNJ 42756493, JNJ-42756493, JNJ42756493 | |||||
| ergometrine |
|
148 | ergonovine, Ergotrate®, Methergine® | ||||||
| ergotamine |
|
|
149 | Cafergot®, Ergomar® | |||||
| eribaxaban |
|
7408 | PD-0348292 | ||||||
| eribulin |
|
|
6813 | E7389, ER 086526, Halaven®, NSC-707389 | |||||
| eritoran |
|
4919 | B1287, E5564 | ||||||
| ERK inhibitor II |
|
5966 | FR-180204, FR180204 | ||||||
| ERK inhibitor III | 5968 | ||||||||
| ERK inhibitor II, negative control | 5967 | HMS3229G08 | |||||||
| erlotinib |
|
|
4920 | NSC 718781, OSI 744, OSI-774, R 1415, Tarceva® | |||||
| ErSO-TFPy | 13693 | compound (R)-26 [PMID: 35080871] | |||||||
| ertapenem |
|
10906 | Invanz®, L-749345, MK-0826, MK-826 | ||||||
| ertugliflozin |
|
8376 | MK-8835, PF-04971729, Steglatro® | ||||||
| ervogastat | 12241 | compound 6 [PMID: 34635855], PF-06865571, PF06865571 | |||||||
| ERW1041E | 10048 | ||||||||
| esaxerenone |
|
|
9894 | CS-3150, XL-550 | |||||
| escitalopram |
|
|
7177 | Cipralex®, Lexapro®, LU-26-054-0 | |||||
| esflurbiprofen |
|
|
|
9420 | (S)-flurbiprofen, BTS-24332, SFPP, TT-063 | ||||
| ESI-09 | 7917 | ESI 09, ESI09 | |||||||
| esketamine |
|
|
9152 | (S)-(+)-Ketamine, (S)-Ketamine, Spravato® | |||||
| eslicarbazepine |
|
7350 | Aptiom®, BIA 2-194, S-licarbazepine, Zebinix® | ||||||
| esmolol |
|
7178 | Brevibloc®, SL-8052 | ||||||
| esomeprazole |
|
5488 | (S)-omeprazole, Nexium® | ||||||
| EST64454 | 11343 | compound 9k [PMID: 33237785], EST-64454, example 39 [WO2011147910A1] | |||||||
| EST73502 | 12777 | compound 14u [PMID: 33064947], EST-73502 | |||||||
| estazolam |
|
7550 | D 40TA, Eurodin®, ProSom® | ||||||
| estetrol |
|
|
11591 | 15 α-hydroxyestriol, 15 alpha-hydroxyestriol, Drovelis® (EMA); ; estetrol monohydrate + drospirenone, E4, Lydisilka® (EMA); ; estetrol monohydrate + drospirenone, Nextstellis® (US); estetrol monohydrate + drospirenone | |||||
| [3H]17β-estradiol |
|
|
|
1012 | [3H]-estradiol, [3H]-estrogen, [3H]E2, [3H]estradiol | ||||
| estradiol disulfate | 8802 | 17beta-estradiol-3,17-disulfate, estradiol-3,17-disulfate | |||||||
| [3H]estradiol-17β-glucuronide |
|
|
|
4687 | [3H]-estradiol-17β-glucuronide | ||||
| estradiol 3-methyl ether |
|
11860 | 17β-estradiol methyl ether, 3-Methoxyoestradiol, EDME, PRU-1 | ||||||
| estradiol valerate |
|
7655 | Climaval® | ||||||
| estramustine |
|
9076 | Emcyt®, Estracyt® | ||||||
| [3H]estrone-3-sulphate |
|
|
4748 | [3H]-estrone hydrogen sulfate, [3H]-estrone-3-sulphate, [3H]estrone-3-sulfate | |||||
| esuberaprost | 8314 | APS-314D free acid, BPS-314d | |||||||
| eszopiclone |
|
7429 | (S)-zopiclone, Lunesta® | ||||||
| etalocib | 2948 | LY 293111, VML 295 | |||||||
| etavopivat | 11975 | FT-4202, FT4202 | |||||||
| etazolate | 7336 | EHT-0202, SQ 20009 | |||||||
| ET bromodomain inhibitor |
|
7808 | |||||||
| [3H]ETB-TBOA |
|
|
4492 | [3H]-ETB-TBOA | |||||
| ETC-1922159 | 11168 | ETC-159, ETC159, ETC1922159 | |||||||
| eteplirsen |
|
7534 | AVI-4658, Exondys 51® | ||||||
| ETG-5773 | 12851 | ETG5773 | |||||||
| ethacrynic acid |
|
|
7179 | Edecrin®, MK-595 | |||||
| ethambutol |
|
|
12996 | Myambutol® | |||||
| ethcathinone | 7398 | ETH-CAT, ethylpropion | |||||||
| ethchlorvynol |
|
7180 | Placidyl® | ||||||
| etheromycin | 10994 | CP‐38 295 | |||||||
| ethidium |
|
4569 | |||||||
| ethinamate |
|
7325 | Valmid® | ||||||
| ethionamide |
|
|
12954 | 1314 TH, Bayer 5312, Trecator® | |||||
| ethopropazine |
|
7181 | Parsidol® | ||||||
| ethosuximide |
|
7182 | CI-366, CN-10395, PM-671, Zarontin® | ||||||
| ethotoin |
|
7183 | Peganone® | ||||||
| ethoxzolamide |
|
|
6814 | Cardrase®, Ethamide®, ethoxazolamide, ethoxyzolamide | |||||
| ethyl bromopyruvate | 10952 | ||||||||
| ethylestrenol |
|
6948 | Maxibolin®, Orabolin® | ||||||
| ethylisopropylamiloride | 4186 | EIPA, 5-(N-Ethyl-N-isopropyl)amiloride | |||||||
| ethylketocyclazocine | 1610 | EKC, (1R,9R,13S) ethyketazocine, EKC, WIN-35,197-2 | |||||||
| eticlopride |
|
966 | |||||||
| etidocaine | 2621 | ||||||||
| etidronic acid |
|
|
7184 | Didronel®, etidronate disodium | |||||
| etifoxine | 5468 | HOE 36-801, HOE-36801 | |||||||
| etodolac |
|
|
7185 | AY-24236, Lodine® | |||||
| etomidate |
|
|
5463 | Amidate®, D-etomidate, R 16659 | |||||
| etomoxir | 9089 | rac-etomoxir ethyl ester | |||||||
| etonitazene | 1624 | ||||||||
| etonogestrel |
|
7590 | 3-keto-desogestrel, Implanon®, Nexplanon®, ORG-3236 | ||||||
| etoposide |
|
|
6815 | (-)-etoposide, Etopophos®, Toposar®, trans-etoposide, VePesid®, VP 16-213, VP-16 | |||||
| etoricoxib |
|
|
|
2896 | Arcoxia®, MK 0663, MK-0663, MK0663 | ||||
| etorphine | 1625 | ||||||||
| etrasimod |
|
|
9331 | APD-334, APD334, APD334-003, compound 4 [PMID: 25516790], Velsipity® | |||||
| etravirine |
|
|
12675 | Intelence®, R-165335, R165335, TMC-125, TMC125 | |||||
| etretinate |
|
7599 | Ro-109359, Tegison® | ||||||
| ETX0282 | 10781 | ETX-0282 | |||||||
| ETX0462 |
|
11753 | ETX-0462, VMM | ||||||
| ETX1317 | 10782 | ETX-1317 | |||||||
| evacetrapib | 8401 | LY2484595 | |||||||
| evans blue dye | 4579 | T-1824 | |||||||
| evatanepag |
|
1929 | CJ042794, CP-533536, CP533536 | ||||||
| evernimicin | 10806 | SCH 27899, SCH-27899, SCH27899, Ziracin® | |||||||
| everolimus |
|
|
5889 | Afinitor®, Certican®, RAD-001, RAD001, rapamycin, 42-O-(2-hydroxyethyl)-, Zortress® | |||||
| evetifator | 12940 | DNL-343, DNL343 | |||||||
| evixapodlin |
|
11684 | compound 139 [WO2019160882A1], GS-4224, GS4224, PD-1/PD-L1-IN 7 | ||||||
| evobrutinib |
|
|
9752 | A250 [WO2012170976], M-2951, M2951, MSC 2364447, MSC-2364447C, MSC2364447C | |||||
| evocalcet |
|
|
9042 | KHK-7580, MT-4580, Orkedia® | |||||
| evodenoson | 5594 | ATL 313, ATL-313 | |||||||
| evofosfamide | 8695 | compound 3b, TH-302 | |||||||
| EVP-21 | 12543 | ||||||||
| EWB-3-14 | 12730 | (+)-ACH-1-135, compound (+)-15 [PMID: 17625813], DC-01-0059 | |||||||
| Example A225 [WO2012170976A2] | 11983 | TL-895, TL895 | |||||||
| example 10 [CN110740999A] | 12952 | compound 40 [PMID: 34323489] | |||||||
| example I-1 [WO2023283831] | 12588 | ||||||||
| example 7 [US8664233] | 8283 | ||||||||
| example 100 [WO2022043374] | 11952 | ||||||||
| example 10 [WO2022129953] | 12042 | ||||||||
| example 1.11 [WO2014139978] | 9143 | ||||||||
| example 131 [WO2009133348] |
|
8489 | |||||||
| example 13 [WO2009109743] | 9077 | ||||||||
| example 15 [WO2015079413] | 12667 | Eriodictyol 7-O-glucoside, Pyracanthoside | |||||||
| example 166 [WO2014154727] | 7892 | ||||||||
| example 184 [WO2014186035] | 12668 | ||||||||
| example 18 [WO2022013684] | 12590 | ||||||||
| example 20 [WO2010128058] | 7853 | ||||||||
| example 25 [WO2018228934] |
|
10201 | |||||||
| example 2 [WO2013004676] | 7852 | entry 2 [PMID: 24900681] | |||||||
| example 2 [WO2013054185] | 9144 | compound 26 [PMID: 26745766] | |||||||
| example 31 (24) [WO2012005227] | 9762 | Ex_31 | |||||||
| example 31 [WO2018183145] | 12666 | ||||||||
| example 36 [WO2016177845] |
|
9555 | |||||||
| example 373 [WO2012093101] | 8296 | ||||||||
| example 41 [WO2012028563] | 7855 | ||||||||
| example 45 [WO2022229458] | 12592 | ||||||||
| example 4 [WO2017114509] |
|
10749 | compound 18p [PMID: 33872498] | ||||||
| example 5 [WO2023245150] | 14089 | ||||||||
| example 92 [WO2012095521] | 7856 | ||||||||
| example 98 [WO2011020806] | 6540 | ||||||||
| example 203 [WO2017058503A1] | 12664 | ||||||||
| example 265 [WO2019097515A1] | 11067 | ||||||||
| example 2 [WO2005113580A1] |
|
11106 | |||||||
| example 2 [WO2013026797A1] | 12114 | ||||||||
| example 320 [WO2018198077A2] | 12662 | ||||||||
| example 37 [WO2022021841A1] | 12041 | ||||||||
| Example 4 [WO2017202275A1] |
|
10449 | |||||||
| example 8 [WO1999033801A1] | 8581 | ||||||||
| example 494 [WO2014028479] parent molecule | 12665 | ||||||||
| exarafenib |
|
12095 | compound 15 [Chen et al., 2024], example 14 [WO2021081375A1], KIN-2787, KIN2787 | ||||||
| exemestane |
|
|
7073 | Aromasin®, FCE-24304 | |||||
| exeporfinium | 13323 | XF-73 (exeporfinium chloride) | |||||||
| exo-THPO | 5418 | ||||||||
| EXP3174 |
|
586 | E-3174, EXP 3174, EXP-3174 | ||||||
| [125I]EXP985 |
|
|
3942 | [125I]-EXP985 | |||||
| ezetimibe |
|
|
6816 | SCH 58235, SCH-58235, Zetia® | |||||
| ezlopitant | 5751 | CJ 11974, CJ-11974, CJ11974 | |||||||
| EZM0414 | 11962 | EZM-0414 | |||||||
| (12E,20Z,18S)-8-hydroxyvariabilin | 4072 | ||||||||
| ezurpimtrostat | 11991 | GNS-561, GNS561 | |||||||
| ezutromid | 11110 | 5-ethylsulfonyl-NBO, SMT C1100, SMTC 1100, SMTC1100 | |||||||
| F | Back to top | ||||||||
| F16357 |
|
9255 | Compound 39 [PMID: 19791800], Example 1 in WO2007147824 | ||||||
| F215 |
|
10121 | |||||||
| F3 | 2400 | ||||||||
| fadraciclib | 10461 | CYC-065, CYC065 | |||||||
| fadrozole |
|
8311 | Afema®, CGS 16949 A, CGS-16949A, FAD 286, FAD-286 | ||||||
| falecalcitriol | 2781 | calcitriol hexafluoride, F6-1α,25(OH)2D3, ST-630 | |||||||
| falnidamol | 7646 | BIBX 1382, BIBX-1382, BIBX1382 | |||||||
| famciclovir |
|
11629 | BRL-42810, BRL42810, Famvir®, FCV | ||||||
| famitinib | 7886 | compound 9 [PMID: 21028894], SHR 1020, SHR-1020, SHR1020 | |||||||
| famlasertib | 13267 | compound 12k [PMID: 31676236], Prosetin, Prostetin | |||||||
| famotidine |
|
7074 | Gaster®, MK-208, Pepcid® | ||||||
| fampridine |
|
2416 | 4-aminopyridine, 4-AP, Ampyra®, EL-970 | ||||||
| fananserin | 5434 | RP 62203, RP-62203, RP62203 | |||||||
| [3H]fananserin |
|
|
3229 | [3H]RP-62203, [3H]RP62203 | |||||
| fanapanel |
|
7636 | ZK 200775, ZK-200775, ZK200775 | ||||||
| fandofloxacin | 10807 | DW-116, DW116 | |||||||
| fanregratinib | 13494 | Compound 78 [WO2014139465] | |||||||
| farglitazar |
|
2672 | GI-262570X | ||||||
| farnesyl thiodiphosphate | 3216 | FSPP, farnesyl thiopyrophosphate | |||||||
| faropenem |
|
10808 | compound 1 [PMID: 9216830], faropenem medoxomil, fropenem | ||||||
| farudodstat | 12106 | ASLAN-003, ASLAN003, LAS186323 | |||||||
| fasidotril | 6501 | aladotril, BP-1137 | |||||||
| fasidotrilat | 6502 | ||||||||
| fasiglifam |
|
6484 | TAK 875, TAK-875, TAK875 | ||||||
| fasudil |
|
|
5181 | dihydrochloride fasudil, HA 1077, HA1077 | |||||
| FAUC213 | 974 | ||||||||
| favipiravir |
|
11139 | T-705, T705 | ||||||
| fazamorexant | 14135 | compound of formula (II) [US20230149402], YZJ 1139, YZJ-1139, YZJ1139 | |||||||
| FD-1 | 1182 | ||||||||
| FD1 | 10214 | 6-[N-(2-isothiocyanatoethyl) aminocarbonyl]forskolin | |||||||
| FD6 | 10215 | 6-[3-(dimethylamino)propionyl]-14 15-dihydroforskolin | |||||||
| febuxostat |
|
|
6817 | Adenuric®, MX-67, Tei 6720, Tei-6720, TMX 67, Uloric® | |||||
| fedratinib |
|
|
5716 | Inrebic®, SAR302503, TG-101348, TG101348 | |||||
| felbamate |
|
5473 | ADD 03055, Felbatol®, W 554 | ||||||
| felodipine |
|
4190 | Plandil®, Renedil® | ||||||
| fenclonine | 5240 | 4-chlorophenylalanine, p-Chlorophenylalanine, para-chlorophenylalanine, PCPA | |||||||
| fenebrutinib |
|
|
9299 | Example 130 [US20140194408], GDC-0853, GDC0853, RG-7845, RG7845 | |||||
| fenfluramine |
|
4613 | Adifax®, Fintepla®, Pondimin®, ZX008 | ||||||
| fenobam |
|
1434 | MCN-3377-98 | ||||||
| [3H]fenobam |
|
|
|
1433 | |||||
| fenofibrate |
|
|
7186 | ABT-335, Lipantil®, Supralip®, Tricor® | |||||
| fenofibric acid |
|
2662 | |||||||
| fenoldopam |
|
939 | Corlopam®, SK&F-82526J, SK-82526-J | ||||||
| fenoprofen |
|
|
4820 | fenoprofen calcium, Nalfon® | |||||
| fenoterol |
|
557 | Berotec®, TH-1165A | ||||||
| fentanyl |
|
|
1626 | Abstral®, Actiq®, Durogesic®, Effentora®, MCN-JR-4263-49, R-4263, Sublimaze® | |||||
| [18F]FEPPG |
|
|
11367 | (S)-N-(2-amino-3-(4-(2-(fluoro-18F)ethoxy)phenyl)propanoyl)-N-methylglycine | |||||
| FERb 033 | 8898 | DPN, compound 3 [PMID: 19128016] | |||||||
| ferroquine |
|
9972 | SSR97193 | ||||||
| fesoterodine |
|
7473 | SPM-8272, SPM-907, Toviaz® | ||||||
| fevipiprant |
|
|
8995 | NVP-QAW039, QAW039 | |||||
| fexagratinib |
|
7707 | AZD-4547, KB-74810 | ||||||
| fexaramine | 2744 | FEX | |||||||
| fexofenadine |
|
|
4819 | Allegra®, fexofenadine HCl | |||||
| fezolinetant |
|
10422 | compound 3 [PMID:26191358], ESN-364, ESN364, Veoza®, Veozah®, Vezoa® | ||||||
| FG-2101 | 13854 | ||||||||
| FG-5893 | 13 | FG 5893, FG5893 | |||||||
| F7H | 12916 | ||||||||
| FHD-286 | 11967 | FHD286 | |||||||
| FHD-609 | 12759 | Compound S-D1 [WO2021155225A1], FHD609 | |||||||
| FHQC | 12859 | compound 1 [PMID: 24870406] | |||||||
| ficonalkib | 12378 | Example 1 [WO2018127184A1] | |||||||
| fidaxomicin |
|
|
10909 | Dificid®, Dificlir®, lipiarmycin, OPT-80, PAR-101, tiacumicin B | |||||
| fidrisertib | 11875 | ALK2-IN-1, BLU-782, BLU782, IPN-60130, IPN60130 | |||||||
| filapixant | 13329 | BAY 1902607, BAY-1902607, BAY1902607, example 348 [WO2016091776A1] | |||||||
| filgotinib |
|
|
|
7913 | GLPG-0634, GLPG0634, Jyseleca® | ||||
| filorexant |
|
4460 | MK 6096, MK-6096, MK6096 | ||||||
| fimepinostat |
|
8952 | CUDC 907, CUDC-907, PI3K/HDAC Inhibitor centn | ||||||
| finafloxacin |
|
10809 | AL-60371, AL60371, Xtoro® | ||||||
| finasteride |
|
|
6818 | MK 906, MK-906, MK906, Propecia®, Proscar® | |||||
| finerenone |
|
8678 | BAY 94-8862, Kerendia® | ||||||
| fingolimod |
|
|
2407 | FTY-720, FTY720, Gilenya® | |||||
| fingolimod-phosphate | 2924 | fingolimod phosphate, FTY-P, FTY720-P, FTY720-phosphate | |||||||
| FIPI |
|
8781 | compound 14 [PMID: 19136975] | ||||||
| fipravirimat | 12360 | compound 9 [PMID: 36044257], GSK'254, GSK-3640254, GSK3640254 | |||||||
| firategrast |
|
11486 | SB-683699, SB683699 | ||||||
| firazorexton | 12603 | TAK-994 (firazorexton sesquihydrate) | |||||||
| firmonertinib |
|
10477 | alflutinib (pseudo INN), ASK120067, AST-2818, AST2818, example 3 [US10072002B2], furmonertinib, Ivesa® | ||||||
| firsocostat | 10645 | GS-0976, GS-ACC, ND 630, ND-630, NDI-010976 | |||||||
| firzacorvir | 11792 | ||||||||
| fisogatinib | 10220 | BLU-554, BLU554, CS-3008, CS3008 | |||||||
| FITM |
|
8767 | compound 5 | ||||||
| [18F]FITM |
|
|
6213 | ||||||
| FK-453 | 5606 | FK 453, FK453 | |||||||
| FK-788 | 5855 | FK 788, FK788 | |||||||
| FK-881 | 10241 | ASP-6537, ASP6537, FK881 | |||||||
| FK-888 | 2114 | FK 888, FK888, L-alaninamide | |||||||
| FL104 | 3501 | ||||||||
| flavanone | 408 | 2,3-dihydroflavone, 4-flavanone, flavonoid, NSC-50393 | |||||||
| flavoxate |
|
|
7187 | Urispas®, W-61 | |||||
| flecainide |
|
|
2560 | Tambocor® | |||||
| fleroxacin |
|
12476 | AM-833, Megalone®, Quinodis®, Ro 23-6240 | ||||||
| flesinoxan | 1 | (+)-flesinoxan, DU-29,373 | |||||||
| flezurafenib | 13233 | compound A-1 [WO2022023450] | |||||||
| flibanserin |
|
8182 | Addyi®, BIMT-17, Girosa® (proposed trade name) | ||||||
| flindokalner | 2307 | BMS 204352, BMS-204352, BMS204352 | |||||||
| flizasertib | 12379 | Example 103 [WO2019072942A1] | |||||||
| flomoxef | 12251 | 6315-S, Flumarin® | |||||||
| florbetaben |
|
|
|
7769 | [18F]BAY 94-9172, AV-1, BAY 94-9172, Neuraceq® | ||||
| florbetapir |
|
|
|
7344 | AMYViD®, AV-45, florbetapir (18F) | ||||
| florfenicol | 12923 | SCH 25298 | |||||||
| flortaucipir (18F) |
|
|
|
9100 | 18F-AV-1451, [F-18]T807, flortaucipir F-18, LY-3191748, Tauvid® | ||||
| floxuridine |
|
4801 | 5-fluoro-2'-deoxyuridine, floxidine, FUDR® | ||||||
| Flt-3 inhibitor | 5970 | TCS 359, TCS-359 | |||||||
| Flt-3 inhibitor II | 5971 | ||||||||
| Flt-3 inhibitor III | 5972 | IN1479 | |||||||
| flucloxacillin |
|
10910 | BRL-2039, BRL2039, floxacillin | ||||||
| fludalanine | 10810 | 3-fluoro-D-alanine, MK-0642, MK0642 | |||||||
| fludarabine |
|
4802 | 2-F-Ara-A, CCRIS 3382, F-Ara-A, Fludara® | ||||||
| fludrocortisone |
|
|
2873 | 9α-Flourocortisol, Florinef® | |||||
| fludroxycortide |
|
|
7606 | Cordran®, flurandrenolide, flurandrenolone, Haelan® | |||||
| flufenamate | 4191 | ||||||||
| flufenamic acid |
|
|
|
2447 | |||||
| flumazenil |
|
|
4192 | Anexate®, Ro15-1788 | |||||
| [11C]flumazenil |
|
|
|
4367 | [11C]flumazenil (PET ligand) | ||||
| flumbatinib |
|
9913 | flumatinib (pseudo INN), Hansoh Xinfu®, HH-GV678, HHGV-678 | ||||||
| flumequine |
|
13650 | R-802 | ||||||
| flumethasone pivalate |
|
|
7075 | Locorten® | |||||
| flunarizine |
|
12488 | R-14950, R14950, Sibelium® | ||||||
| flunisolide |
|
|
7076 | AeroBid®, RS-3999 | |||||
| flunitrazepam |
|
4193 | Narcozep®, Rohypnol® | ||||||
| [3H]flunitrazepam |
|
|
4360 | ||||||
| fluocinolone acetonide |
|
|
7077 | Capex®, Iluvien®, Synalar® | |||||
| fluocinonide |
|
|
7078 | Fluonex®, Lidex® | |||||
| fluorescent MIF ligand B |
|
|
9987 | ||||||
| fluorobexarotene | 8904 | ||||||||
| 7-fluorochromone-2-carboxamide | 1303 | ||||||||
| [18F]fluoroethylflumazenil |
|
|
4368 | [18F]fluoroethylflumazenil (PET ligand) | |||||
| 5'-fluoroindirubinoxime | 4855 | ||||||||
| fluorometholone |
|
|
7079 | Flarex®, FML® | |||||
| α-fluoromethylenephosphonate | 2915 | ||||||||
| 2-fluoromevalonate 5-diphosphate | 3204 | ||||||||
| 6-fluoromevalonate 5-diphosphate | 3205 | ||||||||
| 6-fluoromevalonate pyrophosphate |
|
7996 | 6-FMevPP | ||||||
| 6-fluoro-noradrenaline | 510 | 5-fluoronorepinephrine, 6-fluoro-NE , 6-fluoronorepinephrine | |||||||
| fluorothiazinon | 13810 | CL-55, fluorothiazinone, Ftortiazinon | |||||||
| 5-fluorotryptamine |
|
146 | |||||||
| 6-fluorotryptophan | 5126 | ||||||||
| 5-fluorouracil |
|
|
4789 | Adrucil®, Carac® | |||||
| 5-fluorouridine |
|
4614 | |||||||
| (S)-5-fluorowillardiine |
|
4070 | |||||||
| fluoxetine |
|
203 | Prozac® | ||||||
| fluoxymesterone |
|
2861 | Halotestin® | ||||||
| fluparoxan | 41 | GR-50,360 | |||||||
| flupentixol |
|
948 | cis flupenthixol, alpha-flupenthixol, flupenthixol | ||||||
| fluperlapine | 279 | C10967 | |||||||
| fluphenazine |
|
204 | Prolixin® | ||||||
| flupirtine | 2598 | ||||||||
| fluprostenol | 1940 | ICI 81008 | |||||||
| [3H](+)-fluprostenol |
|
|
3417 | [3H]-(+)-fluprostenol | |||||
| flurazepam |
|
|
7188 | Dalmane®, Ro-5-6901, Ro-56901 | |||||
| flurbiprofen |
|
|
4194 | Ansaid®, Froben® | |||||
| (R)-flurbiprofen |
|
7340 | MPC-7869 | ||||||
| flurithromycin |
|
12927 | (8S)-8-fluoroerythromycin A, P-0501A | ||||||
| (R)-flurocarazolol | 65 | ||||||||
| (S)-flurocarazolol | 66 | ||||||||
| fluspirilene |
|
85 | Imap®, MCN-JR-6218, R-6218, Redeptin® | ||||||
| flutamide |
|
6943 | Eulexin®, SCH-13521 | ||||||
| flutemetamol |
|
|
|
7342 | 18F-flutemetamol, [18F]flutemetamol, flutemetamol F18 | ||||
| fluticasone |
|
|
6699 | Advair®, Avamys®, Flovent HFA®, Veramyst® | |||||
| fluticasone furoate |
|
|
|
10892 | Arnuity Ellipta, Avamys, FF, Flonase Sensimist, Veramyst | ||||
| fluticasone propionate |
|
|
7080 | Advair Diskus®, ArmonAir RespiClickTM, CCI-18781, Flovent® | |||||
| fluvastatin |
|
|
2951 | Canef®, Lescol® | |||||
| fluvoxamine |
|
|
|
7189 | Luvox®, U-23000 | ||||
| fluzoparib |
|
|
13763 | SHR-3162, SHR3162 | |||||
| FLX475 |
|
12153 | example 43 [WO2018022992A1], FLX-475 | ||||||
| [18F]FMBP |
|
|
12670 | ||||||
| 5F-MDMB-P7AICA | 13587 | 5-fluoro MDMB-7-PAICA, 7′N-5F-ADB, compound 12 [PMID: 33253529] | |||||||
| FMH | 5189 | α-fluoromethylhistidine, α-FMH, alpha-FMH | |||||||
| FMK | 9358 | FMK (covalent) | |||||||
| FMOC-L-Leucine | 2705 | ||||||||
| FMS586 | 1563 | FMS 586, FMS-586 | |||||||
| 2F-MT-45 | 10725 | ||||||||
| 3F-MT-45 | 10726 | ||||||||
| 4F-MT-45 | 10727 | ||||||||
| β-FNA | 1631 | beta-funaltrexamine, naltrexone fumarate methyl ester | |||||||
| FNDR-20081 | 13544 | ||||||||
| FNDR-20123 |
|
11797 | |||||||
| fobrepodacin | 13062 | pVXc-486, SPR720 | |||||||
| [3H]folic acid |
|
|
|
4562 | [3H]-folic acid | ||||
| foliglurax | 9622 | PXT-002331, PXT002331 | |||||||
| folinic acid |
|
4816 | 5-formyltetrahydrofolic acid, leucovorin, Wellcovorin® | ||||||
| [3H]folinic acid |
|
|
6690 | ||||||
| fomepizole |
|
|
11705 | 4-methylpyrazole, Antizol® | |||||
| fondaparinux |
|
|
6819 | Arixtra® | |||||
| forasartan |
|
6896 | SC-52458 | ||||||
| foretinib |
|
5679 | EXEL-2880, GSK 1363089G, GSK1363089, XL 880 | ||||||
| formalin |
|
4196 | |||||||
| formamide |
|
4739 | |||||||
| formoterol |
|
|
3465 | BD-40A, CGP-25827A, Foradil®, Oxeze/Oxis®, YM-08316 | |||||
| formycin B |
|
4737 | |||||||
| forodesine |
|
|
8272 | BCX-1777, BCX1777, Fodosine® (proposed trade name), immucillin H, immucillin-H | |||||
| foropafant |
|
1856 | SR 27417, SR-27417, SR27417 | ||||||
| forvisirvat | 14048 | Compound 1 [WO2024148149A2], DS-7830a, SP-624, SP624 | |||||||
| fosamprenavir |
|
12682 | FOS-APV, GW-433908, GW433908, Lexiva®, VX-175, VX175 | ||||||
| fosaprepitant |
|
7623 | Ivemend®, MK-0517 | ||||||
| fosbretabulin | 8857 | CA4DP, combretastatin A4 phosphate, fosbretabulin disodium, fosbretabulin tromethamine, Zybrestat (fosbretabulin disodium) | |||||||
| foscarnet |
|
|
5497 | carboxyphosphonic acid, Foscavir®, phosphonocarboxylic acid, phosphonoformic acid | |||||
| fosdagrocorat |
|
9649 | PF-04171327 | ||||||
| foselutoclax | 13366 | UBX-1325, UBX1325 | |||||||
| fosfomycin |
|
|
10813 | Monurol®, phosphomycin, phosphonomycin, Veramina® | |||||
| fosifidancitinib |
|
10637 | |||||||
| fosigotifator | 12886 | ABBV-CLS-7262, compound 131 [US20220251123A1] | |||||||
| fosinopril |
|
6456 | Monopril®, SQ-28555 | ||||||
| fosinoprilat |
|
|
6457 | SQ-27519 | |||||
| fosizensertib |
|
13806 | compound 19 [WO2023018643A1] | ||||||
| foslevodopa |
|
13174 | Dopa 4-phosphate | ||||||
| foslinanib | 11621 | CVM-1118, TRX 818, TRX-818 | |||||||
| fosphenytoin |
|
7190 | ACC-9653-010, Cerebyx®, CI-982, Sesquient® | ||||||
| fospropofol |
|
|
7475 | Lusedra® | |||||
| fostamatinib |
|
|
|
7796 | R 788, R-788, R7935788, Tavalisse®, Tavlesse® | ||||
| fostemsavir |
|
11100 | FTR, BMS-663068, BMS663068, compound 35 [PMID: 29271653], GSK-3684934, GSK3684934, Rukobia® | ||||||
| fotagliptin |
|
13951 | compound 66 [PMID: 37647598], FCN 005, FCN-005, SAL-067, SAL067, Xinliting® | ||||||
| fovinaciclib | 13207 | Example 5 [WO2017193872] | |||||||
| FP0429 | 1409 | FP 0429, FP-0429 | |||||||
| FP802 | 13602 | FP-802 | |||||||
| [18F]FPIT |
|
|
6392 | ||||||
| FPL64176 | 2518 | FPL 64176, FPL-64176 | |||||||
| FPTQ | 6353 | ||||||||
| [18F]FP-TZTP |
|
|
3266 | [18F]FP-TZTP (PET ligand) | |||||
| FR122047 |
|
5191 | FR 122047, FR 122047 hydrochloride, FR-122047 | ||||||
| FR139317 | 998 | FR 139317, FR-139317 | |||||||
| FR167344 | 673 | FR 167344, FR-167344 | |||||||
| FR173657 | 674 | FK-3657, FR 173657, FR-173657 | |||||||
| FR181157 | 5854 | FR 181157, FR-181157 | |||||||
| FR190997 | 668 | FR 190997, FR-190997 | |||||||
| FR191413 | 669 | FR 191413, FR-191413 | |||||||
| FR194921 | 387 | FR 194921, FR-194921 | |||||||
| FR260010 | 3223 | FR 260010, FR-260010 | |||||||
| FR900359 | 9336 | ||||||||
| FRAX486 |
|
8938 | |||||||
| FRAX597 |
|
8939 | |||||||
| frescolat MGA | 2465 | menthone 1,2-glycerol ketal | |||||||
| frescolat ML | 2466 | (-)-menthyl lactate | |||||||
| frevecitinib | 13206 | example 7i [US8501735] | |||||||
| friluglanstat |
|
12888 | example 11 [US9216968B2] | ||||||
| FRM-024 | 11752 | compound 41 [PMID: 34550687], FRM024 | |||||||
| frovatriptan |
|
7191 | Frova®, SB-209509-AX, VML-251 | ||||||
| fruquintinib |
|
9428 | Elunate®, Fruzaqla®, HMPL-013, HMPL013 | ||||||
| FTI 276 | 6531 | FTI-276, FTI276 | |||||||
| FTIDC | 6363 | ||||||||
| (S)-FTY720-phosphate |
|
6996 | |||||||
| FUB 349 | 1259 | FUB-349, FUB349 | |||||||
| FUB 465 | 1260 | FUB-465, FUB465 | |||||||
| fudapirine | 13002 | sudapyridine, WX-081 | |||||||
| fulvestrant |
|
1015 | Faslodex®, ICI 182,780, ICI 182780, ICI182780, ZD-9238 | ||||||
| fulzerasib |
|
12393 | Dupert®, GFH925, IBI351, structure Z25-2 [WO2021083167A1] | ||||||
| Fumitremorgin C | 10008 | ||||||||
| funapide | 12644 | compound 1 [PMID: 31012583], FX301, PCRX301, TV-45070, TV45070, XEN-402, XEN402, XPF-002 | |||||||
| funobactam | 13114 | XNW4107 | |||||||
| furagin |
|
12367 | furazidin, furazidine, NF416 | ||||||
| furaltadone |
|
13898 | Altafur®, furmethonol | ||||||
| furazolidone |
|
12343 | Furoxone® | ||||||
| furazolium | 10814 | Novofur | |||||||
| furegrelate sodium | 11378 | U-63557A, U63557A | |||||||
| furosemide |
|
|
4839 | dihydroflumethiazide, frusemide, Lasix®, methforylthiazidine | |||||
| furtrethonium | 299 | furmethide | |||||||
| fusidic acid |
|
|
10815 | CEM-102, CEM102, Fucidin®, fusidate, sodium fusidate, Taksta® | |||||
| futibatinib |
|
|
9786 | Example 2 [WO2013108809], FGFR-IN-1, Lytgobi®, TAS 120, TAS-120, TAS120 | |||||
| FUZS-5 |
|
12200 | 5'-deoxy-5'-thiothymidine, 5'-Thiothymidine | ||||||
| FX1 | 9672 | ||||||||
| FX-909 |
|
12626 | FX 909, FX909 | ||||||
| FXIa inhibitor 3f |
|
12133 | |||||||
| FzM1 | 10322 | ||||||||
| FzM1.8 | 10321 | ||||||||
| G | Back to top | ||||||||
| 1G244 |
|
8551 | |||||||
| G0775 | 13608 | ||||||||
| G-1 | 1014 | G1, LNS-8801, LNS8801 | |||||||
| G15 | 3320 | G-15 | |||||||
| G36 | 6480 | G-36 | |||||||
| Gö 6976 |
|
5973 | Go 6976, Go-6976, Go6976, Goe 6976 | ||||||
| Gö 6983 | 5192 | Go 6983, Go-6893, Goe 6983 | |||||||
| Gö 7874 | 335 | Go 7874, Go-7874, Go7874 | |||||||
| [3H]GABA |
|
|
|
5410 | |||||
| gabapentin |
|
|
|
5483 | CI 945, Go 3450, GOE 2450, GOE 3450, Neurontin® | ||||
| gabapentin enacarbil |
|
7560 | Horizant®, Regnite®, XP-13512 | ||||||
| gabazine | 4197 | SR-95531, SR95531 | |||||||
| [3H]gabazine |
|
|
4083 | SR95531 | |||||
| gabexate |
|
7863 | |||||||
| gaboxadol |
|
4322 | LU-02030, MK-0928, MK0928, OV101, THIP | ||||||
| galantamine |
|
|
6693 | galanthamine, Razadyne® | |||||
| Galapagos MAPKAPK5 inhibitor D |
|
9848 | compound 183 [WO2007138072A2] | ||||||
| galeterone |
|
8638 | TOK-001, VN/124-1 | ||||||
| galidesivir |
|
11920 | BCX-4430, BCX4430, Immucillin-A | ||||||
| gallamine |
|
|
356 | Flaxedil® | |||||
| galmic | 6119 | ||||||||
| galnon | 6118 | ||||||||
| GalR3ant | 6127 | ||||||||
| galunisertib | 7797 | inhibitor 15d [PMID: 18314943], LY-2157299, LY2157299 | |||||||
| gamcemetinib |
|
12167 | CC-99677, CC99677 | ||||||
| gamithromycin | 13688 | ML-1709460, Zactran® (veterinary) | |||||||
| ganaplacide |
|
9946 | GNF156, KAF156 | ||||||
| ganaxolone |
|
11942 | CCD-1042, CCD1042, Ztalmy® | ||||||
| gandotinib |
|
|
7909 | LY-2784544, LY2784544 | |||||
| ganetespib |
|
13309 | compound 8 [PMID: 23965125], STA-9090, STA9090 | ||||||
| ganfeborole | 12796 | GSK3036656, GSK656 | |||||||
| Ganglioside GD2 | 11342 | ||||||||
| garenoxacin |
|
12402 | BMS-284756, Ganefloxacin, Garenfloxacin, Geninax®, T-3811 | ||||||
| garsorasib |
|
13767 | AnFangning®, compound 2 [WO2021120045A1], D-1553, D1553 | ||||||
| gartisertib | 11647 | M-4344, M4344, VX-803, VX803 | |||||||
| GAT100 | 9237 | 5-(cyanosulfanyl)-3-ethyl-N-{2-[4-(piperidin-1-yl)phenyl]ethyl}-1H-indole-2-carboxamide | |||||||
| GAT211 | 10272 | ||||||||
| gatifloxacin |
|
10816 | AM-1155, AM1155, Gatiflo®, GTFX, Tequin®, Zymar® | ||||||
| GB110 | 6657 | GB 110, GB-110 | |||||||
| GB1211 | 11202 | compound 11d [Zetterberg et al., 2022], Example 44 [WO2016120403A1], GB-1211 | |||||||
| GB1908 | 13393 | compound 5d [PMID: 38804039], GB-1908 | |||||||
| GB88 |
|
6658 | GB 88, GB-88 | ||||||
| GBR12935 | 4639 | GBR 12935, GBR-12935 | |||||||
| [3H]GBR12935 |
|
|
4638 | [3H]-GBR12935 | |||||
| GC-376 | 10883 | compound 7a [PMID: 23218713], GC376 | |||||||
| GDC-0134 | 11506 | compound 279 [WO2014177060A1], GDC0134 | |||||||
| GDC-0152 | 7733 | GDC 0152, GDC0152 | |||||||
| GDC-0214 |
|
12318 | GDC0214, iJak-381, RG-6151, RG6151 | ||||||
| GDC-0276 | 12779 | compound 1 [PMID: 33682420], compound 4 [PMID: 31012583], GDC0276 | |||||||
| GDC-0334 |
|
12568 | GDC0334 | ||||||
| GDC-0339 |
|
12708 | compound 16 [PMID: 30715878], GDC0339 | ||||||
| GDC-0623 |
|
9909 | G-868, GDC 0623, GDC0623, RG-7421, RG7421 | ||||||
| GDC-0834 |
|
|
9263 | GDC 0834 | |||||
| GDC-0879 |
|
5681 | AR 00341677, AR00341677, GDC 0879, GDC0879 | ||||||
| GDC-2394 |
|
|
12280 | compound 20 [PMID: 36279149], GDC2394 | |||||
| GDI-036 | 12591 | ||||||||
| GDPβS |
|
5416 | Gdp(beta-S), GDP-β-S, GDP-bS, guanosine 5'-O-(2-thiodiphosphate) | ||||||
| GEA 3162 | 4200 | GEA-3162, GEA3162 | |||||||
| gedatolisib |
|
7940 | PF-05212384, PKI 587, PKI-587 | ||||||
| gefapixant |
|
|
|
9540 | AF-219, AF219, Lyfnua®, MK7264, MK‐7264 | ||||
| gefitinib |
|
|
4941 | Iressa®, ZD 1839, ZD1839 | |||||
| gemcitabine |
|
|
4793 | gemcitabine hydrochloride, Gemzar® | |||||
| gemfibrozil |
|
|
3439 | CI-719, Gen-Fibro®, Jezil® | |||||
| gemifloxacin |
|
12406 | Factive®, LB20304, SB 265805 | ||||||
| gemini | 2782 | 1R,25-dihydroxy-21-(3-hydroxy-3-methylbutyl)vitamin D3, KH | |||||||
| gemnelatinib | 11668 | ||||||||
| gentamicin |
|
2427 | Garamycin®, gentamicin sulfate | ||||||
| gepirone |
|
12930 | BMY-13805, BMY13805, Exxua®, MJ-13805, MJ13805, ORG-13011, Travivo (gepirone extended-release) | ||||||
| gepotidacin |
|
|
10817 | Blujepa®, GSK-2140944, GSK2140944 | |||||
| geranyl biphosphonate | 3175 | ||||||||
| gestodene |
|
11246 | Femodene® (ethinylestradiol, gestodene), Millinette® (ethinylestradiol, gestodene), SH-B-331 | ||||||
| GFB-8438 |
|
12527 | GFB8438 | ||||||
| GF109203X |
|
5193 | bisindolylmaleimide I, Gö6850, GF 109203X | ||||||
| GGsTop | 10265 | ||||||||
| GI‐530159 | 10337 | ||||||||
| gilmelisib | 11876 | compound 25 [WO2015192760A1] | |||||||
| gilteritinib |
|
|
8708 | ASP-2215, ASP2215, Xospata® | |||||
| ginkgolide X | 4201 | ||||||||
| giredestrant |
|
12715 | compound 35 [PMID: 34251202], GDC-9545, GDC9545, RG-6171, RG6171, RO-7197597, RO7197597 | ||||||
| girocitinib | 13208 | Example 4 [US10738060] | |||||||
| gisadenafil | 6558 | UK 369003, UK-369003 | |||||||
| GIV3727 | 9112 | ||||||||
| givinostat |
|
|
7490 | Duvyzat®, gavinostat, ITF-2357, ITF2357 | |||||
| GI254023X |
|
9687 | GI 254023X, GI-254023X | ||||||
| GJG057 |
|
14087 | compound 1 [PMID: 39960261], GJG-057 | ||||||
| GKT136901 | 9935 | compound 67 [PMID: 20942471], GKT 136901, GKT-136901 | |||||||
| glasdegib |
|
8201 | Daurismo®, PF 04449913, PF-04449913 | ||||||
| Glaxo-11p | 866 | ||||||||
| GlaxoSmithKline compound 5h [PMID:20542694] | 5807 | ||||||||
| GlaxoSmithKline compound 6i [PMID:18926700] | 5806 | ||||||||
| GlcC14C18 |
|
9483 | 6-O-(2'(R,S)-tetradecyloctadecanoyl)-D-glucose | ||||||
| glecaprevir |
|
|
11267 | ABT-493, ABT493, Maviret®, Mavyret® (glecaprevir + pibrentasvir) | |||||
| glemanserin | 186 | Mdl 11939, MDL-11,939, MDL-11939 | |||||||
| glesatinib | 9133 | compound 10a [PMID: 18434145], MGCD 265, MGCD-265, MGCD265 | |||||||
| glibenclamide |
|
|
|
2414 | Amglidia®, Diabeta®, glyburide, Glynase® | ||||
| glimepiride |
|
6820 | Amaryl®, glimepride, HOE-490, Sugral® | ||||||
| glipizide |
|
6821 | CP-28720, Glucotrol®, K-4024 | ||||||
| glovadalen | 13232 | ||||||||
| gloximonam | 10880 | SQ 82,531 | |||||||
| GLPG0974 |
|
|
8417 | compound 99 [PMID 25380412] | |||||
| GLPG1205 |
|
10171 | compound 122 [WO2013092791A1], GLPG-1205 | ||||||
| GLPG1837 |
|
12735 | ABBV-974, ABBV974, GLP-1837, GLPG-1837 | ||||||
| GLPG2534 | 12510 | GLPG-2534 | |||||||
| GLPG2737 | 13290 | compound 52 [PMID: 38527911], GLPG-2737 | |||||||
| GLPG3312 |
|
13303 | compound 28 [PMID: 38147525], GLPG-3312 | ||||||
| GLPG3970 |
|
12157 | compound 32 [PMID: 38552030], compound 88 [WO2019238424A1], GLPG-3970 | ||||||
| GLPG4716 |
|
11617 | compound 9 [PMID: 33078933] | ||||||
| [14C]glutamine |
|
|
|
4633 | [14C]-glutamine | ||||
| [3H]glutamine |
|
|
|
4634 | [3H]-glutamine | ||||
| glutethimide |
|
7192 | Doriden® | ||||||
| GLXC-26326 | 12617 | example 45 [WO2010056563A1], GLXC26326, LY-2780301, LY2780301 | |||||||
| [14C]glycine |
|
|
|
4635 | [14C]-glycine | ||||
| [3H]glycine |
|
|
|
4084 | |||||
| glycopyrrolate |
|
|
7459 | AHR-504, Qbrexza® (glycopyrronium cloth), Robinul®, Seebri Neohaler®, Tovanor Breezhaler® | |||||
| glycyl-[13C3]-sarcosine |
|
|
12598 | ||||||
| GlyH-101 | 4202 | AGN-PC-005HH0, CTK8E9894 | |||||||
| [11C]GlySar |
|
|
4489 | [11C]-GlySar, [11C]glycylsarcosine | |||||
| [14C]GlySar |
|
|
4599 | [14C]-GlySar, glycylsarcosine | |||||
| [3H]GlySar |
|
|
4659 | [3H]-GlySar, tritiated glycylsarcosine | |||||
| GlyT1 inhibitor 27a | 10064 | compound (7S,8R)-27a | |||||||
| GlyT1 inhibitor 51b | 10065 | ||||||||
| GMQ | 4203 | 2-GMQ, 2-guanidine-4-methylquinazoline, GNF-Pf-3515 | |||||||
| GNE-049 |
|
13247 | compound 10 [PMID: 28892380], GNE049 | ||||||
| GNE-064 | 12206 | compound 5 [PMID: 35930799], GNE064 | |||||||
| GNE-0877 |
|
9393 | compound 11 [PMID: 24354345], DNL-201, DNL201, GNE0877 | ||||||
| GNE-131 | 10003 | compound 13 [PMID: 29737846], GNE 131, GNE131 | |||||||
| GNE-235 | 13104 | compound 23 [PMID: 37702400], GNE235 | |||||||
| GNE-3500 |
|
9660 | |||||||
| GNE-3511 |
|
9355 | compound 26 [PMID: 25341110], GNE 3511, GNE3511 | ||||||
| GNE-4997 |
|
|
9995 | compound 28 [PMID: 25844760], GNE 4997, GNE4997 | |||||
| GNE-616 | 10355 | compound 24 [PMID: 30943032], GNE616 | |||||||
| GNE684 |
|
|
13107 | GNE-684 | |||||
| GNE-7883 | 12814 | GNE7883 | |||||||
| GNE-7915 |
|
8073 | GNE 7915, GNE7915 | ||||||
| GNE-8505 | 9990 | example 152 [WO2014111496] | |||||||
| GNE-9605 | 7919 | GNE 9605, GNE9605 | |||||||
| GNF-1331 | 12019 | GNF1331 | |||||||
| GNF2133 |
|
10687 | compound 13g [PMID: 32077280], GNF-2133 | ||||||
| GNF362 |
|
9548 | example 71 [US20090306039] | ||||||
| GNF4877 | 10688 | GNF-4877 | |||||||
| GNF-5 | 8065 | GNF 5, GNF5 | |||||||
| GNF-5837 | 8071 | GNF 5837, GNF5837 | |||||||
| GNF-6231 | 11166 | compound 19 [PMID: 27437076], GNF6231 | |||||||
| golcadomide | 13021 | CC-99282, CC99282, compound 1 [US20220324855] | |||||||
| golidocitinib |
|
10744 | AZD-4205, AZD4205, compound 21 [PMID: 32297743], example 32 [US9714236B2], GaoRuizhe (Chinese trade name), JAK1-IN-3 | ||||||
| golvatinib |
|
7956 | E-7050, E7050 | ||||||
| GoSlo-SR-5-69 | 14020 | ||||||||
| gosogliptin |
|
7413 | PF-00734200 | ||||||
| govorestat |
|
13307 | AT-007, AT007 | ||||||
| gozanertinib |
|
12711 | ABT-101, ABT101, compound 78 [PMID: 31560541], DBPR-112 | ||||||
| GPI-1046 |
|
11483 | GPI1046 | ||||||
| G10 [PMID: 26646986] | 9206 | ||||||||
| GPR4 antagonist 3b | 10207 | compound 3b [PMID: 27190599] | |||||||
| GPX4 inhibitor C18 | 12799 | ||||||||
| GR 113808 | 247 | GR 125487, GR-113,808, GR-113808, GR113808 | |||||||
| GR 125487 | 248 | GR-125487, GR125487 | |||||||
| GR 125,743 | 69 | GR 125743, GR125743 | |||||||
| GR 127935 | 14 | GR-127935, GR127935 | |||||||
| GR 128107 | 1348 | GR-128107, GR128107, L000276 | |||||||
| GR 144053 |
|
6587 | GR 144053 trihydrochloride, GR-144053, GR144053 | ||||||
| GR 159897 | 2115 | GR-159,897, GR-159897, GR159897 | |||||||
| GR 175737 | 1243 | GR-175737, GR175737 | |||||||
| GR 196429 | 1349 | GR-196429, GR196429 | |||||||
| GR 218,231 | 70 | GR 218231, GR218231 | |||||||
| GR-389988 |
|
10257 | Ex. 3-15 [US9174986B2], GR389988, GZ389988, GZ389988A | ||||||
| GR-55562 | 113 | GR 55562, GR55562 | |||||||
| GR 63799 | 1937 | GR-63799, GR-63799X, GR63799 | |||||||
| GR79236 | 3288 | GR 79236, N-[(1s,2s)-2-hydroxycyclopentyl adenosine | |||||||
| GR 89696 | 1649 | GR 85571, GR-103545, GR-89696 | |||||||
| [3H]GR 113808 |
|
|
259 | GR 125487 [H3], GR113808 | |||||
| [3H]GR 125,743 |
|
|
131 | [3H]GR125743, GR125743 | |||||
| [3H]GR65630 |
|
|
2303 | [3H]-GR65630 | |||||
| GRA2 | 13991 | ||||||||
| granisetron |
|
2300 | BRL 43694, BRL-43694, Kytril®, LY-278584, Sancuso®, Sustol® | ||||||
| [3H]granisetron |
|
|
2292 | [3H]-BRL-43694, [3H]-granisetron | |||||
| grapiprant | 5858 | AT-001, CJ 023423, CJ-023423, RQ-00000007 | |||||||
| grazoprevir |
|
|
11573 | analog 15 [PMID: 24900473], MK-5172, MK5172, Zepatier® [elbasvir (NS5A inhibitor) + grazoprevir] | |||||
| grepafloxacin |
|
10818 | OPC 17116, OPC-17116, OPC17116, Raxar® | ||||||
| GRI977143 | 6580 | GRI-977143 | |||||||
| GRL-0496 | 11173 | ALP-POS-c59291d4-5, compound 10 [PMID:18796354], GRL0496 | |||||||
| GRL-0617 |
|
11078 | compound 25 [PMID: 19645480], GRL0617 | ||||||
| GRN-529 | 6428 | ||||||||
| group E 1682-2106 [PMID:16118363] | 5827 | ||||||||
| Grp94 inhibitor 54 |
|
10118 | |||||||
| GR148672X | 6701 | ||||||||
| GS39783 |
|
5446 | GS-39783 | ||||||
| GS-441524 |
|
11445 | EVO-984, EVO984, GS441524 | ||||||
| GS-444217 |
|
10430 | |||||||
| GS-458967 | 9858 | GS967 | |||||||
| GS-621763 | 11840 | GS621763 | |||||||
| GS9667 | 5593 | CVT-3619, GS-9667 | |||||||
| GSA-10 | 10326 | GSA10 | |||||||
| GSK030 |
|
10611 | GSK3212030A | ||||||
| GSK065 |
|
|
10358 | GSK3335065, inhibitor C1 [PMID: 28604669] | |||||
| GSK0660 | 3441 | GSK 0660, GSK-0660 | |||||||
| GSK1059615 | 9826 | ||||||||
| GSK-1059865 |
|
12506 | GSK1059865 | ||||||
| GSK1070916 | 8358 | compound 17k [PMID 20420387], GSK-1070916 | |||||||
| GSK126 |
|
7012 | GSK 126, GSK-126, GSK2816126 | ||||||
| GSK1331258 | 6252 | GSK 1331258, GSK-1331258 | |||||||
| GSK1331268 | 6253 | GSK 1331268, GSK-1331268 | |||||||
| GSK143 |
|
9388 | compound 20 [PMID: 21903390] | ||||||
| GSK1482160 |
|
|
10504 | compound 1b [PMID: 31525963], compound 31 [PMID: 20673717], GSK-1482160 | |||||
| GSK1511931 | 8644 | compound 14 [PMID: 19081716], GSK-1511931, GSK1511931A | |||||||
| GSK1521498 | 9287 | GSK-1521498 | |||||||
| GSK1614343 | 5870 | GSK 1614343, GSK-1614343 | |||||||
| GSK 172981 | 5773 | GSK-172981, GSK172981 | |||||||
| GSK1795091 | 11150 | compound 4 [PMID: 18835160], CRX-601, CRX601, GSK'091, GSK-1795091 | |||||||
| GSK180 |
|
9007 | inhibitor A1 [PMID: 28604669] | ||||||
| GSK-189254 | 10736 | GSK-189,254, GSK189254 | |||||||
| GSK2018682 | 11311 | GSK-2018682 | |||||||
| GSK2033 | 8690 | GSK 2033, GSK-2033 | |||||||
| GSK2193874 | 6465 | GSK 2193874, GSK-2193874 | |||||||
| GSK2194069 |
|
8605 | GSK 2194069, GSK-2194069 | ||||||
| GSK2210875 | 6435 | GSK-2210875 | |||||||
| GSK2245035 |
|
9254 | compound 32 [PMID: 26861551] | ||||||
| GSK2256098 | 7939 | GSK-2256098 | |||||||
| GSK2256294 |
|
9718 | GSK-2256294, GSK-2256294A, GSK2256294A | ||||||
| GSK2292767 |
|
|
10633 | compound 2 [PMID: 30532965], compound 3 [PMID: 26301626], GSK-2292767 | |||||
| GSK2334470 | 8008 | GSK 2334470, GSK-2334470 | |||||||
| GSK2556286 | 13078 | GSK286 | |||||||
| GSK256073 |
|
8470 | GSK 256073, GSK-256073 | ||||||
| GSK 256471 | 5774 | GSK-256471 | |||||||
| GSK2606414 | 6740 | 3-fluoro-GSK2606414, compound 38 [PMID: 22827572], GSK PERK Inhibitor | |||||||
| GSK2636771 | 7967 | GSK-2636771 | |||||||
| GSK2646264 |
|
|
10108 | compound 44 [PMID: 30249354] | |||||
| GSK2656157 | 9544 | compound 6 [PMID: 24900593], GSK-2656157 | |||||||
| GSK2793660 | 13960 | GSK-2793660 | |||||||
| GSK2798745 |
|
12557 | GSK-2798745 | ||||||
| GSK2801 |
|
8233 | KB-146016 | ||||||
| GSK2830371 | 11103 | compound 8 [PMID: 24390428], GSK-2830371 | |||||||
| GSK2838232 | 12680 | example 51 [WO2013090664A1], GSK-2838232, GSK-8232, GSK232 | |||||||
| GSK2879552 |
|
9116 | Example 26 [WO2012135113], GSK-2879552 | ||||||
| GSK2881078 | 11151 | GSK'078, GSK-2881078 | |||||||
| GSK2981278 |
|
9661 | |||||||
| GSK2982772 |
|
|
9554 | compound 5 [PMID: 28151659] | |||||
| GSK3008348 | 12736 | GSK-3008348 | |||||||
| GSK312948 | 8647 | ||||||||
| GSK3145095 |
|
12245 | compound 6 [PMID: 31223438], GSK-3145095 | ||||||
| GSK329 |
|
11806 | compound 47 [PMID: 34699203], GSK-329 | ||||||
| GSK334429 | 9103 | GSK 334429, GSK-334429 | |||||||
| GSK343 |
|
|
8240 | compound 6 [PMID 24900432], GSK 343 | |||||
| GSK3527497 |
|
12560 | compound 13 [PMID: 31532662], GSK-3527497 | ||||||
| GSK3685032 | 11750 | GSK-3685032 | |||||||
| GSK369796 |
|
10411 | N-tert-Butyl isoquine | ||||||
| GSK4112 | 2903 | GSK-4112, SR6452 | |||||||
| GSK4716 | 2835 | GSK 4716, GSK-4716 | |||||||
| GSK484 | 8577 | GSK 484, GSK-484 | |||||||
| GSK484 |
|
13705 | GSK-484, MMV-1793192, MMV1793192 | ||||||
| GSK5182 |
|
8908 | GSK 5182, GSK-5182 | ||||||
| GSK'547 |
|
11274 | example 6 [WO2020044206A1], GSK-547, GSK547 | ||||||
| GSK583 |
|
|
9134 | GSK'583 | |||||
| GSK591 |
|
8954 | EPZ015866, GSK3203591 | ||||||
| GSK650394 |
|
8040 | GSK-650394 | ||||||
| GSK690693 |
|
5196 | compound 3g [PMID 18800763], GSK 690693, GSK-690693 | ||||||
| GSK839 | 13955 | ||||||||
| GSK852 | 11690 | compound 71 [PMID: 34260229], GSK-852 | |||||||
| GSK8612 |
|
10343 | |||||||
| GSK864 | 8961 | compound 4 [PMID: 26436839] | |||||||
| GSK866 |
|
|
9653 | ||||||
| GSK8814 |
|
9521 | |||||||
| GSK931145 | 4598 | ||||||||
| GSK963 |
|
10132 | GSK'963, GSK′963A | ||||||
| GSK9772 | 8693 | GSK 9772, GSK-9772 | |||||||
| [11C]GSK215083 |
|
|
8430 | ||||||
| [3H]GSK931145 |
|
|
4490 | [3H]-GSK931145 | |||||
| GSK1016790A |
|
4205 | |||||||
| GSK1370319A | 10503 | compound 1a [PMID: 31525963] | |||||||
| GSK1702934A | 10278 | ||||||||
| GSK-1838705A | 5683 | GSK 1838705A, GSK1838705, GSK1838705A | |||||||
| GSK2239633A |
|
10416 | compound 6 [PMID: 23409871], GSK-2239633A | ||||||
| GSK2603566A | 10496 | compound 39 [PMID: 31497959] | |||||||
| GSK-264220A | 6697 | ||||||||
| GSK269962A | 8037 | aminofurazanyl-azabenzimidazole 6n, GSK-269962A, GSK269962 | |||||||
| GSK2833503A | 10284 | example 19 [PMID: 23886683] | |||||||
| GSK417651A | 10279 | compound 3 [PMID: 23886683] | |||||||
| GSK429286A | 9356 | compound 15 [PMID: 17201405] | |||||||
| GSK-461364A | 5684 | GSK 461364, GSK-461364, GSK461364, GSK461364A | |||||||
| GSK494581A | 5562 | ||||||||
| GSK575594A | 5561 | ||||||||
| GSK579289A | 8150 | compound 25 [PMID 19237286], GSK-579289A | |||||||
| GSK682753A |
|
13053 | GSK-682753A | ||||||
| GSK-7975A |
|
10088 | example 36 [US20120053150A1], GSK7975A | ||||||
| GSK2332255B | 12529 | example 17 [PMID: 23886683], GSK255B | |||||||
| GSK-3beta inhibitor I |
|
5977 | TDZD-8 | ||||||
| GSK-3beta inhibitor II | 5978 | GSK-3b inhibitor II | |||||||
| GSK-3beta inhibitor VIII |
|
5979 | AR-A014418, GSK-3b inhibitor VIII | ||||||
| GSK-3beta inhibitor XI | 5981 | GSK-3b inhibitor XI | |||||||
| GSK-Bz derivative 2b | 12558 | compound 2b [PMID: 36696767] | |||||||
| GSK Compound 34 | 3502 | ||||||||
| GSK-3 inhibitor IX | 5974 | 6-bromoindirubin-3-oxime, BIO, BRW, indirubin deriv. 7a | |||||||
| GSK-3β inhibitor 3 [PMID: 25845281] |
|
9811 | GSK-3β inhibitor 1 [Jiang et al., 2018] | ||||||
| GSK-3 inhibitor X | 5975 | indirubin deriv. 8a | |||||||
| GSK-3 inhibitor XIII |
|
5976 | K00244 | ||||||
| GSK-J1 |
|
|
7027 | ||||||
| GSK-J4 |
|
8979 | GSK J4, GSKJ4 | ||||||
| GSK-LSD1 | 8241 | ||||||||
| GT-0198 | 11297 | GT0198 | |||||||
| GT-1 | 13251 | LCB10-0200 | |||||||
| GT2394 | 1261 | ||||||||
| [125I]GTI |
|
|
3250 | serotonin-5-O-carboxymethyl-glycyl-(125I)tyrosinamide | |||||
| GTP-14564 | 5982 | ||||||||
| GTPγS |
|
4207 | |||||||
| GTS-21 |
|
11384 | DMBX-A | ||||||
| guaifenesin |
|
7617 | glyceryl guaiacolate, guaiphenesin, Mucinex® | ||||||
| guanabenz |
|
5443 | GBZ, NSC 68982, Wy 8678, Wytensin® | ||||||
| guanadrel |
|
7193 | CL-1388R, Hylorel®, U-28288D | ||||||
| guanethidine |
|
7194 | Ismelin®, SU-5864 | ||||||
| guanfacine |
|
522 | Estulic®, Intuniv®, Tenex® | ||||||
| guanidinoethane sulfonic acid |
|
5492 | γ-guanidino sulphonic acid | ||||||
| 5'-guanidinonaltrindole | 1669 | GNTI | |||||||
| β-guanidinopropionic acid |
|
4707 | β-GPA | ||||||
| guanylpirenzepine | 3276 | ||||||||
| Gue1654 | 6173 | Gue 1654 | |||||||
| gumarontinib | 11623 | glumetinib (pseoudo INN), SCC-224, SCC224 | |||||||
| gunagratinib | 11669 | ICP-192, ICP192 | |||||||
| gusacitinib |
|
10000 | ASN-002, ASN002, example 189 [WO2013028818A1] | ||||||
| GV150013 | 3503 | GV 150013 | |||||||
| GV196771A | 4208 | GV 196771A | |||||||
| GW0072 |
|
2695 | GW 0072 | ||||||
| GW1100 | 1057 | GW 1100, GW-1100 | |||||||
| GW1929 |
|
2703 | GW 1929, GW-1929 | ||||||
| GW2331 |
|
2680 | GW 2331, GW-2331 | ||||||
| GW2433 |
|
2716 | GW 2433, GW-2433 | ||||||
| GW-2580 |
|
5685 | cFMS receptor tyrosine kinase inhibitor, GW2580, GW632580X | ||||||
| GW274150 |
|
9849 | [2-[(1-iminoethyl) amino]ethyl]-L-homocysteine, GW-274150 | ||||||
| GW3965 |
|
|
2754 | C473027, GW 3965, GW-3965 | |||||
| GW405833 |
|
11149 | GW 405833, GW-405833, L-768,242, L768242 | ||||||
| GW406381 |
|
9850 | compound 8 [PMID: 15454242], GW-406381 | ||||||
| GW4064 |
|
2743 | C412815, GW-4064 | ||||||
| GW409544 |
|
2656 | GW 409544 | ||||||
| GW441756 | 4946 | GW 441756, GW-441756 | |||||||
| GW501516 |
|
2687 | GSK-516, GW 501516, GW-501516, GW1516 | ||||||
| GW5074 | 8072 | GW-5074, Raf1 kinase inhibitor I | |||||||
| GW-5823 | 865 | GW 5823, GW5823 | |||||||
| GW583340 | 4947 | GW 583340 | |||||||
| GW 627368 |
|
1953 | GW-627368, GW627368, saccharic acid | ||||||
| GW6471 |
|
3440 | GW 6471, GW-6471 | ||||||
| GW7647 |
|
2674 | GW 7647, GW-7647 | ||||||
| GW766994 |
|
9680 | GSK766994, GW-766994 | ||||||
| GW7845 | 2704 | GW 7845, GW-7845 | |||||||
| GW791343 |
|
9022 | GW-791343 | ||||||
| GW803430 | 4033 | GW 803430, GW-803,430 | |||||||
| GW842166 | 12753 | compound 35 [PMID: 17477516], GW8-42166, GW8-42166X, GW842166X | |||||||
| GW853606 | 8645 | compound 22 [PMID: 19097784], GW853606X | |||||||
| GW9508 |
|
1050 | GW 9508, GW-9508 | ||||||
| GW9578 | 2673 | GW 9578, GW-9578 | |||||||
| GW9662 |
|
3442 | GW 9662, GW-9662 | ||||||
| [3H]GW2331 |
|
|
2706 | ||||||
| GW0742X |
|
2686 | GW-0742X, GW0742 | ||||||
| GW542573X | 9313 | ||||||||
| GW841819X | 7514 | KB-75882 | |||||||
| GW848687X | 3360 | GW 848687X, GW-848687X | |||||||
| GYKI53655 | 4209 | GYKI 53655, GYKI-53655, LY300168 | |||||||
| GYKI53784 |
|
4210 | GYKI-52466, LY303070 | ||||||
| GYY4137 parent molecule |
|
9808 | GYY4137 | ||||||
| H | Back to top | ||||||||
| 6H05 | 8023 | S7330 | |||||||
| H05 | 9880 | ||||||||
| H-151 |
|
10122 | H 151, H151 | ||||||
| H-8 |
|
2348 | |||||||
| H87/07 | 542 | H 87-07 | |||||||
| H-89 |
|
5983 | H 89 | ||||||
| (+)-HA966 | 4066 | (R)-(+)-HA-966 | |||||||
| halazepam |
|
7195 | Alapryl®, SCH-12041 | ||||||
| halofantrine |
|
|
10019 | Halfan®, WR-171669 | |||||
| halofuginone |
|
|
10153 | ||||||
| haloperidol |
|
|
86 | Haldol®, MCN-JR-1625, R-1625, Serenace® | |||||
| halothane |
|
2401 | Fluothane® | ||||||
| HAMI3379 | 6197 | ||||||||
| H4 antagonist 48 |
|
9879 | |||||||
| H3B-960 | 13019 | ||||||||
| H3B-968 | 13020 | H3B968 | |||||||
| HBI-2375 | 14178 | formula IIIb [WO2023177592], HBI2375, HYBI-084 | |||||||
| HC030031 | 4211 | HC-030031 | |||||||
| HC-056456 | 4212 | HC056456 | |||||||
| HC067047 |
|
4213 | HC 067047 | ||||||
| HC-070 |
|
10286 | |||||||
| HC-5404 | 13275 | compound 4 [PMID: 33895276], HC-5404-FU | |||||||
| HC-7366 | 13340 | compound 29 [PMID: 38530741], HC7366 | |||||||
| 5-HEAT | 1345 | 5-hydroxyethoxy-N-acetyltryptamine | |||||||
| HEAT (BE2254) |
|
|
482 | [125I] BE2254, [125I] HEAT, [125I]-HEAT, [125I]BE2254 | |||||
| [125I]HEAT (BE2254) |
|
|
500 | 2-[[2-(4-hydroxy-3-iodanylphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one, 2-{p-(4-hydroxy-3-[125I]iodophenyl)ethylaminomethyl}-tetralone, [125I]BE-2254, HEAT | |||||
| HEMADO | 5599 | ||||||||
| [3H]HEMADO |
|
|
5736 | ||||||
| hemicholinium-3 | 4494 | HC-3 | |||||||
| [3H]hemicholinium-3 |
|
|
4493 | [3H]-HC-3 , [3H]-hemicholinium-3, [3H]HC-3 | |||||
| hemicholinium mustard | 5502 | HCM | |||||||
| henagliflozin |
|
13762 | SHR-3824, SHR3824 | ||||||
| henatinib | 9930 | compound 25 [PMID: 21028894] | |||||||
| hesperadin |
|
8354 | |||||||
| HET0016 |
|
11373 | HET-0016 | ||||||
| hetacillin |
|
12263 | |||||||
| hetrombopag |
|
10657 | Hengqu®, SHR-8735 | ||||||
| hexachlorophene |
|
|
11069 | Inh 1 [PMID: 32284327], Nabac® | |||||
| hexadecanal | 6627 | palmitaldehyde | |||||||
| hexahydrodifenidol | 322 | ||||||||
| hexahydrosiladifenidol | 310 | HHSiD, GNF-Pf-5565, hexahydro-sila-diphenidol, Hhsi-difenidol | |||||||
| hexamethonium | 3963 | ||||||||
| 1,6-hexamethylene diisocyanate | 6291 | HDI, HMDI | |||||||
| hexestrol | 2823 | ||||||||
| hexocyclium | 323 | ||||||||
| hexylcaine |
|
7196 | Cyclaine® | ||||||
| (S)-hexylhomoibotenic acid | 5448 | (S)-HexylHIBO | |||||||
| 2-hexynyl-NECA | 373 | adenosine-5'-N-ethyluronamide, HE-NECA, HENECA, NECA | |||||||
| 5H3'FPE | 8748 | ||||||||
| HG-10-102-01 | 9392 | compound 15 [PMID: 22591441] | |||||||
| HG106 | 13931 | HG-106 | |||||||
| HG-9-91-01 |
|
|
8049 | HY-15776 | |||||
| hGCGR antagonist | 1148 | acylated aminothiophene nitrile, glucagon receptor antagonist I | |||||||
| (-)-HIP-A | 5328 | ||||||||
| His-Leu-lopinavir | 9502 | His-Leu-LPV, Histidine-Leucine-Lopinavir | |||||||
| [3H]histamine |
|
|
|
1247 | |||||
| histaprodifen | 4026 | ||||||||
| [14C]histidine |
|
|
4623 | [14C]-histidine | |||||
| [3H]histidine |
|
|
4670 | [3H]-histidine | |||||
| HJC0152 | 12140 | compound 11 [PMID: 23459613], compound 11 [WO2014113467A1], HJC-0152, HJC-1-52 | |||||||
| HJC 0350 | 6556 | HJC0350 | |||||||
| HK370 | 13573 | compound 18l [PMID: 39220762], HK-370 | |||||||
| H2L5186303 | 6579 | compound 4 [PMID: 19800804] | |||||||
| HM01 | 10740 | ||||||||
| HM50316 | 8788 | compound 5g [PMID: 21481589], HM 50316 | |||||||
| HMR-1556 | 2590 | chromanol HMR1556 | |||||||
| HNF4α inhibitor | 14183 | ||||||||
| HNHA | 7911 | histone deacetylase inhibitor VI | |||||||
| hobartine | 13177 | ||||||||
| 13-HODE | 5426 | α-artemisolic acid, 13-hydroxylinoleic acid, coriolic acid | |||||||
| homo-AMPA | 3359 | ||||||||
| homoquinolinic acid |
|
4216 | HQA | ||||||
| 5H78PF | 11351 | ||||||||
| HPG1860 | 12910 | compound 23 [PMID: 37424079], HPG-1860 | |||||||
| (S)-3HPG | 1366 | 3-hydroxyphenylglycine | |||||||
| (R)-2h [PMID:19625189] | 10590 | Pfizer compound 1 | |||||||
| HPN | 9732 | ||||||||
| HPTE |
|
2827 | |||||||
| HQL-79 |
|
6662 | HQL 79, HQL79 | ||||||
| HR1405-01 | 11973 | compound 5a [PMID: 14980665], loxoprofen trans-alcohol | |||||||
| HRO761 |
|
13018 | example 42 [WO2022249060], HRO-761 | ||||||
| HS-173 | 8243 | ||||||||
| HS665 | 9189 | compound 4 [PMID: 23134120] | |||||||
| HSD1590 | 10424 | ||||||||
| HSGN-218 | 13054 | ||||||||
| HSK31858 | 13959 | compound 54 [PMID: 34374541] | |||||||
| HSK3486 | 10812 | HSK 3486, HSK-3486 | |||||||
| HSL119 | 13138 | HSL-119 | |||||||
| HT1042 | 8649 | ||||||||
| [3H]5-HT |
|
|
3248 | [3H]-5-HT | |||||
| HTH-01-015 | 8977 | HTH01-015 | |||||||
| HTH-02-006 | 11085 | ||||||||
| HTI-1 |
|
11255 | compound 1c | ||||||
| HTL22562 |
|
11113 | compound 8 [PMID: 32558564], HTL-22562 | ||||||
| HTL6641 |
|
11695 | compound 27 [Christopher et al., 2015], HTL'641, HTL-6641 | ||||||
| HTMT |
|
1273 | histamine-trifluoromethyl-toluidine, histamine-trifluoromethyltoluide, HTFMT | ||||||
| HTS01037 | 6736 | compound 1 [PMID: 19754198], HTS 01037 | |||||||
| HU-210 |
|
731 | HU 211, HU210 | ||||||
| HU-580 | 10599 | cannabidiolic acid methyl ester, CBDA-ME, HU580 | |||||||
| Hu7691 | 12722 | compound B5 [PMID: 34375113], Hu-7691 | |||||||
| [3H]HU-243 |
|
|
735 | ||||||
| huperzine A |
|
|
13727 | ||||||
| HWL-088 | 10668 | CS-0105155, HWL 088, HWL088, HY-130120 | |||||||
| HX 531 | 8079 | HX-531, HX531 | |||||||
| hydralazine |
|
|
7326 | Apresoline® | |||||
| hydrochlorothiazide |
|
|
4836 | Apo-hydro® | |||||
| hydrocodone |
|
7081 | Zohydro® | ||||||
| hydroflumethiazide |
|
|
7197 | Saluron® | |||||
| hydromorphone |
|
7082 | Dilaudid®, hydromorphone hydrochloride, Palladone® | ||||||
| 3-hydroxybenzylhydrazine | 5116 | ||||||||
| hydroxychloroquine |
|
|
|
7198 | Dolquine®, Plaquenil® | ||||
| hydroxycitronellal | 2468 | ||||||||
| 16α-hydroxyestrone |
|
12965 | 16α-OHE1, 16-hydroxyestrone, 16alpha-hydroxyestrone, 16alpha-OHE1 | ||||||
| hydroxyethylamine transition-state inhibitor 1 |
|
8688 | |||||||
| hydroxyflutamide |
|
2862 | |||||||
| 5-hydroxyindole |
|
2295 | |||||||
| 5-hydroxyindoleacetic acid |
|
|
11900 | ||||||
| 6-hydroxymelatonin | 1347 | 6-OH-melatonin, 6-OH-MLT | |||||||
| (hydroxymethylphenyl)agomelatine | 7922 | compound 21 [PMID: 18778943] | |||||||
| 3-hydroxy-3-methyl-6-phosphohexanoic acid | 3202 | ||||||||
| 4-hydroxyphenyl acetaldehyde | 6635 | p-hydroxyphenylacetaldehyde | |||||||
| 2-hydroxy-saclofen | 1068 | 2-hydroxy-s-(-)-saclofen, 2-hydroxysaclofen, 2-OH-saclofen | |||||||
| 7-hydroxystaurosporine |
|
7907 | KRX-0601, KRX0601, UCN 01, UCN-01 | ||||||
| 4-hydroxytamoxifen | 2817 | 4HT, 4-OHT, afimoxifene | |||||||
| hydroxyurea |
|
|
6822 | Droxia®, Hydrea®, hydroxycarbamide, Siklos®, SQ-1089, Xromi® | |||||
| hydroxyzine |
|
|
7199 | Atarax®, hydroxyzine hydrochloride, hydroxyzine pamoate, Vistaril® | |||||
| hyp 9 | 4101 | 2,4-(1-keto-hexyl) phloroglucinol | |||||||
| I | Back to top | ||||||||
| I-191 | 10268 | ||||||||
| I-287 | 12491 | ||||||||
| I-432 | 10733 | I432 | |||||||
| α3IA | 4094 | ||||||||
| α5IA | 4095 | ||||||||
| IAA-94 |
|
4217 | indanyloxyacetic acid 94, MK-473 | ||||||
| I-ABA | 458 | IABA, N6-(4-amino-3-iodobenzyl)adenosine | |||||||
| I-ABOPX | 446 | BW-A522 | |||||||
| IACS-52825 |
|
12909 | compound 22 [PMID: 37436942], IACS52825 | ||||||
| IACS-9439 | 11192 | compound 1 [PMID: 32787110] | |||||||
| IAG933 |
|
13367 | IAG-933, NVP-IAG933 | ||||||
| IAMA-6 | 13840 | ||||||||
| IBA |
|
13674 | |||||||
| ibafloxacin | 10819 | R-835, R835, S-25930, S25930 | |||||||
| ibandronic acid |
|
|
3059 | Bondronat®, Boniva®, ibandronate | |||||
| IBC 293 | 1597 | IBC-293, IBC293 | |||||||
| ibcasertib | 10475 | chiauranib (pseudo INN), CS-2164, CS2164, example 32 [US20100298358A1] | |||||||
| iberdomide |
|
|
9618 | CC-220, compound 6 [PMID: 28425720] | |||||
| I-BET151 |
|
7518 | GSK1210151A | ||||||
| I-BET282 |
|
12717 | compound 32 [PMID: 34387088] | ||||||
| ibezapolstat | 11030 | ACX-362E, ACX362E | |||||||
| ibipinabant | 9234 | BMS-646256, SLV319 | |||||||
| ibodutant | 2117 | MEN 15596 | |||||||
| I-BOP |
|
1938 | |||||||
| iboxamycin | 11790 | IBX, OPP-3 | |||||||
| I-BRD9 |
|
8397 | compound 45 [PMID 25856009], GSK602 | ||||||
| ibrutinib |
|
|
|
6912 | Imbruvica®, PCI-32765 | ||||
| ibudilast |
|
|
|
7399 | AV-411, KC-404, Ketas®, MN-166 | ||||
| ibuprofen |
|
|
2713 | Advil®, Brufen®, ibuprofen lysine, ibuprofen sodium, Motrin®, Nurofen®, U-18573 | |||||
| ibutamoren |
|
5867 | ibutamoren mesylate, L-163,191, MK-0677, MK677 | ||||||
| [35S]ibutamoren |
|
|
1097 | [35S]MK-0677 | |||||
| ibutilide |
|
7200 | Corvert®, U-70226E | ||||||
| ibuzatrelvir | 12897 | compound 9 [PMID: 38687966], Example 95 [US20220257563], N-(Methoxycarbonyl)-3-methyl-L-valyl-(4R)-N-{(1S)-1-cyano-2-[(3S)-2-oxopyrrolidin-3-yl]ethyl}-4-(trifluoromethyl)-L-prolinamide, PF-07817883, PF07817883 | |||||||
| I-C11 |
|
10374 | |||||||
| IC261 | 5985 | IC 261, IC-261 | |||||||
| IC-87114 |
|
|
9376 | IC87114 | |||||
| ICA-069673 | 14111 | compound 51 [PMID: 24900334], ICA069673 | |||||||
| ICA-105574 | 7656 | ICA 105574, ICA105574 | |||||||
| ICA-121431 |
|
14012 | ICA 121431, ICA121431 | ||||||
| ICA-27243 | 7667 | ICA 27243, ICA27243 | |||||||
| icanbelimod |
|
|
12098 | compound 2 [WO2015039587A1], S1p-receptor-agonist-1, YUN88562 | |||||
| iCARM1 | 13358 | WLZ3370 | |||||||
| IcatCXPZ-01 |
|
11179 | compound 8a [PMID: 30978322], XPZ-01 | ||||||
| I-CBP112 | 8236 | ||||||||
| ICeD-2 | 12238 | Inducer of cell death-2 | |||||||
| icenticaftor | 11547 | compound 33 [PMID: 34028270], QBW-251, QBW251 | |||||||
| icerguastat | 13263 | IFB-088, IFB088, Sephin-1, Sephin1 | |||||||
| ICI 118551 |
|
543 | ICI-118,551, ICI-118551 | ||||||
| ICI 169369 | 273 | ICI-169,369, ICI-169369 | |||||||
| ICI 192605 | 6072 | ICI 192,605 | |||||||
| ICI198615 | 3358 | ICI 198615, ICI-198615 | |||||||
| ICI-199441 | 11691 | ICI 199,441, ICI199441, ligand 1 [PMID: 8893842] | |||||||
| ICI 204448 | 1650 | ICI-204,448, ICI-204448 | |||||||
| ICI-89406 | 12581 | ICI 89,406, ICI 89406, ICI89406 | |||||||
| [3H]ICI-198615 |
|
|
3414 | [3H]-ICI198615, [3H]ICI-198,615, [3H]ICI198615 | |||||
| icilin |
|
2429 | |||||||
| iclaprim | 10820 | AR-100, AR100, Mersarex®, RO-48-2622, RO-482622 | |||||||
| iclepertin |
|
12110 | BI 425809, BI-425809, BI425809 | ||||||
| ICOA-13 |
|
11196 | |||||||
| icosapent |
|
7441 | AMR-101, icosapent ethyl, icosapentate, Vascepa®, Vazkepa® | ||||||
| icotinib |
|
7641 | BPI-2009H, Conmana® | ||||||
| icovamenib | 13456 | BMF-219, BMF219, Compound 10 [US20200223853A1] | |||||||
| [125I]ICYP |
|
|
562 | [125I]cyanopindolol, [125I]iodocyanopindolol | |||||
| idalopirdine | 8689 | compound 52, Lu AE58054, LU-AE58054 | |||||||
| idazoxan | 12575 | TR-01-XRR | |||||||
| idelalisib |
|
|
|
6741 | CAL-101/CAL101, GS-1101, Zydelig® | ||||
| IDRA-21 | 4219 | ||||||||
| idremcinal | 11813 | EM-574, EM574 | |||||||
| ifebemtinib | 12369 | BI-853520, BI853520, IN10018 | |||||||
| ifenprodil | 5472 | (±)-ifenprodil, RC 61-91 | |||||||
| ifetroban | 1987 | BMS 180,291, BMS 180291, BMS 180291-02, BMS180291 | |||||||
| ifidancitinib |
|
10638 | A-301, ATI-50002, ATI-502 | ||||||
| ifosfamide |
|
7201 | Holoxan®, Ifex®, MJF-9325, Z-4942 | ||||||
| iguratimod |
|
|
|
9736 | Careram®, Iremod, Kolbet®, T-614 | ||||
| IHMT-MST1-58 | 12168 | compound 19 [PMID: 36037148] | |||||||
| IIK7 | 1350 | ||||||||
| IK-862 |
|
8680 | compound 32, IK862 | ||||||
| IKK-beta inhibitor R-28 |
|
10134 | (R)-28, example 225 [US8372875B2] | ||||||
| IKK-2 inhibitor IV |
|
|
5986 | TPCA-1, TPCA1 | |||||
| IKs124 | 2591 | ||||||||
| Il-94 | 8132 | ||||||||
| ilacirnon | 11185 | CCX-140B, CCX140, CCX140-B, CCX140B, Example 5 [WO2009009740A1] | |||||||
| ilaprazole |
|
10512 | IY-81149, IY81149, Noltec® | ||||||
| ilginatinib |
|
7839 | NS-018, NS018 | ||||||
| illudalic acid | 8770 | ||||||||
| ilomastat |
|
7409 | CS 610, GM 6001 | ||||||
| iloperidone |
|
87 | Fanapt®, HP-873 | ||||||
| iloprost |
|
|
1895 | Aurlumyn®, Ventavis® | |||||
| [3H]iloprost |
|
|
1966 | [3H]-Iloprost, [3H]ciloprost, [3H]ventavis | |||||
| ilorasertib | 9914 | A-968660, ABT 348, ABT-348, ABT348 | |||||||
| ilunocitinib | 11670 | LY-3411067, LY3411067 | |||||||
| IM-12 | 8017 | ||||||||
| imaradenant |
|
|
11153 | AZD-4635, AZD4635 | |||||
| imatinib |
|
|
|
5687 | CGP 57148, Gleevec®, Glivec®, STI571 | ||||
| IMB-808 | 10034 | ||||||||
| imbutamine | 1249 | ||||||||
| imetit |
|
|
1250 | ||||||
| imexon | 8273 | Amplimexon® (proposed trade name), BM 06002, BM-06002 | |||||||
| imidapril |
|
6377 | imidapril hydrochloride | ||||||
| imidaprilat |
|
6378 | |||||||
| imidazole ketone erastin | 13930 | IKE | |||||||
| 12-Imidazolyl-1-dodecanol | 11354 | ||||||||
| imiglitazar | 2675 | TAK-559 | |||||||
| imiloxan | 3470 | GNF-Pf-2156, RS-21361 | |||||||
| imipenem |
|
10821 | MK-0787, MK0787, Primaxin® (imipenem + cilastatin), Recarbrio® (imipenem + cilastatin + relebactam). | ||||||
| imipramine |
|
|
357 | imidobenzyle, Tofranil® | |||||
| imiquimod |
|
|
|
5003 | Aldara®, R837, S-26308, Zyclara® | ||||
| imlunestrant | 12896 | Example 1B {WO2020014435A1], LY-3484356, LY3484356 | |||||||
| immepip |
|
|
1251 | ||||||
| immethridine |
|
4024 | |||||||
| imnopitant | 10462 | compound 20 [PMID: 16332435] | |||||||
| imocitrelvir | 13223 | AG-7404, AG7404, compound 1 [PMID: 23499651] | |||||||
| IMP-1002 |
|
|
11850 | ||||||
| impentamine | 1252 | PDSP1_000940, PDSP2_000926 | |||||||
| improgan | 1276 | ||||||||
| impromidine |
|
1226 | SK&F-92676-A3 | ||||||
| IMR-1 | 11362 | ||||||||
| I3MT-3 |
|
10210 | compound 3 [PMID: 28079151] | ||||||
| IN-3 | 5584 | analogue 24 [PMID: 11551758], IN 3 | |||||||
| inamrinone |
|
7202 | amrinone lactate, Inocor®, WIN-40680 | ||||||
| inavolisib |
|
|
9636 | GDC-0077, GDC0077, Itovebi®, RG6114, Ro7113755 | |||||
| INCB086550 | 11528 | ||||||||
| INCB13739 | 12121 | Compound 39 [PMID: 35537608] | |||||||
| INCB3284 |
|
9045 | compound 13 [PMID: 24900329], INCB 3284 | ||||||
| INCB3344 | 777 | INCB 3344 | |||||||
| INCB3619 | 8679 | compound 52, INCB-3619 | |||||||
| INCB-38579 | 8982 | ||||||||
| INCB8761 |
|
9032 | compound 17 [PMID: 24900280], INCB-8761, PF-4136309, PF4136309 | ||||||
| incensole acetate | 4220 | ||||||||
| indacaterol |
|
|
7455 | Arcapta Neohaler®, Onbrez®, QAB-149, QAB149 | |||||
| indanidine | 512 | Sgd 101/75 | |||||||
| indapamide |
|
7203 | Hypen SR®, Lozol® | ||||||
| indinavir |
|
|
12684 | Crixivan®, L 735,524, L-735524, MK-639, MK639 | |||||
| indiplon | 4221 | ||||||||
| indirubin derivative E804 | 5988 | compound 2 [PMID: 21632247], indirubin E804 | |||||||
| indirubin-3'-monoxime | 5989 | indirubin-3'-oxime | |||||||
| indisulam |
|
7046 | E7070 | ||||||
| indocyanine green | 4844 | cardio-green | |||||||
| indole-3-carbinol |
|
|
10047 | 3-hydroxymethylindole, 3-indolemethanol, 3-indolylcarbinol, I3C | |||||
| 2-(indolin-1yl)-melatonin | 7782 | ||||||||
| indolmycin |
|
|
11021 | PA 155 A, PA-155-A, PA-155A, TAK-083 | |||||
| indolo[3,2-b]carbazole | 10046 | ICZ, ICZ-carbazole | |||||||
| indomethacin |
|
|
|
1909 | Indocid®, Indocin® | ||||
| indoramin |
|
501 | Baratol®, Doralese®, indoramine, WY-21901 | ||||||
| indoximod | 8226 | 1-methyl-D-tryptophan, 1MT, D-1MT | |||||||
| INE963 |
|
11929 | MMV1582617, NVP-INE963 | ||||||
| inecalcitol | 7747 | TX522 | |||||||
| infigratinib |
|
|
7877 | BGJ 398, BGJ-398, BGJ398, NVP-BGJ398, Truseltiq® | |||||
| inhibitor A [PMID: 12482429] | 8847 | ||||||||
| inhibitor CB3 | 11229 | ||||||||
| inhibitor 1 [Colombo et al., 2012] | 8624 | ||||||||
| inhibitor E18 | 11228 | ||||||||
| inhibitor E4 | 11227 | ||||||||
| inhibitor M9 [PMID: 38236416] |
|
13113 | |||||||
| inhibitor 19 [PMID: 21476495] | 8621 | ||||||||
| inhibitor 32 [PMID: 29620892] |
|
9898 | |||||||
| iniparib |
|
8360 | BSI-201, SAR240550 | ||||||
| inixaciclib | 12078 | compound 442 [WO2019161224A1], example 50 [WO2019161224A1] | |||||||
| inlexisertib | 13209 | example 53 [US11530206] | |||||||
| inobrodib |
|
13063 | CCS-1477, CCS1477 | ||||||
| INS48823 | 1746 | INS 48823, INS-48823 | |||||||
| INS49266 | 1769 | ||||||||
| INSCoV-614 (1B) | 12415 | INSCoV-614 (1B) [WO2021219089] | |||||||
| INT-767 | 10198 | 6α-ethyl-3α,7α,23-trihydroxy-24-nor-5β-cholan-23-sulfate, INT767 | |||||||
| intepirdine | 9444 | RVT-101, SB-742457 | |||||||
| iodipamide |
|
|
|
7400 | adipiodone meglumine, iodipamic acid, radio-cholografin | ||||
| 2-iodoacetamide | 6271 | iodoacetamide | |||||||
| 6-iodoamiloride | 14117 | compound 94 [PMID: 37260417] | |||||||
| iodoaminopotentidine | 1232 | I-APT | |||||||
| [125I]iodoaminopotentidine |
|
|
1230 | [125I]-iodoaminopotentidine, [125I]APT | |||||
| [123I]iodobenzovesamicol |
|
|
4762 | [123I]-IBVM, [123I]-iodobenzovesamicol | |||||
| iodocyanopindolol | 7583 | ||||||||
| 2-iodo-[125I]5MCA-NAT |
|
|
5396 | 2-iodo-[125I]-5MCA-NAT | |||||
| 2-iodo-melatonin |
|
1343 | 2-I-MLT, 2-iodomelatonin | ||||||
| 6-iodo-nordihydrocapsaicin | 4110 | ||||||||
| iodophenpropit | 1266 | ||||||||
| [125I]iodophenpropit |
|
|
3960 | ||||||
| 2-(3-iodophenyl)histamine | 1196 | ||||||||
| iodoproxyfan | 1253 | ||||||||
| [123I]iodoproxyfan |
|
|
1264 | [125I]-iodoproxyfan | |||||
| 5'-iodoresiniferatoxin | 4109 | I-RTX | |||||||
| 3-iodotyrosine | 5117 | ||||||||
| [125I]iodovinyl-TBZ |
|
|
4764 | [125I]-iodovinyl-TBZ , [125I]-iodovinyltetrabenazine | |||||
| (S)-5-iodowillardiine |
|
4071 | |||||||
| ioflupane |
|
7653 | 123I-FP-CIT, 123I-ioflupane, DaTSCAN® | ||||||
| IOX1 |
|
8230 | |||||||
| IOX2 | 8229 | compound 6 | |||||||
| IPA-3 | 8940 | IPA3 | |||||||
| ipatasertib |
|
7887 | GDC-0068 | ||||||
| iperoxo |
|
6937 | |||||||
| [3H]iperoxo |
|
|
12486 | ||||||
| Ip5I | 4225 | diinosine-5',5"-pentaphosphate | |||||||
| ipivivint | 11187 | example 18 [WO2013166396A2] | |||||||
| IPN60090 | 12712 | Compound 27 [PMID: 33118821], IACS-6274, IACS6274, IPN-60090 | |||||||
| ipragliflozin |
|
9394 | ASP-1941, ASP1941, Suglat® | ||||||
| ipratropium |
|
|
325 | Atrovent®, Ipraxa® | |||||
| ipsapirone | 42 | ||||||||
| iptacopan |
|
|
|
10710 | compound 41 [PMID: 32073845], Fabhalta®, LNP-023, LNP023 | ||||
| IQM-97423 | 876 | IQM-97,423 | |||||||
| IRAK-1/4 inhibitor |
|
5990 | |||||||
| IRAK4 inhibitor 4b [PMID: 18474425] |
|
|
8080 | ||||||
| IRAK4 inhibitor rac-45 [PMID: 18501603] |
|
8081 | |||||||
| IRAK3 PROTAC 23 | 11785 | compound 23 [PMID: 32803978] | |||||||
| iralukast | 5861 | ||||||||
| irbesartan |
|
589 | Aprovel®, Avapro®, Karvea®, SR 47436 | ||||||
| [3H]irbesartan |
|
|
6908 | ||||||
| irinotecan |
|
|
6823 | (+)-irinotecan, biotecan, Campto®, Camptosar®, CPT-11, irinotecan hydrochloride, Onivyde® | |||||
| IRL752 | 11098 | IRL 752, IRL-752 | |||||||
| irpagratinib | 12869 | ABSK-011, ABSK011, example 790 [US10968220] | |||||||
| Irresistin-16 | 10973 | IRS-16, IRS16 | |||||||
| iruplinalkib |
|
11877 | example 9 [US10053477B2], Qixinke®, WX-0593, WX0593 | ||||||
| IS1 | 8517 | ||||||||
| IS20 | 8518 | ||||||||
| ISA-2011B | 8444 | ||||||||
| ISAM-140 | 11223 | compound 22b [PMID: 26824742], ISAM140 | |||||||
| I-SAP | 3332 | ||||||||
| isatin sulfonamide 34 [PMID: 11384246] | 6515 | ||||||||
| ischemin | 7506 | MS120 | |||||||
| isepamicin |
|
12136 | HAPA-B, Sch 21420 | ||||||
| ISM5939 | 13936 | ISM-5939 | |||||||
| ISO-1 |
|
9984 | IN1228 | ||||||
| isoamyl-agomelatine | 7781 | ||||||||
| isobutylmethylxanthine |
|
388 | IBMX, methylisobutylxanthine | ||||||
| 3-isobutyl-8-pyrrolidinoxanthine | 447 | IPDX | |||||||
| isocarbacyclin | 1934 | 9-O-methanoprostaglandin I | |||||||
| isocarboxazid |
|
7204 | Marplan® | ||||||
| isoetarine |
|
|
7205 | Bronkometer®, Bronkosol®, WIN-3406 | |||||
| isoferulic acid |
|
7980 | |||||||
| isoflurane |
|
2505 | Forane® | ||||||
| isogranulatimide | 5991 | IZA, pyridone 6 | |||||||
| isoguvacine | 4226 | ||||||||
| isoniazid |
|
|
12761 | isonicotinic acid hydrazide, Nydrazid®, Rimifon® | |||||
| isonipecotic acid |
|
4227 | |||||||
| isoprenaline |
|
536 | isoproterenol, Isuprel®, Medihaler-Iso® | ||||||
| isopulegol | 2462 | coolact P | |||||||
| isoquinoline 17 [PMID: 30122040] | 10071 | ||||||||
| isosorbide dinitrate |
|
7051 | Dilatrate-Sr®, ISDN, Isordil® | ||||||
| isosorbide mononitrate |
|
7052 | AHR-4698, BM-22-145, Imdur®, IS-5-MN, ISMN, Monosorb® | ||||||
| isothiourea-1a | 2900 | IT1a | |||||||
| isothiourea-1t |
|
|
2899 | IT1t | |||||
| isotonitazene | 12955 | ||||||||
| isotretinoin |
|
7600 | 13-cis retinoic acid | ||||||
| isovelleral | 6287 | (+)-isovelleral, iso-velleral | |||||||
| isoxazole azepine compound 3 |
|
7527 | |||||||
| (+)-isradipine | 2513 | (+)-PN 200-110, (+-)-isradipine, PN200-110 | |||||||
| isradipine |
|
4488 | (±)-isradipine, DynaCirc®, PN-200-110, Prescal® | ||||||
| [3H](+)-isradipine |
|
|
2733 | (+)-[3H]isradipine, (+)-[3H]O5-methyl O3-propan-2-yl 4-(2,1,3-benzoxadiazol-7-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, 3H-(+)-PN 200-110 | |||||
| israpafant | 1857 | Y 24180, Y-24180 | |||||||
| istisociclib | 13068 | compound 28 [PMID: 37967851], KB-0742, KB0742 | |||||||
| istradefylline |
|
|
5608 | KW-6002, KW6002, Nourianz® | |||||
| isuzinaxib | 11985 | APX-115, APX115, EWHA-18278 (free base) | |||||||
| itacitinib |
|
|
8364 | Examlpe 294 [WO2011112662], INCB-039110 | |||||
| itacnosertib | 10632 | example 11 [WO2014151871A9], TP-0184, TP0184 | |||||||
| IT-62-B | 11032 | ||||||||
| ITH15004 | 11826 | compound 6 [PMID: 33560845], ITH-15004 | |||||||
| ITK7 | 13123 | ||||||||
| itraconazole |
|
11426 | ITZ, R-51211, R51211, Sporanox® | ||||||
| itriglumide | 909 | CR-2945 | |||||||
| IU1 |
|
8880 | |||||||
| ivabradine |
|
|
2357 | Corlanor®, Corlentor®, Procoralan®, S-16257 | |||||
| ivacaftor |
|
|
4342 | compound 48 [PMID: 25441013], Kalydeco®, VX-770 | |||||
| ivarmacitinib |
|
|
11878 | example 34 [WO2013091539A1], SHR-0302, SHR0302 | |||||
| ivermectin |
|
2373 | Heartgard®, ivermectin B1a, MK-933, Sklice®, Soolantra® | ||||||
| ivosidenib |
|
|
9217 | AG-120, AG120, Tibsovo® | |||||
| IWY357 |
|
13524 | IWY-357 | ||||||
| ixabepilone |
|
|
6824 | azaepothilone B, BMS 247550-1, BMS-247550, BMS-247550-01, Ixempra® | |||||
| ixazomib |
|
|
8450 | MLN-2238, MLN2238, Ninlaro® | |||||
| izencitinib |
|
10458 | example 1 [WO2016191524A1], JNJ-8398, JNJ8398, TD-1473, TD1473 | ||||||
| izorlisib |
|
7743 | CH 5132799, CH-5132799, CH5132799, MEN-1611, MEN1611 | ||||||
| J | Back to top | ||||||||
| J-104118 | 3070 | J 104118 | |||||||
| J-104123 | 3110 | ||||||||
| J-113397 | 1691 | J-113,397, J113397 | |||||||
| J-2156 |
|
10115 | J 2156, J2156 | ||||||
| J27644 | 12804 | compound 15 [PMID: 37463500], J-27644 | |||||||
| J30-8 | 10429 | ||||||||
| JAK3 inhibitor 32 |
|
10156 | compound 32 [PMID: 30423248] | ||||||
| JAK3 inhibitor 34 |
|
|
10157 | compound 34 [PMID: 30423248] | |||||
| JAK inhibitor 20a |
|
10147 | |||||||
| JAK inhibitor 17b |
|
10148 | |||||||
| JAK inhibitor I |
|
5992 | CMP-6 | ||||||
| JAK3 inhibitor II | 5993 | WHI-P154 | |||||||
| JAK3 inhibitor IV | 5994 | ZM-39923, ZM39923 | |||||||
| JAK3 inhibitor VI | 5995 | ||||||||
| janagliflozin |
|
13950 | Huiyoujing®, XZP-5695, XZP5695 | ||||||
| JB 98064 | 1262 | JB-98064 | |||||||
| [3H]JB-93182 |
|
|
908 | ||||||
| JBI-589 |
|
12481 | compound 13 [WO2022034616A1], JBI589 | ||||||
| JBJ-04-125-02 |
|
12982 | |||||||
| JBJ-09-063 | 12001 | ||||||||
| JCF 109 | 1564 | JCF-109, JCF109 | |||||||
| JD5037 | 10690 | JD-5037 | |||||||
| JDTic |
|
7362 | compound 10 [PMID: 11495579] | ||||||
| Jedi1 |
|
10249 | |||||||
| Jedi2 | 10111 | Jedi 2, Jedi-2 | |||||||
| JEDI-852 |
|
13332 | |||||||
| JFD00064 | 9668 | ||||||||
| JH112 |
|
11403 | compound 2 [PMID: 32669442] | ||||||
| JH-LPH-33 |
|
14115 | |||||||
| JH-VIII-49 | 9886 | compound 19 [Hatcher et al., 2018] | |||||||
| JH-XI-10-02 | 9887 | ||||||||
| JH-XII-03-02 | 12908 | compound 6 [PMID: 37591317] | |||||||
| JJKK 048 | 9481 | JJKK-048 | |||||||
| JK1 | 11458 | (S)-JK0621-D008 | |||||||
| JL-2-39 | 12731 | JL-02-0111 | |||||||
| JMS-053 | 12480 | compound 13 [PMID: 33766767] | |||||||
| JMS-17-2 | 10390 | JMS 17-2 | |||||||
| JMV3008 | 5872 | ||||||||
| JN122 | 13126 | inhibitor (-)60 [PMID: 38062557], JN-122 | |||||||
| JND3229 | 12986 | JND-3229 | |||||||
| JNJ-10191584 |
|
1277 | compound 12, JNJ 10191584, VUF 6002, VUF6002 | ||||||
| JNJ-10311795 |
|
6563 | |||||||
| JNJ-10397049 | 1701 | compound 9 [PMID: 15261275], JNJ 10397049, JNJ10397049 | |||||||
| JNJ16259685 | 1385 | JNJ-16259685 | |||||||
| JNJ-16567083 | 7442 | ||||||||
| JNJ1661010 | 5206 | JNJ 1661010, JNJ-1661010 | |||||||
| JNJ-17156516 | 877 | JNJ 17156516 | |||||||
| JNJ17203212 | 4228 | compound 41 [PMID: 15771431], JNJ-17203212 | |||||||
| JNJ-18038683 | 8432 | JNJ 18038683 | |||||||
| JNJ1930942 | 3966 | JNJ-1930942 | |||||||
| JNJ-26070109 | 6665 | JNJ26070109 | |||||||
| JNJ-27141491 |
|
10586 | JNJ27141491 | ||||||
| JNJ-28312141 | 5689 | JNJ 28312141 | |||||||
| JNJ303 | 11477 | JNJ 303, JNJ-303 | |||||||
| JNJ-37822681 | 14136 | JNJ37822681 | |||||||
| JNJ-38431055 | 5727 | APD597, JNJ38431055 | |||||||
| JNJ-39319202 | 9437 | compound 7a [PMID: 19731961] | |||||||
| JNJ-39758979 |
|
8984 | JNJ 39758979, JNJ39758979 | ||||||
| JNJ-40068782 | 6330 | ||||||||
| JNJ40355003 | 9050 | compound 23 [PMID: 24900385], JNJ-40355003 | |||||||
| JNJ-40411813 |
|
8946 | ADX-71149, ADX71149, JNJ 40411813, JNJ40411813 | ||||||
| JNJ-42153605 | 6317 | JNJ 42153605 | |||||||
| JNJ-42165279 | 9012 | Example 1 [WO2011139951 A1], JNJ42165279 | |||||||
| JNJ-42226314 | 10661 | JNJ 42226314, JNJ42226314 | |||||||
| JNJ-46281222 | 8947 | ||||||||
| JNJ-47965567 |
|
7538 | JNJ-479655, JNJ47965567 | ||||||
| JNJ-5207787 | 3504 | JNJ5207787 | |||||||
| JNJ-5207852 | 1256 | JNJ 5207852 | |||||||
| JNJ-54717793 | 12508 | JNJ54717793 | |||||||
| JNJ-6204 | 13345 | compound 21 [PMID: 38628796], JNJ-78386204 | |||||||
| JNJ-63533054 |
|
8766 | compound 7c [PMID: 26396690], JNJ63533054 | ||||||
| JNJ-63576253 | 12709 | compound 5 [PMID: 33470111], JNJ63576253, TRC-253, TRC253 | |||||||
| JNJ-64264681 | 12239 | compound 13 [PMID: 36314537], JNJ64264681 | |||||||
| JNJ-65234637 |
|
12414 | compound 58 [PMID: 36793435], JNJ65234637, OICR-12694, OICR12694 | ||||||
| JNJ-6640 | 13971 | ||||||||
| JNJ-67569762 |
|
11751 | compound 12 [PMID: 34553934], JNJ67569762 | ||||||
| JNJ-67856633 | 11507 | example 158 [WO2018119036], JNJ67856633 | |||||||
| JNJ-67869386 | 11473 | ||||||||
| JNJ-7706621 |
|
5932 | aurora kinase/Cdk inhibitor, JNJ7706621 | ||||||
| JNJ 7777120 | 1278 | JNJ-7777120 | |||||||
| JNJ-799760 |
|
11472 | |||||||
| JNJ-9676 |
|
13827 | JNJ9676 | ||||||
| [11C]JNJ-16567083 |
|
|
3418 | [11C]-JNJ-16567083 | |||||
| [3H]JNJ-40068782 |
|
|
6331 | ||||||
| [3H]JNJ 7777120 |
|
|
1279 | [3H]-JNJ7777120 | |||||
| JNK-IN-8 | 8058 | ||||||||
| JNK inhibitor IX |
|
5996 | AC1LG8KT, BAS 01816608, TCS JNK 5a | ||||||
| JNK inhibitor 9l |
|
9377 | JNK-9L | ||||||
| JNK inhibitor, negative control | 5999 | N1-Methyl-1,9-pyrazoloanthrone | |||||||
| JNK inhibitor V | 5997 | AS-601245, AS601245, SAPK inhibitor V | |||||||
| JNK inhibitor VIII | 5998 | aminopyridine deriv. 2 | |||||||
| JP1302 | 3930 | JP-1302, MMV006172 | |||||||
| JPC-3210 |
|
10395 | MMV646, MMV892646 | ||||||
| JPIII | 14180 | ||||||||
| (+)-JQ1 | 7511 | ||||||||
| JQEZ5 | 9332 | EZ-005, JQ5, JQE5 | |||||||
| JR14a |
|
|
10595 | ||||||
| JSF-3285 |
|
13585 | |||||||
| JT010 |
|
10275 | JT-010, molecule 1 [PMID: 26630251] | ||||||
| JTC-801 | 1692 | ||||||||
| JTE-013 | 2917 | JTE 013, JTE013, pyrazolopyridine analog | |||||||
| JTV-803 | 11364 | JTV803 | |||||||
| Jun12682 |
|
13481 | Jun-12682 | ||||||
| Jun10541R | 12864 | ||||||||
| JWH015 | 5558 | JWH 015, JWH-015 | |||||||
| JWH-018 | 9706 | AM-678, JWH 018, JWH018 | |||||||
| JWH-133 | 747 | JWH 133, JWH133 | |||||||
| JX21108 |
|
11808 | |||||||
| JX35 |
|
11945 | |||||||
| JYL1421 | 4230 | JYL-1421, SC-0030, SC0030 | |||||||
| JZL184 | 5207 | JZL 184, JZL-184 | |||||||
| JZL195 | 8606 | JZL 195, JZL-195 | |||||||
| K | Back to top | ||||||||
| K02288 |
|
13266 | hit 3 [PMID: 38177100] | ||||||
| K11777 |
|
11515 | K-777, K777, N-methyl-Pip-F-hF-VSφ, NMePip-Phe-hPhe-VSPh, S-001, SLV213 | ||||||
| K185 | 1359 | K 185, K-185 | |||||||
| K-604 | 10150 | compound 2 [PMID: 30433781], K604 | |||||||
| K-80003 |
|
10347 | |||||||
| K-8794 |
|
9651 | |||||||
| KA1010 |
|
9663 | |||||||
| KA2507 | 12269 | ||||||||
| [3H]kainate |
|
|
4085 | ||||||
| KB-130015 | 7659 | KB 130015, KB130015 | |||||||
| KB-141 |
|
2638 | KB 141, KB141 | ||||||
| KB-5246 | 11046 | KB5246, LS-99630 | |||||||
| KB-74935 |
|
7370 | KB 74935 | ||||||
| kb-NB142-70 | 9369 | kb NB 142-70 | |||||||
| KBP-7018 |
|
9691 | compound 3 [Huang et al., 2017] | ||||||
| KB-R7943 | 4232 | ||||||||
| KC-12615 | 6507 | ||||||||
| KC-130 | 12845 | compound 8 [PMID: 37220641], KC130 | |||||||
| KC-180-2 | 12176 | ||||||||
| KCL-286 | 12792 | BHBA-001, BHBA001, C-286, C286, compound 10 [PMID: 30792038], KCL286 | |||||||
| KDM5 inhibitor N71 | 10141 | ||||||||
| KDOAM25 |
|
8576 | KDOAM-25 | ||||||
| KDU691 |
|
11863 | |||||||
| KDX1381 |
|
13949 | compound 19 [PMID: 40493957], KDX-1381 | ||||||
| kelatorphan |
|
11656 | |||||||
| kenpaullone | 6000 | 9-bromopaullone | |||||||
| ketamine |
|
4233 | Ketalar, ketamine HCl | ||||||
| ketanserin |
|
|
88 | ketaserin, R41 468 | |||||
| [3H]ketanserin |
|
|
|
197 | |||||
| ketoconazole |
|
2568 | Nizoral®, R-41400 | ||||||
| 5-ketodihydromevinolin | 3013 | compound 69 [PMID: 3656359] | |||||||
| α-ketoisocaproate |
|
4656 | α-ketoisocaproic acid, 2-oxoisohexanoate, alpha-oxoisohexanoate | ||||||
| ketoprofen |
|
|
4795 | Actron®, Orudis® | |||||
| ketorolac |
|
|
6661 | Acular®, Toradol® | |||||
| ketotifen |
|
7206 | HC-20511, Zaditor® | ||||||
| keverprazan |
|
12653 | Example 1 [WO2016119505A1], Keprason® | ||||||
| KF24345 | 4734 | KF 24345, KF-24345 | |||||||
| KF26777 | 5618 | KF 26777 | |||||||
| KF 17837S | 428 | ||||||||
| KGP94 | 6533 | ||||||||
| KH064 |
|
6703 | sPLA2-2A inhibitor, compound 2b | ||||||
| KH7 |
|
10216 | KH 7, KH-7 | ||||||
| KH-CB19 |
|
8055 | KH CB19 | ||||||
| Ki16425 | 2907 | ||||||||
| Ki-20227 | 5690 | Ki 20227, Ki20227 | |||||||
| KI-CDK9d-32 | 13866 | ||||||||
| KIN-8741 | 13940 | compound 9 [PMID: 40459881] | |||||||
| kinase inhibitor 2 [PMID: 30199702] | 10081 | ||||||||
| KL044 |
|
8609 | KL-044 | ||||||
| KM11060 | 4234 | KM 11060, KM-11060 | |||||||
| KML110 | 8702 | ||||||||
| KML29 |
|
9482 | |||||||
| KMN-159 | 12521 | compound 8 [PMID: 30964292] | |||||||
| KMUP-1 | 8896 | KMUP 1 | |||||||
| KN-62 | 6001 | KN-62 (non-isomeric) | |||||||
| KN62 | 4235 | KN 62, KN-62, KN62 (S isomer) | |||||||
| KN-93 |
|
6002 | |||||||
| Ko 143 |
|
10007 | Ko-143, Ko143 | ||||||
| KO-947 | 9976 | KO947 | |||||||
| KOS1326 | 1446 | 4'' deoxy EM-A enolether | |||||||
| KPR-5714 | 10698 | KPR 5714, KPR5714 | |||||||
| K-Ras(G12C) inhibitor 12 | 8020 | ||||||||
| K-Ras(G12C) inhibitor 6 | 8021 | ||||||||
| K-Ras(G12C) inhibitor 9 | 8022 | ||||||||
| KS0365 | 12552 | ||||||||
| KS 176 | 10006 | KS-176, KS176 | |||||||
| KSP-1007 | 13547 | ||||||||
| KSQ-4279 |
|
11964 | example 143 [WO2020132269A1], KSQ4279, RO-7623066, RO7623066, USP1-IN-1 | ||||||
| KT-109 |
|
10245 | KT109 | ||||||
| KT-333 | 13369 | ||||||||
| KT-474 |
|
12892 | Compound A [WO2022174269A1], KT474 | ||||||
| KT 5720 | 337 | KT5720 | |||||||
| KT 5823 | 338 | ||||||||
| KU0058948 |
|
13125 | compound 4 [PMID: 19354255], KU-0058948 | ||||||
| KU-0060648 | 8011 | KU 0060648 | |||||||
| KU-0063794 | 9360 | KU-63794, KU0063794 | |||||||
| KU124 | 14097 | ||||||||
| KU-55933 |
|
5928 | ATM kinase inhibitor, KU55933 | ||||||
| KU-60019 | 8041 | ||||||||
| KV-37 | 10262 | ||||||||
| KW-2449 | 5691 | KW 2449 | |||||||
| KW-3635 | 1977 | KW3635 | |||||||
| KX2-361 | 10004 | KX-02, KX2 361, KX2361 | |||||||
| KYH1872 | 13031 | KYH-1872, PROTAC 26 [PMID: 37567174] | |||||||
| KYT-0353 |
|
9347 | COMPOUND-JP [US20160279103], JPH-203, JPH203, KYT0353 | ||||||
| L | Back to top | ||||||||
| L023103 | 2194 | L 023103, L-023103 | |||||||
| L-054,522 |
|
2046 | L 054522, L054522 | ||||||
| L-152,804 | 1565 | L-152804, L152804 | |||||||
| L-162,313 | 3936 | L 162313, L-162313 | |||||||
| L-163,101 | 6895 | L-163101 | |||||||
| L-165041 |
|
2691 | L165041 | ||||||
| L-165461 | 2690 | L 165461, L165461 | |||||||
| L-168,049 | 3505 | L 168049, L-168049, L168049 | |||||||
| L-365260 | 879 | (R)-L 365260, L 365260, L365260 | |||||||
| L-366,509 | 2242 | L-366509 | |||||||
| L-367,773 | 2246 | L 367773, L-367773 | |||||||
| L-367,938 | 2247 | ||||||||
| L-368,228 | 2248 | ||||||||
| L-368,899 | 2249 | L 368,899 , L 368899, L-368899 | |||||||
| L-368,930 | 2250 | ||||||||
| L-369,020 | 2251 | ||||||||
| L-371,257 | 2252 | L 371257, L-371257 | |||||||
| L-372662 | 2253 | L012255, L372662 | |||||||
| L-45 |
|
|
11703 | L-Moses | |||||
| L-644,698 | 1879 | L-644698, L644698 | |||||||
| L655708 | 4238 | L 655708, L-655,708 | |||||||
| L659989 | 3426 | L-659,989, L-659989 | |||||||
| L689560 | 4239 | compound 35 (Leeson et al., 1992), L-689,560, L-689560 | |||||||
| L690330 |
|
5208 | L 690330, L-690,330, L-690330 | ||||||
| L-692,429 | 5868 | L 692429, L-692429, MK 0751 | |||||||
| L-694,247 | 15 | L-694247 | |||||||
| L701324 | 4240 | compund 13 [PMID: 8182696], L-701,324, L-701324 | |||||||
| L-701677 | 11042 | L-701,677 | |||||||
| L-703,606 | 2104 | L-703606 | |||||||
| L-708365 | 10980 | L 708,365, L 708365, L-708,365 | |||||||
| L-731120 | 3069 | L 731120 | |||||||
| L-731128 | 3068 | L 731128 | |||||||
| L-732,138 | 9461 | L-732138, L732138 | |||||||
| L-733,060 | 13432 | L-733060 | |||||||
| L-735021 | 3117 | L 735021 | |||||||
| L735821 | 2592 | C13853 | |||||||
| L-736380 | 880 | L 736380, L736380 | |||||||
| L-739,750 |
|
8030 | L 739750 | ||||||
| L-740093 | 881 | L 740093, L-740,093, L740093 | |||||||
| L-741,626 | 177 | L 741626, L741626 | |||||||
| L741742 | 3302 | L 741742, L-741,742, L-741742 | |||||||
| L742791 | 3467 | compound 3 [PMID:9873496], L 742791, L-742,791 | |||||||
| L745870 |
|
3303 | L 745870, L-745,870 | ||||||
| L-748328 | 3463 | L-748,328 | |||||||
| L-748337 | 3932 | L 748337, L-748,337, L748337 | |||||||
| L-750,667 | 978 | L-750667, L750667, Lopac-L-133 | |||||||
| L 755507 | 3931 | L-755,507, L755507 | |||||||
| L-759,633 | 748 | L-759633, L759633 | |||||||
| L-759,656 | 749 | L-759656, L759656 | |||||||
| L760735 |
|
10349 | |||||||
| L-764406 | 2696 | L 764406, L764406 | |||||||
| L-765314 | 506 | L-765,314 | |||||||
| L-772,405 | 16 | L 772405, L-772405 | |||||||
| L-775,606 | 114 | L-775606 | |||||||
| L779450 | 9129 | compound 1 [PMID:18346893], compound 2 [PMID: 16260133], L-779,450, L-779450 | |||||||
| L-779,976 | 2050 | L 779976, L-779976 | |||||||
| L-783483 |
|
2688 | F3MethylAA | ||||||
| L-796449 | 2689 | L 796449, L-796,449, L796449 | |||||||
| L-796,778 | 2073 | L-796778, L796778 | |||||||
| L-797,591 | 2015 | L797591 | |||||||
| L-798,106 |
|
1941 | L-798106, L798106 | ||||||
| L-803,087 | 2082 | L803087 | |||||||
| L-817,818 | 2016 | L 817818, L-817818, L817818 | |||||||
| L-826266 | 5844 | compound 10b [PMID: 11504634], LS-193774, MF266-3 | |||||||
| L838417 | 4241 | L 838,417, L-838417 | |||||||
| L873724 | 7860 | L-873724 | |||||||
| L-888,291 | 1880 | L-883,595 | |||||||
| L-888,607 | 1907 | L-888607 | |||||||
| L902688 | 3357 | 8-aza-1-decarboxy-11-deoxy-16,16-difluoro-16-phenyl-ω-tetranor-1-(5-tetrazolo) PGE1 | |||||||
| L-97-1 | 389 | ||||||||
| [125I]L703,606 |
|
|
3471 | [125I]-L703,606, [125I]L703606 | |||||
| [125I]L750667 |
|
|
3295 | [125I]-L750667 | |||||
| [3H]L158809 |
|
|
3939 | [3H]-L158809, [3H]L-158,809 | |||||
| [3H]L365260 |
|
|
3477 | [3H]L-365,260 | |||||
| [3H]L655708 |
|
|
4363 | ||||||
| [3H]L689560 |
|
|
4086 | ||||||
| [3H]L748337 |
|
|
13196 | ||||||
| labetalol |
|
7207 | AH-5158A, Normodyne®, SCH-15719W, Trandate® | ||||||
| labuxtinib |
|
12870 | Compound 1 [WO2022109595], example F91 [WO2013033070], THB-335, THB335 | ||||||
| lacidipine |
|
11740 | GR-43659X, GR43659X, GX 1048, GX-1048, GX1048, Lacipil®, Molap®, Motens® | ||||||
| lacosamide |
|
|
7472 | ADD 234037, erlosamide, harkeroside, SPM 927, Vimpat® | |||||
| lactisole | 13900 | (±)-lactisole, 2-PMP-PA | |||||||
| laduviglusib |
|
8014 | CHIR 99021, CHIR-99021, CHIR99021, CT-99021, CT99021 | ||||||
| lamivudine |
|
|
12673 | BCH-189, BCH189, Epivir®, GR-109714X | |||||
| lamotrigine |
|
|
2622 | Lamictal® | |||||
| lanabecestat | 7789 | AZD 3293, AZD-3293, LY3314814 | |||||||
| landiolol |
|
13192 | ONO-1101, ONO1101, Rapiblyk® | ||||||
| lanepitant | 3510 | LY 303870, LY-303870, LY303870 | |||||||
| lanicemine | 7681 | AR-R15896AR, ARL 15896, AZD-6765, AZD6765 | |||||||
| lanifibranor |
|
12737 | compound 5 [PMID: 29446942], IVA-337, IVA337 | ||||||
| laniquidar | 11789 | ||||||||
| lanraplenib |
|
|
9764 | compound 39 [PMID: 32292557], Ex.-2, US9290505, example 2 [US9290505], GS-9876, GS9876 | |||||
| lansoprazole |
|
7208 | A-65006, AG-1749, Prevacid® | ||||||
| L-AP4 |
|
1410 | L-2-amino-4-phosphonobutiric acid, S-2-amino-4-phosphonobutyrate | ||||||
| lapatinib |
|
|
5692 | FMM, GW 572016, GW572016, Tykerb®, Tyverb® | |||||
| laquinimod | 7639 | ABR-215062, TV-5600 | |||||||
| larixyl acetate | 10295 | ||||||||
| laropiprant | 3356 | MK-0524, MK0524 | |||||||
| laroprovstat | 13419 | AZD-0780, AZD0780, example 458B [US11248001B2] | |||||||
| larotrectinib |
|
8909 | (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, example 14 [US8865698 B2], LOXO-101, Vitrakvi® | ||||||
| lartesertib |
|
12319 | compound 1M [PMID: 34662544], M-4076, M4076 | ||||||
| larubrilstat | 13745 | Compound 2-1 [US20240083873A1] | |||||||
| LAS38096 | 5617 | ||||||||
| lascufloxacin | 10823 | KRP-AM1977 | |||||||
| lasmiditan |
|
|
3928 | COL-144, LY573144, Reyvow® | |||||
| lasmotinib | 13746 | PHI-101, PHI101 | |||||||
| lasofoxifene |
|
7542 | lasofoxifene tartrate | ||||||
| [3H]L-aspartic acid |
|
|
|
4534 | [3H]-L-aspartate, [3H]-L-aspartic acid | ||||
| LASSBio-1524 |
|
11066 | |||||||
| LASW1393 |
|
|
10527 | compound 34 [PMID: 31609613], LASW-1393 | |||||
| latamoxef |
|
12031 | 6059-S, LY127935, moxalactam, Moxam® | ||||||
| latanoprostene bunod |
|
9635 | BOL-303259-X, NCX-116, PF-3187207, Vyzulta® | ||||||
| latanoprost (free acid form) |
|
|
1960 | latanoprost-free acid, PHXA85 | |||||
| latanoprost (isopropyl ester) |
|
1961 | PHXA-41, XA-41, Xalatan® | ||||||
| LAU159 | 12404 | compound 16 [PMID: 23472852], LAU 159, LAU-159 | |||||||
| LAU463 | 12405 | compound 8n [PMID: 29481759] | |||||||
| lazabemide | 6640 | ||||||||
| lazertinib |
|
10136 | Compound 73 [WO2016060443A2], GNS-1480, GNS1480, Lazcluze®, Leclaza®, YH-25448, YH25448 | ||||||
| lazucirnon |
|
10653 | AKST-4290, AKST4290, ALK-4290, ALK4290, Example 11 [WO2012045803A1] | ||||||
| LB-100 | 11105 | LB100 | |||||||
| LB42708 | 8029 | ||||||||
| LB42908 | 8028 | LB 42908 | |||||||
| LBA | 12536 | ||||||||
| L-β-BA | 4625 | L-β-threo-benzyl-aspartate | |||||||
| LBM-415 | 11043 | LBM415, NVP LBM-415, NVP-PDF-713, PDF-713, VIC-104959 | |||||||
| LC52-0332 | 12980 | ||||||||
| L-CCG-I | 1368 | 3,4-Cyclopropylglutamate, CCPG, L-2-(Carboxypropyl)glycine | |||||||
| L-(cis)-diltiazem |
|
2349 | |||||||
| Lck inhibitor |
|
6003 | |||||||
| LCL161 |
|
7912 | LCL-161, NVP-LCL161 | ||||||
| L-cycloserine |
|
9488 | levcycloserine, Seromycin® | ||||||
| L-cysteine sulphinic acid |
|
5447 | L-CSA, cysteine sulfinic acid, L-cysteine sulfinic acid | ||||||
| LDC1267 |
|
8247 | |||||||
| LDC7559 | 13324 | LDC-7559 | |||||||
| LDN-214117 | 8481 | compound 10 [PMID: 25101911], LDN214117 | |||||||
| LDN-91946 | 8661 | compound 7 | |||||||
| LE135 | 3433 | LE 135 | |||||||
| ledaborbactam | 13082 | VNRX-5236 | |||||||
| ledipasvir |
|
11271 | GS-5885, GS5885, Harvoni® (ledipasvir + sofosbuvir) | ||||||
| lefamulin |
|
|
10824 | BC-3781, BC3781, compound 7 [PMID: 24874438], Xenleta® | |||||
| leflunomide |
|
|
6825 | Arabloc®, Arava®, HWA 486, HWA-486, lefunamide, SU-101 | |||||
| LEI105 | 10246 | LEI-105 | |||||||
| LEI-401 | 11054 | LEI401 | |||||||
| LEI-515 | 13445 | compound ±73 [Jiang et al., 2024], LEI515 | |||||||
| LEI-800 |
|
13475 | |||||||
| lemborexant |
|
|
9302 | compound 34 [PMID: 25953512], Dayvigo®, E-2006, E2006 | |||||
| lenabasum |
|
|
9772 | ajulemic acid, CPL-7075, CPL7075, CT-3, IP-751, IP751 | |||||
| lenacapavir |
|
|
11446 | GS-6207, GS6207, Sunlenca®, Yeztugo® (twice-yearly injection) | |||||
| lenalidomide |
|
|
7331 | CC-5013, CDC-501, Revlimid® | |||||
| lenapenem | 10825 | BO-2727, BO2727, L-739,428, L-739428 | |||||||
| leniolisib |
|
|
|
9424 | CDZ-173, CDZ173, Example 67 [WO2012004299], Joenja® | ||||
| lenrispodun |
|
12003 | compound 3 [PMID: 26789933], ITI-214, ITI214 | ||||||
| lenvatinib |
|
|
7426 | E 7080, ER-203492-00, Kisplyx®, Lenvima® | |||||
| LEO 134310 |
|
11901 | LEO-134310, LEO134310 | ||||||
| LEO 239652 |
|
|
12725 | compound 40 [PMID: 33054196], LEO-239652, LEO239652 | |||||
| LEO 29102 |
|
12724 | compound 20 [PMID: 24984230], LEO-29102, LEO29102 | ||||||
| L-161,982 (EP4A) |
|
1952 | EP4A, L-161982, L161982 | ||||||
| lepzacitinib |
|
12871 | example 117 [WO2019090158A1] | ||||||
| lergotrile | 270 | LY 79907 | |||||||
| leritrelvir |
|
13480 | RAY-1216, RAY1216 | ||||||
| lerociclib | 10313 | example GG [US9464092B2], G1T-38, G1T38 | |||||||
| lerzeparib | 12885 | compound 25-B [US20220144850A1] | |||||||
| lesinurad |
|
|
7673 | RDEA-594, RDEA594, Zurampic® | |||||
| lesogaberan | 7705 | AZD-3355, AZD3355 | |||||||
| lestaurtinib |
|
|
5672 | CEP-701, KT-5555, SP924 | |||||
| letrozole |
|
5209 | Femara® | ||||||
| leucettine L41 | 8167 | ||||||||
| leucomethylthioninium |
|
9274 | leuco-methylthioninium, LMTM, LMTX, TRx-0237, TRx0237 | ||||||
| levallorphan |
|
7209 | Lorfan® | ||||||
| levamisole |
|
7210 | Ergamisol®, R-12564 | ||||||
| levetimide | 358 | (-)-benzetimide, l-benzetimide | |||||||
| levetiracetam |
|
|
6826 | Keppra®, Spritam®, UCB L059, UCB-L 059 | |||||
| levobetaxolol |
|
8035 | (-)-betaxolol, (S)-betaxolol, AL-1577A, Betaxon® | ||||||
| levobupivacaine |
|
|
7211 | Chirocaine®, levobupivacaine hydrochloride | |||||
| levocabastine |
|
1586 | levocobastine, Livostin® | ||||||
| levofloxacin |
|
|
10911 | DR-3355, Levaquin®, Quinsair® | |||||
| levoketoconazole |
|
|
11829 | (2S,4R)-ketoconazole, COR-003, COR003, Recorlev® | |||||
| levomepromazine |
|
7603 | Levoprome®, methotrimeprazine, Nosinan®, Nozinan®, RP-7044, SK&F-5116 | ||||||
| levomethadyl acetate |
|
7212 | LAAM, MK-790, Orlaam® | ||||||
| levomilnacipran |
|
7435 | F-2695, Fetzima® | ||||||
| levonadifloxacin | 10757 | (S)-(-)-nadifloxacin, WCK 771, WCK-771, WCK771 | |||||||
| levonantradol | 11818 | (-)-nantradol, CP 50,556-1 | |||||||
| levonorgestrel |
|
|
2881 | l-norgestrel, Norplant® | |||||
| levopropicillin | 10826 | BRL-284, BRL284, L-Propicillin, P-248, P248 | |||||||
| levorphanol |
|
7595 | (-) 3-hydroxy-N-methylmorphinan, Levo-Dromoran®, levorphanol hydrochloride, levorphanol tartrate | ||||||
| levosalbutamol |
|
|
|
9816 | (-)-albuterol, (-)-salbutamol, (R)-salbutamol, levalbuterol, Xopenex® | ||||
| lexacalcitol |
|
2775 | 1α,25-(OH),-20-epi-22-oxa-24,26,27-trishomovitamin D, KH1060 | ||||||
| LF22 | 14053 | ||||||||
| LFM-A13 |
|
9262 | α-cyano-beta-hydroxy-β-methyl-N-(2, 5-dibromophenyl)propenamide, alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide | ||||||
| LG100268 |
|
2808 | LG-100268 | ||||||
| LG100754 |
|
2814 | LG 100754, LG754 | ||||||
| LG190178 | 2787 | LG-190178 | |||||||
| LGB321 |
|
9367 | |||||||
| LGK974 |
|
11167 | LGK-974, WNT-974, WNT974 | ||||||
| 77-LH-28-1 |
|
3271 | |||||||
| L6H21 |
|
9027 | |||||||
| LHVS |
|
9298 | morpholinurea-leucine-homophenylalanine-vinylsulfone-phenyl, morpholinurea-leucine-homophenylalaninevinyl phenyl sulfone | ||||||
| liarozole | 5210 | ||||||||
| licogliflozin | 10654 | example 62 [WO2011048112A1], LIK-066, LIK066 | |||||||
| lidocaine |
|
|
2623 | Xylocaine® | |||||
| lidorestat |
|
7411 | IDD-000676-01, IDD-676 | ||||||
| lifibrol | 5885 | K 12148, K12.148, U-83860 | |||||||
| lifirafenib |
|
8958 | BGB-283, compound 2.2b | ||||||
| lifitegrast |
|
|
7533 | compound 1g [PMID: 24900456], SAR 1118, SAR-1118, SAR-1118-023, Xiidra® | |||||
| ligritinib | 14072 | AB-801, AB801, compound 37 [PMID: 40407274], example 26 [WO2024006726] | |||||||
| limertinib |
|
14195 | ASK-120067 | ||||||
| LIMKi3 |
|
9839 | BMS 5, BMS-5, LIMKi 3 | ||||||
| linagliptin |
|
|
6318 | BI-1356, Tradjenta® | |||||
| linaprazan |
|
13761 | AZD-0865, AZD0865, compound 2 [PMID: 19467868] | ||||||
| linezolid |
|
|
10827 | PNU-100766, PNU100766, U-100,766, U-100766, ZLD, Zyvox® | |||||
| linifanib | 5657 | ABT 869, ABT-869 | |||||||
| linopirdine |
|
2599 | |||||||
| linperlisib | 10466 | compound 10 [US20160244432], PI3Kdelta-IN-2, YY-20394, YY20394 | |||||||
| linrodostat |
|
9707 | BMS-986205, BMS986205, Compound 2 [PMID: 29531094], Example 19 [US20160137652A1] | ||||||
| linsitinib | 7423 | ASP-7487, OSI 906, OSI-906, OSI906 | |||||||
| lintitript |
|
890 | SR-27897, SR27897 | ||||||
| linzagolix |
|
12283 | KLH-2109, KLH2109, OBE-2109, OBE2109, Yselty® | ||||||
| lirafugratinib |
|
12370 | example 343 [WO2020231990A1], RLY-4008, RLY4008 | ||||||
| lirodegimod | 13231 | ||||||||
| lirucitinib | 13747 | compound T4-B [US20220106319A1], GGW-101, GGW101 | |||||||
| lisaftoclax | 13108 | APG-2575, APG2575 | |||||||
| lisdexamfetamine |
|
7213 | NRP104, Vyvanse® | ||||||
| lisinopril |
|
|
6360 | Prinivil®, Zestril® | |||||
| lisinopril-tryptophan |
|
7893 | compound 5b [PMID: 16784843], LisW | ||||||
| lisofylline |
|
9225 | (R)-lisophylline, CT-1501R | ||||||
| lisuride |
|
|
43 | (+)-lisuride, Dopergin®, lysuride | |||||
| LIT-001 | 10444 | compound 57 [PMID: 30199637], LIT001 | |||||||
| LIT-927 |
|
10075 | compound 57 [PMID: 30106292] | ||||||
| lithocholylcholine | 326 | ||||||||
| lixivaptan | 2238 | VPA-985, VPA985, WAY-VPA-985 | |||||||
| LIZA-7 | 12199 | 5'-azido-5'-deoxy-thymidine | |||||||
| LJ-4517 |
|
12150 | compound 2 [PMID: 35977382], LJ4517 | ||||||
| LK 204-545 | 544 | LK-204545 | |||||||
| LK-980 | 13567 | LK980 | |||||||
| LLC0424 | 13380 | compound 10l [PMID: 38687638], LLC-0424 | |||||||
| L-leucinol |
|
4751 | |||||||
| LL-K9-3 | 12107 | ||||||||
| LLL12 | 12267 | LLL-12 | |||||||
| LLP019 | 13910 | ||||||||
| LLY-283 |
|
9527 | |||||||
| LLY-507 |
|
8239 | |||||||
| LM10 |
|
9016 | LM-10 | ||||||
| LM11A-31 | 13391 | LM-11A-31 | |||||||
| L-βγ-meATP |
|
4236 | βγ-methylene-adenosine 5'-triphosphate | ||||||
| L-α-methyldopa |
|
5217 | Aldomet®, Aldoril®, Dopamet®, L-α-Methyl-3,4-dihydroxyphenylalanine | ||||||
| L-NAME | 5213 | ||||||||
| L-NNA |
|
8759 | compound 2 [PMID: 9667974], nitroarginine | ||||||
| lodoxamide |
|
|
|
9743 | Alomide® | ||||
| lofentanil | 13539 | R-32792 | |||||||
| lofepramine |
|
7551 | Gamanil ®, Lomont ®, WHR-2908A | ||||||
| lofexidine |
|
9868 | BritLofex®, Lucemyra® | ||||||
| lolamicin | 13410 | ||||||||
| lomedeucitinib |
|
13210 | BMS-986322, BMS986322, example 252 [US20210253554] | ||||||
| lomefloxacin |
|
12407 | Maxaquin®, NY-198, SC-47111, Uniquin® | ||||||
| lomitapide |
|
7439 | AEGR-733, BMS-201038, Juxtapid®, Lojuxta® | ||||||
| lomonitinib | 13750 | ZE46-0134 | |||||||
| lomustine |
|
7214 | CCNU, CeeNU® | ||||||
| lonafarnib |
|
|
8024 | SCH 66336, SCH-66336, SCH66336, Zokinvy® | |||||
| londamocitinib |
|
11716 | AZD-4604, AZD4604, example 35 [WO2018134213A1], Jak1-IN-7 | ||||||
| lonidamine | 12601 | AF 1890, AF-1890, Diclondazolic acid | |||||||
| lonodelestat |
|
11275 | cyclo[Ala-Ser-Ile-Pro-Pro-Gln-Lys-Tyr-D-Pro-Pro-Nle(Bu)-Glu-Thr], POL-6014, POL6014 | ||||||
| loperamide |
|
7215 | Fortasec®, Imodium®, R-18553 | ||||||
| lopinavir |
|
|
11504 | A-157378-0, A-1573780, ABT-378, ABT378, Aluviran®, Kaletra® (LPV+RTV) | |||||
| loracarbef |
|
12247 | KT-3777, Lorabid®, LY163892 | ||||||
| loratadine |
|
|
7216 | Claritin®, SCH-29851 | |||||
| lorazepam |
|
5884 | Ativan®, Orfidal® | ||||||
| lorcaserin |
|
|
2941 | APD-356, Belviq® | |||||
| lorecivivint |
|
9620 | adavivint (deprecated INN), SM0-4690, SM04690 | ||||||
| loreclezole |
|
5466 | R 72063 | ||||||
| lorglumide | 891 | CR-1409 | |||||||
| lorlatinib |
|
|
7476 | (10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile, Lorbrena®, Lorviqua®, PF-06463922, PF06463922 | |||||
| lormetazepam |
|
7553 | chlorotemazepam, Dormagen®, methyllorazepam, WY-4082 | ||||||
| lorpucitinib | 10631 | compound 2 [PMID: 32134643], example 1 [WO2018112379A1], JNJ-64251330, JNJ64251330 | |||||||
| lorundrostat | 13883 | MT-4129, MT4129 | |||||||
| losartan |
|
|
590 | allisartan, Cozaar®, DuP 753, MK-954 | |||||
| [3H]losartan |
|
|
|
3941 | [3H]-losartan | ||||
| losmapimod |
|
7835 | GS856553, GW856553 | ||||||
| lotiglipron | 14092 | example 10 [US10676465], PF-07081532, PF07081532 | |||||||
| loxapine |
|
205 | Adasuve®, CL-62362, CL-71563, Loxapac®, Loxitane®, SUM-3170 | ||||||
| loxiglumide | 892 | CR-1505 | |||||||
| 5-LOX inhibitor 2m [PMID: 30199704] |
|
10079 | |||||||
| loxoribine |
|
5018 | 7-allyl-7,8-dihydro-8-oxo-guanosine | ||||||
| LP-12 | 8434 | compound 21 [PMID 17649988] | |||||||
| LP-211 | 8436 | compound 25 [PMID 18800769] | |||||||
| LP-360924 | 8773 | ||||||||
| LP-403812 | 4576 | LP 403812, LP403812 | |||||||
| LP-44 | 8435 | compound 5 [PMID 17649988] | |||||||
| LP-471756 | 8774 | ||||||||
| LP533401 | 11405 | LP-533401 | |||||||
| LP99 |
|
8572 | compound 60 [PMID: 25864491] | ||||||
| LPC-233 |
|
13824 | |||||||
| L-phenylalaninol |
|
4752 | |||||||
| Lpi-1 | 13958 | compound II-b-2 [US20200172521A1] | |||||||
| LPS2336 | 14093 | LPS-2336 | |||||||
| LRE1 |
|
10023 | RU-0204277 | ||||||
| LRK-4189 | 14199 | Compound 319 [WO2024233846], LRK4189 | |||||||
| LRRK2-IN-1 |
|
9396 | LRRK2-IN1, LRRK2IN1 | ||||||
| LRRK2 inhibitor 6 [PMID: 40353293] | 13902 | ||||||||
| LS-192629 | 2192 | LS 192629, LS192629 | |||||||
| (+)-LSD | 154 | ||||||||
| [125I]LSD |
|
|
261 | [125I]lysergamid, [125I]lysergic acid diethylamide, [125I]lysergide, [125I]N,N-diethyllysergamide | |||||
| [3H]LSD |
|
|
219 | [3H]lysergic acid diethylamide, [3H]lysergide, [3H]N,N-diethyllysergamide | |||||
| LSN2424100 | 9121 | ||||||||
| LSN2463359 |
|
6394 | LSN 2463359 | ||||||
| LSN2814617 | 6395 | ||||||||
| LSN3318839 |
|
11927 | |||||||
| LSP1-2111 | 6739 | ||||||||
| LSP4-2022 | 6706 | ||||||||
| LSZ102 |
|
12145 | compound 10 [PMID: 29562737], LSZ-102 | ||||||
| [3H]LTB4 |
|
|
3413 | ||||||
| [3H]LTC4 |
|
|
6195 | ||||||
| [3H]LTD4 |
|
|
3412 | [3H]-LTD4 | |||||
| [3H]LTE4 |
|
|
|
5863 | |||||
| LTGO-33 | 13163 | ||||||||
| LTK-14 | 8385 | 14-methoxy IG (isogarcinol), LTK14 | |||||||
| L-trans-2,4-pyrolidine dicarboxylate | 4516 | ||||||||
| LuAE51090 | 5435 | compound 6 [PMID: 25590655], Lu AE51090 | |||||||
| Lu AF21934 | 6237 | ||||||||
| Lu AF64196 | 13576 | ||||||||
| LU32-176B | 4756 | ||||||||
| lubiprostone |
|
4242 | Amitiza®, SPI-0211 | ||||||
| lucitanib |
|
7649 | E-3810 amine, E3810 | ||||||
| LUF5831 | 376 | LUF 5831, LUF-5831 | |||||||
| LUF5962 | 9813 | LUF 5962, LUF-5962 | |||||||
| LUF5981 | 5607 | LUF 5981, LUF-5981 | |||||||
| LUF6000 | 9446 | ||||||||
| LUF6096 | 9447 | ||||||||
| LUF6200 | 7847 | ||||||||
| LUF7244 | 10447 | compound 7i [PMID: 26519929] | |||||||
| LUF7602 | 10351 | compound 17b [PMID: 30869893], LUF-7602 | |||||||
| lufotrelvir |
|
11249 | PF-07304814, PF07304814 | ||||||
| luliconazole |
|
7366 | Lulicon®, Luzu®, NND-502, PR-2699 | ||||||
| lumacaftor |
|
|
7481 | VRT-826809, VX-809, VX809 | |||||
| lumateperone |
|
9099 | Caplyta®, ITI-007 | ||||||
| lumefantrine |
|
|
9969 | benflumetol, Coartem® (lumefantrine + artemether) | |||||
| luminespib |
|
9261 | AUY922, NVP-AUY922 | ||||||
| lumiracoxib |
|
|
|
2897 | Prexige® | ||||
| lunacalcipol | 11382 | CTA-018, CTA018, CTA018/MT2832 | |||||||
| lunbotinib | 13212 | compound 17 [WO2020168939] | |||||||
| lunresertib |
|
13211 | (Rac)-RP-6306 | ||||||
| lurasidone |
|
7461 | Latuda®, SM-13496 | ||||||
| lurbinectedin |
|
10681 | PM 01183, PM-01183, PM01183, Zepzelca® | ||||||
| lusutrombopag |
|
10032 | Mulpleta®, S-888711, S888711 | ||||||
| LUT014 | 11568 | LUT-014 | |||||||
| luvixasertib | 11664 | CFI-402257, CFI402257, compound 24 [PMID: 27437075] | |||||||
| luvometinib |
|
13495 | Example 6 [WO2014169843] | ||||||
| luxeptinib | 11671 | CG-026806, CG-806, CG026806, CG806, example 7 [US9758508B2] | |||||||
| luzindole | 1363 | 2-benzyl-N-acetyltryptamine, N0774 | |||||||
| L-valinol |
|
4750 | |||||||
| LW106 |
|
9940 | |||||||
| LW-213 | 11177 | compound 18c [PMID: 28987604], LW213 | |||||||
| LWY713 | 13116 | compound 13ba [PMID: 38007910], LWY-713 | |||||||
| LX2931 |
|
9851 | LX3305 | ||||||
| [3H]LXA4 |
|
|
3411 | [3H]-LXA4 | |||||
| LY063518 | 178 | LY 063518, LY-063518 | |||||||
| LY108742 | 179 | LY 108742, LY-108742 | |||||||
| LY134046 |
|
6631 | LY 134046, LY-134046 | ||||||
| LY 156735 | 1351 | LY-156,735, LY-156735, LY156735, TIK-301 | |||||||
| LY 165,163 | 18 | LY-165163, PAPP | |||||||
| LY2033298 |
|
3262 | LY 2033298, LY-2033298 | ||||||
| LY2077855 | 8989 | example 66a [WO2009117444] | |||||||
| LY2087101 | 3992 | LY 2087101, LY-2087101 | |||||||
| LY2090314 | 7958 | LY-2090314 | |||||||
| LY2109761 | 8075 | LY 2109761, LY-2109761 | |||||||
| LY2119620 |
|
6938 | LY 2119620, LY-2119620 | ||||||
| LY215840 | 180 | LY 215840, LY-215,840, LY-215840 | |||||||
| LY233053 | 4243 | LY 233053, LY-233053 | |||||||
| LY233536 | 4244 | LY 233536, LY-233536 | |||||||
| LY2365109 | 4712 | LY 2365109, LY-2365109 | |||||||
| LY2389575 | 9694 | LY 2389575, LY-2389575 | |||||||
| LY255283 |
|
3351 | CGS 23356, LY 255283, LY-255283 | ||||||
| LY2584702 | 8248 | LY 2584702, LY-2584702 | |||||||
| LY262691 | 3509 | LY-262691, LY-288513 | |||||||
| LY2811376 |
|
6936 | LY 2811376, LY-2811376 | ||||||
| LY2828360 | 12751 | compound 26 [PMID: 23795771], LY-2828360 | |||||||
| LY2874455 |
|
8104 | LY-2874455 | ||||||
| LY-288513 | 902 | LY-288512 | |||||||
| LY2886721 |
|
6475 | LY 2886721, LY-2886721 | ||||||
| LY293284 | 19 | LY 293284, LY-293,284, LY-293284 | |||||||
| LY 294002 |
|
6004 | LY-294002, LY294002, SF 1101 | ||||||
| LY2940094 | 9462 | BTRX-246040, compound 36 [PMID: 24678969], LY-2940094 | |||||||
| LY3009120 |
|
8943 | LY-3009120 | ||||||
| LY301875 | 6909 | LY 301875, LY-301875 | |||||||
| LY3023703 |
|
|
12211 | compound 9 [PMID: 25260492] | |||||
| LY303336 | 6910 | LY 303336, LY-303336 | |||||||
| LY 303511 |
|
6005 | LY-303511, LY303511 | ||||||
| LY307452 | 3350 | LY 307452, LY-307,452, LY-307452 | |||||||
| LY310762 | 13560 | LY-310,762, LY-310762 | |||||||
| LY314228 | 181 | LY 314228, LY-314228 | |||||||
| LY3154885 | 11938 | compound 5 [PMID: 35175768], LY-3154885 | |||||||
| LY320135 | 742 | LY 320135, LY-320135 | |||||||
| LY3202626 |
|
11557 | compound 22 [PMID: 34081466], LY-3202626 | ||||||
| LY320954 | 182 | LY-320954, PDSP1_001629, PDSP2_001613 | |||||||
| LY334362 | 231 | LY 334362, LY-334362 | |||||||
| LY334370 | 20 | LY 334370, LY-334,370, LY-334370 | |||||||
| LY339434 | 4246 | LY 339434, LY-339434 | |||||||
| LY3405105 | 11356 | ||||||||
| LY3410738 | 12340 | example 2 [US11001596B2], LY-3410738 | |||||||
| LY341495 |
|
1378 | LY 341495, LY-341,495, LY-341495 | ||||||
| LY344864 | 21 | LY 344864, LY-344864 | |||||||
| LY3499446 | 12066 | compound B [WO2022002018A1], LY-3499446 | |||||||
| LY3509754 |
|
13164 | |||||||
| LY3522348 |
|
13033 | compound 23 [PMID: 37992274], LY-3522348 | ||||||
| LY3556050 | 13682 | Example 47 [WO2014184275A1], Example XLVII [WO2014184275A1], LY-3556050, mazisotine | |||||||
| LY367385 | 1379 | (+)-2-methyl-4-carboxyphenylglycine, LY 367385, LY-367385 | |||||||
| LY379268 | 1394 | LY 379268, LY-379,268, LY-379268 | |||||||
| LY382884 | 4247 | LY 382884, LY-382884 | |||||||
| LY389795 | 3349 | LY 389795, LY-389795 | |||||||
| LY392098 | 4248 | LY 392098, LY-392098 | |||||||
| LY395756 | 11614 | (±)-LY 395756, LY 395756, LY-395756, LY39 | |||||||
| LY404187 | 4249 | LY 404187, LY-404,187, LY-404187 | |||||||
| LY456066 | 3347 | LY 456066, LY-456066 | |||||||
| LY456236 | 3346 | LY 456236, LY-456236 | |||||||
| LY-465608 | 2659 | LY 465608, LY465608 | |||||||
| LY466195 | 4250 | LY 466195, LY-466195 | |||||||
| LY503430 | 4251 | LY 503430, LY-503,430, LY-503430 | |||||||
| LY-510929 | 2657 | LY 510929, LY510929 | |||||||
| LY-518674 | 2658 | LY 518674, LY518674 | |||||||
| LY53857 | 183 | LY 53857, LY-53,857 | |||||||
| LY593093 | 5441 | LY 593093, LY-593093 | |||||||
| LY86057 | 184 | LY 86057, LY-86057 | |||||||
| LY97241 | 2606 | LY 97241, LY-97241 | |||||||
| [3H]LY278584 |
|
|
4087 | ||||||
| [3H]LY334370 |
|
|
151 | LY334370 | |||||
| [3H]LY341495 |
|
|
|
1399 | [3H]α-9'-xantheylmethyl-2-(carboxycyclopropyl)glycine | ||||
| lymecycline |
|
10912 | N-Lysinomethyltetracycline, tetracycline-L Methylene-Lysine, Tetralysal® | ||||||
| LYS006 |
|
|
11205 | LYS-006 | |||||
| Lys01 |
|
|
10320 | compound 3a [PMID: 30344903] | |||||
| Lysergide |
|
17 | LSD, (+)-lysergic acid diethylamide, N,N-diethyllysergamide | ||||||
| lysergol | 123 | lysergole | |||||||
| Lys-thiol | 8667 | ||||||||
| Lys[Z(NO2)]-Lys[Z(NO2)] | 4499 | ||||||||
| Lys[Z(NO2)]-Pro | 4498 | ||||||||
| M | Back to top | ||||||||
| 3M-002 |
|
|
9270 | CL-075, CL075 | |||||
| M084 | 10288 | M-084 | |||||||
| M14659 | 11047 | GR 63116, GR-63116, M 14659, M-14659 | |||||||
| M5717 |
|
9737 | DDD107498, DDD498, MMV121 | ||||||
| M826 | 8654 | compound 4sx | |||||||
| M8891 | 12714 | M-8891 | |||||||
| M201-A | 13228 | ||||||||
| MA-2029 | 4036 | MA2029 | |||||||
| macimorelin |
|
|
9745 | AEZS-130, AEZS130, Aib-DTrp-DgTrp-CHO, EP-1572, EP1572, UMV1843 | |||||
| macitentan |
|
|
7352 | ACT-064992, Opsumit®, Opsynvi® (combination of macitentan + tadalafil) | |||||
| macozinone | 13055 | PBTZ169 | |||||||
| Macquarimicin A | 10978 | ||||||||
| mafenide |
|
|
12697 | homosulfanilamide, Sulfamylon® | |||||
| MAGLi 432 |
|
12123 | |||||||
| MAK683 |
|
10515 | EED inhibitor-1, example 2 [WO2016103155A1], MAK-683 | ||||||
| makomakinol | 13178 | ||||||||
| maleic acid |
|
9630 | |||||||
| α-mangostin derivative 4e |
|
13470 | compound 4e [PMID: 32115956] | ||||||
| manidipine |
|
11739 | Artedil®, CV-4093, CV4093, Franidipine®, Iperten® | ||||||
| MAP4 | 1414 | ||||||||
| MAP855 | 11940 | compound 30 [PMID: 35195996], MAP-855 | |||||||
| MAPK13-IN-1 |
|
|
11096 | compound 61 [WO2014015056A2] | |||||
| mapracorat |
|
9654 | BOL-303242-X, ZK-245186, ZK245186 | ||||||
| maprotiline |
|
2402 | maprotiline hydrochloride | ||||||
| maralixibat |
|
11708 | compound 74 [PMID: 16134951], Livmarli®, lopixibat (deleted INN), LUM 001, LUM-001, LUM001 | ||||||
| maraviroc |
|
|
806 | Celsentri®, Selzentry®, UK 427857, UK-427,857 | |||||
| [3H]maraviroc |
|
|
803 | [3H]UK 427,857, [3H]UK-427,857 | |||||
| marbofloxacin | 13670 | ||||||||
| marbostat-100 |
|
9891 | compound 5a [PMID: 29589441] | ||||||
| mardepodect |
|
9617 | MP-10, PF-02545920, PF-2545920, PF2545920, pyrazole 9 [PMID: 19630403] | ||||||
| maresin 1 |
|
12056 | 7R,14S-dihydroxydocosa-4Z,8E,10E,12Z,16Z,19Z-hexaenoic acid, 7R-Maresin 1, MaR1, Maresin-1 | ||||||
| maresin 2 |
|
12055 | 13R,14S-diHDHA, 13R,14S-dihydroxy-docosahexaenoic acid, MaR2, maresin-2 | ||||||
| maribavir |
|
12049 | 1263W94, benzimidavir, Camvia®, G1263, GW-1263, Livtencity® | ||||||
| maridomycin | 10828 | LS-87912, Maridomycin III | |||||||
| marimastat |
|
5220 | BB-2516, BB2516 | ||||||
| martinostat | 11118 | compound 6 [PMID: 25203558] | |||||||
| masitinib |
|
|
5656 | AB-1010, AB1010, Masican® (proposed trade name) | |||||
| 3-MATIDA | 3396 | α-amino-5-carboxy-3-methyl-2-thiopheneacetic acid | |||||||
| MAT-POS-b3e365b9-1 |
|
12226 | |||||||
| MAT-POS-932d1078-3 |
|
11764 | |||||||
| MAT-POS-e194df51-1 |
|
13003 | |||||||
| mavacamten |
|
|
11265 | Camzyos®, MYK-461, MYK461 | |||||
| mavatrep | 12755 | compound 4 [PMID: 25850459], JNJ-39439335, JNJ39439335 | |||||||
| mavelertinib | 9765 | compound 21 [PMID: 28287730], PF-06747775, PF06747775 | |||||||
| mavoglurant |
|
7586 | AFQ-056 | ||||||
| mavorixafor |
|
|
|
8580 | AMD 070, AMD-070, AMD-11070, AMD11070, compound 2 [PMID: 20297846], X4P-001, X4P-001-IO, X4P-001-LD, Xolremdi® | ||||
| maxacalcitol |
|
2784 | 22-oxa-1α,25(OH)2D3, 22-oxacalcitriol, OCT | ||||||
| mazindol |
|
4797 | Mazanor®, Sanorex® | ||||||
| [3H]mazindol |
|
|
4591 | [3H]-mazindol | |||||
| M8-B | 6376 | ||||||||
| MB07344 | 12769 | MB-07344 | |||||||
| MB-28767 | 1913 | Dpt-prostaglandin E1, M&B 28767, M&B-28767 | |||||||
| MB-3 | 8393 | α-methylene-γ-butyrolactone 3 | |||||||
| MBX-2982 |
|
10166 | MBX2982 | ||||||
| MC-02479 | 11033 | MC 02479, MC02479, RWJ 54428, RWJ-54428 | |||||||
| MC12 | 13985 | ||||||||
| MC1568 | 11121 | compound 2f [PMID: 15857140], HDAC-IN-1, MC-1568 | |||||||
| MC2050 |
|
10671 | |||||||
| 5MCA-NAT |
|
3393 | 5-methoxy-carbonylamino-N-acetyltryptamine | ||||||
| MCC950 |
|
|
8228 | CP-456,773, CP-456773, CRID3, MCC-950 | |||||
| MCCG | 1439 | MCCG-I | |||||||
| m-chlorophenylpiperazine | 142 | m-CPP, 1-(m-chlorophenyl)piperazine, meta chlorophenyl piperazine | |||||||
| MCL0129 | 1340 | MCL-0129, TCMDC-134847 | |||||||
| McN-A-343 | 290 | ||||||||
| MCOPPB | 12419 | compound 1 [PMID: 19125610] | |||||||
| (+)-MCPG |
|
1373 | alpha-Mcpg, alpha-methyl-4-carboxyphenylglycine, alpha-methyl-cpgly | ||||||
| MCUF-42 | 14106 | compound 24 [PMID: 38894878] | |||||||
| MCU-i11 | 14133 | ||||||||
| MCU-i4 | 14134 | ||||||||
| 2MD |
|
2776 | 2-methylene-19-nor-(20S)-1 alpha,25-dihydroxy-vitamin D3, VDZ | ||||||
| MD-222 | 11725 | compound 13 [PMID: 30525597], MD222 | |||||||
| MD-224 | 12914 | MD224 | |||||||
| α-MDG |
|
4640 | α-methyl-D-glucose pyranoside, methyl α-D-glucopyranoside | ||||||
| MDG 548 |
|
9888 | compound 1 [PMID: 22582973], MDG-548, MDG548 | ||||||
| MDIP | 6218 | ||||||||
| MDL-28170 | 10745 | calpain inhibitor III, MDL28170, N-benzyloxycarbonyl-L-valyl-L-phenylalaninal, N-CBZ-Val-Phe-al | |||||||
| MDL-800 | 10123 | ||||||||
| [3H]MDL105519 |
|
|
4088 | ||||||
| MDL12330A (parent) | 11357 | MDL 12330A, MDL-12330A, RMI 12330A, RMI12330A | |||||||
| MDMA | 4574 | 3,4-methylenedioxymethamphetamine, ecstasy, midomafetamine | |||||||
| MDMB-Fubinaca |
|
10178 | Fub-mdmb, Mdmb-bz-F, Mdmb-fub | ||||||
| MDOLL-0229 |
|
13321 | compound 27 [PMID: 38592023], MDOLL0229 | ||||||
| MDP-rhodamine |
|
9506 | MDP-Hex-Rhodamine B | ||||||
| ME0328 |
|
8468 | compound 5b [PMID 24188023], ME-0328 | ||||||
| ME1071 | 13948 | ||||||||
| ME-344 | 7961 | ||||||||
| ME36 | 1447 | N-ethyl,N-methyl EM-A | |||||||
| ME4 | 1448 | EM-A enolether, erythromycin enol ether, ME-4 | |||||||
| ME67 | 1449 | EM-B enolether | |||||||
| ME-1228 acid | 11045 | ME1228 | |||||||
| MeAIB |
|
4697 | α-(methylamino)isobutyric acid, 2-(methylamino)isobutyric acid | ||||||
| 10-Me-Aplog-1 | 13409 | compound 1 [PMID: 32053979], compound 5 [PMID: 22625994] | |||||||
| αβ-meATP |
|
4093 | αβ-methylene-adenosine 5'-triphosphate | ||||||
| [3H]αβ-meATP |
|
|
|
5405 | |||||
| mebendazole |
|
|
13427 | Emverm®, Vermox® | |||||
| mebeverine |
|
9011 | Colofac®, CSAG-144, Duspatalin® | ||||||
| ME bromodomain inhibitor |
|
7807 | |||||||
| mecamylamine |
|
3990 | |||||||
| 2'-Me-CCPA | 5591 | 2'methyl-2-chloro-N6-cyclopentyladenosine | |||||||
| mechlorethamine |
|
7218 | Ledaga®, Mustargen®, mustine, nitrogen mustard, nitrogen mustard N-oxide hydrochloride | ||||||
| mecillinam |
|
12813 | amdinocillin, Coactin®, FL 1060, Selexidin® | ||||||
| meclinertant | 1582 | reminertant, SR-48692, SR48692 | |||||||
| [3H]meclinertant |
|
|
1583 | [3H]-SR48692, [3H]reminertant, [3H]SR-48692 | |||||
| meclizine |
|
2757 | Antivert®, Dramamine®, Sea-Legs® | ||||||
| meclocycline |
|
13540 | GS-2989, Meclan® | ||||||
| meclofenamic acid |
|
|
|
7219 | CL-583, INF-4668, Meclomen® | ||||
| medica 16 | 1053 | medic-16 | |||||||
| medroxyprogesterone |
|
2879 | MPA, hydroxymethylprogesterone | ||||||
| mefenamic acid |
|
|
|
2593 | CI-473, CN-35355, INF-3355, Ponstan®, Ponstel® | ||||
| mefloquine |
|
|
|
4252 | GNF-Pf-5544, Lariam®, Ro-21-5998-001, WR-142490 | ||||
| megestrol |
|
9128 | Chronopil, Magestin, Megace®, megestryl acetate | ||||||
| meglutol |
|
2960 | |||||||
| 5-Me-IAA | 4107 | 5-methy-1H-imidazole-4-acetic acid | |||||||
| MEK1/2 inhibitor | 6008 | SL-327, SL327 | |||||||
| MEK inhibitor I | 6006 | ||||||||
| MEK inhibitor II | 6007 | NSC-686549, NSC686549 | |||||||
| MEL57A | 6260 | ||||||||
| melagatran |
|
6382 | H-319-68 | ||||||
| 2-[125I]melatonin |
|
|
1344 | 2-[125I]MLT, 2-(125I)Iodomelatonin, 2-iodo-[125I]-melatonin, 2[125I]iodomelatonin | |||||
| [3H]melatonin |
|
|
|
1357 | [3H]-melatonin, [3H]MLT | ||||
| MELK-TI | 9366 | compound 7 [PMID: 25589925] | |||||||
| meloxicam |
|
|
|
7220 | Mobic®, UHAC-62XX | ||||
| melphalan |
|
|
7620 | Alkeran®, CB-3025, L-phenylalanine mustard (L-PAM), L-sarcolysine, melfalan, Phelinun®, Sarcolysin® | |||||
| melphalan flufenamide |
|
11605 | Melflufen, Pepaxti®, Pepaxto®, Prodrug J 1, Prodrug J-1 | ||||||
| memantine |
|
4253 | Axura®, Ebixa®, Namenda® | ||||||
| (+)-menthol | 2471 | ||||||||
| 5-MeO-DMT |
|
145 | 5-methoxydimethyltryptamine, MeODMT | ||||||
| 5-MeOT |
|
107 | 5-methoxytryptamine, 5-MT, mexamine | ||||||
| mepacrine |
|
|
|
10172 | Atabrine®, quinacrine | ||||
| mepenzolic acid |
|
10470 | (±)-mepenzolate, Cantril®, glycophenylate, mepenzolate, racemic mepenzolate | ||||||
| mephentermine |
|
7222 | mephentermine sodium, mephentermine sulfate, Wyamine Sulfate® | ||||||
| mephenytoin |
|
7223 | Mesantoin® | ||||||
| mepivacaine |
|
7224 | Carbocaine®, mepivacaine hydrochloride, Polocaine® | ||||||
| meprobamate |
|
7225 | Equanil®, Meprospan®, Miltown® | ||||||
| meptazinol |
|
9083 | Meptid® | ||||||
| mepyramine |
|
|
|
1227 | Anthisan®, mepiramine, mepyramine maleate, pyrilamine, pyrilamine tannate, Pyrlex® | ||||
| mequinol |
|
|
6827 | 4-hydroxyanisole, BMS-181158, Leucobasal®, Leucodine B, p-hydroxyanisole | |||||
| mercaptamine |
|
|
7440 | CI-9148, Cystagon®, Cystaran®, cysteamine hydrochloride, L-1573 | |||||
| mercaptoacrylate inhibitor of calpain 1 | 8570 | ||||||||
| mercaptopurine |
|
|
7226 | 6-mercaptopurine, Purinethol®, Xaluprine® | |||||
| merestinib |
|
|
9841 | LY-2801653, LY2801653 | |||||
| merigolix | 12394 | example 2-13 [US9481684B2], Formula 1 [US20220002312A1], NCE403, SKI2670, TU-2670, TU2670 | |||||||
| merimepodib | 10741 | MMPD, VX-497, VX497 | |||||||
| meropenem |
|
|
10829 | ICI 194,660, Merrem®, SM-7338 | |||||
| mersalyl | 5331 | ||||||||
| MerTK inhibitor 11 |
|
13918 | |||||||
| MES304 | 13945 | ||||||||
| 2MeSADP |
|
1710 | 2-MeSADP, 2-methylthio-adenosine-5'-diphosphate, 2-methylthio-ADP | ||||||
| [33P]2MeSADP |
|
|
1774 | [33P]2-methylthio-ADP | |||||
| [3H]2MeSADP |
|
|
|
1763 | [3H]2-methylthio-ADP | ||||
| mesalazine |
|
|
2700 | 5-aminosalicylic acid, 5-ASA, mesalamine (USAN), Pentasa® | |||||
| 2MeSAMP | 1764 | 2-methylthio-AMP, poly(2'-methylthioadenylic acid) | |||||||
| 2MeSATP |
|
1711 | 2-MeSATP, 2-methylthio-adenosine-5'-triphosphate, 2-methylthio-ATP | ||||||
| mesdopetam | 10811 | IRL790 | |||||||
| mesoridazine |
|
7227 | NC-123, Serentil®, TPS-23 | ||||||
| mesulergine | 206 | CQ 32085 | |||||||
| [3H]mesulergine |
|
|
232 | ||||||
| mesuximide |
|
7228 | Celontin®, Petinutin® | ||||||
| [3H]meta-chlorophenylbiguanide |
|
|
2304 | ||||||
| meta-chlorphenylbiguanide | 2287 | mCPBG, 1-(3-chlorophenyl)biguanide, 3-chlorophenyl-biguanide, m-chlorophenylbiguanide | |||||||
| metacycline |
|
13618 | GS-2876, methacycline, methylenecycline, Physiomycine®, Rondomycin® | ||||||
| metamizole | 10608 | dipyrone | |||||||
| metampicillin | 12274 | methampicillin, methylenampicillin, Micinovo®, Viderpen® | |||||||
| metaraminol |
|
7229 | Aramine®, metaradrine, metaraminol bitartrate | ||||||
| metatinib |
|
12614 | BMS-794833, BMS794833 | ||||||
| metaxalone |
|
7609 | AHR-438, Skelaxin® | ||||||
| metergoline | 133 | FI-6337, liserdol, metergoline phenylmethyl ester | |||||||
| metformin |
|
|
|
4779 | Glucophage®, LA-6023 | ||||
| [14C]metformin |
|
|
|
4503 | [14C]-metformin | ||||
| methacholine |
|
|
7438 | methacholine bromide, Provocholine® | |||||
| (-)-methadone | 1605 | (R)-methadone, l-methadone, levomethadone | |||||||
| methadone |
|
5458 | (±)-methadone, dl-methadone, Dolophine HCL®, methadone HCl, Methadose® | ||||||
| methamphetamine |
|
4803 | deoxyephedrine, Desoxyn®, DL-methamphetamine, methamphetamine hydrochloride | ||||||
| metharbital |
|
|
7230 | Gemonil® | |||||
| methazolamide |
|
6828 | methenamide, Neptazane® | ||||||
| methdilazine |
|
7231 | methdilazine hydrochloride, Tacaryl® | ||||||
| methenamine |
|
10913 | Hiprex®, Mandelamine®, Urex® | ||||||
| methicillin |
|
|
12264 | meticillin | |||||
| methimazole |
|
|
|
6649 | Tapazole®, Thiamazole® | ||||
| methimepip | 1254 | ||||||||
| methionine benzimidazole 6 | 5829 | ||||||||
| methiothepin | 89 | methiothepine | |||||||
| methixene |
|
7232 | metixene, SJ-1977, Trest® | ||||||
| methnaridine |
|
11318 | |||||||
| methocarbamol |
|
6829 | Robaxin® | ||||||
| methoctramine | 327 | ||||||||
| methohexital |
|
7233 | methohexitone | ||||||
| methoprene acid | 2812 | ||||||||
| methotrexate |
|
|
|
4815 | Abitrexate®, amethopterin, Nordimet®, Rasuvo® | ||||
| [3H]methotrexate |
|
|
|
4674 | [3H]-methotrexate | ||||
| methoxamine |
|
483 | 2,5-dimethoxynorephedrine | ||||||
| 2-methoxy-α,β-didehydro-agomelatine | 7775 | ||||||||
| methoxyflurane |
|
7234 | Penthrane® | ||||||
| 5-methoxy-luzindole | 1364 | 5-methoxyluzindole | |||||||
| methoxymethyl-MTEP | 3345 | ||||||||
| [3H]methoxymethyl-MTEP |
|
|
5394 | [3H]-methoxymethyl-MTEP | |||||
| methoxy-MPEP |
|
3344 | M-MPEP, M-MPEP | ||||||
| 7-methoxy-1-naphthylpiperazine | 6 | ||||||||
| [3H]methoxy-PEPy |
|
|
6425 | ||||||
| methyclothiazide |
|
7235 | Aquatensen®, Enduron® | ||||||
| [14C]methylamine |
|
|
4624 | [14C]-methylamine | |||||
| methyl arachidonyl fluorophosphonate | 5218 | MAFP, methylarachidonoylflurophosphonate | |||||||
| methylcarbamyl PAF | 3427 | mc-PAF, methyl-carbamyl platelet-activating factor | |||||||
| 7-methylcyanopindolol |
|
13191 | |||||||
| 1-methylcyclopropanecarboxylic acid | 6500 | ||||||||
| α-methyl-D,L-tryptophan | 4693 | ||||||||
| αβ-methyleneADP |
|
5092 | α,β-methyleneadenosine 5'-diphosphate (αβmeADP), [αβCH2]ADP, AMP-CP, AMPCP | ||||||
| α.β-methylene-2-thio-UDP | 6203 | α,β-methylene-UDP | |||||||
| methylergonovine |
|
|
150 | Methergine®, methylergobasin | |||||
| methylfurmethide | 300 | 5 MFT, 5-methylfurmithide | |||||||
| 3-methylhexanal | 12471 | ||||||||
| 2-methylhistamine | 1268 | ||||||||
| 4-methylhistamine | 1269 | ||||||||
| (R)-α-methylhistamine |
|
1236 | (R)-α-MeHA, alpha-methylhistamine | ||||||
| (S)-α-methylhistamine | 1238 | (S)-α-MeHA | |||||||
| [3H](R)-α-methylhistamine |
|
|
1237 | (R)-[3H]α-methylhistamine, [3H]-R-α-Methylhistamine | |||||
| methylhistaprodifen | 1205 | N-methylhistaprodifen | |||||||
| 4-methylhomoibotenic acid | 5449 | (R,S)-4-methylhomoibotenic acid | |||||||
| 2-methyl-5-HT | 218 | 2-Me-5-HT, 2-methyl-5-hydroxytryptamine, 2-methylserotonin | |||||||
| α-methyl-5-HT | 152 | α-methylserotonin, α-Me-5-HT | |||||||
| 29-methylidene-2,3-oxidosqualene | 6719 | 29-MOS | |||||||
| methyl isocyanate | 6290 | MIC, isocyanatomethane, isocyanic acid, methyl carbonimide | |||||||
| 1-methyl-L-tryptophan |
|
8225 | 1-L-MT, 1-LMT | ||||||
| [3H]methyllycaconitine |
|
|
|
3980 | |||||
| methylmalonic acid |
|
9633 | |||||||
| 5-methyl-5-(5-methylthiophen-3-yl)-4-oxo-4,5-dihydrofuran-2-carboxylic acid | 1599 | compound 5aj [PMID: 17358052] | |||||||
| methylnaltrexone |
|
7563 | MNTX, MRZ-2663BR, Relistor® | ||||||
| 5-methyl nicotinic acid | 1592 | ||||||||
| 15(R)-15-methyl-PGD2 |
|
1902 | 15R-15-methyl PGD2 | ||||||
| 15(S)-15-methyl-PGD2 | 1903 | BRN 5989341 | |||||||
| 2-methyl-3-phenethyl-3H-pyrimidin-4-one | 713 | compound 2H [PMID: 15863312] | |||||||
| methylphenidate |
|
7236 | Concerta®, Jornay PM® (a.k.a. HLD200), Ritalin®, Tuzulby® | ||||||
| methyl p-hydroxybenzoate |
|
6273 | methylparaben, nipagin | ||||||
| methyl-piperidino-pyrazole | 3459 | MPP | |||||||
| methyl salicylate | 2431 | ||||||||
| α-methylserine-O-phosphate | 1398 | MSOP, α-MSOP | |||||||
| methyl 5-[(4-tert-butylbenzoyl)amino]-2H-1,2,4-triazole-3-carboxylate | 6553 | ||||||||
| methyltestosterone | 6945 | 17-methyltestosterone | |||||||
| methyltrienolone |
|
2857 | R1881 | ||||||
| [3H]methyltrienolone |
|
|
|
3457 | [3H]-R1881, [3H]R1881 | ||||
| 1-methyltryptophan | 4694 | ||||||||
| 5-methylurapidil | 489 | 5 methylurapidil, 5-methyl-urapidil | |||||||
| methylurea |
|
4662 | |||||||
| methyprylon |
|
7238 | Noludar® | ||||||
| methysergide |
|
|
134 | 1-methylmethylergonovine, Deseril®, Sansert®, UML-491 | |||||
| metiamide | 1233 | NSC 307755, SK&F 92058 | |||||||
| metipranolol |
|
7239 | BM-01004, Optipranolol®, VUAB-6453, VUAB6453 | ||||||
| metoclopramide |
|
241 | Gimoti® (metoclopramide nasal spray), metaclopromide, methochlopramide, metochlopramide, metoclopramide hydrochloride, Reglan® | ||||||
| metolazone |
|
4838 | SR-720-22, Zaroxolyn® | ||||||
| metopimazine |
|
11140 | EXP-999, NG-101, RP-9965, Vogalene® | ||||||
| metoprine |
|
7412 | BW-197U, DDMP, methodichlorophen, NSC-19494, NSC7364, TCMDC-123931 | ||||||
| metoprolol |
|
553 | CGP-2175C, GP-2175E, H-93/26, Lopressor®, Toprol® | ||||||
| MeTRH | 2137 | His(1-methyl)-thyrotropin-releasing hormone, His(1-methyl)-TRH, pGlu-His(1(τ)-methyl)-ProNH2 | |||||||
| [3H]MeTRH |
|
|
2141 | [3H]Me-thyrotropin-releasing hormone, [3H]pGlu-His(1(τ)-methyl)-ProNH2 | |||||
| metrifudil | 426 | TH-322, Y-341 | |||||||
| metronidazole |
|
|
10914 | BAY-5360, BAYER 5360, Flagyl®, Metrogel®, ROZEX® | |||||
| metyrapone |
|
|
5224 | mepyrapone, Metopirone® | |||||
| mevastatin |
|
3031 | compactin, ML-236B | ||||||
| mevidalen |
|
10506 | compound 3 [PMID: 31532644], LY-3154207, LY3154207 | ||||||
| mevociclib | 10467 | compound 264 [WO2015154039A2], SY-1365, SY1365 | |||||||
| mevrometostat |
|
10516 | compound 23a [PMID: 29211475], PF-06821497, PF06821497 | ||||||
| mexiletine |
|
2629 | Mexitil® | ||||||
| mezigdomide |
|
12718 | CC-92480, CC92480, compound 4 [PMID: 32130004] | ||||||
| mezlocillin |
|
12272 | BAYPEN®, Mezlin®, Multocillin® | ||||||
| MF266-1 | 6068 | ||||||||
| MF 498 | 5856 | C528911, MF-498 | |||||||
| MF63 |
|
14084 | MF-63 | ||||||
| MG149 | 7488 | MG 149, MG-149 | |||||||
| MG-277 | 11724 | MG277 | |||||||
| MGB-BP-3 | 10996 | compound 50 [PMID: 17960927], MGB-BP3 | |||||||
| MGS0028 | 1395 | MGS 0028, MGS-0028 | |||||||
| MGS0039 | 1397 | MGS 0039, MGS-0039 | |||||||
| MI-05 | 12826 | MI05 | |||||||
| MI-06 | 12828 | MI06 | |||||||
| MI-09 | 11440 | compound 11i [PMID: 33602867] | |||||||
| MI-11 | 12827 | MI11 | |||||||
| MI-1148 | 8601 | 4-guanidinomethyl-phenylacteyl-Arg-Tle-Arg-4-amidinobenzylamide, para-guanidinomethyl-Phac-R-Tle-R-Amba | |||||||
| MI-13 | 12824 | MI13 | |||||||
| MI-14 | 12825 | MI14 | |||||||
| MI-21 | 12822 | MI21 | |||||||
| MI-23 |
|
11432 | compound 18i [PMID: 33602867] | ||||||
| MI-28 | 12823 | MI28 | |||||||
| MI-3 | 8103 | ||||||||
| MI-30 | 11441 | compound 18p [PMID:33602867] | |||||||
| MI-503 |
|
9526 | |||||||
| mianserin |
|
135 | (+-)-athymil, Norval®, ORG GB 94 | ||||||
| mibefradil |
|
|
2522 | Posicor®, Ro-405967-001 | |||||
| mibolerone | 2859 | (7alpha,17beta)-17-hydroxy-7,17-dimethylestr-4-en-3-one | |||||||
| [3H]mibolerone |
|
|
3456 | ||||||
| miconazole |
|
2449 | florid(nitrate), Monistat®, R-14889 | ||||||
| midazolam |
|
|
3342 | Buccolam®, Dormicum®, Nayzilam®, USL261 (nasal spray formulation), Versed® | |||||
| MIDD0301 |
|
9890 | |||||||
| midobrutinib | 14049 | Example 13 [US9580432B2] | |||||||
| midodrine |
|
7240 | A-4020 Linz, Proamatine®, ST-1085 | ||||||
| midostaurin |
|
|
|
5702 | CGP 41231, CGP 41251, N-benzoylstaurosporine, PKC412, Rydapt® | ||||
| mifamurtide |
|
8274 | CGP 19835, CGP-19835, L-MTP-PE, liposomal muramyl tripeptide phosphatidyl ethanolamine, Mepact®, MLV 19835A | ||||||
| mifanertinib | 12380 | compound Ie/Example 5 [WO2013135176A1], mefatinib | |||||||
| mifepristone |
|
|
|
2805 | Mifeprex®, RU-486, RU486 | ||||
| MIF inhibitor 3bb |
|
|
9986 | ||||||
| migalastat |
|
|
10200 | 1-Deoxygalactonojirimycin, Galafold®, GR-181413A, GR181413A | |||||
| miglitol |
|
|
4842 | Glyset®, N-hydroxylethyl-1-deoxynojirimycin | |||||
| miglustat |
|
|
4841 | N-butyl-1-deoxynojirimycin, NB-DNJ, Zavesca® | |||||
| migoprotafib |
|
12970 | GDC-1971, GDC1971, RLY-1971, RLY1971 | ||||||
| milademetan | 12941 | DS-3032, DS-3032B, DS3032, DS3032b, RAIN-32 | |||||||
| milameline | 301 | ||||||||
| milategrast |
|
10463 | example 9 [US20050261291A1] | ||||||
| milciclib |
|
7938 | PHA 848125, PHA-848125, PHA848125 | ||||||
| milnacipran |
|
7436 | Savella® | ||||||
| milrebrutinib | 12371 | AS-1763, AS1763, inhibitor 13f [PMID: 34529443] | |||||||
| milrinone |
|
|
5225 | milrinone lactate, Primacor® | |||||
| miltefosine |
|
|
11355 | D-18506, D18506, Impavido®, Miltex®, n-hexadecylphosphorylcholine | |||||
| milvexian |
|
11754 | BMS-986177, BMS986177, compound 17 [PMID: 34494428], JNJ-70033093, JNJ70033093 | ||||||
| minaxolone | 5478 | ||||||||
| mindeudesivir |
|
11993 | deuremidevir, JT001, Mindavi®, VV-116, VV116, X6 hydrobromide [PMID: 34584244] | ||||||
| minocycline |
|
10831 | CL 59806, CL-59806, CL59806, Dynacin®, MINO, Minocin®, NSC-141993 | ||||||
| minodronic acid |
|
3164 | BPH 261, ONO 5920, YH 529 | ||||||
| minoxidil |
|
|
4254 | Rogaine® | |||||
| MIPS1780 | 14055 | compound 2 [PMID: 32851779], MIPS-1780 | |||||||
| mirabegron |
|
|
7445 | Betmiga®, Myrbetriq®, YM-178 | |||||
| miransertib |
|
9429 | ARQ 092, ARQ-092, compound 21a [PMID: 27305487] | ||||||
| mirdametinib |
|
|
7935 | Gomekli®, PD 0325901, PD-0325901, PD0325901 | |||||
| miricorilant | 10059 | C-118335, C118335, compound 7 [PMID: 23131342], CORT118335 | |||||||
| miridesap |
|
8256 | compound 52 [PMID 14998318], CPHPC, GSK2315698, Ro 63-8695 | ||||||
| mirodenafil |
|
11738 | Mvix®, SK-3530, SK3530 | ||||||
| mirogabalin |
|
|
8303 | DS-5565, DS5565 | |||||
| [3H]mirogabalin |
|
|
|
12597 | |||||
| mirtazapine |
|
7241 | ORG-3770, Remeron® | ||||||
| misoprostol (free acid form) | 1935 | misoprostol acid, SC 30695 | |||||||
| misoprostol (methyl ester) |
|
1936 | Arthrotec®, BRN 4155643, CCRIS 6859, Cytotec®, HSDB 3573, SC 29333 | ||||||
| mitapivat |
|
|
10473 | AG-348, AG348, compound 80a [WO2011002817A1], PKM2 activator 1020, PKR-IN-1, Pyrukynd® | |||||
| mitemcinal | 3511 | GM-611, GM611 | |||||||
| mitiperstat | 12154 | AZD-4831, AZD4831, compound 16 [PMID: 36005476] | |||||||
| mitoglitazone | 11303 | MSDC-0160, MSDC0160 | |||||||
| mitotane |
|
6957 | CB-313, Lysodren® | ||||||
| mitoxantrone |
|
|
7242 | CL-232315, Novantrone® | |||||
| mivacurium |
|
7243 | BWB109OU, Mivacron® | ||||||
| mivavotinib |
|
|
9600 | compound 3b [PMID: 27839918], TAK-659, TAK659 | |||||
| mivebresib |
|
9117 | ABBV-075, ABBV075, Example 36 [WO2013097601] | ||||||
| mizagliflozin | 9547 | DSP-3235 | |||||||
| mizolastine |
|
|
10102 | Mizollen®, MKC-431, MKC431, SL 85.0324, SL-850324, SL850324 | |||||
| MJN110 | 10028 | MJN 110, MJN-110 | |||||||
| MJN228 | 8515 | ||||||||
| MK-0159 | 12111 | compound 37 [PMID: 35762533], MK0159 | |||||||
| MK-0249 | 7346 | MK 0249, MK0249 | |||||||
| MK 0354 | 5784 | MK-0354 | |||||||
| MK-0359 |
|
9852 | L-454,560, L-454560, MK0359 | ||||||
| MK-0429 | 9689 | compound 6 [PMID:14561098], MK-429, MK0429 | |||||||
| MK-0752 | 11360 | MK0752 | |||||||
| MK-0767 | 2677 | KRP 297, KRP-297, MK 767 , MK-767 | |||||||
| MK-0812 |
|
9048 | MK0812 | ||||||
| MK-0873 |
|
9853 | compound 20 [PMID: 18835163], MK0873 | ||||||
| MK-0893 |
|
9135 | compound 9m [PMID: 22708876], MK 0893, MK-0893-005, MK0893, N-[(4-{(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-β-alanine | ||||||
| MK-1064 | 9306 | ||||||||
| MK 1903 | 5785 | ||||||||
| MK-212 | 165 | MK 212 | |||||||
| MK-2206 | 7945 | MK 2206 | |||||||
| MK-2461 | 7962 | MK 2461 | |||||||
| MK-2894 | 4041 | MK 2894, MK2894 | |||||||
| MK-3697 | 9307 | compound 24 [PMID: 25248679] | |||||||
| MK-4256 | 10114 | MK 4256, MK4256 | |||||||
| MK-4815 |
|
|
10410 | MK4815 | |||||
| MK-499 | 2607 | L 706000, MK 499, MK499 | |||||||
| MK-5046 |
|
6170 | MK 5046, MK5046 | ||||||
| MK-5108 | 8061 | MK5108, VX-689, VX689 | |||||||
| MK-5435 | 6335 | ||||||||
| MK-571 | 10346 | MK 571, MK-0571, MK571 | |||||||
| MK6-83 | 9783 | ||||||||
| MK-6884 | 14057 | MK6884 | |||||||
| MK 6892 |
|
5788 | MK-6892 | ||||||
| MK-7145 | 10382 | example 2A [WO2010129379], MK7145 | |||||||
| MK-7622 | 10712 | MK7622 | |||||||
| MK-7725 | 8502 | MK7725 | |||||||
| MK-7762 | 13542 | MK7762, TBD09 | |||||||
| MK-7845 | 13173 | compound 27 [PMID: 38365209], MK7845 | |||||||
| MK-8153 | 12780 | compound 22e [PMID: 34038119], MK8153 | |||||||
| MK-8189 |
|
12323 | compound 18 [PMID: 36624931], MK8189 | ||||||
| MK-8262 | 11729 | compound 87 ]PMID: 34375108], MK8262 | |||||||
| MK-8353 |
|
9974 | MK8353, SCH900353 | ||||||
| MK-8719 |
|
10508 | compound 42 [PMID: 31487175], MK8719 | ||||||
| MK-8776 | 7943 | MK 8776, SCH 900776 | |||||||
| MK-886 |
|
|
2655 | L 663536, MK886 | |||||
| MK-912 | 12577 | L-657,743, L-657743, MK912 | |||||||
| [18F]MK-1312 |
|
|
6334 | ||||||
| [3H]MK-912 |
|
|
527 | [3H]L-657,743 | |||||
| MK2a inhibitor | 6009 | CMPD1, MAPKAPK2a inhibitor | |||||||
| ML10 |
|
|
10225 | ||||||
| ML1000 | 11508 | ||||||||
| ML 10302 | 235 | ML-10302 | |||||||
| ML 10375 | 249 | ML-10375, ML10375 | |||||||
| ML130 |
|
8887 | compound 1c [PMID: 22003428], ML-130, Noditinib-1 | ||||||
| ML148 | 14085 | ML-148 | |||||||
| ML162 | 12800 | ML-162 | |||||||
| ML169 | 5437 | ML-169, VU0405652 | |||||||
| ML-18 | 8505 | ||||||||
| ML193 | 9967 | ML 193, ML-193 | |||||||
| ML204 | 4255 | ||||||||
| ML211 | 13415 | ML-211 | |||||||
| ML213 | 7665 | ML 213, ML-213 | |||||||
| ML216 | 13026 | ML-216 | |||||||
| ML218 |
|
7720 | ML 218, ML-218 | ||||||
| ML221 | 6282 | ||||||||
| ML233 | 6314 | ML-233 | |||||||
| ML252 | 14112 | ML-252 | |||||||
| ML277 | 7666 | ML 277, ML-277 | |||||||
| ML290 | 8322 | compound 8 [PMID: 23764525], ML 290 | |||||||
| ML297 | 7768 | ML 297, ML-297 | |||||||
| ML300 |
|
11657 | compound 16e [PMID: 24080461], ML-300 | ||||||
| ML315 | 8162 | ||||||||
| ML321 | 8368 | compound 65 [PMID 24666157] | |||||||
| ML323 |
|
7898 | ML 323, ML-323 | ||||||
| ML324 |
|
|
9584 | ML-324, MMV1580488 | |||||
| ML337 | 8765 | ML 337, ML-337 | |||||||
| ML347 | 8121 | ML-347 | |||||||
| ML348 |
|
13412 | ML-348 | ||||||
| ML349 |
|
13413 | |||||||
| ML351 | 10263 | ML-351 | |||||||
| ML354 | 9459 | VU0099704 | |||||||
| ML355 |
|
8752 | ML-355 | ||||||
| ML364 | 13057 | ML-364 | |||||||
| ML375 | 7631 | VU0483253-3 | |||||||
| ML380 | 8687 | VU0481443-3 | |||||||
| ML381 | 8591 | VU0488130-1 | |||||||
| ML385 | 10154 | compound 2 [PMID: 27552339], ML-385 | |||||||
| ML398 | 8440 | ||||||||
| ML9 | 4256 | ||||||||
| MLI-2 |
|
11663 | compound 1 [PMID: 28245354], MLi-2 | ||||||
| MLKL compound 1 |
|
9513 | compound 23 [PMID: 15990302], GW806742X | ||||||
| MLN0905 | 9402 | compound 12c [PMID: 22070629] | |||||||
| MLN-3897 | 10750 | AVE-9897, AVE9897, MLN3897 | |||||||
| MLN-4760 |
|
7866 | MLN 4760, MLN4760 | ||||||
| MLN-8054 |
|
5696 | MLN 8054, MLN8054 | ||||||
| MLN-120B |
|
5694 | ML120B, MLN120B | ||||||
| MLS000536924 |
|
10264 | |||||||
| MLS1547 | 8369 | MLS000051547 | |||||||
| ML1-SA1 | 11846 | EVP-169, EVP169, ML1SA1 | |||||||
| ML2-SA1 |
|
10301 | EVP-22, EVP22, ML2 SA1, ML2SA1 | ||||||
| ML3-SA1 | 11847 | EVP-77, EVP77, ML3 SA1, ML3SA1 | |||||||
| ML SA1 | 6386 | ML-SA1 | |||||||
| ML-SA5 |
|
12542 | |||||||
| MM 11253 | 4062 | MM-11253, MM11253 | |||||||
| MM3122 | 11533 | Ac-GQFR-kbt, compound 4 [Mahoney et al, 2021], MM-3122 | |||||||
| MM-433593 |
|
9944 | MM433593 | ||||||
| m3M3FBS | 5097 | ||||||||
| M-5MPEP | 6396 | ||||||||
| [3H]M-MPEP |
|
|
|
1425 | [3H]-M-MPEP | ||||
| MMPIP | 3341 | ||||||||
| MMP13 tracer [18F]5j |
|
|
12669 | ||||||
| [11C]MMTP |
|
|
6212 | ||||||
| MMV008138 |
|
10229 | GNF-Pf-4188, TCMDC-125815 | ||||||
| MMV009108 |
|
|
11463 | GNF-Pf-3616 | |||||
| MMV019313 |
|
|
11456 | TCMDC-123889 | |||||
| MMV024101 |
|
10017 | compound 8 [PMID: 29889526] | ||||||
| MMV030084 |
|
11201 | TCMDC-140369 | ||||||
| MMV048 |
|
9726 | MMV390048 | ||||||
| MMV1803022 |
|
11824 | |||||||
| MMV367 |
|
13673 | GSK3772701, GSK701, MMV1582367 | ||||||
| MMV688533 |
|
11704 | MMV533, SAR121, SAR441121 | ||||||
| MMV689258 |
|
11466 | |||||||
| MMV693183 |
|
11796 | MMV183 | ||||||
| MMV897698 |
|
11825 | compound 6 [PMID: 32678591], OSM-S-369 | ||||||
| MNI-135 | 6219 | MNI 135 | |||||||
| MNI-136 | 6220 | MNI 136 | |||||||
| MNI-137 | 6221 | MNI 137 | |||||||
| MNK1 inhibitor | 6010 | CGP 57380, CGP-57380 | |||||||
| mobinitinib | 13496 | CCT-241736, CCT241736 | |||||||
| mobocertinib |
|
10468 | AP32788, example 94 [WO2015195228A1], Exkivity®, TAK-788, TAK788 | ||||||
| mocaciclib | 13499 | compound 64 [WO2019197546A1] | |||||||
| mocetinostat | 7008 | MGCD0103 | |||||||
| moclobemide |
|
7428 | GNF-Pf-695, Manerix® | ||||||
| mocravimod |
|
9727 | compound 2 [PMID: 23124563], KRP-203, KRP203 | ||||||
| mocravimod-phosphate |
|
2923 | KRP 203-phosphate, KRP203-phosphate | ||||||
| modafinil |
|
7555 | Provigil® | ||||||
| modithromycin | 13000 | EDP-420, EP-013420, S-013420 | |||||||
| modzatinib | 14051 | ATI-2138, ATI2138, com[pound 49 [US12297203B2] | |||||||
| moexipril |
|
6571 | RS-10085, SPM-925, Univasc® | ||||||
| moexiprilat |
|
6572 | RS-10029 | ||||||
| mofegiline |
|
9754 | MDL 72974, MDL-72,974, MDL-72974A | ||||||
| molibresib |
|
|
7033 | CS-0717, GSK 525762A, GSK-525762, GSK525762, I-BET-762, I-BET762 | |||||
| molidustat |
|
8456 | BAY 85-3934, BAY-853934, BAY85-3934 | ||||||
| molindone |
|
207 | (+-)-molindone, EN-1733A, Moban® | ||||||
| molnupiravir |
|
|
10737 | EIDD-2801, EIDD2801, Lagevrio®, MK-4482, MK4482 | |||||
| momelotinib |
|
|
7791 | CYT-387, CYT387, GS-0387, GS0387, Ojjaara®, Omjjara® | |||||
| mometasone |
|
|
9029 | Elocon® (topical), Nasonex® | |||||
| monlunabant |
|
13717 | (S)-MRI-1891, INV-202, MRI-1891 | ||||||
| MONNA | 12258 | compound 3 [PMID: 28493701] | |||||||
| monobenzone |
|
6830 | p-benzyloxyphenol | ||||||
| monomethyl fumarate |
|
|
5786 | methyl hydrogen fumarate | |||||
| montelukast |
|
|
|
3340 | Singulair® | ||||
| monzosertib | 11746 | AS-0141, AS0141, compound 24 [PMID: 34607435] | |||||||
| moracizine |
|
7244 | EN-313, Ethmozine®, moricizine | ||||||
| morphanthridine | 6473 | ||||||||
| mosapride |
|
242 | |||||||
| mosedipimod |
|
9771 | EC-18, Plag, (+/-) | ||||||
| mosperafenib | 13500 | Example 7 [WO2021116050], RG-6344, RG6344 | |||||||
| motesanib |
|
5660 | AMG 706, AMG-706 | ||||||
| motolimod |
|
9026 | VTX-2337 | ||||||
| moxifloxacin |
|
|
10915 | Avelox®, BAY-12-8039, BAY-128039, BAY128039, MFX, MOXIVIG® (opthalmic solution) | |||||
| moxisylyte |
|
12306 | Opilon®, thymoxamine | ||||||
| moxonidine |
|
12574 | BDF-5895, BDF5895, Cynt®, LY 326869, LY326869, Norcynt® | ||||||
| mozavaptan | 2197 | OPC 31260, OPC-31260, OPC31260 | |||||||
| MP-001 | 13657 | compound 10b [PMID: 33493827], example 12 [WO2017203083A1], MP001 | |||||||
| MP-004 | 13656 | example 20 [WO2017203083A1], MP004 | |||||||
| MP-010 | 13655 | MP010 | |||||||
| MP1104 | 9759 | ||||||||
| MP13 | 11175 | example 13 [WO2006061714] | |||||||
| MPA | 4595 | ||||||||
| MP-A08 | 10219 | ||||||||
| MPC-MECA | 460 | ||||||||
| MPD2 | 13349 | ||||||||
| MPDT | 71 | ||||||||
| 5-MPEP | 1419 | ||||||||
| MPEP | 1426 | ||||||||
| MPI-0479605 |
|
9399 | |||||||
| MPI-0485520 |
|
9580 | MPC-9528, MPI-485520 | ||||||
| MPI60 | 12891 | ||||||||
| 2-MPP | 280 | ||||||||
| MPP+ |
|
4568 | 1-methyl-4-phenylpyridinium, cyperquat | ||||||
| MPPA |
|
9897 | inhibitor 23 [PMID: 29614224] | ||||||
| MPPG | 1415 | ||||||||
| 3-MPPTS | 1401 | ||||||||
| 4-MPPTS | 1402 | LY-487379, LY487379 | |||||||
| Mpro inhibitor 38a [PMID: 40186586] |
|
13857 | |||||||
| Mpro inhibitor 13b | 13382 | 13b-K ((S,S,S)-diastereomer) | |||||||
| Mpro inhibitor 119 [PMID: 40186586] |
|
13858 | |||||||
| MPS1-IN-1 |
|
9271 | |||||||
| MQ1 | 8587 | compound (R)-10a, MQ-1 | |||||||
| MRE-269 |
|
5852 | ACT 333679, ACT-333679, MRE 269 | ||||||
| MRE 2029F20 | 390 | MRE-2029F20 | |||||||
| MRE 3008F20 | 459 | MCP-NECA , MRE 3008-F20 | |||||||
| MRE 3010F20 | 465 | MRE-3010F20 | |||||||
| [3H]MRE 3008F20 |
|
|
477 | ||||||
| MRGPRX2 antagonist 17 | 12152 | ||||||||
| MRI-1867 |
|
10521 | (-)-MRI-1867, MRI1867 | ||||||
| MRK016 | 4257 | MRK 016, MRK-016 | |||||||
| MRK-1 | 3651 | CMPD 167, L167 | |||||||
| MRL20 |
|
6742 | |||||||
| MRL24 |
|
6743 | MRL 24 | ||||||
| MRL-248 |
|
9080 | |||||||
| MRL-367 |
|
9079 | |||||||
| MRL-871 |
|
|
10642 | MRL871 | |||||
| MRS1041 | 392 | 3,5,7-triethoxyflavone, MRS-1041 | |||||||
| MRS1042 | 393 | MRS-1042 | |||||||
| MRS1062 | 394 | MRS-1062 | |||||||
| MRS1065 | 395 | MRS 1065 | |||||||
| MRS1066 | 396 | ||||||||
| MRS1067 | 466 | MRS-1067 | |||||||
| MRS1084 | 397 | 4-(propyloxy)-7-trans-styrylvisnagin | |||||||
| MRS1086 | 398 | MRS-1086 | |||||||
| MRS1088 | 429 | 3,6-dichloroflavone, MRS-1088, NSC-74876 | |||||||
| MRS1093 | 399 | 3,7-Diethoxy-5-hydroxyflavone, MRS-1093 | |||||||
| MRS1097 | 467 | MRS-1097 | |||||||
| MRS1132 | 400 | 3-chloroflavone | |||||||
| MRS1177 | 468 | ||||||||
| MRS1186 | 469 | MRS-1186 | |||||||
| MRS1191 | 470 | MRS-1191 | |||||||
| MRS1220 | 448 | MRS 1220, MRS-1220 | |||||||
| MRS1476 | 471 | MRS-1476, MRS1191 | |||||||
| MRS-1477 | 12545 | MRS 1477, MRS1477 | |||||||
| MRS1486 | 472 | MRS-1486 | |||||||
| MRS1505 | 473 | MRS-1505 | |||||||
| MRS1523 | 474 | MRS 1523 , MRS-1523 | |||||||
| MRS1706 | 3287 | MRS 1706, MRS-1706 | |||||||
| MRS1754 | 449 | MRS-1754 | |||||||
| MRS2159 | 11231 | MRS-2159 | |||||||
| MRS2179 | 1720 | MRS-2179 | |||||||
| MRS2211 | 1777 | MRS-2211 | |||||||
| MRS 2219 | 6496 | MRS-2220, MRS2219 | |||||||
| MRS2279 | 1721 | MRS-2279 | |||||||
| MRS2298 | 1722 | MRS 2298, MRS-2298 | |||||||
| MRS2365 | 3338 | (N)-methanocarba-2-MeSADP, MRS 2365 | |||||||
| MRS2496 | 1723 | MRS-2496 | |||||||
| MRS2500 |
|
1724 | MRS 2500, MRS-2500 | ||||||
| MRS2567 | 1752 | ||||||||
| MRS2578 |
|
1753 | MRS 2578, MRS-2578 | ||||||
| MRS2603 | 1778 | MRS 2603 | |||||||
| MRS2690 | 3337 | MRS 2690, MRS-2690 | |||||||
| MRS2693 | 1747 | 5-iodo-UDP, 5-iodo-uridine-5'-diphosphate, MRS 2693, MRS-2693 | |||||||
| MRS2698 | 1733 | 2'-amino-2-thio-UTP, MRS-2698 | |||||||
| MRS2768 | 4043 | uridine-5'-tetraphosphate δ-phenyl ester | |||||||
| MRS2782 |
|
1748 | Uridine-5'-α,β-methylene-diphosphate triethylammonium salt | ||||||
| MRS2802 | 5909 | ||||||||
| MRS2905 | 5908 | ||||||||
| MRS2927 | 6199 | compound 34 [PMID:21528910], Up4 -[1]3'-deoxy-3'-fluoroglucose | |||||||
| MRS2950 | 5809 | ||||||||
| MRS2957 | 5903 | MRS 2957 | |||||||
| MRS3558 | 5601 | CF502, MRS 3558, MRS-3558 | |||||||
| MRS4062 | 4044 | MRS 4062, MRS-4062, N4-phenylpropoxycytidine-5'-triphosphate | |||||||
| MRS4174 |
|
9470 | derivative 30 [PMID: 25299434] | ||||||
| MRS4183 |
|
9471 | compound 11 [PMID: 26303895] | ||||||
| MRS4458 |
|
9998 | compound 20 [Yu et al., 2018] | ||||||
| MRS4478 |
|
9999 | compound 30 [Yu et al., 2018] | ||||||
| MRS4625 | 11453 | compound 4 [PMID: 32551012], MRS-4625 | |||||||
| MRS4654 | 14170 | compound 32 [PMID: 33787273], MRS-4654 | |||||||
| MRS4738 | 14171 | compound 15 [PMID:35113556], MRS-4738 | |||||||
| MRS4833 | 14172 | compound 15 [PMID: 37382926], MRS-4833 | |||||||
| MRS4841 | 14163 | compound 2b [PMID: 39195256], MRS-4841 | |||||||
| MRS5151 | 5622 | ||||||||
| MRS5698 | 8421 | MRS 5698, MRS-5698 | |||||||
| MRS7469 | 10235 | ||||||||
| MRS8054 | 12483 | compound 39 [PMID: 36367749] | |||||||
| MRS923 | 401 | ||||||||
| MRS928 | 402 | galangin trimethyl ether | |||||||
| [32P]MRS2500 |
|
|
1726 | [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate | |||||
| [3H]MRS1754 |
|
|
453 | [3H]-MRS1754 | |||||
| [3H]MRS2279 |
|
|
1727 | [3H]-MRS2279 | |||||
| MRS4162-BODIPY conjugate |
|
9469 | BODIPY 630/650 conjugate 28 | ||||||
| MRT-2359 | 12629 | MRT2359 | |||||||
| MRT67307 |
|
|
8062 | MRT-67307 | |||||
| MRT-92 | 10332 | ||||||||
| MRTX0902 |
|
11966 | MRTX-0902 | ||||||
| MRTX1133 |
|
11851 | compound 1 [PMID: 34889605], MRTX-1133 | ||||||
| MS023 |
|
8955 | |||||||
| MS049 | 9529 | compound 17 [PMID: 27584694] | |||||||
| MS102 | 13058 | compound #56 [PMID: 38055802], MS-102 | |||||||
| MS132 | 13043 | compound 11 [PMID: 38019706], MS-132, XF056-132 | |||||||
| MS15 | 12216 | compound 62 [PMID: 36197750] | |||||||
| MS154 | 10635 | compound 10 [PMID: 31895569] | |||||||
| MS31 |
|
13300 | compound 3 [PMID: 31260300], MS-31 | ||||||
| MS363 | 8876 | compound 29 | |||||||
| MS39 | 10634 | compound 6 [PMID: 31895569] | |||||||
| MS40 | 12000 | ||||||||
| MS417 |
|
7512 | |||||||
| MS432 | 10563 | compound 23 [PMID: 31730343], MS-432 | |||||||
| MS436 |
|
7509 | |||||||
| MS48107 | 10440 | GPR68 α-PAM 71, compound 71 [PMID: 31298539] | |||||||
| MS7972 |
|
7508 | |||||||
| MS8535 | 13299 | compound 18 [PMID: 38533580], MS-8535 | |||||||
| MS8709 | 13288 | Compound 10 [PMID: 38464025], MS-8709 | |||||||
| MS8815 | 12138 | compound 16 [PMID: 35837138], MS-8815 | |||||||
| MSA-2 |
|
13531 | compound 62 [PMID: 31820978], example 16 [WO2018067423A1], MSA2 | ||||||
| MSC2032964A | 8076 | ||||||||
| MSOPPE | 1440 | alpha-methylserine-O-phosphate monophenyl ester | |||||||
| MSVIII-19 | 4258 | 8,9-dideoxyneodysiherbaine | |||||||
| MSX-2 | 5610 | ||||||||
| MT-1207 | 13442 | compound II-13 [PMID: 38968440], MT1207 | |||||||
| MT-45 | 10724 | CDEP, IC-6, MT45, NSC 299236 | |||||||
| MT47-100 | 8821 | ||||||||
| MT-8 | 11857 | 3'-hydroxybiochanin A, MT8, pratensein | |||||||
| MTEB | 1428 | ||||||||
| MTEP | 3336 | ||||||||
| [14C]MTEP |
|
|
1429 | LS-131849 | |||||
| MTK458 | 13011 | MTK-458 | |||||||
| MTSEA | 6272 | methanethiosulfonate ethylammonium | |||||||
| mubritinib | 6011 | TAK 165, TAK-165, TAK165 | |||||||
| mupirocin |
|
|
|
10916 | Bactroban®, BRL-4910A, BRL-4910F, Centany®, pseudomonic acid | ||||
| [3H]muscimol |
|
|
|
4090 | |||||
| MUT056399 |
|
11000 | Fab-001, FAB001, MUT-056399 | ||||||
| muvalaplin |
|
12939 | LY-3473329, LY3473329 | ||||||
| MW01 | 12974 | ||||||||
| MW05 | 12975 | ||||||||
| MW150 |
|
|
10524 | compound 11 [PMID: 30978288], compound 27 [WO2014145485A2], compound 8 [PMID: 25676389], MW-150, MW01-18-150SRM | |||||
| MX-2401 | 13518 | ||||||||
| mycophenolate mofetil |
|
|
6831 | Cellcept®, RS-61443, RS-61443-190 | |||||
| myriocin |
|
6664 | ISP-1, thermozymocidin | ||||||
| MYX1715 | 13849 | Comparator Compound 1 [WO2024052685A1], MYX-1715 | |||||||
| MZ1 | 10728 | ||||||||
| MZ-101 | 13115 | MZ101 | |||||||
| Mz438 |
|
12805 | compound 9a [PMID: 37463496], Mz-438 | ||||||
| N | Back to top | ||||||||
| N-0920 | 13836 | compound 2-9A [PMID: 40163818], N0920 | |||||||
| nabilone |
|
9071 | Cesamet®, LY 109514, LY-109514 | ||||||
| nabumetone |
|
|
|
7245 | BRL-14777, Relafen® | ||||
| N-acetyl-4-benzoquinoneimine | 6299 | N-acetyl-p-benzo-quinoneimine, napqi | |||||||
| N-acetyloxyethyl-exo-THPO | 5420 | ||||||||
| nacresertib |
|
13502 | compound 001 [WO2021057785] | ||||||
| nacubactam | 10833 | OP-0595, OP0595, RG-6080, RG6080, RO-7079901, RO7079901 | |||||||
| NADA | 4261 | N-arachidonyl dopamine | |||||||
| nadifloxacin |
|
12919 | Nadixa®, OPC-7251 | ||||||
| nadolol |
|
554 | Corgard®, corzide, SQ-11725 | ||||||
| NAEPA | 6982 | N-acyl ethanolamide phosphate | |||||||
| nafadotride | 44 | ||||||||
| nafamostat |
|
|
4262 | CKD-314, CKD314, FUT-175, Nafabelltan® | |||||
| nafcillin |
|
10942 | Ethoxynaphthamido Penicillin Sodium, Nallpen®, Unipen® | ||||||
| nafithromycin | 10834 | WCK 4873, WCK-4873, WCK4873 | |||||||
| nafoxidine | 4263 | ||||||||
| Nag 26 | 9305 | compound 26 [PMID: 26267383], Nag26 | |||||||
| nahuoic acid A | 7022 | ||||||||
| nalbuphine |
|
1663 | Nubain® | ||||||
| naldemedine |
|
9150 | compound 9k [PMID: 30446313], S-297,995, S-297995 | ||||||
| nalfurafine |
|
|
1651 | TRK 820, TRK820 | |||||
| nalidixic acid |
|
|
12773 | NegGram®, Win 18,320 | |||||
| nalmefene |
|
1628 | JF-1, nalmetrene, Opvee® (nalmefene hydrochloride nasal spray), ORF-11676, Revex® (nalmefene hydrochloride), Selincro® | ||||||
| nalorphine |
|
1629 | N-allyl-normorphine | ||||||
| naloxegol |
|
7539 | AZ-13337019, AZ13337019, Movantik®, Moventig®, NKTR-118 | ||||||
| naloxonazine | 1677 | NSC 612113 | |||||||
| (+)-naloxone | 1668 | ||||||||
| naloxone |
|
|
1638 | (-)-naloxone, Kloxxado® (naloxone hydrochloride nasal spray), l-naloxone, Narcan®, Nyxoid® | |||||
| [3H]naloxone |
|
|
|
1676 | [N-allyl-2,3-3H]naloxone | ||||
| naloxone benzoylhydrazone | 1664 | nalbzoh | |||||||
| naltrexone |
|
1639 | (-)naltrexone, naltrexone HCl, ReVia® | ||||||
| naltriben |
|
1640 | NTB, naltrindole benzofuran | ||||||
| [3H]naltriben |
|
|
|
3828 | [3H]-naltriben | ||||
| naltrindole |
|
1641 | |||||||
| [3H]naltrindole |
|
|
|
3829 | [3H]-naltrindole | ||||
| NAMPT PROTAC B4 | 12271 | compound 5 [PMID: 36442664] | |||||||
| NAN 190 | 73 | NAN-190, NAN190 | |||||||
| nandrolone |
|
|
6949 | 19-norandrostenolone, Deca-Durabolin® (decanoate ester), Durabolin® (phenylpropionate ester) | |||||
| NANT |
|
10622 | nNOS inhibitor I | ||||||
| napabucasin |
|
11358 | BBI-608, BBI608 | ||||||
| naperiglipron | 14175 | example 2 [WO2020263695], LY-3549492, LY3549492 | |||||||
| naphazoline |
|
5509 | Naphcon® | ||||||
| naphthoquine |
|
10396 | |||||||
| 1-naphthylpiperazine | 3 | 1-NP | |||||||
| naphthylvinylmethylpyridine | 8807 | (E)-4-(1-naphthylvinyl)pyridine methochloride, compound 2 [PMID: 3351860] | |||||||
| naporafenib |
|
10658 | compound 15 [PMID: 31059256], example 1156 [WO2014151616A1], LXH-254, LXH254 | ||||||
| naproxcinod |
|
9551 | AZD-3582, AZD3582, HCT-3012, NO-naproxen | ||||||
| naproxen |
|
|
|
5230 | (S)-naproxen, Aleve®, Naprosy® | ||||
| naquotinib |
|
9248 | ASP8273 | ||||||
| N-arachidonyl-γ-aminobutyric acid | 5494 | arachidonoyl GABA, NA-GABA | |||||||
| N-arachidonyl-D-alanine | 5495 | ||||||||
| N-arachidonyl-glycine | 5493 | ||||||||
| narasin | 10835 | C-7819B, Lilly 79891, Monteban®, Narasin A | |||||||
| naratriptan |
|
45 | Amerge®, GR-85548A | ||||||
| narazaciclib |
|
11879 | compound 7x [PMID: 24417566], ON-123300, ON123300 | ||||||
| narlaprevir |
|
11572 | Arlansa®, SCH 900518, SCH-900518, SCH900518 | ||||||
| narmafotinib | 12373 | AMP-945, AMP945, CTX-0294945, example 3 [US9120761B2] | |||||||
| NAS181 | 3226 | ||||||||
| NAS-181 free base | 14201 | (R)-25 [PMID:9599242] | |||||||
| nateglinide |
|
6833 | AY-4166, SDZ-DJN-608, Starlix® | ||||||
| natrin | 14029 | 2,4,5-TES | |||||||
| NAV2729 | 14182 | Grassofermata, NAV-2729 | |||||||
| navacaprant | 10452 | BTRX-335140, BTRX335140, compound 58 [PMID: 30707578], CYM-53093, CYM53093, NMRA-140, NMRA-335140, NMRA140 | |||||||
| navamepent |
|
9463 | RX-10045 | ||||||
| navarixin |
|
8497 | MK-7123, MK7123, SCH-527123, SCH527123 | ||||||
| navitoclax |
|
8319 | ABT 263, ABT-263 | ||||||
| navlimetostat |
|
12116 | (M)-27, (S)-MRTX-1719, MRTX-1719, MRTX1719 | ||||||
| navoximod |
|
|
9019 | GDC-0919, NLG-919, NLG919, RG6078 | |||||
| navtemadlin | 11133 | AMG232, compound 2 [PMID: 24456472], KRT-232, KRT232 | |||||||
| nazartinib | 9204 | compound 47 [PMID: 27433829], EGF-816, EGF816 | |||||||
| NB-360 |
|
9822 | NB360 | ||||||
| NB-598 |
|
3103 | NB 598 | ||||||
| NBA |
|
10039 | compound 6 [PMID: 29579323] | ||||||
| NBBCC | 2374 | n-butyl-β-carboline-3-carboxylate, n-butyl-beta-carboline-3-carboxylate | |||||||
| N-benzyl brucine | 332 | BNO | |||||||
| N6 benzyl-cAMP | 5228 | N6-benzyl cyclic AMP | |||||||
| NBI27914 | 3512 | NBI 27914, NBI-27914 | |||||||
| NBI-34041 | 10375 | compound 16a [PMID: 16078829], NBI34041, SB-723620, SB723620 | |||||||
| NBI-35965 | 11025 | NBI 35965, NBI35965 | |||||||
| NBI-42902 | 1178 | NBI 42902, NBI42902 | |||||||
| NBI-59159 | 4626 | ||||||||
| NBI-74330 |
|
839 | (±)-NBI 74330, NBI74330 | ||||||
| [3H]NBI-49202 |
|
|
1187 | ||||||
| NBOMe | 13550 | 2C-I-NMBOMe, CIMBI-5 | |||||||
| NBQX |
|
4264 | 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline | ||||||
| NBTGR | 4513 | nitrobenzylthioguanosine | |||||||
| NC00075159 | 7664 | ||||||||
| NC1 |
|
10373 | |||||||
| NCATS-SM3710 |
|
11822 | |||||||
| NCFP | 6471 | ||||||||
| NCG21 | 5587 | compound 12 [PMID: 19007110], NGC21 | |||||||
| NCGC607 | 10697 | KUC107647N, NCGC00241607 | |||||||
| NCGC 84 | 9168 | ML 154, NCGC 00185684, NCGC00185684 | |||||||
| N-chloromethyl-brucine | 344 | CMB, N-chloromethylbrucine | |||||||
| NCL-1 | 7024 | ||||||||
| NCRW0105-E06 | 12363 | ||||||||
| NCRW0005-F05 | 8775 | ||||||||
| NCX-4016 |
|
9018 | NCX 4016, NCX4016, nitric oxide-releasing aspirin, nitroaspirin | ||||||
| N(6)-cyclohexyladenosine | 423 | CHA | |||||||
| ND-2110 |
|
|
8082 | ||||||
| ND-2158 |
|
8083 | |||||||
| (R)-ND-336 | 10887 | ||||||||
| N1-dansyl-spermine | 4260 | ||||||||
| NDD-713 | 12579 | ||||||||
| NDD-825 | 12580 | ||||||||
| N-desalkylquetiapine | 7545 | norquetiapine | |||||||
| N-desmethylclozapine | 333 | desmethylclozapine, N-desmethyl-clozapine, norclozapine | |||||||
| NDI-091143 |
|
12854 | NDI091143 | ||||||
| N′,2-diphenylquinoline-4-carbohydrazide | 2129 | compound 2g [PMID: 16950620] | |||||||
| N',2-diphenylquinoline-4-carbohydrazide 8m | 2130 | compound 8m [PMID:16950617] | |||||||
| N-docosatetra-7,10,13,16-enoylethanolamine | 5445 | N-docosatetraenoylethanolamine | |||||||
| NDPPC | 12846 | ||||||||
| NDT-19795 |
|
13009 | NDT19795 | ||||||
| NDT9513727 |
|
|
9746 | NDT 9513727, NDT-9513727 | |||||
| NDT9520492 | 578 | ||||||||
| NE-100 |
|
6679 | NE100 | ||||||
| NE10575 |
|
3184 | NE 10575, NE-10575 | ||||||
| NE10790 | 3165 | NE 10790 | |||||||
| NE11808 |
|
3160 | NE 11808 | ||||||
| NE21650 | 3167 | NE 21650 | |||||||
| NE58018 | 3168 | NE 58018, NE-58018 | |||||||
| NE58027 | 3154 | NE 58027 | |||||||
| NE58043 | 3179 | NE 58043 | |||||||
| NE58062 | 3166 | NE 58062 | |||||||
| NE97220 |
|
3171 | CGA 103586, NE 97220, Q 332 | ||||||
| nebivolol |
|
7246 | Bystolic®, R-65824, Ro-67555 | ||||||
| NECA |
|
377 | 5'-N-ethylcarboxamidoadenosine | ||||||
| [3H]NECA |
|
|
|
425 | [3H]adenosine-5'-(N-ethylcarboxamide) | ||||
| necrostatin-1 |
|
9750 | methyl-thiohydantoin-tryptophan, MTH-DL-tryptophan, MTH-trp, nec-1, Necrostatin 1 | ||||||
| necrostatin-1s |
|
9751 | 7-Cl-O-Nec-1, nec-1s, necrostatin 2 racemate | ||||||
| nedizantrep | 12895 | Example 8 [WO2019182925A1], GDC-6599, GDC6599, RG6341 | |||||||
| nedocromil |
|
|
7607 | FPL-59002, nedocromil sodium, Rapitil®, Tilade® | |||||
| nedometinib | 12872 | Example 2 [US11161845B2], NFX-179, NFX179 | |||||||
| nefazodone |
|
7247 | BMY-13754, MJ-13754-1, Nefadar® | ||||||
| nefextinib | 13213 | example 31 [CN106366093A], MAX-40279, MAX-40279-01, MAX40279 | |||||||
| neflamapimod |
|
|
5719 | VD-31745, VRT-031745, VX 745, VX-745 | |||||
| neladalkib |
|
13214 | compound 1 [WO2023196910] | ||||||
| neladenoson | 11222 | BAY 1067197, BAY-1067197, BAY1067197 (amide ester prodrug), neladenoson dalanate (deprecated INN) | |||||||
| nelarabine |
|
7090 | 506U78, Arranon®, Atriance® | ||||||
| nelfinavir |
|
|
11090 | AG-1343, AG1343, Viracept® | |||||
| nelivaptan | 2202 | SSR-149,415, SSR149415 | |||||||
| [3H]nelivaptan |
|
|
3483 | [3H]-SSR149415, [3H]SSR149415 | |||||
| nemiralisib |
|
|
9425 | compound 2 [PMID: 26301626], GSK-2269557, GSK2269557 | |||||
| nemonapride | 983 | emonapride, YM 09151-2, YM-09151-2 | |||||||
| [3H]nemonapride |
|
|
|
962 | |||||
| nemonoxacin |
|
10836 | Taigexyn®, TG-873870, TG873870 | ||||||
| nemtabrutinib |
|
11413 | ARQ-531, ARQ531, ArQule 531, MK-1026, MK1026 | ||||||
| neoceptin-3 |
|
|
9137 | ||||||
| neoceptin-4 |
|
9138 | |||||||
| neolymphostin A | 10151 | compound 4 [PMID: 30380865] | |||||||
| neostigmine |
|
8993 | Prostigmin® | ||||||
| nepafenac |
|
7564 | AHR-9434, AL-6515, Nevanac® | ||||||
| nepicastat | 6630 | RS-25560-197, SYN117 | |||||||
| NE 52-QQ57 |
|
|
10206 | example 35 [WO2012131633A1], GPR4 antagonist 13, NE52-QQ57 | |||||
| nerandomilast |
|
12518 | BI 1015550, BI-1015550, BI1015550 | ||||||
| neratinib |
|
5686 | HKI 272, HKI-272, Nerlynx® | ||||||
| α-NETA |
|
9781 | |||||||
| netarsudil |
|
9322 | AR-11324, AR11324, ester 60 [PMID: 27072905], Rhokiinsa®, Rhopressa® | ||||||
| N-ethyl-1-deoxynojirimycin | 4586 | ||||||||
| N-ethylhistamine | 1271 | ||||||||
| N-ethylmaleimide |
|
5335 | |||||||
| netilmicin |
|
12159 | 1-N-ethylsisomicin, Sch 20569 | ||||||
| netoglitazone | 2707 | MCC-555, MCC555, RWJ-241947 | |||||||
| netupitant |
|
|
5742 | Ro 67-31898/000, Ro-673189000 | |||||
| neurounina-1 | 11160 | ||||||||
| nevirapine |
|
|
12676 | BI-RG-587, BIRG-587, BIRG587, NVP, Viramune® | |||||
| Nexinhib20 |
|
9419 | |||||||
| nexturastat A |
|
7504 | S7473 | ||||||
| nezulcitinib |
|
11304 | example 1 [WO2020051105A1] | ||||||
| NF023 | 4266 | NF-023 | |||||||
| NF157 | 1761 | NF-157 | |||||||
| NF279 | 11230 | ||||||||
| NF340 | 1762 | NF 340, NF-340 | |||||||
| NF449 | 4267 | ||||||||
| NF546 | 4046 | NF-546 | |||||||
| NF770 | 9545 | ||||||||
| NF778 | 9546 | ||||||||
| NF-56-EJ40 |
|
|
10519 | ||||||
| NF-kB activation inhibitor | 6012 | AG-F-89549, EVP4593 | |||||||
| NFP | 10185 | compound 1 [PMID: 30608693] | |||||||
| NFPS | 4620 | N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine | |||||||
| (R)-NFPS |
|
4618 | (+)-NFPS, ALX 5407, ALX5407 | ||||||
| [3H]NFPS |
|
|
4619 | [3H]-NFPS | |||||
| NG-25 |
|
8074 | NG25 | ||||||
| NGB 2904 | 6674 | NGB-2904 | |||||||
| NGD 94-1 | 979 | NGD941 | |||||||
| [3H]NGD941 |
|
|
3297 | [3H]-NGD941, [3H]NGD 94-1 | |||||
| NH-3 | 2633 | thyromimetic, 5b | |||||||
| N-homo-γ-linolenoylethanolamine | 5444 | N-dihomo-γ -linolenoylethanolamine | |||||||
| NHWD-870 | 10743 | NHWD870 | |||||||
| 7NI |
|
5127 | 7-nitroindazole | ||||||
| NI-57 |
|
8573 | |||||||
| NIBR-0213 | 6997 | ||||||||
| NIBR189 | 13052 | compound 4m [PMID: 24678947] | |||||||
| NIBR51 | 13051 | compound 1 [PMID: 24678947] | |||||||
| nibrozetone |
|
13184 | ABDNAZ, RRx-001, RRx001 | ||||||
| NIC-0102 | 12174 | compound 27 [PMID: 36063115] | |||||||
| nicardipine |
|
2559 | (R,S)-nicardipine, Cardene® | ||||||
| niclosamide |
|
|
8494 | VU0243604 | |||||
| nicorandil |
|
2411 | Ikorel®, SG-75 | ||||||
| [3H]nicotine |
|
|
3978 | ||||||
| [3H]nicotinic acid |
|
|
|
1594 | [3H]-nicotinic acid | ||||
| nidufexor | 10655 | compound 1 [PMID: 31940200], LMB-763, LMB763 | |||||||
| nifedipine |
|
|
2514 | Adalat®, BAY-A-1040, Procardia® | |||||
| niflumic acid |
|
|
|
2439 | |||||
| nifuratel |
|
12348 | Macmiror®, Magmilor®, methylmercadone | ||||||
| nifuroxazide |
|
12358 | NSC-759261, RC-27109, SJ000287313 | ||||||
| nifurprazine | 10837 | carofur, HB-115, HB115 | |||||||
| nifurquinazol | 12344 | NF-1088 | |||||||
| nifurtimox |
|
12364 | BAY 2502, BAY A2502, Bayer 2502, Lampit® | ||||||
| nifurtoinol |
|
12346 | hydroxymethylnitrofurantoin, Urfadyn PL® | ||||||
| nifurzide | 12365 | Ricridene® | |||||||
| NIHP | 545 | ||||||||
| NiK-21273 | 10500 | NiK21273 | |||||||
| NIK inhibitor 12f |
|
10947 | |||||||
| NIK SMI1 |
|
9964 | |||||||
| NIL | 5231 | L-N6-(1-iminoethyl)lysine, N6-ethanimidoyl-D-lysine | |||||||
| nilofabicin |
|
10984 | CG-400549, CG400549 | ||||||
| nilotinib |
|
|
5697 | AMN 107, AMN107, Danziten®, Tasigna® | |||||
| nilutamide |
|
2864 | Nilandron® | ||||||
| nilvadipine | 10160 | Escor®, FR-34235, FR34235 | |||||||
| nimesulide |
|
|
|
7401 | R-805 | ||||
| nimodipine |
|
2523 | BAY-E-9736, Nimotop® | ||||||
| nimucitinib | 12390 | ||||||||
| ningetinib | 11624 | CT-053, CT053, CT053PTSA, Example 1 [US9133162] | |||||||
| nintedanib |
|
|
5936 | BIBF-1120, BIBF1120, Ofev®, Vargatef® | |||||
| NIP | 546 | N-isopropyl-phenoxypropanolamine | |||||||
| NIP-142 | 2408 | ||||||||
| nipecotic acid | 4564 | ||||||||
| niraparib |
|
|
8275 | Akeega® (niraparib and abiraterone acetate), compound 56 [PMID 19873981], MK 4827, MK-4827, Zejula® | |||||
| nirmatrelvir |
|
|
11503 | example E61 [WO2021250648A1], Paxlovid® (nirmatrelvir + ritonavir), PF-07321332, PF07321332 | |||||
| nirogacestat |
|
|
7746 | Ogsiveo®, PF-03084014, PF3084014, Z-3181 | |||||
| nisoldipine |
|
2524 | Sular® | ||||||
| N-1-isopropyl-5-MeOT | 158 | N-1-isopropyl-5-methoxytryptamine | |||||||
| N-1-isopropyltryptamine | 159 | ||||||||
| nisoxetine | 4637 | ||||||||
| [3H]nisoxetine |
|
|
4636 | [3H]-nisoxetine | |||||
| nispomeben | 13507 | ||||||||
| NITD-349 |
|
13874 | |||||||
| nitisinone |
|
6834 | Orfadin®, SC-0735 | ||||||
| nitrendipine |
|
2334 | |||||||
| nitrobenzylmercaptopurine ribonucleoside | 4512 | NBMPR, NBTI, nitrobenzylthioinosine | |||||||
| [3H]nitrobenzylmercaptopurine ribonucleoside |
|
|
4511 | [3H]NBMPR, [3H]-NBTI , [3H]NBTI | |||||
| nitrofural |
|
|
12366 | Furacin®, Furacine®, nitrofurazone | |||||
| nitrofurantoin |
|
|
10917 | Furadantin®, Macrobid®, Macrodantin®, Nitro Macro®, NSC-2107, NSC-44150 | |||||
| nitroglycerin |
|
|
7053 | glyceryl trinitrate, Glytrin®, Minitran®, Rectogesic® | |||||
| nitrooleic acid | 6296 | 9-nitrooleate | |||||||
| 4-Nitrophenyl-β-D-mannopyranoside |
|
12453 | (4-nitrophenyl) D-manno-hexopyranoside, 4-Nitrophenyl beta-D-mannopyranoside, 4-nitrophenyl d-mannopyranoside, paranitrophenyl mannopyranoside | ||||||
| nitrosoprodenafil | 9552 | ||||||||
| nitroxoline |
|
|
13964 | ||||||
| nivasorexant | 12719 | ACT-539313, ACT539313 | |||||||
| nivegacetor | 13509 | ||||||||
| nizatidine |
|
7248 | Axid®, LY-139037 | ||||||
| nizubaglustat | 13906 | AZ-3102, AZ3102, compound 76 [PMID: 25250725] | |||||||
| NK01-63 |
|
12228 | coronastat | ||||||
| NK3201 | 6503 | NK 3201, NK-3201 | |||||||
| NK7-902 |
|
14003 | |||||||
| NKH477 | 5232 | 6-(3-dimethylaminopropionyl) forskolin hydrochloride, colforsin dapropate hydrochloride, NKH-477 | |||||||
| NKY80 | 5233 | adenylyl cyclase type V Inhibitor, NKY 80, NKY-80 | |||||||
| NL13 | 13416 | compound 7 [PMID: 39142876] | |||||||
| NLX-101 | 3924 | F-15,599, F-15599, F15599 | |||||||
| [3H]NLX-112 |
|
|
|
3925 | [3H]F13640 | ||||
| NMD670 | 13343 | NMD-670 | |||||||
| NMDA |
|
4268 | |||||||
| N-Me-aminopyrimidinone 9 | 5733 | ||||||||
| (N)methanocarba-UTP | 1740 | ||||||||
| [3H]N-methyl-AZ10419369 |
|
|
3219 | [N-methyl-3H3]AZ10419369 | |||||
| N-methyl-exo-THPO | 5419 | ||||||||
| [3H]N5-methylfolate |
|
|
6689 | ||||||
| N-α-methylhistamine | 1239 | NAMH, N-α-MeHA | |||||||
| N-methylhistamine | 1242 | 1-methylhistamine, tele-methylhistamine | |||||||
| N-[3H]α-methylhistamine |
|
|
1240 | [3H]-Na-methylhistamine, [3H]NAMH | |||||
| N-[3H]methylhistamine |
|
|
1241 | ||||||
| N-methyl LTC4 | 6194 | N-methyl-leukotriene C4 | |||||||
| N-methyl-pyridinium-2-aldoxime | 4652 | ||||||||
| N-methyl-2-pyrrolidone |
|
|
9520 | NMP, N-methyl-pyrrolidone | |||||
| N-methyl scopolamine |
|
316 | NMS, methylscopolamine, methylscopolamine bromide, N-methylscopolamine, Pamine® | ||||||
| [3H]N-methyl scopolamine |
|
|
317 | [3H]N-methylscopolamine, [3H]NMS | |||||
| [3H]N-methylspiperone |
|
|
196 | [3H]methylspiperone | |||||
| N-methyl-SSR504734 | 4604 | ||||||||
| [3H]N-methyl-SSR504734 |
|
|
4603 | [3H]-N-methyl-SSR504734 | |||||
| (S)-N-[1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-acrylamide | 2600 | (S)-1 [PMID: 16904708], compound 2 [PMID: 12852750] | |||||||
| [3H]4NMPB |
|
|
352 | [3H](1-methyl-4-piperidyl) 2-hydroxy-2,2-diphenyl-acetate, [3H]1-Methyl-4-piperidyl diphenylglycolate, [3H]enpiperate | |||||
| NMS-P715 |
|
9401 | compound 15 [PMID: 21723120], NMSP715 | ||||||
| NMT5 | 12201 | ||||||||
| NMT inhibitor 1 [WO2024052685A1] | 13848 | ||||||||
| N,N`-bis-alkyl butylimmidazole 12b | 6911 | compound 12b [PMID: 23376252] | |||||||
| N, N-bis (5-ethyl-2-hydroxybenzyl) methylamine | 10940 | EMD | |||||||
| NNC052090 | 4610 | NNC 05-2090 | |||||||
| NNC0640 |
|
9574 | |||||||
| NNC 11-1314 | 291 | ||||||||
| NNC 11-1585 | 292 | ||||||||
| NNC 11-1607 | 293 | ||||||||
| NNC269100 | 3513 | NNC 269100, NNC-269100 | |||||||
| NNC55-0396 | 4269 | NNC 55-0396 | |||||||
| NNC-711 |
|
4669 | NO-711 | ||||||
| NNC 92-1687 | 3515 | NNC92-1687 | |||||||
| N,N-dimethylhistamine | 1270 | ||||||||
| 5-(N,N-hexamethylene)-amiloride |
|
1192 | HMA | ||||||
| NNMT inhibitor 14 [PMID: 35904556] | 12166 | ||||||||
| 6-n-octylaminouracil |
|
5846 | 6-n-octyl aminouracil | ||||||
| (R)-N-oleoyltyrosinol | 5720 | ||||||||
| (S)-N-oleoyltyrosinol | 5721 | OMDM-1 | |||||||
| nolpitantium | 2107 | SR 140,333, SR 140333, SR-140333, SR140333 | |||||||
| nomegestrol |
|
11245 | |||||||
| nomifensine |
|
4792 | Alival®, Merital® | ||||||
| nonabine | 9235 | BRL-4664 | |||||||
| [35S]non-peptide OT antagonist |
|
|
3484 | [35S]-non-peptide OT antagonist | |||||
| 5-(nonyloxy)-tryptamine | 106 | ||||||||
| 6-nonylpyridine-2,4-diol |
|
11212 | |||||||
| nor-binaltorphimine |
|
1642 | nor-bni, norbinaltorphimine | ||||||
| norendoxifen | 10204 | Z-norendoxifen | |||||||
| norethisterone |
|
|
2880 | Micronor®, norethindrone, Noriday® | |||||
| (+)-norfenfluramine | 216 | (S)-norfenfluramine | |||||||
| (-)-norfenfluramine | 217 | ||||||||
| norfenfluramine | 215 | (±)-norfenfluramine | |||||||
| norfloxacin |
|
12408 | AM-715, Chibroxin®, MK-0366, Noroxin® | ||||||
| norfluoxetine | 208 | ||||||||
| norgestimate |
|
7091 | dexnorgestrel, ORF-10131, RWJ-10131 | ||||||
| normorphine | 1630 | ||||||||
| nortriptyline |
|
|
2404 | Aventyl®, nortriptyline hydrochloride, Pamelor® | |||||
| norzotepine | 7537 | ||||||||
| NOX-6-18 | 12944 | ||||||||
| NOX-6-7 |
|
12945 | |||||||
| NP10679 |
|
13847 | NP-10679 | ||||||
| NP118809 | 7765 | NP 118809, NP-118809 | |||||||
| NP3-253 |
|
|
13645 | compound 16 [PMID: 39574318], NP3253 | |||||
| NPC1161B |
|
10393 | NPC-1161B | ||||||
| N-(4'-pentanonyl)-4-(4''-dimethylamino-styryl)pyridinium | 4773 | ||||||||
| N4-phenylethoxycytidine-5'-triphosphate | 6200 | compound 15 [PMID:21528910], N4-(phenylethoxy)-CTP | |||||||
| (-)-N-porphynorapomorphine | 969 | (-)-N-porphynorapomorphine, n-propylapomorphine | |||||||
| NPPB |
|
4270 | HOE 144, HOE-144 | ||||||
| NP-1815-PX | 11233 | ||||||||
| 4-(n-propyl)amino-3-nitrobenzoic acid |
|
5801 | compound 5c [PMID: 17931863] | ||||||
| Nωpropyl-L-arginine | 6525 | ||||||||
| N-propylnorapomorphine | 934 | NPA | |||||||
| NPS 2143 |
|
716 | NPS-2143, NPS2143 | ||||||
| NPS2390 | 1384 | NPS 2390, NPS-239 | |||||||
| NPT520-34 |
|
13271 | compound 1 [WO2019246454] | ||||||
| NPTS | 4601 | (N-[3-phenyl-3-(4'-(4-toluoyl) phenoxy)propyl]sarcosine | |||||||
| [3H](R)-NPTS |
|
|
4602 | [3H]-(R)-NPTS | |||||
| NQN-1 | 7058 | NSC 73233, PPM-18 | |||||||
| NS004 | 4271 | NS 004, NS-004, NS-O04 | |||||||
| NS11021 | 11854 | NS 11021, NS-11021 | |||||||
| NS11757 | 2944 | compound 39 [PMID: 18998663], NS-11757 | |||||||
| NS13001 | 9316 | ||||||||
| NS1619 | 4272 | NS 1619, NS-1619 | |||||||
| NS1643 | 2308 | NS 1643, NS-1643 | |||||||
| NS1738 |
|
4000 | NS-1738 | ||||||
| NS19504 |
|
14024 | NS 19504, NS-19504 | ||||||
| NS 2028 |
|
6554 | NS-2028, NS2028 | ||||||
| NS-220 | 2678 | LS-191458 | |||||||
| NS309 |
|
2317 | NS-309 | ||||||
| NS3623 | 7660 | NS 3623, NS-3623 | |||||||
| NS3728 | 4273 | NS 3728, NS-3728 | |||||||
| NS3763 | 4274 | NS-3763 | |||||||
| NS383 | 11474 | ||||||||
| NS-398 |
|
|
8976 | NS 398 | |||||
| NS-49 | 481 | ||||||||
| NS5818 | 4275 | NS-5818 | |||||||
| NS6180 |
|
9318 | |||||||
| NS6740 |
|
11383 | A-793394, A793394, NS-6740 | ||||||
| NS8593 |
|
2318 | NS 8593, NS-8593 | ||||||
| NS9283 |
|
3993 | NS-9283 | ||||||
| N3SA |
|
13772 | 1,3,7-Naphthalenetrisulfonic acid, naphthalene-1,3,7-trisulfonic acid | ||||||
| NSC151066 | 11238 | NSC-151066 | |||||||
| NSC157058 | 9652 | ||||||||
| NSC 157449 | 834 | SK&F 83589 | |||||||
| NSC212069 | 11239 | NSC-212069 | |||||||
| NSC 23766 | 11057 | NSC-23766, NSC23766 | |||||||
| NSC600684 | 11240 | NSC-600684 | |||||||
| NSC61610 |
|
10364 | |||||||
| NSC620333 | 13461 | NSC-620333 | |||||||
| NSC 780521 | 9933 | compound 521 [PMID: 28709950], NSC-780521, NSC780521 | |||||||
| NSC80734 |
|
10497 | |||||||
| NSC-84963 | 10956 | NSC 84963, NSC84963 | |||||||
| NSC-93169 | 10957 | NSC 93169, NSC93169 | |||||||
| nsp16 inhibitor 5a |
|
13462 | compound 5a [PMID: 37728236] | ||||||
| NST-628 |
|
13370 | |||||||
| NT-0249 |
|
13338 | NT0249 | ||||||
| NT-0796 |
|
13008 | NT0796 | ||||||
| NT23 | 11819 | compound 1 [PMID: 20158183], NT-23 | |||||||
| NTB-3119 | 13584 | compound 6b [PMID: 30336450] | |||||||
| NTE-1 |
|
8596 | |||||||
| NTE-2 |
|
8597 | |||||||
| NTP42 | 11537 | NTP-42 | |||||||
| NTQ1062 | 12112 | compound 22b [PMID: 35679512], NTQ-1062 | |||||||
| nTzDpa |
|
2699 | NZA | ||||||
| NU-7026 | 5959 | DNA-PK inhibitor II, LY-293646, NU 7026, NU7026 | |||||||
| NU-7441 |
|
8010 | KU-57788, NU7441 | ||||||
| NUDT7-COV-1 | 10384 | ||||||||
| nuvisertib | 13215 | SGI-9481, SGI9481, TP-3654, TP3654 | |||||||
| NV-31 | 2375 | ||||||||
| NVP-2 | 8053 | Compound 310 [US8778951], Example 93 [US8778951] | |||||||
| NVP 231 | 6668 | NVP-231, NVP231 | |||||||
| NVP-AAM077 | 4276 | PEAQX | |||||||
| NVP-AEW541 | 8067 | AEW541, NVP AEW541, NVP-AEW 541, NVP-AEW541-A | |||||||
| NVP-BBT594 |
|
7584 | |||||||
| NVP-CLR457 |
|
12119 | compound 40 [PMID: 35500094] | ||||||
| NVP-DFF332 | 13702 | Example 31 [WO2021217508A1], NVP DFF332 | |||||||
| NVP-DKY709 |
|
12583 | compound 5 [PMID: 36863346], DKY-709, DKY709 | ||||||
| NVP-SAA164 | 659 | NVP SAA164 | |||||||
| NVP-TAE 226 |
|
9382 | NVP-TAE226, TAE226 | ||||||
| NVP-TAE684 |
|
5714 | NVP-TAE 684, TAE-684, TAE684 | ||||||
| NVP‐TNKS656 | 10674 | compound 43 [PMID: 23844574], example 5 [WO2013012723A1], NVP-TNKS-656, NVPTNKS656, TNK-S656, TNKS656 | |||||||
| NVS-1 | 8951 | NVS-CECR2-1 | |||||||
| NVS-VHL720 |
|
14122 | |||||||
| NX-1607 |
|
12694 | C-7683, C7683, compound 23 [WO2020264398], NX1607 | ||||||
| NX-2127 |
|
12519 | |||||||
| NXE0041178 | 13909 | compound 1 [PMID: 37077397], HTL-0041178, HTL0041178, NXE-0041178 | |||||||
| NXP800 | 14086 | CCT361814, compound 22 [PMID: 37017629], NXP-800 | |||||||
| NY0116 | 10381 | ||||||||
| NYX-2925 | 11289 | NYX2925 | |||||||
| O | Back to top | ||||||||
| O-1602 |
|
5525 | O 1602 | ||||||
| O-1812 | 732 | O1812 | |||||||
| obatoclax |
|
11086 | GX-15-070, GX15-070, obatoclax mesylate, SB16622 | ||||||
| obefazimod | 11698 | ABX-464, ABX464, MMV1581032, SPL-464 | |||||||
| obeldesivir | 12901 | ATV-006, ATV006, compound 5c [PMID: 34450570], GS-5245, GS5245 | |||||||
| obeticholic acid |
|
|
3435 | 6-ECDCA, 6-Et CDCA, 6-ethylchenodeoxycholic acid, INT-747, OCA, Ocaliva® | |||||
| OBI-3424 |
|
12770 | OBI3424, TH-3424, TH3424 | ||||||
| obicetrapib | 12205 | AMG-899, DEZ-001, TA-8995, TA8995 | |||||||
| OBT076 | 13819 | MEN-1309, MEN1309, OBT-076 | |||||||
| ocadusertib |
|
13504 | compound I-30 [WO2021046407], LY-3871801, LY3871801, R-552, R552 | ||||||
| ocaperidone | 46 | ||||||||
| ocedurenone | 12040 | Example 12 [US9468635B2], KBP-5074, KBP5074 | |||||||
| ocifisertib | 12083 | CFI-400945, CFI400945 | |||||||
| ocinaplon | 4277 | ||||||||
| ocipumaltib |
|
14050 | compound A [WO2023149450A1], CTX-177, CTX177 | ||||||
| oclacitinib |
|
9696 | Apoquel® (veterinary use), PF-03394197 | ||||||
| OCT2013 | 11803 | lidocaine N-oxide | |||||||
| 17-octadecynoic acid |
|
8851 | 17-ODYA | ||||||
| octyl thiophosphatidic acid | 6995 | ||||||||
| OD36 |
|
|
10406 | ||||||
| odanacatib | 6478 | MK-0822 | |||||||
| odevixibat |
|
11194 | A-4250, A4250, Bylvay®, example 5 [US9694018B1], Kayfanda® (odevixibat sesquihydrate), Unk-D-nTyr-Abu-OH (IUPAC condensed name) | ||||||
| oditrasertib | 12372 | example 29 [WO2018213632A1] | |||||||
| ODQ | 5234 | ||||||||
| OF-1 |
|
9523 | OF 1 | ||||||
| o-F-amidine | 8625 | compound 17 [PMID: 21882827] | |||||||
| ofirnoflast |
|
13227 | example 10 [WO2021242505] | ||||||
| ofloxacin |
|
10918 | DL-8280, Exocin® (eye drops), Floxin®, HOE-280, OFX, Tarivid® | ||||||
| ogerin | 9155 | ZINC67740571 | |||||||
| OG-L002 | 7023 | ||||||||
| 3β-OH | 10537 | (3β,5β,17β)-3-hydroxyandrostane-17-carbonitrile, B260 | |||||||
| 5-OH-DPAT | 128 | 6-dipropylaminotetralin-1-ol | |||||||
| 7-OH-DPAT | 950 | (+)-7-hydroxy-2-aminopropylaminotetralin, (+)7-OH-DPAT | |||||||
| 8-OH-DPAT | 7 | ||||||||
| [3H]7-OH-DPAT |
|
|
3296 | [3H]-7-OH-DPAT | |||||
| [3H]8-OH-DPAT |
|
|
31 | ||||||
| 4OH-GTS-21 |
|
11385 | 4-OH-GTS-21, 4-OH-MBA | ||||||
| ohmefentanyl | 13538 | Beta-Hydroxy-3-methylfentanyl, F-7302, F7302, OMF | |||||||
| 9-OH-risperidone | 67 | 9-hydroxy-risperidone | |||||||
| o-hydroxyatorvastatin |
|
6705 | BMS-243887 | ||||||
| OICR-8268 |
|
12817 | compound 26e [PMID: 36948210], OICR8268 | ||||||
| OICR-9429 |
|
8231 | |||||||
| OL135 | 5235 | OL-135, ORL 135 | |||||||
| olafertinib | 9863 | CK101, CK‐101, Example 153 [US20170050936A1], RX-518, RX518 | |||||||
| olamufloxacin | 10838 | HSR-903, HSR903 | |||||||
| olanzapine |
|
47 | LY-170053, Zyprexa® | ||||||
| olaparib |
|
|
7519 | AZD-2281, AZD2281, Lynparza® | |||||
| olaptesed pegol |
|
9674 | NOX-A12 | ||||||
| olcegepant |
|
702 | BIBN 4096 BS, BIBN4096BS | ||||||
| 1-oleoyl glycerol |
|
5756 | |||||||
| oleoyl-lysophosphatidylcholine | 3623 | LPC 18:1, lysolecithin, lysophosphatidylcholine(18:1), OLPC | |||||||
| oleoyl-thiophosphate | 6983 | ||||||||
| olesoxime | 8542 | cholest-4-en-3-one, oxime, TRO-19622, TRO19622 | |||||||
| olgotrelvir | 13926 | STI-1558, STI1558 | |||||||
| oliceridine |
|
|
7334 | Olinvyk®, TRV130, TRV130A | |||||
| olinciguat |
|
10213 | IW-1701, IW1701 | ||||||
| olisutrigine | 11116 | ASN-008, ASN008 | |||||||
| olitigaltin |
|
12148 | GB-0139, GB0139, TD-139, TD139 | ||||||
| olmesartan |
|
591 | Benicar®, CS-866, Olmetec® | ||||||
| olmutinib |
|
9196 | BI-1482694, Example 1 [US20130116213], HM-61713, HM61713 | ||||||
| olodanrigan |
|
8374 | [S]-enantiomer of EMA400, [S]-enantiomer of PD-126,055, EMA-401, EMA401 | ||||||
| olodaterol |
|
|
|
7543 | BI-1744, BI-1744-CL, Striverdi® | ||||
| olopatadine |
|
|
7249 | ALO-4943A, KW-4679, Opatanol®, Patanol®, Pazeo® | |||||
| olorinab |
|
10058 | APD-371, APD371, compound 6 [PMID: 29259753] | ||||||
| olsalazine |
|
11578 | CJ-91B, CJ91B, Dipentum® | ||||||
| olutasidenib |
|
|
10319 | example 26 [US9834539B2], FT-2102, FT2102, Rezlidhia® | |||||
| olvanil | 2488 | ||||||||
| olverembatinib |
|
|
|
10630 | compound 10a [PMID: 23301703], GZD-824, GZD824, HQP-1351, HQP1351 | ||||
| OM-1700 |
|
11082 | compound 13 [PMID: 32511917], OM1700 | ||||||
| omadacycline |
|
|
10839 | amadacycline, compound 6 [PMID: 21302930], Nuzyra®, PTK-0796, PTK0796 | |||||
| omarigliptin | 8402 | MK-3102, MK3102 | |||||||
| omaveloxolone |
|
|
7573 | RTA 408, RTA-408, Skyclarys® | |||||
| ombitasvir |
|
11272 | ABT-267, ABT267, compound 38 [PMID: 24400777], Technivie® (ombitasvir + paritaprevir + ritonavir), Viekirax® (ombitasvir + paritaprevir + ritonavir; EU) | ||||||
| 4-OMe-ARM1 |
|
|
10562 | compound 7 [PMID: 31751136] | |||||
| omecamtiv mecarbil |
|
8740 | AMG 423, AMG-423, CK-1827452 | ||||||
| omega-chloroacetophenone | 6285 | chloromethyl phenyl ketone, mace (lacrimator), phenacyl chloride, tear gas | |||||||
| omeprazole |
|
4279 | H 168/68, Losec®, Prilosec® | ||||||
| omidenepag |
|
10315 | DE-117 (omidenepag isopropyl ophthalmic solution), Omlonti®, UR-7276, UR7276 | ||||||
| omilancor |
|
10363 | analogue 7 [PMID: 27933891], BT-11, BT11, Example 1 [US9556146B2] | ||||||
| omipalisib |
|
|
8974 | GSK 2126458, GSK-2126458, GSK2126458 | |||||
| OMO-1 | 10507 | example 60 [WO2007075567A1], JNJ-38877618, JNJ38877618, OMO1 | |||||||
| OMPT | 2912 | (2S)-OMPT | |||||||
| onametostat |
|
11749 | Example 80 [WO2017032840A1], JNJ-64619178, JNJ45031882 | ||||||
| onapristone | 2882 | ZK299, ZK98299 | |||||||
| onatasertib | 8914 | ATG-008, ATG008, CC-223, CC223, compound 37 [PMID: 26083478] | |||||||
| ONC212 | 11337 | example 52 [WO2017132661A2], ONC-212 | |||||||
| ondansetron |
|
|
2290 | GR-38032F/GR-38032, ondansetron hydrochloride, ondansetron hydrochloride dihydrate, Zofran® | |||||
| onfasprodil | 12156 | ||||||||
| ONO-1301 | 1964 | ||||||||
| ONO-2570366 |
|
10580 | compound 11a [PMID: 31811124], ONO2570366 | ||||||
| ONO-2920632 | 14094 | ONO2920632, VU6011887 | |||||||
| ONO-3080573 |
|
8588 | ON3 | ||||||
| ONO-3708 | 1978 | BRN 4205392, ONO 3708, ONO3708 | |||||||
| ONO-4057 | 6157 | ONO 4057, ONO-LB 457 | |||||||
| ONO-4817 | 6544 | ONO 4817, ONO4817 | |||||||
| ONO-5334 | 10747 | ONO 5334, ONO5334 | |||||||
| ONO-7300243 | 9499 | compound 17a | |||||||
| ONO-7579 | 10729 | ONO 7579, ONO7579 | |||||||
| ONO-8130 | 11536 | ||||||||
| ONO-8590580 | 9908 | ||||||||
| ONO-8711 | 1920 | ONO 8711, ONO8711 | |||||||
| ONO-8713 | 1921 | ONO 8713, ONO8713 | |||||||
| ONO-9054 | 9875 | sepetaprost | |||||||
| ONO-9780307 |
|
8589 | ON7, ONO9780307 | ||||||
| ONO-9910539 |
|
8590 | ON9 | ||||||
| ONO-AE1-259 | 1932 | ||||||||
| ONO-AE1-329 | 1933 | ||||||||
| ONO-AE1-437 | 8541 | ||||||||
| ONO-AE2-227 | 5824 | ||||||||
| ONO-AE-248 | 1931 | 11,15-O-dimethyl-PGE2 | |||||||
| ONO-AE3-208 |
|
1942 | ONO AE3 208 | ||||||
| ONO-AE3-237 | 8537 | ||||||||
| ONO-AE3-240 | 1943 | ONO-AE3240 | |||||||
| ONO-AE5-599 | 5823 | ||||||||
| ONO-AP-324 | 5821 | ONO AP 324 | |||||||
| ONO-DI-004 | 1914 | ||||||||
| ONO-2333MS | 10376 | compound 7b [PMID: 21865047], ONO-2333, ONO2333, ONO2333MS | |||||||
| ONO-TR-772 | 14095 | VU6018042 | |||||||
| onternabez | 746 | HU-308, HU308, LS-193061 | |||||||
| ontunisertib | 13846 | AGMB-129, Example 26 [WO2021105317A1], ORG-129 | |||||||
| onvansertib |
|
7918 | NMS P937, NMS-1286937, NMS-P937, NMS1286937 | ||||||
| ONX-0801 |
|
9590 | BGC 945, BGC-945, N-[4-[2-Propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-γ-glutamyl-d-glutamic acid 1, ONX 0801 | ||||||
| ONX-0914 |
|
9031 | PR-957 | ||||||
| opaganib | 6624 | ABC 294640, ABC-294640, Yeliva® | |||||||
| OPB-171775 | 13643 | Example 124 [US20190023662], OPB171775 | |||||||
| OPC-21268 | 2196 | OPC 21268 | |||||||
| OPC 4392 | 268 | OPC-4392 | |||||||
| OPC-51803 | 2173 | OPC51803 | |||||||
| opevesostat | 13856 | Compound 185 [WO2018115591A1], MK-5684, MK5684, ODM-208, ODM208 | |||||||
| opicapone |
|
8988 | BIA 9-1067, compound 37d [PMID: 20334432], Ongentys®, Ontilyv® | ||||||
| opipramol |
|
11247 | Insidon® | ||||||
| opiranserin | 11298 | VVZ-149, VVZ149 | |||||||
| opnurasib | 11715 | compound 5 [PMID: 35404998], example 1a [WO2021120890A1], JDQ 443, JDQ-443, JDQ443, Nvp-jdq443 | |||||||
| oprozomib | 8739 | ONX 0912, ONX-0912, PR-047 | |||||||
| OPS-2071 | 13197 | ||||||||
| OptoBI-1 | 12525 | ||||||||
| OptoDArG | 12526 | ||||||||
| orantinib |
|
7816 | SU-6668, TSU-68 | ||||||
| orbifloxacin | 13671 | AT-4526, CP-104,354, Orbax® (veterinary) | |||||||
| orciprenaline |
|
7250 | Alupent®, metaproterenol sulfate, TH-152 | ||||||
| orelabrutinib |
|
|
10629 | example 3 [WO2015048662A2], ICP-022, ICP022 | |||||
| orforglipron |
|
12175 | LY-3502970, LY3502970, OWL833 | ||||||
| Org 12962 | 170 | Org-12962, Org12962 | |||||||
| ORG2058 | 3453 | ORG 2058, ORG-2058 | |||||||
| ORG 214007-0 |
|
11310 | [(-)-N-(2S,10S,14bS)]-N-(8-cyano-1,2,3,4,10,14b-hexahydro-10-methyl dibenzo[c,f]pyrido[1,2-a]azepin-2-yl)-4-methyl-1,2,3-thiadiazole-5-carboxamide]], ORG214007-0 | ||||||
| Org 24598 | 4600 | ORG-24598 | |||||||
| Org 25543 | 4667 | ORG-25543 | |||||||
| Org27569 |
|
7851 | Org 27569 | ||||||
| ORG-34167 | 12946 | ORG 34167, ORG34167 | |||||||
| ORG-37684 | 171 | ORG-37,684 | |||||||
| [3H]ORG2058 |
|
|
3454 | [3H]-ORG2058 | |||||
| ORIC-101 | 13167 | compound 28 [PMID: 30091920], ORIC101 | |||||||
| ORIC-114 | 13880 | ORIC114 | |||||||
| ORIC-533 | 13294 | Example 25 [WO2021087136A1], ORIC533 | |||||||
| oridonin derivative 32 [PMID: 38751194] | 13421 | compound 32 [PMID: 38751194] | |||||||
| Orita-13 |
|
|
9985 | compound 13 [PMID: 11170644] | |||||
| oritavancin |
|
10877 | Kimyrsa®, LY-333328, LY333328, Orbactiv® | ||||||
| orlistat |
|
5277 | Alli®, tetrahydrolipstatin, THL, Xenical® | ||||||
| orludodstat |
|
11897 | BAY-2402234, BAY2402234 | ||||||
| ORM-10103 | 6481 | ||||||||
| ORM-10921 | 13130 | ORM 10921, ORM10921 | |||||||
| ORM-10962 | 11161 | ORM10962 | |||||||
| ORM-12741 | 13129 | DB105, ORM 12741, ORM12741 | |||||||
| [11C]-ORM-13070 |
|
|
13182 | 11C-ORM-13070 | |||||
| orphenadrine |
|
7251 | Invagesic® | ||||||
| orteronel |
|
13853 | compound (+)-3c [PMID: 21978946], S-TAK-700, TAK-700, TAK700 | ||||||
| ORY-1001 | 8390 | RG-6016 | |||||||
| osanetant | 2110 | SB-236984, SR 142,806, SR 142801, SR-142,801, SR-142801, SR-142806, SR142801 | |||||||
| [3H]osanetant |
|
|
3480 | [3H]SR142,801, [3H]SR142801 | |||||
| oseltamivir |
|
11427 | GS-4104, GS4104, RO-640796, RO640796, Tamiflu®, Tamvir® | ||||||
| OSI-930 | 9383 | OSI 930, OSI930 | |||||||
| osilodrostat |
|
|
8310 | Isturisa®, LCI-699, LCI699 | |||||
| osimertinib |
|
|
7719 | AZD 9291, AZD-9291, AZD9291, mereletinib (obsolete INN), Tagrisso® | |||||
| OSIP339391 | 450 | OSIP-339391, UCS15A | |||||||
| [3H]OSIP339391 |
|
|
454 | ||||||
| osivelotor |
|
12856 | example 8 [US20210047309], GBT-021601, GBT-601, GBT021601 | ||||||
| OSM-S-38 |
|
9708 | |||||||
| ospemifene |
|
7349 | FC-1271, Osphena®, Senshio® | ||||||
| OSU-03012 |
|
8005 | AR-12, OSU03012 | ||||||
| otamixaban |
|
10732 | compound 9c [PMID: 12039587], FXV-673, FXV673, XRP-0673, XRP0673 | ||||||
| OTB-658 | 13548 | compound 19c [PMID: 32666789] | |||||||
| otenabant | 9232 | CP-945,598, CP-945598 | |||||||
| otenaproxesul |
|
9534 | ATB 346, ATB-346, ATB-346, (S)-, ATB346 | ||||||
| otenzepad | 309 | AF-DX 116, AFDX116 | |||||||
| OTS964 |
|
7813 | |||||||
| OTSSP167 | 8046 | AMX10201, OTSSP-167 | |||||||
| OUL35 |
|
13119 | compound 1 [PMID: 30006177], OUL-35 | ||||||
| oveporexton | 13513 | example 3 [US20210276949] | |||||||
| OX04529 | 13103 | compound 69 [PMID: 38146625], OX-04529 | |||||||
| oxacillin |
|
10943 | Bactocill® | ||||||
| oxaliplatin |
|
7433 | ACT-078, Eloxatin® | ||||||
| oxantel |
|
10840 | CP-14,445, CP-14445 | ||||||
| oxaprozin |
|
|
|
7252 | Daypro®, WY-21743 | ||||
| oxaquin | 10997 | DNV-3837, DNV3837, MCB-3837, MCB3837 | |||||||
| oxazepam |
|
7253 | Serax®, WY-3498 | ||||||
| oxazine 89 |
|
6944 | |||||||
| oxcarbazepine |
|
7254 | GP-47680, KIN-493, Trileptal® | ||||||
| oxidised ATP | 11234 | 2',3'-dialdehyde ATP, ATP dialdehyde, oATP, oxo-ATP | |||||||
| oxiglutatione |
|
|
6835 | glutathione disulfide, Navstel® | |||||
| oximonam | 12297 | SQ 82,291 | |||||||
| oxo-arpromidine | 1199 | UR-PG136 | |||||||
| [3H]5-oxo-ETE |
|
|
3416 | [3H]-5-oxo-ETE | |||||
| oxolinic acid |
|
|
12999 | ||||||
| 5-oxo-1-2-4-oxadiazol biphenyl | 6913 | compound 1c [PMID: 22410249] | |||||||
| 2-oxothiazolidine-4-carboxylate | 4521 | ||||||||
| oxotremorine | 302 | ||||||||
| oxotremorine-M | 303 | ||||||||
| [3H]oxotremorine-M |
|
|
8595 | ||||||
| oxprenolol |
|
7255 | BA-39089, Trasacor® | ||||||
| oxybuprocaine |
|
7123 | benoxinate hydrochloride, Minims Oxybuprocaine®, Novesin | ||||||
| oxybutynin |
|
359 | Cystrin®, Ditropan®, oxybutynin chloride | ||||||
| oxycodegol | 10652 | loxicodegol (deleted INN), NKTR-181, NKTR181 | |||||||
| oxycodone |
|
|
7093 | oxycodone hydrochloride, Roxicodone® | |||||
| oxymetazoline |
|
|
124 | Afrin®, oxymethazoline, SCH-9384, Upneeq® (opthalmic solution), Vicks Sinex® | |||||
| oxymorphone |
|
7094 | Opana®, oxymorphone hydrochloride | ||||||
| oxyphencyclimine |
|
7256 | |||||||
| oxyphenonium |
|
7257 | oxyphenonium bromide | ||||||
| oxytetracycline |
|
|
10919 | E703, NSC-9169, Terramycin® | |||||
| ozagrel |
|
|
9866 | Cataclot®, KCT-0809, OKY-046, Pulmoza® | |||||
| ozanimod |
|
|
|
8709 | RPC-1063, RPC1063, Zeposia® | ||||
| ozenoxacin |
|
10841 | Ozadub®, T-3912, T3912, Xepi® | ||||||
| P | Back to top | ||||||||
| P218 |
|
|
9740 | MMV000147 | |||||
| P505-15 |
|
|
8070 | BIIB057, PRT-062607, PRT062607 | |||||
| P552-02 | 4280 | ||||||||
| P6949 | 8877 | ||||||||
| PA451 | 2815 | PA 451 | |||||||
| PA452 | 8905 | compound 6b [PMID: 12139443], compound 9 [PMID: 24900278], PA 452, PA-452 | |||||||
| PA21A092 |
|
10415 | PA92 | ||||||
| PAC1 | 5238 | PAC-1 | |||||||
| pacritinib |
|
|
7793 | SB-1518, SB1518, Vonjo® | |||||
| padnarsertib |
|
10593 | KPT-9274, KPT9274, PAK4-IN-1 | ||||||
| [3H]PAF |
|
|
|
1833 | [3H]platelet activating factor | ||||
| pafuramidine | 10842 | DB-289, DB289 | |||||||
| PAK-104P | 8776 | PAK104P | |||||||
| palacaparib |
|
11946 | AZD-9574, AZD9574, example 20 [WO2021260092A1], TQB3823 | ||||||
| palbociclib |
|
|
7380 | Ibrance®, PD-0332991, PD0332991 | |||||
| paldimycin | 10843 | Antibiotic 273 A, U-70,138, U-70138F | |||||||
| paliperidone |
|
7258 | 9-hydroxyrisperidone, Invega®, Ro-76477, Ro-92670 | ||||||
| Palmostatin B | 13414 | ||||||||
| palonosetron |
|
|
7486 | Aloxi®, aurothioglucose, RS-25259-197 | |||||
| palosuran | 3516 | ||||||||
| palovarotene |
|
8276 | CLM-001, IPN-60120, IPN60120, R-667, R667, RG-667, Ro-3300074, Sohonos® | ||||||
| paltimatrectinib | 11880 | example I-147 [US20210094956A1] | |||||||
| palupiprant | 14139 | AN0025, E-7046, E7046, ER-886046, ER886046 | |||||||
| 135PAM1 | 8343 | ||||||||
| 5PAM523 | 6414 | ||||||||
| PAM_16A | 13570 | Compound 1 [WO2021014168A], PAM-16A | |||||||
| pamapimod |
|
|
9915 | compound 2b [PMID: 21375264], Ro 4402257, Ro-4402257, Ro4402257 | |||||
| pamidronic acid |
|
|
7259 | disodium pamidronate, Aredia®, CGP-23339AE | |||||
| pamiparib |
|
|
12345 | BGB-290, BGB290, compound 139 [PMID: 33264017], Partruvix® | |||||
| pamoic acid |
|
2920 | embonic acid | ||||||
| pamufetinib | 10460 | TAS-115, TAS115 | |||||||
| pancuronium |
|
4001 | Pavulon® | ||||||
| panipenem |
|
12184 | Carbenin® (panipenem + betamipron), CS-533, RS-533 | ||||||
| panobinostat |
|
|
|
7489 | Farydak®, LBH-589, LBH589 | ||||
| pantoprazole |
|
7260 | BY-1023, Protonix®, SK-96022 | ||||||
| panulisib | 9916 | example 96 [WO2012007926A1], P7170 | |||||||
| para-aminosalicylic acid |
|
|
13652 | 4-aminosalicylic acid, Granupas®, p-aminosalicylic acid, Paser®, Rezipas® | |||||
| paracetamol |
|
|
5239 | acetaminophen, N-Acetyl-p-aminophenol, Panadol®, Tylenol® | |||||
| para-coumaric acid |
|
5787 | hydroxycinnamic acid, p-coumaric acid | ||||||
| paramethadione |
|
7261 | isoethadione, Paradione® | ||||||
| paraquat | 4552 | 1,1'-dimethyl-4,4' bipyridinium dichloride | |||||||
| parecoxib |
|
|
|
2895 | Dynastat®, SC-69124 | ||||
| pargyline |
|
7262 | A-19120, Eutonyl®, MO-911 | ||||||
| paritaprevir |
|
11273 | ABT-450, ABT450, veruprevir (deprecated INN), Viekirax® (ombitasvir + paritaprevir + ritonavir; EU) | ||||||
| paroxetine |
|
|
4790 | paroxetine hydrochloride (anhydrous or hemihydrate), Paxil®, Seroxat® | |||||
| [3H]paroxetine |
|
|
4561 | [3H]-paroxetine | |||||
| PARP1 inhibitor (S)-G9 | 13961 | ||||||||
| parsaclisib |
|
10098 | compound 20 [PMID: 31749910], IBI376, INCB-050465 | ||||||
| pasodacigib | 13751 | Example 298 [US11998539B2] | |||||||
| PAT5A | 2709 | ||||||||
| pavinetant | 5775 | AZD-2624, AZD4901, MLE4901 | |||||||
| paxalisib | 10097 | compound 16 [PMID: 27096040], GDC-0084, GDC0084 | |||||||
| paxilline | 2309 | ||||||||
| pazopanib |
|
5698 | GW 786034, indazolylpyrimidine 13, Votrient® | ||||||
| Paz-PC | 5427 | 1-palmitoyl-2-azelaoyl PC, azelaoyl PC | |||||||
| pazufloxacin |
|
12410 | Pasil®, Pazucross®, T-3761 | ||||||
| PB-28 | 6681 | PB28 | |||||||
| PBD150 |
|
8356 | compound 53 [PMID 16420052] | ||||||
| PBF-509 |
|
10193 | PBF509 | ||||||
| PBF-999 | 13188 | example 42 [US9447095], PBF999 | |||||||
| PBI-4547 | 12819 | PBI4547 | |||||||
| PBI-8192 |
|
13996 | |||||||
| PBIT | 7026 | ||||||||
| PBMC | 6370 | ||||||||
| PBT2 | 11108 | PBT-1033, PBT-2, PBT1033 | |||||||
| PBT-3 |
|
9755 | |||||||
| PC-25 | 8519 | traizine compound PC25 | |||||||
| PCA 4248 |
|
6080 | PCA-4248, PTEMC | ||||||
| PCC0105003 | 12936 | ||||||||
| PCC0208017 | 12937 | ||||||||
| PCCG-4 | 3335 | (2S,1'S,2'S,3?R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine | |||||||
| p-chloroamphetamine | 4592 | para-chloroamphetamine | |||||||
| PCI-27483 | 11585 | Example 1 [WO2005118554A2], PCI27483 | |||||||
| pCMBS | 1773 | p-Chloromercuribenzenesulfonate, para-Chloromercuriphenylsulfonate, pCMPS | |||||||
| PCO371 |
|
12788 | compound 16c [PMID: 32022560], PCO-371 | ||||||
| 8-pCPT-2'-O-Me-cAMP |
|
5172 | 8CPT-2MecAMP, CPT-2'OMe-cAMP | ||||||
| PCS1055 | 11499 | PCS-1055 | |||||||
| PD 102807 | 11498 | LSM-1888, LSM1888, PD-102807, PD102807 | |||||||
| PD-118057 | 7676 | PD 118057, PD118057 | |||||||
| PD123177 | 596 | PD 123177, PD-123177 | |||||||
| PD123319 | 597 | PD 123319, PD-123319 | |||||||
| PD 128907 | 952 | PD-128,907, PD128907 | |||||||
| PD-135158 | 882 | CAM 1028, PD 135158 | |||||||
| PD-135666 | 903 | PD 135666, PD135666 | |||||||
| PD136450 | 867 | CAM 1189, PD 136450, PD-136,450, PD-136450 | |||||||
| PD-140548 | 904 | PD 140548, PD-140,548, PD140548 | |||||||
| PD-144418 |
|
10731 | PD144418 | ||||||
| PD-146176 | 11390 | PD 146176, PD146176 | |||||||
| PD-149164 | 905 | PD 149164, PD149164 | |||||||
| PD 154740 | 5766 | PD-154740, PD154740 | |||||||
| PD-156707 | 999 | PD 156707, PD156707 | |||||||
| PD157672 | 2125 | PD 157672, PD-157672, PD157,672 | |||||||
| PD 158780 | 6015 | AC1L1IRV, PD-158780, PD158780 | |||||||
| PD159790 | 8617 | PD-159790 | |||||||
| PD 161182 | 5767 | CAM 5187, PD-161182, PD161182 | |||||||
| PD164333 | 3519 | PD 164333, PD-164333 | |||||||
| PD 165929 | 620 | PD-165929, PD165929 | |||||||
| PD166285 |
|
8183 | PD-166285, PD0166285 | ||||||
| PD168,077 | 975 | PD 168077, PD-168,077, PD168077 | |||||||
| PD 168368 |
|
621 | PD-168368, PD168368 | ||||||
| PD 169316 | 6016 | PD-169316, PD169316 | |||||||
| PD173074 |
|
5037 | PD 173074, PD-173074 | ||||||
| PD-173955 |
|
5699 | PD 173955, PD-0173955 | ||||||
| PD 174265 |
|
6017 | 4-aminoquinazoline, 2a, PD-174265 | ||||||
| PD 176252 |
|
626 | PD-176252 | ||||||
| PD-307243 | 7677 | PD 307243, PD307243 | |||||||
| PD81723 | 9445 | ||||||||
| PD98059 | 5241 | PD 98059, PD-98059 | |||||||
| [125I]PD142308 |
|
|
3472 | ||||||
| [125I]PD164333 |
|
|
1002 | [125I]-PD164333 | |||||
| [3H]PD128907 |
|
|
3298 | [3H]PD 128907, [3H]-PD128907 | |||||
| [3H]PD140376 |
|
|
3478 | [3H]-PD140,376, [3H]PD 140376 | |||||
| PDE4 inhibitor 16 |
|
|
10400 | ||||||
| PDGF receptor tyrosine kinase inhibitor II | 6018 | bis(1H-2-indolyl)methanone deriv. 52, D-65476 | |||||||
| PDGF receptor tyrosine kinase inhibitor III | 6019 | ||||||||
| PDGF receptor tyrosine kinase inhibitor IV | 6020 | JNJ-10198409 | |||||||
| PDGF RTK inhibitor | 6021 | Ki 11502, PDGF Receptor Tyrosine Kinase Inhibitor V | |||||||
| 4α-PDH | 4105 | 4α-phorbol 12,13-dihexanoate | |||||||
| PDK1/Akt/Flt dual pathway inhibitor | 6022 | AG-L-66494, GNF-Pf-3800 | |||||||
| PD-L1 inhibitor D6 [PMID: 40153736] | 13829 | ||||||||
| PD-L1/VISTA dual inhibitor P17 |
|
13680 | compound P17 [PMID: 39731560] | ||||||
| pebezertinib | 13064 | BLU-451, BLU451, compound I [WO2023215431A1], Example 37 [WO2022094354A1], LNG-451, LNG451 | |||||||
| pecazine |
|
|
9782 | mepazine, nothiazine, Pacatal® | |||||
| peficitinib |
|
|
8315 | ASP015K, JNJ-54781532 | |||||
| pefloxacin |
|
12411 | 1589 RB, AM-725 | ||||||
| pegcantratinib | 11609 | CT-327, CT327, K-252a-PEG2K, Pegylated K-252, SNA-120, SNA120 | |||||||
| pelabresib |
|
9120 | compound 10 [PMID: 26815195], CPI-0610, CPI0610 | ||||||
| pelcitoclax | 13069 | APG-1252, APG1252, BM-1252 | |||||||
| pelitinib |
|
7644 | EKB-569 | ||||||
| pelubiprofen |
|
9876 | compound 13b [PMID: 6607354], CS-670, DW-330SR, DW330SR, RS-2131 | ||||||
| pemetrexed |
|
6837 | Alimta®, LY-231514 | ||||||
| [3H]pemetrexed |
|
|
6688 | ||||||
| pemigatinib |
|
|
9767 | example 126 [WO2014007951], INCB 54828, INCB-54828, INCB054828, INCB54828, Pemazyre® | |||||
| pemirolast |
|
7329 | Alamast®, Alegysal®, BMY-26517 | ||||||
| pemrametostat |
|
13679 | EPZ015938, GSK-3326595, GSK3326595 | ||||||
| penamecillin |
|
12808 | Havapen®, WY-20788 | ||||||
| penbutolol |
|
7263 | HOE-39-893d, HOE-893d, Levatol® | ||||||
| PENECA | 378 | 2-phenylethynyl-NECA, 2-phenylethynylNECA | |||||||
| penicillamine |
|
|
|
7264 | Cuprimine® | ||||
| penicillin G |
|
|
4796 | penicillin G sodium, penicillin-G potassium | |||||
| pentafluoro-trityl clotrimazole analogue 29a | 12535 | ||||||||
| (-)-pentazocine |
|
1606 | pentazocine, WIN-20228 | ||||||
| [3H]pentazocine |
|
|
6683 | ||||||
| 2-pentenal | 2417 | ||||||||
| pentobarbitone |
|
5480 | (±)-pentobarbital, (RS)-pentobarbital, Nembutal®, NSC 28708, pentobarbital sodium, pentobarbituric acid | ||||||
| pentostatin |
|
|
4805 | 2'-deoxycoformycin, deoxycoformycin, Nipent® | |||||
| pentoxifylline |
|
|
7095 | BL-191, Trental® | |||||
| pentylthio-TZTP | 304 | ||||||||
| peposertib |
|
9766 | example 136 [WO2014183850], M3814, MSC2490484A, nedisertib (deleted INN) | ||||||
| peptide 22d | 12063 | ||||||||
| peptide 18 [PMID: 24350995] | 8658 | Ac-LLLLRVK-Amba | |||||||
| peptide 1 [PMID: 31774287] |
|
10594 | |||||||
| peptide 4 [PMID: 18294843] | 8582 | ||||||||
| perampanel |
|
|
7050 | E2007, ER-155055-90, Fycompa® | |||||
| pergolide |
|
48 | LY-127809, Permax® | ||||||
| periciazine |
|
9216 | pericyazine, propericiazine, RP-8909 | ||||||
| perifosine | 7424 | D 21266, KRX-0401, NSC 639966 | |||||||
| perindopril |
|
6367 | Coversyl®, Preterax®, S-9490 | ||||||
| perindoprilat |
|
|
6373 | S-9780 | |||||
| perospirone |
|
7556 | Lullan® (Japan) | ||||||
| perphenazine |
|
209 | Decentan®, Fentazin®, Trilafon® | ||||||
| perzebertinib | 13741 | example 31 [WO2020057511A1], ZN-1041, ZN-A-1041, ZNA-1041 | |||||||
| PETCM | 5242 | 1-(trichloromethyl)-2-(4-pyridine)ethanol | |||||||
| petesicatib |
|
9855 | RG-7625, RG7625, RO-5459072 | ||||||
| pethidine |
|
7221 | Demerol®, meperidine | ||||||
| PET-UNK-29afea89-2 |
|
12227 | |||||||
| pevonedistat |
|
12117 | MLN 4924, MLN-4924, MLN4924, TAK-924, TAK924 | ||||||
| pexacerfont | 10379 | BMS-562086, BMS562086 | |||||||
| pexidartinib |
|
|
8710 | PLX-3397, PLX3397, Turalio® | |||||
| pexmetinib |
|
9917 | ARRY-614, ARRY614 | ||||||
| pezulepistat | 14103 | GDC-5780, RG6319 | |||||||
| [18F]PF-06684511 |
|
|
9832 | ||||||
| 65PF | 11350 | ||||||||
| PF-00489791 | 8377 | PF-489,791, PF-489791 | |||||||
| PF-00835231 |
|
11250 | compound 4 [Hoffman et al., 2020], PF-0835231 | ||||||
| PF-01247324 | 8521 | PF01247324 | |||||||
| PF-03463275 | 9057 | compound 10 [PMID: 19410451], KB-79869, PF-3463275 | |||||||
| PF-03654746 | 9058 | compound 6 [PMID: 21928839], PF 03654746, PF03654746 | |||||||
| PF-03715455 |
|
|
8179 | ||||||
| PF-03882845 | 9061 | compound 2 [PMID: 24738581], PF-3882845 | |||||||
| PF-04191834 |
|
9054 | PF 4191834, PF-4191834 | ||||||
| PF-04418948 |
|
5817 | PF 04418948, PF04418948 | ||||||
| PF-04457845 | 6694 | compound 23 [PMID: 21666860], PF04457845 | |||||||
| PF-04620110 | 7829 | ||||||||
| PF-04634817 |
|
9979 | example 13 [US8293903], PF-4634817, PF04634817, PF4634817 | ||||||
| PF-04691502 |
|
7936 | PF 04691502, PF04691502 | ||||||
| PF-04852946 | 8538 | PF 04852946, PF04852946 | |||||||
| PF-04856264 | 14015 | PF04856264 | |||||||
| PF-04859989 |
|
9038 | compound 1 [PMID: 23466229] | ||||||
| PF-04885614 | 11864 | compound 13 [Bagal et al., 2016] | |||||||
| PF-04905428 |
|
9062 | CE-224,535, CE-224535, compound 3 [PMID: 21782426], compound 33 [PMID: 21565499] | ||||||
| PF-04957325 |
|
9659 | |||||||
| PF-04995274 | 9059 | compound 2d [PMID: 22974325], PF 04995274, PF04995274 | |||||||
| PF-05089771 |
|
10723 | PF 05089771, PF05089771 | ||||||
| PF-05105679 | 10300 | PF05105679 | |||||||
| PF-05180999 | 11626 | compound 30 [PMID: 29293004], PF 05180999, PF-999, PF05180999 | |||||||
| PF-05190457 |
|
9060 | PF-5190457 | ||||||
| PF06260933 | 13265 | compound 16 [PMID: 26617966], PF-06260933, PF-6260933 | |||||||
| PF-06263276 |
|
|
9432 | compound 2 [PMID: 27983835], PF 0626327, PF0626327 | |||||
| PF-06282999 |
|
10053 | compound 8 [PMID: 26509551], PF06282999 | ||||||
| PF-06372222 |
|
9575 | |||||||
| PF-06426779 |
|
9666 | example 189 [WO2015150995], example 38 [PMID:28498658] | ||||||
| PF-06447475 |
|
8054 | |||||||
| PF-06454589 |
|
8295 | compound 28 [PMID: 25353650] | ||||||
| PF‐06526290 | 9980 | PF06526290 | |||||||
| PF-06648671 | 13411 | compound 22 [PMID: 38848667], PF06648671 | |||||||
| PF-06649298 |
|
12849 | compound 1a [PMID: 26734723], PF06649298 | ||||||
| PF-06684511 | 9831 | ||||||||
| PF-06751979 | 9943 | compound 64 [PMID: 29613789], PF06751979 | |||||||
| PF-06761281 |
|
12850 | compound 4a [PMID: 26734723], PF06761281 | ||||||
| PF-06767832 | 9228 | PF-6767832, PF06767832 | |||||||
| PF-06835919 |
|
12748 | compound 8 [PMID: 32910646], PF06835919 | ||||||
| PF-06840003 |
|
9565 | EOS200271, PF06840003 | ||||||
| PF-06843195 |
|
12720 | compound 1 [PMID: 33356246], PF06843195 | ||||||
| PF-06873600 |
|
10426 | example 10 [WO2018033815], PF06873600 | ||||||
| PF‐06928215 |
|
11324 | |||||||
| PF-06939999 |
|
11844 | |||||||
| PF-07038124 |
|
11950 | Example 4 [US2020108083A1], PF07038124 | ||||||
| PF-07054894 |
|
12765 | PF07054894 | ||||||
| PF-07059013 |
|
12786 | compound 23 [PMID: 33356244], PF07059013 | ||||||
| PF-07202954 | 13010 | compound 12 [PMID: 37849537], PF07202954 | |||||||
| PF-07258669 | 12158 | ||||||||
| PF-07293893 | 14198 | example 2 [WO2024084390], PF07293893 | |||||||
| PF-07853578 | 13839 | example 11 [O2024084360A1], PF07853578 | |||||||
| PF-07957472 |
|
13285 | compound 4 [Garnsey et al., 2024], PF07957472 | ||||||
| PF0998425 | 6698 | PF-998425 | |||||||
| PF-152 |
|
9014 | compound 43a, example 64 [WO2009016498], PF152 | ||||||
| PF-3644022 |
|
8045 | PF 3644022, PF3644022 | ||||||
| PF-3758309 |
|
8937 | compound 1 [PMID: 24432870], example 114 [US8530652], PF-03758309, PF3758309 | ||||||
| PF3845 |
|
5243 | PF 3845, PF-3845 | ||||||
| PF-4708671 |
|
8036 | PF4708671 | ||||||
| PF-477736 | 8043 | PF 477736, PF-00477736 | |||||||
| PF-4800567 |
|
8050 | PF4800567 | ||||||
| PF-4840154 | 6309 | PF 4840154, PF4840154 | |||||||
| PF-514273 | 11693 | compound 19d [PMID: 19351113], PF 514273, PF514273 | |||||||
| PF-543 |
|
6623 | compound 22a [PMID: 22397330], PF 543, sphingosine kinase 1 Inhibitor II | ||||||
| PF-562271 |
|
9381 | PF-00562271, PF-562,271, PF-562,271-26 | ||||||
| PF-592379 | 7683 | PF-592,379 | |||||||
| PF-670462 |
|
9371 | |||||||
| PF-6870961 | 12413 | GLXC-25347, GLXC25347, PF-06870961, PF6870961 | |||||||
| PF750 | 5244 | PF 750, PF-750 | |||||||
| PF-8380 |
|
9142 | compound 21 [PMID: 26745766], compound 4 [PMID: 23300119], PF8380 | ||||||
| PF-9363 |
|
12938 | CTX-3648, CTx-648, PF9363 | ||||||
| PF-956980 |
|
11060 | PF 956980, PF-00956980, PF956980 | ||||||
| p-F-HHSiD | 308 | p-pluorohexahydrosiladyphenidol, pFHHSiD | |||||||
| (R)-PFI-2 |
|
8235 | |||||||
| PFI-1 |
|
7523 | HY-16586, PF-6405761, QCR-192 | ||||||
| PFI-3 |
|
7915 | compound 16 [PMID: 27115555], IN2080, PF-06687252, PFI 3 | ||||||
| PFI-4 |
|
8575 | |||||||
| Pfizer compound 11 [PMID:18445527] | 5804 | ||||||||
| Pfizer compound 67 [PMID:18445527] | 5805 | ||||||||
| PFK15 |
|
9562 | PFK-015 | ||||||
| PFKFB3 kinase Inhibitor 69 | 10125 | compound 69 [PMID: 30378281], example 110 [WO2016180537] | |||||||
| PG01037 | 6675 | PG 01037, PG-01037 | |||||||
| [3H]PGD2 |
|
|
|
1891 | [3H]-PGD2, [3H]11-dehydroprostaglandin F2-alpha, [3H]prostaglandin D2 | ||||
| [3H]PGE2 |
|
|
|
1916 | [3H]-PGE2, [3H]prostaglandin E2, [3H]prostin E2 | ||||
| P'-geranyl 2-fluoromevalonate 5-diphosphate | 3207 | ||||||||
| P'-geranyl 3,5,7-trihydroxy-3-methylheptanate 7-diphosphate | 3208 | ||||||||
| P'-geranyl 3,5,9-trihydroxy-3-methylnonanate 9-diphosphate | 5621 | ||||||||
| P'-geranyl 3,5,8-trihydroxy-3-methyloctanate 8-diphosphate | 3210 | ||||||||
| [3H]PGF2α |
|
|
1957 | [3H]dinoprost, [3H]prostaglandin F2alpha | |||||
| PGF2-1-ethanolamide | 5456 | prostaglandin F2α ethanolamide, prostamide F2α | |||||||
| PGN-9856 | 10110 | PGN 9856, PGN9856 | |||||||
| PH-797804 |
|
|
7818 | ||||||
| PHA-408 |
|
9398 | PHA408 | ||||||
| PHA-543613 | 3998 | PHA-543,613 | |||||||
| PHA-665752 | 5700 | PHA 665752, TCMDC-125885 | |||||||
| PHA-709829 | 3997 | ||||||||
| phaclofen | 1091 | ||||||||
| PHCCC | 1416 | (-) PHCCC | |||||||
| phenacemide |
|
7265 | Phenurone® | ||||||
| phenacetin |
|
|
7402 | acetophenetidin | |||||
| 3-phenacyl-UDP | 1745 | phenacyl-UDP | |||||||
| phenamil |
|
4281 | |||||||
| 9-phenanthrol | 4114 | ||||||||
| 1,10-Phenanthroline |
|
12425 | O-PHE, o-phenanthroline | ||||||
| phenazopyridine |
|
7616 | NC-150, Pyridium®, W-1655 | ||||||
| phencyclidine |
|
4282 | |||||||
| phenelzine |
|
7266 | Nardil®, phenelzine sulfate | ||||||
| pheneticillin |
|
12275 | alfacilin, Broxil®, feneticillin, phenethicillin | ||||||
| phenindione |
|
|
6838 | Dindevan®, phenylindanedione | |||||
| pheniramine |
|
7267 | |||||||
| phenobarbital |
|
|
2804 | fenobarbital, Luminal®, phenobarb, phenobarbital sodium, phenobarbitone, phenylethylbarbiturate | |||||
| phenoxybenzamine |
|
7268 | Dibenzyline®, phenoxybenzamine hydrochloride | ||||||
| 5-(4-phenoxybutoxy)psoralen | 2554 | ||||||||
| phenprocoumon |
|
6839 | Liquamar®, phenprocoumarol | ||||||
| phensuximide | 7612 | Lifene®, Milontin® | |||||||
| phentermine |
|
7269 | Adipex-P®, Ionamin®, phentermine hydrochloride | ||||||
| phentolamine |
|
502 | dibasin, fentolamin, Regitine®, Rogitine®, Ryzumvi® (opthalmic solution) | ||||||
| phenylacetyl-Ala,DTrp-phenthylamide | 6192 | ||||||||
| phenylacetyl-Arg-Val-Arg-4-amidinobenzylamide | 6564 | compound 15 [PMID:20038105] | |||||||
| phenylacetylrinvanil | 4283 | 12-Phenylacetyl-ricinoleoyl-vanillamide, compound 1e [PMID: 15356216], IDN5890, PhAR | |||||||
| phenylarsine oxide |
|
9201 | PAO, arzene, oxophenylarsine, PAO, phenylarsenoxide | ||||||
| 1-phenylbiguanide | 2284 | ||||||||
| phenylbutazone |
|
|
|
7270 | Butazolidine® | ||||
| phenylbutyrate |
|
|
8480 | 4-phenylbutanoic acid, Ammonaps®, Buphenyl®, gamma-phenylbutyric acid, triButyrate | |||||
| 3-phenyl-CPP | 4104 | ||||||||
| phenylephrine |
|
485 | m-oxedrine, metasynephrine | ||||||
| 2-phenylethylyl-adenosine derivative | 5600 | ||||||||
| phenylglycine-01 | 4284 | PG-01, PG 01 | |||||||
| 17-phenyl-ω-trinor-PGE2 | 1912 | 17-Ph-ω-trinor-PGE2, 17-phenyl-ω-trinor-prostaglandin E2, 17-phenyl-PGE2, 17-phenyl-trinor-PGE2, 17-pt-PGE2 | |||||||
| phenytoin |
|
2624 | Dilantin®, Epanutin®, Phenytex®, phenytoin sodium | ||||||
| pholcodine |
|
9086 | Covonia Dry Cough®, Galenphol®, Pavacol-D® | ||||||
| phorbol 12-myristate 13-acetate | 2341 | PMA, 12-O-tetradecanoylphorbol-13-acetate, tetradecanoyl-β-phorbol acetate, TPA | |||||||
| phosphoethanolamine | 6628 | 2-ammonioethyl phosphate, O-phosphonatoethanaminium | |||||||
| phosphoramidon |
|
11653 | |||||||
| PHT-427 | 8009 | PHT 427, PHT427 | |||||||
| phthalylsulfathiazole | 13907 | sulfathalidine | |||||||
| PHTPP | 3461 | ||||||||
| PHTPP-1304 | 12144 | ||||||||
| PhTX-11 | 8883 | compound 7e | |||||||
| p-hydroxyatorvastatin | 7359 | ||||||||
| phytosphingosine 1-phosphate | 2922 | phytoS1P | |||||||
| PI1 | 5814 | ||||||||
| PI-103 |
|
5701 | compound 2 [PMID: 17601739], PI 103, PIK 103 | ||||||
| PI-3065 | 8242 | PI 3065 | |||||||
| (R)-PIA | 414 | (R)-PIA, phenylisopropyladenosine | |||||||
| (S)-PIA | 415 | (S)-PIA | |||||||
| piboserod | 225 | SB 207256, SB 207266, SB 207266-A, SB207256 | |||||||
| pibrentasvir |
|
11268 | ABT-530, ABT530, Mavyret® (glecaprevir + pibrentasvir) | ||||||
| PIBTU |
|
5246 | 1,3-PB-ITU | ||||||
| piclamilast |
|
|
11627 | RP 73401, RP-73-401, RP73401 | |||||
| piclidenoson |
|
|
422 | IB-MECA, CF 101, CF101, N(6)-ibamu | |||||
| Pico145 |
|
10291 | C31, compound 31 [PMID: 28325835] | ||||||
| picotamide | 11379 | ||||||||
| picropodophyllin | 7873 | AXL1717 | |||||||
| picrotin | 4286 | ||||||||
| pictilisib |
|
5682 | GDC-0941, GDC0941, GNE 0941, pictrelisib | ||||||
| pifusertib | 12084 | TAS-117, TAS117 | |||||||
| PIK-108 |
|
8968 | |||||||
| PIK-75 |
|
8012 | imidazopyridine derivative 8c [PMID 17601739], PIK 75, PIK75 | ||||||
| PIK-93 |
|
6062 | PIK 93, PIK93 | ||||||
| PI 3-Kg inhibitor |
|
6023 | AS 605240, AS-605240 | ||||||
| PI 3-Kg inhibitor II |
|
6024 | AS 604850, PI 3-Kgamma inhibitor II, PI3Kgamma inhibitor | ||||||
| PIK-III |
|
9379 | |||||||
| pilaralisib | 7963 | SAR-245408, XL-147, XL147 | |||||||
| pilavapadin | 11957 | BMS-986176, BMS986176, LX-9211, LX9211 | |||||||
| pilocarpine |
|
|
305 | pilocarpine hydrochloride, pilocarpine nitrate, pilokarpin, Salagen®, Vuity® (pilocarpine HCI ophthalmic solution) | |||||
| PIM447 |
|
9790 | compound 8 [PMID: 26505898], LGH-447, LGH447, PIM-447 | ||||||
| pimasertib |
|
7872 | AS-703026, AS703026, MSC1936369B | ||||||
| pimavanserin |
|
|
8423 | ACP 103, ACP-103, Nuplazid (proposed trade name) | |||||
| pimecrolimus |
|
6783 | Elidel®, SDZ ASM 981, SDZ-ASM 981 | ||||||
| pimicotinib | 12873 | ABSK-021, ABSK021, example 41 [WO2018214867A9] | |||||||
| pimitespib |
|
12284 | compound 16e [PMID: 30525599], Jeselhy®, TAS-116, TAS116 | ||||||
| pimozide |
|
|
90 | haldol decanoate, Orap®, R-6238 | |||||
| PIM447-VHL-01 | 13038 | ||||||||
| pinacidil |
|
2412 | pinacidil hydrate, Pindac® | ||||||
| (-)-pindolol | 127 | ||||||||
| pindolol |
|
91 | betapindol, LB-46, Visken® | ||||||
| pinometostat |
|
7019 | EPZ 5676, EPZ-5676, EPZ5676 | ||||||
| [125I]p-iodoclonidine |
|
|
13179 | [125I]p-iodo-Clonidine | |||||
| pioglitazone |
|
2694 | Actos®, Glustin®, pioglitazone HCl, U-72107A | ||||||
| pipacycline | 13612 | mepicycline | |||||||
| pipamperone | 92 | dipiperone, floropipamide | |||||||
| pipemidic acid |
|
12774 | Pipram® | ||||||
| piperacillin |
|
|
10921 | CL 227,193, CL-227193, PIPC, T-1220, Tazocin® (piperacillin + tazobactam) | |||||
| piperaquine |
|
|
10025 | ||||||
| piperidine |
|
5477 | cyclopentimine, cypentil, hexazane | ||||||
| piperidine-4-sulphonic acid |
|
4287 | |||||||
| piperine |
|
2489 | |||||||
| pipobroman |
|
7271 | A-8103, Vercyte® | ||||||
| pipotiazine |
|
7557 | Piportil®, pipothiazine | ||||||
| piracetam |
|
|
4288 | Nootropil® | |||||
| pirazmonam | 10844 | compound 2 [PMID: 25658376], SQ 83,360, SQ-83360, SQ83360 | |||||||
| pirbenicillin | 10845 | CP-33,994, CP-33,994-2 | |||||||
| pirbuterol |
|
7272 | CP-24314-1, CP-24314-14, CP-2431414, Maxair® | ||||||
| pirenperone | 283 | R-47465 | |||||||
| pirenzepine |
|
328 | |||||||
| [3H]pirenzepine |
|
|
3272 | [3H]PZ | |||||
| piretanide | 4742 | ||||||||
| pirfenidone |
|
|
7532 | AMR-69, Esbriet® | |||||
| piribedil | 49 | ||||||||
| piridronic acid | 3183 | NE 97221, NE-97221, NE97221 | |||||||
| pirinixic acid |
|
2666 | WY14643 | ||||||
| piritrexim |
|
7414 | |||||||
| pirlimycin | 13621 | Pirsue® (veterinary), U-57,930E, U-57930E | |||||||
| pirlindole |
|
6638 | Pyrazidol ® | ||||||
| piromidic acid |
|
12475 | Bactramyl®, Panacid®, PD-93 | ||||||
| pirotinib | 12612 | example 18 [WO2012027960A1], KBP-5209, KBP5209 | |||||||
| piroxicam |
|
|
7273 | CP-16171, Feldene® | |||||
| pirtobrutinib |
|
|
|
11628 | BTK inhibitor 16, Jaypirca®, LOXO-305, LOXO305, MCL-133, MCL133, RXC005 | ||||
| pitavastatin |
|
|
3035 | itavastatin, Livalo® | |||||
| pitolisant |
|
8924 | BF2.649, Ozawade®, tiprolisant [USAN], Wakix® | ||||||
| pivampicillin | 12920 | MK-191, Pondocillin® | |||||||
| pivmecillinam |
|
10922 | amdinocillin pivoxil, pivmecillinam hydrochloride, Pivya®, RO-10-9071, RO-109071, Selexid® | ||||||
| pixantrone |
|
7544 | BBR-2778, Pixuvri® | ||||||
| pixatimod |
|
9870 | compound 18 [PMID: 22458531], PG-545, PG545 | ||||||
| pizotifen |
|
93 | BC-105, pizotifan, pizotyline, sandomigran | ||||||
| PJ34 |
|
|
11348 | PJ-34 | |||||
| PK 11195 | 8703 | PK-11195, PK11195 | |||||||
| PKCbeta inhibitor | 6025 | K00248 | |||||||
| PKCθ inhibitor 14 |
|
9452 | compound 14 [PMID: 27117263] | ||||||
| PKI166 | 7642 | NVP-PKI166, PKI-166 | |||||||
| PKR-A | 6066 | ||||||||
| PKR inhibitor |
|
6026 | AC1O5VPR, ASN 11124542 | ||||||
| PKR inhibitor, negative control | 6027 | RNA-dependent protein kinase inhibitor, negative control | |||||||
| PKUMDL_MH_1001 |
|
9141 | |||||||
| PL265 | 9090 | compound 2a [PMID: 25692029] | |||||||
| PL37 | 7896 | 19-IIIa, Debio 0827, Debio-0827 | |||||||
| plazinemdor | 12051 | CAD-9303, CAD9303, Compound 1 [WO2020086136A2] | |||||||
| plazomicin |
|
|
10847 | ACHN-490, ACHN490, Zemdri® | |||||
| plerixafor |
|
|
|
844 | AMD 3100, AMD3100, bicyclam JM-2987, JM 3100, Mozobil® | ||||
| plevitrexed | 8278 | ZD 9331, ZD-9331, ZD9331 | |||||||
| plixorafenib | 9131 | FORE-8394, FORE8394, PLX 8394, PLX-8394, PLX8394 | |||||||
| plogosertib | 12085 | compound 384 [WO2009040556A1] | |||||||
| PLpro inhibitor 7 [PMID: 36977673] | 12596 | ||||||||
| PLX-4545 | 13574 | compound 10 [WO2023283425A1], PLX4545 | |||||||
| PLX-4720 |
|
5703 | PLX 4720 | ||||||
| PLX5622 |
|
|
9105 | PLX 5622, PLX-5622 | |||||
| PLX7486 |
|
9104 | OPN 7486, OPN-7486, PLX-7486 | ||||||
| 2-PMAP | 7530 | AGN-PC-0031SD, ARN-2966 | |||||||
| p38 MAP kinase inhibitor | 6013 | compound 6 [PMID: 9873604] | |||||||
| p38 MAP kinase inhibitor III | 6014 | ML-3403, ML3403 | |||||||
| PMBA | 4289 | 3-[2'-phosphonomethyl[1,1'-biphenyl]-3-yl]alanine | |||||||
| PMD38 | 2472 | p-menthane-3,8-diol | |||||||
| 3570-0208 [PMID:19807662] | 5828 | ||||||||
| (S)-23 [PMID: 27933945] |
|
|
9796 | ||||||
| (R)-16 [PMID: 32267688] |
|
10751 | |||||||
| (R)-70 [PMID: 36171289] | 13553 | ||||||||
| p-[18F]MPPF |
|
|
3227 | [(18)F]p-MPPF, P-[18F]MPPF | |||||
| [3H]p-MPPF |
|
|
81 | ||||||
| p-MPPI | 68 | ||||||||
| PN10 |
|
10089 | |||||||
| PN6047 | 10675 | ||||||||
| p-nitrophenyl glutamyl anilide | 4508 | ||||||||
| PNU109291 | 3228 | PNU 109291, PNU-109,291, PNU-109291 | |||||||
| PNU-120596 |
|
3991 | PNU-120,596 | ||||||
| PNU-282987 | 3988 | PNU 282987 | |||||||
| PNU-288034 | 10977 | compound 2 [PMID: 16644216], PNU288034 | |||||||
| PNU-37883 | 13269 | ||||||||
| PO-322 |
|
10739 | 1H-indole-2,3-dione 3-(1,3-benzoxazol-2-ylhydrazone), PO322 | ||||||
| pobilukast | 3334 | SKF 104353 | |||||||
| pociredir | 11523 | Example 90 [WO2020190754], FTX-6058, FTX6058 | |||||||
| polfurmetinib | 14063 | Example 69 [WO2022208391A1] | |||||||
| polmacoxib |
|
|
|
8316 | Acelex® (S. Korea), CG-100649, CG100649 | ||||
| polvitolimod | 11872 | compound 32 [WO2019226977A1] | |||||||
| polygodial | 10293 | ||||||||
| poly(I:C) | 5047 | polyinosine-polycytosine, polyinosine:polycytidylic acid | |||||||
| polythiazide |
|
7274 | P-2525, Renese® | ||||||
| pomalidomide |
|
|
7348 | CC-4047, IMID-3, Imnovid®, Pomalyst® | |||||
| POM2-C-HMBP |
|
9616 | |||||||
| pomotrelvir | 12958 | PBI 0451, PBI0451 | |||||||
| ponatinib |
|
|
|
5890 | AP24534, Iclusig® | ||||
| ponazuril | 12223 | ACD-855, ACD855, Marquis® (vet use only), toltrazuril, toltrazuril sulfone | |||||||
| ponesimod |
|
|
9320 | ACT-128800, ACT128800, Compound 8bo [PMID:20446681], Ponvory® | |||||
| posaconazole |
|
|
11428 | Noxafil®, SCH-56592, SCH56592, Schering 56592 | |||||
| poseltinib |
|
9862 | Example 228 [WO2011162515A2], HM71224, HM‐71224, LY333764 | ||||||
| posizolid | 12762 | AZD2563, AZD5847 | |||||||
| potrasertib | 13216 | example 77 [WO2018090939] | |||||||
| povorcitinib |
|
11881 | compound 7 [US20210238168A1] | ||||||
| poziotinib | 7903 | HM781-36B, NOV120101 | |||||||
| PP1 |
|
8836 | pyrazolopyrimidine 1 | ||||||
| PP121 |
|
8013 | PP 121, PP-121 | ||||||
| PP2 |
|
9404 | |||||||
| PP-242 |
|
5704 | PP242, TORKinib | ||||||
| PP3 | 6029 | SBB028425 | |||||||
| PPADS |
|
1725 | |||||||
| PPAHV | 2490 | phorbol-12-phenylacetate-13-acetate-20-homovanillate | |||||||
| PP1 analog II |
|
6028 | 1-naphthyl PP1, AC1NP9I6, mutant kinases inhibitor II, NM-PP1 | ||||||
| 4P-PDOT | 1358 | 4-phenyl-2-propionamidotetraline, N-(4-phenyltetralin-2-yl)propanamide | |||||||
| PPG | 1438 | phosphonophenylglycine | |||||||
| PPTN | 5802 | 4-((piperindin-4-yl)-phenyl)-(7-(4-(trifluoromethyl)-phenyl)-2-naphthoic acid | |||||||
| PQ401 | 5048 | IGF-1R inhibitor II, PQ 401, PQ-401 | |||||||
| PQA-18 |
|
9454 | |||||||
| PQR620 | 10142 | compound 3 [PMID: 30359003], PQR-620 | |||||||
| pracinostat | 8365 | SB 939, SB-939 | |||||||
| practolol |
|
555 | AY-21011, ICI-50172 | ||||||
| pradigastat | 7830 | LCQ-908, LCQ908 | |||||||
| pradofloxacin | 13687 | Veraflox® (veterinary) | |||||||
| pralatrexate |
|
6840 | Folotyn®, PDX | ||||||
| praliciguat |
|
9900 | IW-1973, IW1973 | ||||||
| pralidoxime |
|
7597 | 2-PAM, Contrathion®, pralidoxime chloride | ||||||
| pralnacasan |
|
6467 | VX-740, VX740 | ||||||
| pralsetinib |
|
10033 | BLU-667, BLU667, Gavreto® | ||||||
| pralurbactam | 13037 | ||||||||
| pramipexole |
|
|
953 | Mirapex®, Mirapexin®, Sifrol®, SND-919CL2Y, U-98528E | |||||
| pranazepide | 874 | FK 480, FK-480, FR-120480 | |||||||
| pranlukast |
|
|
|
3634 | ONO RS-411 | ||||
| prasugrel |
|
7562 | CS-747, Effient®, Efient® | ||||||
| pravastatin |
|
2953 | Lipostat®, Pravachol®, pravastatin sodium | ||||||
| pravibismane | 13590 | BisEDT, MBN-101 | |||||||
| prazepam |
|
7275 | Centrax®, W-4020 | ||||||
| prazosin |
|
|
503 | CP-12299-1, Hypovase®, Minipress®, prazosine | |||||
| [3H]prazosin |
|
|
|
5385 | [3H]-prazosin | ||||
| PRD_002214 | 10716 | inhibitor N3, N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE | |||||||
| PRE-084 |
|
6678 | PRE084 | ||||||
| prednicarbate |
|
|
7605 | Dermatop®, Hoe 777, Hoe-777, S-770777 | |||||
| prednisolone |
|
|
|
2866 | DELTA.1-Cortisol, Orapred®, Pediapred® | ||||
| prednisone |
|
|
7096 | Lodotra®, Sterapred® | |||||
| pregabalin |
|
5484 | (S)-pregabalin, CI 1008, Lyrica®, Nervalin®, PD 144723 | ||||||
| 5β-pregnane-3,20-dione |
|
2759 | |||||||
| pregnenolone-16α-carbonitrile | 2762 | 16α-carbonitrile, pregnenolone | |||||||
| [3H]pregnenolone sulphate |
|
|
|
6504 | [3H]-pregnenolone sulfate | ||||
| preladenant |
|
5614 | SCH-420814, SCH420814 | ||||||
| premafloxacin | 10848 | compound 21 [PMID: 17303420], U-95376, U95376 | |||||||
| prenalterol | 537 | CGP 7760B | |||||||
| pretomanid |
|
11172 | PA-824, PA824 | ||||||
| prexasertib | 9549 | LY2606368 | |||||||
| pridopidine | 13833 | ACR-16, ACR16, compound 12b [PMID: 20155917] | |||||||
| prifetrastat | 14088 | example 34 [WO2020254946], PF-07248144, PF07248144 | |||||||
| prilocaine |
|
7276 | ASTRA 1512, L-67, Prilotekal® | ||||||
| primaquine |
|
|
|
9952 | |||||
| primidone |
|
|
5338 | Mysoline® | |||||
| prinaberel |
|
6700 | ERB 041, ERB-041, PF-00913086 | ||||||
| prinomastat |
|
6505 | AG-3340 | ||||||
| privosegtor | 13222 | BN-201, BN201, OCS-05 | |||||||
| PRMT5 inhibitor D3 | 13678 | compound D3 [PMID: 39722476] | |||||||
| PRN1371 |
|
9788 | compound 34 [PMID: 28665128], PRN-1371 | ||||||
| PRN694 |
|
9285 | |||||||
| probenecid |
|
|
4357 | Probalan® | |||||
| probe 1.1 [PMID: 24187130] | 9191 | KSC-12-192 | |||||||
| probe 2.1 [PMID: 24187130] | 9192 | ||||||||
| probucol |
|
7277 | DH-581, Lorelco® | ||||||
| procainamide |
|
4811 | Procan®, Pronestyl® | ||||||
| procaine |
|
4291 | Novocain® | ||||||
| procarbazine |
|
7278 | Matulane®, Ro-4-6467/1, Ro-4646711 | ||||||
| procaterol |
|
|
3464 | ||||||
| prochlorperazine |
|
|
7279 | Buccastem®, Compazine®, prochlorperazine edisylate, prochlorperazine maleate | |||||
| procyclidine |
|
7280 | Arpicolin®, Kemadrin®, procyclidine hydrochloride | ||||||
| proglumide | 893 | W-5219 | |||||||
| proguanil |
|
|
|
9676 | Bigumal®, chloroguanide, Paludrine® | ||||
| promazine |
|
|
7281 | Sparine® | |||||
| promegestone | 2877 | R5020 | |||||||
| promethazine |
|
7282 | Phenergan®, Sominex® | ||||||
| prontosil | 12743 | prontosil red, prontosil rubrum, sulfamidochrysoidine | |||||||
| propafenone |
|
2561 | Arythmol®, GNF-Pf-4594, Rythmol® | ||||||
| propantheline |
|
329 | Pro-Banthine® | ||||||
| proparacaine |
|
7283 | Alcaine®, Paracaine®, proparacaine hydrochloride, proxymetacaine hydrochloride | ||||||
| propargylglycine | 5247 | ||||||||
| propiomazine |
|
7284 | CB-1678, Largon®, WY-1359 | ||||||
| propofol |
|
|
5464 | 2,6-diisopropylphenol, Diprivan®, ICI 35868 | |||||
| (+)-propranolol | 7596 | dextropropranolol, R(+)-propranolol | |||||||
| (-)-propranolol |
|
63 | |||||||
| propranolol |
|
564 | Bedranol®, Hemangiol®, Inderal®, propranolol hydrochloride | ||||||
| α-propyldopacetamide | 5095 | ||||||||
| propylpyrazoletriol | 2819 | PPT | |||||||
| propylthiouracil |
|
|
6650 | Thyreostat® | |||||
| PROTAC 3 | 10636 | Gefitinib-based PROTAC 3 | |||||||
| PROTAC 23 [PMID: 38321747] | 13142 | ||||||||
| PROTAC T3 | 13175 | ||||||||
| protriptyline |
|
7285 | MK-240, Vivactil® | ||||||
| proximod |
|
13783 | compound 53b [Tian et al., 2013], IMMH001, LJR001, SYL930 | ||||||
| proxyfan |
|
1255 | |||||||
| PRT3789 | 13837 | compound 1 [WO2024076985A2], PRT-3789 | |||||||
| PRU-10 | 11861 | ||||||||
| PRU-12 |
|
11862 | 1-[17beta-Hydroxy-1(10),2,4-estratriene-3-yl]ethanone, PRU12 | ||||||
| prucalopride |
|
243 | Motegrity®, R-093877, R-108512, Resolor® | ||||||
| prulifloxacin |
|
12860 | NM441 | ||||||
| prunetin | 6919 | 4',5-dihydroxy-7-methoxyisoflavone | |||||||
| pruvonertinib | 13740 | Analogue 6 [PMID: 37406381], YK-029A | |||||||
| pruxelutamide | 11992 | GT-0918, GT0918, proxalutamide | |||||||
| PRX-2904 | 14036 | compound 31 [PMID: 33859800], PRX2904 | |||||||
| PS020990 | 660 | ||||||||
| PSAB-OFP | 3968 | ||||||||
| PSB-0702 | 14168 | compound 41 [PMID: 19463000], PSB0702 | |||||||
| PSB-0739 | 5904 | PSB 0739 | |||||||
| PSB-0788 | 6561 | PSB 0788, PSB0788 | |||||||
| PSB-0963 | 9023 | ||||||||
| PSB-10 | 5619 | ||||||||
| PSB-10211 | 9539 | compound 63 [PMID: 21207957] | |||||||
| PSB-11 | 5620 | ||||||||
| PSB1114 | 5902 | PSB 1114, PSB-1114 | |||||||
| PSB1115 |
|
3286 | compound 17 [PMID: 11906291], PSB 1115, PSB-1115 | ||||||
| PSB-12054 | 12566 | PSB12054 | |||||||
| PSB-12062 | 9542 | 10-tosyl-10H-phenoxazine, compound 21 [PMID: 23075067] | |||||||
| PSB-1584 | 10717 | 6-hexylaminouracil, compound 20 [PMID: 30023867], PSB1584 | |||||||
| PSB-16133 | 11451 | compound 61 [PMID: 28306255], PSB16133 | |||||||
| PSB-16434 | 11210 | ||||||||
| PSB-17365 |
|
9871 | compound 48 [Pillaiyar et al., 2018], PSB17365 | ||||||
| PSB-22219 | 14165 | PSB22219 | |||||||
| PSB36 | 3285 | PSB-36 | |||||||
| PSB-416 | 9468 | SB-416 | |||||||
| PSB603 | 3284 | PSB 603, PSB-603 | |||||||
| PSB-6426 | 9033 | compound 19a [PMID: 18630897] | |||||||
| [3H]PSB-0413 |
|
|
6147 | [3H]AR-C67085, [3H]AR-C67085MX | |||||
| [3H]PSB-11 |
|
|
5729 | ||||||
| [3H]PSB-22219 |
|
|
14166 | [3H]18 | |||||
| [3H]PSB603 |
|
|
5728 | ||||||
| PSB-KD107 |
|
11081 | compound 2Ak [PMID: 17827019], compound 5 [Schoeder et al., 2020] | ||||||
| PSB-KK1415 | 13425 | compouind 51 [PMID: 38885438], PSB KK1415, PSBKK1415 | |||||||
| PSB-KK1445 | 13424 | compound 50 [PMID: 38885438], PSB KK1445, PSBKK1445 | |||||||
| pseudoephedrine |
|
7286 | pseudoephedrine hydrochloride, pseudophedrine sulphate, Sinutab®, Sudafed® | ||||||
| PSN375963 | 3318 | PSN 375963, PSN-375,963, PSN-375963 | |||||||
| PSN632408 | 3319 | PSN 632408, PSN-632,408, PSN-632408 | |||||||
| psora-4 |
|
9583 | 5-(4-phenylbutoxy)psoralen, psora 4 | ||||||
| PT2385 |
|
12707 | MK-3795, MK3795, PT-2385 | ||||||
| PT-91 | 13993 | compound 7p [PMID: 38060818], PT91 | |||||||
| [125I]PTA-OH |
|
|
1981 | I-PTA-OH | |||||
| PTBE | 1403 | ||||||||
| PTD10 | 12687 | ||||||||
| PTeB | 1430 | ||||||||
| pudafensine | 13226 | IP2015, IPED-2015, IPED2015 | |||||||
| pumecitinib | 12374 | compound I [WO2022042577A1] | |||||||
| puquitinib | 9928 | XC-302, XC302 | |||||||
| purmorphamine | 10356 | ||||||||
| purvalanol A | 6030 | AC1L1JD0, IN1131, L-745,870 | |||||||
| purvalanol B |
|
7806 | NG-95, NG95 | ||||||
| PXS-4681A |
|
9753 | |||||||
| PXS-4728A |
|
9346 | PXS4728A | ||||||
| Pyr10 | 10282 | Pyr-10 | |||||||
| Pyr3 | 4293 | ||||||||
| P2Y14R antagonist I-17 |
|
13422 | compound I-17 [PMID: 38874515] | ||||||
| pyrazinamide |
|
|
7287 | aldinamide, Zinamide® | |||||
| Pyrazolo-pyrimidine 14a [PMID: 29859875] | 12533 | ||||||||
| pyrazolopyrimidine 4n | 10281 | ||||||||
| pyridostigmine |
|
8994 | Mestinon®, Regonol® | ||||||
| 2-pyridylethylamine |
|
1197 | PEA | ||||||
| 2,2'-pyridylisatogen tosylate | 1729 | PIT | |||||||
| [11C]pyrilamine |
|
|
|
3957 | [11C]-mepyramine, [11C]-pyrilamine | ||||
| [3H]pyrilamine |
|
|
1220 | [3H]mepyramine | |||||
| pyrimethamine |
|
|
|
4800 | Daraprim®, GNF-Pf-5586, TCMDC-125860 | ||||
| pyronaridine |
|
10086 | 7351, Malaridine® | ||||||
| pyrotinib |
|
9662 | Airuini®, compound 12 [PMID: 28115222], SHR-1258, SHR1258 | ||||||
| pyrrolidine MCHR1 antagonist 1 | 7756 | ||||||||
| pyrrolopyrimidine 48 [PMID: 22318156] | 5731 | ||||||||
| PZ-II-029 | 12403 | compound 6 [PMID: 23472852], compound 6 [PMID: 23472935], PZ II-029 | |||||||
| PZL-A |
|
13865 | |||||||
| PZM21 |
|
9286 | (S,S)-1-[2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-(1-thiophen-3-ylpropan-2-yl)urea, (S,S)-21 [PMID: 27533032] | ||||||
| Q | Back to top | ||||||||
| QA1 | 5815 | ||||||||
| QAV680 |
|
8996 | NVP-QAV680 | ||||||
| QC-01-175 | 10544 | ||||||||
| QC-182 | 13143 | compound 19 [PMID: 38316017] | |||||||
| [3H]QNB |
|
|
318 | [3H]quinuclidinylbenzilate | |||||
| QNZ 46 | 7845 | KB-275239 | |||||||
| QO-58 | 7669 | ||||||||
| QP5020 | 13400 | compound 4 [PMID: 38097557], QP-5020 | |||||||
| QP5038 | 13401 | compound 28 [PMID: 38097557], QP-5038 | |||||||
| QR-6401 | 12511 | compound 23 [PMID: 36923916], QR6401 | |||||||
| quabodepistat | 13059 | OPC-167832 | |||||||
| quadazocine | 1633 | (-)-quadazocine, (-)-WIN 44,441 | |||||||
| quazepam |
|
7288 | Doral®, SCH-16134 | ||||||
| quecitinib |
|
14064 | QY-201, QY201, VVN-461, VVN461 | ||||||
| quemliclustat |
|
|
10707 | AB-680, AB680 | |||||
| quetiapine |
|
50 | Seroquel®, ZM-204636 | ||||||
| quinapril |
|
6350 | Accupril®, Accupro®, Accuretic®, CI-906 | ||||||
| quinaprilat |
|
|
6352 | CL-928 | |||||
| quinazolin-4(3H) derivative 36 |
|
12554 | compound 36 [PMID: 30629441], TRPV4 agonist 36 | ||||||
| quin-C1 | 6265 | ||||||||
| quin-C7 | 1039 | ||||||||
| quinelorane | 954 | ||||||||
| quinestrol |
|
7097 | Estrovis®, W-3566 | ||||||
| quinethazone |
|
7289 | Hydromox® | ||||||
| quinoline 2 |
|
8599 | |||||||
| quinostatin | 8978 | ||||||||
| quinpirole | 2 | (-)-quinpirole | |||||||
| 3-quinuclidinyl-benzilate | 3260 | QNB, Buzz, BZ, EA-2277, Substance 78 | |||||||
| quinupristin |
|
10798 | RP 57669, RP-57669, RP57669, Synercid® (dalfopristin + quinupristin) | ||||||
| quipazine | 173 | ||||||||
| quisinostat |
|
|
7503 | JNJ-26481585 | |||||
| quisqualate |
|
1372 | quisqualic acid | ||||||
| [3H]quisqualate |
|
|
|
1370 | |||||
| quizartinib |
|
|
5658 | AC 010220, AC 220, AC220, Vanflyta® | |||||
| QX-314 | 2405 | ||||||||
| R | Back to top | ||||||||
| 1R-11 |
|
10138 | |||||||
| R116010 | 11380 | NIL6PST6V7 | |||||||
| R116031 | 5754 | R 116031, R-116031 | |||||||
| R121919 | 3520 | R 121919, R-121919 | |||||||
| R-138727 | 1771 | R 138727, R138727 | |||||||
| R214127 | 6336 | R 214127, R-214127 | |||||||
| R283 |
|
10049 | 1,3-Dimethyl-2[(oxopropyl)thio]imidazolium | ||||||
| R547 |
|
5707 | R-547, Ro 4584820 | ||||||
| R55 | 7520 | compound 1 [PMID: 24747528], TPT-260, TPT260 | |||||||
| [3H]R214127 |
|
|
1391 | [3H]-R214127 | |||||
| RA-2 | 9317 | ||||||||
| RA839 |
|
|
10487 | compound 7 [PMID: 31411465], RA-839 | |||||
| rabeprazole |
|
7290 | AcipHex®, E-3810, Pariet® | ||||||
| rabeximod |
|
9856 | Rob-803, Rob803 | ||||||
| rabusertib | 7960 | LY-2603618, LY2603618 | |||||||
| rac-BHFF | 10267 | (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one, rac-BHFF | |||||||
| racecadotril |
|
11654 | (+/-)-acetorphan, acetorphan, Hidrasec® | ||||||
| raclopride | 94 | (-)-raclopride, S-(-)-raclopride, S-raclopride | |||||||
| [3H]raclopride |
|
|
3299 | [3H]-raclopride | |||||
| ractopamine | 10455 | EL-737, Optaflexx®, Paylean®, ractopamin, Tomax® | |||||||
| radezolid |
|
10849 | Rx-01_667, RX-103, RX-1741, RX103, RX1741 | ||||||
| Radioprotectin-1 | 11316 | RP-1 | |||||||
| radotinib |
|
7814 | IY-5511, IY5511, IY5511HCl, KB-146009, Supect® | ||||||
| ragaglitazar |
|
2664 | |||||||
| ralimetinib |
|
7959 | LY-2228820, LY-2228820 free base, LY2228820 | ||||||
| ralinepag | 14138 | APD-811, APD811, compound 5c [PMID: 28072531] | |||||||
| ralmitaront |
|
12190 | Example 1 [WO2017157873A1], RG-7906, RG7906, RO-6889450, RO6889450 | ||||||
| ralometostat |
|
13320 | TNG-908, TNG908 | ||||||
| raloxifene |
|
|
2820 | Evista®, LY-156758, Optruma®, raloxifene hydrochloride | |||||
| raltegravir |
|
|
11571 | Isentress®, MK-0518, MK0518 | |||||
| raltitrexed |
|
|
7403 | ICI-D-1694, Tomudex®, ZD1694 | |||||
| ramatroban |
|
1911 | BAY U3405, BAY-U-3405, baynas, EN-137774 | ||||||
| [3H]ramatroban |
|
|
|
1910 | [3H]Bay u 3405, [3H]BAY u3405, [3H]baynas | ||||
| ramelteon |
|
|
1356 | Rozerem®, TAK-375, TAK375 | |||||
| ramipril |
|
6339 | Altace®, HOE-498, Tritace® | ||||||
| ramiprilat |
|
|
6344 | ||||||
| ramosetron | 2301 | ||||||||
| [3H]ramosetron |
|
|
2305 | ||||||
| R(-)amphetamine |
|
2146 | l-amphetamine | ||||||
| ranbezolid | 11007 | RBx 7644 | |||||||
| ranimycin | 10850 | Rancomycin 2, U-25,873, U-25873 | |||||||
| ranitidine |
|
1234 | AH-19065, Gavilast®, GR-122311X, Zantac® | ||||||
| ranolazine |
|
7291 | CVT-303, Ranexa®, RS-43285, RS-43285-003 | ||||||
| RapaLink-1 | 9212 | 40-O-(2-((1-(32-(4-amino-3-(2-aminobenzo[d]oxazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-27-oxo-3,6,9,12,15,18,21,24-octaoxa-28-azadotriacontyl)-1H-1,2,3-triazol-4-yl)methoxy)ethyl)-rapamycin | |||||||
| rasagiline |
|
|
6641 | Azilect®, TVP-1012 | |||||
| RasGRP activator 1 | 10066 | compound 1 [PMID: 24794745] | |||||||
| ratutrelvir | 13737 | Example 1 [WO2023093834A1], TRX-01, TRX01 | |||||||
| [3H]rauwolscine |
|
|
223 | ||||||
| ravoxertinib |
|
9229 | example 39 [WO2013130976], GDC-0994 | ||||||
| razupenem | 10851 | PZ-601, SM-216601, SMP-601 | |||||||
| razuprotafib | 11336 | AKB-9778, AKB9778, Compound AA34 [US10220048] | |||||||
| RB101 | 11650 | RB 101, RB-101 | |||||||
| RB120 | 11651 | RB 120, RB-120 | |||||||
| RB3007 | 11652 | RB 3007, RB-3007 | |||||||
| RBI257 | 981 | RBI 257, RBI-257 | |||||||
| RBM2-1B | 8879 | ||||||||
| RBN012759 | 13124 | RBN-012759 | |||||||
| RCI-0879 | 11439 | RCI0879 | |||||||
| RDp002 | 13825 | ID210203C-1 | |||||||
| reactive blue-2 | 1739 | affi gel blue, cibacron blue, procion blue HB | |||||||
| rebamipide |
|
871 | OPC-12759, pramipide | ||||||
| rebastinib |
|
|
9173 | DCC 2036, DCC-2036, DP-1919 | |||||
| reboxetine |
|
|
4808 | Edronax®, PNU-165442G | |||||
| Rec 15/2615 | 8459 | ||||||||
| Rec 15/3079 | 74 | ||||||||
| recilisib | 11620 | EX-RAD®, ON 01210, ON-01210 | |||||||
| refametinib |
|
7942 | BAY-869766, RDEA119 | ||||||
| regadenoson |
|
5596 | CVT-3146, Lexiscan®, Rapiscan® | ||||||
| reglitazar | 2670 | JTT-501 | |||||||
| regorafenib |
|
5891 | BAY 73-4506, Stivarga® | ||||||
| regrelor | 1770 | INS 50589, INS-50589, INS50589 | |||||||
| relacatib | 7862 | SB-462795, SB462795 | |||||||
| relacorilant |
|
13830 | compound 7 [PMID: 28368581], CORT-125134, CORT125134 | ||||||
| RelA inhibitor A55 | 13328 | ||||||||
| relcovaptan | 2200 | SR 49059, SR-49059, SR49059 | |||||||
| [3H]relcovaptan |
|
|
3482 | [3H] SR 49059, [3H]SR-49059, [3H]SR49059 | |||||
| reldesemtiv | 11801 | CK-107, CK-2127107, CK2127107 | |||||||
| relebactam |
|
10852 | MK-7655, MK-7655A, MK7655 | ||||||
| relenopride | 8427 | YKP10811 | |||||||
| relugolix |
|
5586 | Orgovyx®, Ryeqo® (relugolix-estradiol-norethisterone acetate), TAK 385, TAK-385 | ||||||
| relutrigine | 12643 | PRAX-562, PRAX562 | |||||||
| remdesivir |
|
10715 | compound 4b [PMID: 28124907], GS-5734, GS5734, Veklury® | ||||||
| remdesivir triphosphate |
|
11899 | GS-441524 triphosphate, GS-443902, RDV-TP | ||||||
| remibrutinib |
|
10457 | compound 25 [PMID: 32083858], example 6 [WO2015079417A1], LOU-064, LOU064, LOU064-NXA, NVP-LOU064-NXA | ||||||
| remifentanil |
|
7292 | GI-87084B, Ultiva® | ||||||
| remimazolam |
|
8442 | Byfavo®, CNS-7056, CNS7056 | ||||||
| remodelin | 8102 | ||||||||
| remogliflozin | 4588 | ||||||||
| rentosertib |
|
13279 | compound 112 [WO2022179528], compound 4 [PMID: 39422731], INS-018-055, INS-018_055, INS018-055, ISM001-055 | ||||||
| renzapride | 244 | BRL 24924, BRL-24924 | |||||||
| repaglinide |
|
|
6841 | (-)-repaglinide, AGEE-623ZW, Prandin® | |||||
| reparixin |
|
8498 | DF 1681Y, repertaxin | ||||||
| repibresib | 14071 | example 1 [US20220204500], TAY-B1, TAYB1 | |||||||
| repinatrabit | 12899 | JNT-517, JNT517 | |||||||
| repinotan | 95 | ||||||||
| repotrectinib |
|
|
10316 | Augtyro®, example 93 [US20170334929A1], TPX-0005, TPX0005 | |||||
| reproxalap |
|
10613 | ADX-102, ADX102, example 5 [WO2018039197A1], NS-2, NS2 | ||||||
| repunapanor | 14075 | Example 6-1 [US20170210736], formula 123 [US20170210736] | |||||||
| resatorvid |
|
9036 | TAK-242, TAK242 | ||||||
| resencatinib | 12381 | Example 152 [WO2020228756A1] | |||||||
| reserpine |
|
|
4823 | Serpalan® | |||||
| resigratinib | 12874 | Example 78 [WO2021247969A1], KIN-3248, KIN3248 | |||||||
| [125I]resiniferatoxin |
|
|
2492 | ||||||
| [3H]resiniferatoxin |
|
|
|
4091 | |||||
| resiquimod |
|
|
5051 | R-848, R848 | |||||
| resmetirom |
|
12026 | compound 53 [PMID: 24712661], MGL-3196, MGL3196, Rezdiffra®, VIA-3196, VIA3196 | ||||||
| resminostat |
|
7502 | 4SC-201, BYK408740, RAS2410 | ||||||
| resolvin D3 | 14158 | RvD3 | |||||||
| [3H]resolvin D1 |
|
|
|
4356 | [3H]-RvD1 | ||||
| [3H]resolvin E1 |
|
|
|
2901 | [(3)H]-labeled RvE1, [3H]RvE1 | ||||
| retapamulin |
|
11035 | Altabax®, Altargo®, SB-275833, SB275833 | ||||||
| retaspimycin hydrochloride | 9827 | 17-AAG (hydrochloride), 17-Allylamino-17-demethoxygeldanamycin (hydrochloride), IPI-504, IPI504 | |||||||
| retigabine |
|
|
2601 | AWD-21360, D-23129, ezogabine, Potiga®, Trobalt®, WAY-143841 | |||||
| retigabine derivative 10g | 11479 | compound 10g [PMID: 30655942] | |||||||
| retosiban |
|
8403 | GSK-221,149-A, GSK-221149A, GSK221149A | ||||||
| revamilast |
|
9865 | Example 26 [WO2006064355A2], GRC 4039, GRC-4039, GRC4039 | ||||||
| revaprazan |
|
12007 | Revanex®, YH-1885, YH1885 | ||||||
| revefenacin |
|
10129 | GSK-1160724, GSK1160724, TD4208, Yupelri® | ||||||
| revumenib |
|
|
11882 | Revuforj®, SNDX-5613, SNDX5613 | |||||
| rezivertinib |
|
10628 | example 1 [WO2016094821A2] | ||||||
| rezvilutamide |
|
12798 | Ariane®, example 44 [WO2014036897A1], SHR-3680, SHR3680 | ||||||
| RG-1530 | 10361 | compound 2 [PMID: 24900658], R-1530, R1530, RG1530 | |||||||
| RG7112 |
|
|
9599 | ||||||
| RGB-286638 | 7744 | RGB 286638, RGB286638 | |||||||
| RGFP109 | 7501 | RG-2833, RG2833, RGFP-109 | |||||||
| RGFP966 | 7500 | RGFP-966 | |||||||
| RGN6024 | 13968 | ||||||||
| RGS4 inhibitor 11b | 8033 | thiadiazolidinone (TDZD) deriv. 6 | |||||||
| RHC80267 | 5255 | RHC 80267, RHC-80267, U 57908 | |||||||
| rhodamine123 | 4607 | rhodamine 123 | |||||||
| Rho kinase inhibitor III | 6032 | rockout | |||||||
| Rho kinase inhibitor IV |
|
6033 | glycyl-H 1152 | ||||||
| riamilovir | 11996 | Triazavirin®, TZV | |||||||
| ribavirin |
|
|
6842 | RBV, Copegus®, Rebetol®, ribofluranosyl carboxamide, Virazole® | |||||
| ribociclib |
|
|
7383 | example 74 [US8962630], Kisqali®, LEE-011, LEE011 | |||||
| ricasetron | 2302 | BRL-46470 | |||||||
| ricolinostat |
|
7010 | ACY-1215 | ||||||
| ridaforolimus | 7884 | AP-23573, AP23573, deforolimus, MK-8669 | |||||||
| ridinilazole |
|
10853 | SMT-19969, SMT19969 | ||||||
| rifabutin |
|
12015 | BV100 (for infusion), LM 427, Mycobutin®, Rifabutine | ||||||
| rifapentine |
|
|
12014 | DL 473, MDL 473, Priftin® | |||||
| rifaquizinone | 11028 | CBR-2092, TNP-2092 | |||||||
| rifasutenizol | 12959 | TNP-2198 | |||||||
| rifaximin |
|
|
12012 | L/105, Rifamycin L 105, Xifaxan® | |||||
| rigosertib |
|
7833 | Estybon® (proposed trade name), ON-01910, ON01910.Na | ||||||
| rilapladib |
|
7376 | SB 659032 | ||||||
| rilmenidine |
|
13356 | Albarel®, S-3341, S-3341-3, S3341 | ||||||
| rilpivirine |
|
|
11387 | Edurant®, TMC-278, TMC278 | |||||
| riluzole |
|
|
2326 | Rilutek®, RP-54274, Tiglutik® (thickened oral suspension) | |||||
| rilzabrutinib |
|
|
|
9993 | Example 31 [WO2014039899], PRN-1008, PRN1008, Wayrilz® | ||||
| rimacalib |
|
9364 | SMP-114 | ||||||
| rimegepant |
|
10704 | BHV-3000, BHV3000, BMS-927711, BMS927711, compound 8 [PMID: 23153230], Nurtec ODT®, Vydura® | ||||||
| rimonabant |
|
|
743 | A 281, Acomplia®, SR 141716 | |||||
| [3H]rimonabant |
|
|
745 | [3H]-rimonabant, [3H]-SR141716, [3H]SR141716A | |||||
| rimtuzalcap |
|
12649 | CAD-1883, CAD1883, compound 1 [US9975886B1] | ||||||
| rineterkib | 11200 | ERK-IN-1, example 184 [WO2015066188A1], LTT-462, LTT462 | |||||||
| riociguat |
|
|
5257 | Adempas®, BAY 63-2521 | |||||
| RIPA-56 |
|
9643 | compound 56 [PMID: 27992216], compound 92 [WO2016101885] | ||||||
| ripasudil |
|
10423 | Glanatec®, K-115 (ripasudil hydrochloride dihydrate) | ||||||
| RIPK2 inhibitor 3 |
|
|
10413 | compound 3 [PMID: 31265286], Example 1 [WO2014043446A1], GSK2983559 | |||||
| RIPK2 inhibitor 5 |
|
|
10419 | compound 5 [PMID: 31265286] | |||||
| RIPK2 inhibitor 8 |
|
9688 | |||||||
| RIPK3 inhibitor 18 |
|
|
10389 | ||||||
| RIPK3 inhibitor 42 |
|
10401 | |||||||
| RIPK1 inhibitor 22b | 10155 | compound 22b [PMID: 30480444] | |||||||
| ripretinib |
|
9175 | DCC-2618, DCC2618, Quinlock® | ||||||
| risdiplam |
|
11170 | compound 1 [PMID: 30044619], Evrysdi®, RG-7916, RG7916, RO-7034067, RO7034067 | ||||||
| risedronate |
|
|
3176 | Actonel®, Atelvia®, NE-58095, risedronate sodium | |||||
| risovalisib | 12382 | compound 37 [PMID: 33109399], CYH-33, CYH33 | |||||||
| risperidone |
|
|
96 | Okedi®, R-64-766, R-64766, Risperdal® | |||||
| risvodetinib | 12383 | Compound 809 [US20200046699A1] | |||||||
| ritanserin |
|
97 | R-55667 | ||||||
| ritipenem | 10854 | FCE-22101, FCE22101 | |||||||
| ritlecitinib |
|
|
9559 | compound 11 [PMID: 28139931], example 5 [WO2015083028], Litfulo®, PF-06651600, PF06651600 | |||||
| ritodrine |
|
|
7294 | DU-21220, Yutopar® | |||||
| ritonavir |
|
|
8804 | RTV, A-84538, ABBOTT-84538, ABT 538, ABT-538, Norvir® | |||||
| rivanicline | 3994 | metanicotine, RJR-2403, TC 2403, TC-2403, TC2403, trans-metanicotine | |||||||
| rivaroxaban |
|
|
6388 | BAY 59-7939, Xarelto® | |||||
| rivastigmine |
|
6602 | Ena 713 free base, Exelon® | ||||||
| rivenprost | 1930 | ONO-4819, ONO4819 | |||||||
| riviciclib | 7934 | P276-00 | |||||||
| rivipansel | 8307 | GMI-1070, PF-06460031, PF-0646003102 | |||||||
| rivoceranib |
|
7648 | apatinib (in China), YN968D1 | ||||||
| rizatriptan |
|
51 | Maxalt®, MK-0462, MK-462, MK-A462, rizatriptan benzoate | ||||||
| rizavasertib |
|
8204 | A 443654, A-443654, A443654 | ||||||
| RJG-2051 | 13894 | compound 21 [PMID: 40277220], RJG2051 | |||||||
| RJW100 | 10484 | 24-exo | |||||||
| RK-287107 |
|
10673 | RK287107 | ||||||
| RKI-1447 |
|
8152 | compound 5g [PMID 23275831], RKI1447 | ||||||
| R-L3 | 2595 | R-L364,373 | |||||||
| RLX-33 | 12120 | compound 33 [PMID: 35594150], RLX33 | |||||||
| RM65 | 7029 | ||||||||
| RMC-5552 | 12338 | compound 38 [PMID: 36533617], RMC5552 | |||||||
| RMC-9805 | 13482 | Example A26 [WO2023060253A1], RMC9805 | |||||||
| R-(+)-methanandamide | 2506 | (R)-methanandamide, AM-356, methanandamide | |||||||
| RN-1 | 8980 | ||||||||
| RN1734 | 4294 | RN 1734, RN-1734 | |||||||
| RN1747 | 4295 | RN 1747, RN-1747 | |||||||
| RN486 |
|
8249 | compound 29 [PMID 22394077], RN-486 | ||||||
| RN-9893 | 10304 | compound 26 [PMID: 26235950], RN9893 | |||||||
| RO0094889 | 10514 | compound 11c [PMID: 2617910], Ro 09-4889 | |||||||
| Ro01-6128 | 1386 | Ro-016128 | |||||||
| Ro 04-6790 | 274 | Ro 4-6790, Ro-046790 | |||||||
| Ro-0505124 | 8203 | RO0505124 | |||||||
| Ro0711401 | 6204 | compound 14a [PMID: 19233648] | |||||||
| Ro 10-4548 | 982 | ||||||||
| RO 116 1148 | 252 | RO 116-1148 | |||||||
| RO116-4875/608 | 789 | ||||||||
| RO116-9132/238 | 790 | ||||||||
| Ro15-4513 |
|
4296 | Ro-154513 | ||||||
| Ro19-4603 | 4297 | Ro-194603 | |||||||
| Ro20-1724 | 5258 | RO-201724 | |||||||
| Ro26-4550 |
|
5052 | Ro 26-4550, Ro-26-4550 | ||||||
| RO3 | 4298 | RO-3 | |||||||
| Ro31-8220 |
|
5259 | bisindolymaleimide IX, Ro 318220, Ro-318220 | ||||||
| RO320-2947/001 | 791 | ||||||||
| Ro-32-0432 | 6034 | Ro 32-0432, Ro-320432 | |||||||
| RO3244794 | 4042 | ||||||||
| Ro3280 |
|
9403 | compound 7 [PMID: 22172702] | ||||||
| RO330-0802/001 | 792 | ||||||||
| RO3306 | 10095 | RO-3306 | |||||||
| (-)-Ro 363 | 5571 | RO 363, RO-363, RO363 | |||||||
| Ro 40-6055 |
|
2647 | AM 580, AM580, CD-336, Ro406055 | ||||||
| Ro-406890 | 11048 | ceftrazonal, Ro 40-6890, Ro 406890, Ro406890 | |||||||
| Ro 41-5253 | 2642 | LG629, Ro-415253, Ro415253 | |||||||
| Ro4491533 | 6226 | Ro 4491533, Ro-4491533 | |||||||
| Ro 46-8443 | 1011 | Ro468443 | |||||||
| Ro 48-8071 |
|
6710 | compound 2 [PMID: 22533316] | ||||||
| RO4929097 |
|
7338 | RG-4733, RG4733, Ro4929097 | ||||||
| RO4938581 |
|
4299 | Ro-4938581 | ||||||
| RO4988546 | 6324 | Ro4988546 | |||||||
| Ro5028442 | 8529 | RG-7713, RG7713, Ro-5028442 | |||||||
| RO5101576 | 6158 | Ro 5101576 | |||||||
| RO5166017 | 5862 | RO 5166017, RO-5166017 | |||||||
| RO5256390 |
|
10722 | RO 5256390, RO-5256390 | ||||||
| RO5488608 | 6325 | ||||||||
| RO5508887 |
|
9821 | RG7129 | ||||||
| Ro 60-0175 | 166 | Ro-600175, Ro600175 | |||||||
| Ro 63-0563 | 275 | Ro-63-0563, Ro-630563, Ro630563 | |||||||
| Ro64-5229 | 3955 | Ro 64-5229 | |||||||
| Ro64-6198 | 1684 | compound 3c, Ro 64-6198, Ro-646198, Ro646198 | |||||||
| Ro67-4853 | 1387 | Ro-67-4853 | |||||||
| Ro67-7476 | 1388 | Ro 677476, Ro-677476 | |||||||
| Ro-70-0004 | 497 | Ro-700004, RS-100975 | |||||||
| RO7075573 |
|
13375 | |||||||
| Ro 8-4304 | 4300 | Ro-84304, Ro84304 | |||||||
| (R)-Ro65-6570 | 8864 | (R)-Ro 65-6570 | |||||||
| [3H]Ro154513 |
|
|
|
4365 | |||||
| [3H]Ro 63-0563 |
|
|
3246 | ||||||
| robalzotan | 72 | AZD-7371, NAD 299, NAD-299, NAD299, robalzotan tartrate hydrate | |||||||
| [3H]robalzotan |
|
|
82 | [3H]NAD 299, [3H]NAD-299 | |||||
| roblitinib |
|
9768 | Example 83 [US9266883], FGF-401, FGF401, NVP-FGF401 | ||||||
| rocbrutinib |
|
12875 | |||||||
| rociletinib |
|
7966 | AVL-301, CO-1686 | ||||||
| ROCK inhibitor 3 | 10425 | Chiesi Rock inhibitor, example 3 [WO2010032875A2] | |||||||
| rocuronium |
|
|
4003 | Esmeron®, ORG-9426, Zemuron® | |||||
| rodatristat |
|
10647 | compound 15a [PMID: 28041831], KAR-5417, KAR5417 | ||||||
| rodatristat ethyl | 10646 | compound 15b [PMID: 28041831], KAR-5585, KAR5585, RVT-1201 | |||||||
| rofecoxib |
|
|
|
2893 | Ceoxx®, MK 966, Vioxx® | ||||
| roflumilast |
|
|
|
6962 | ARQ-151/Zoryve® (roflumilast cream), BY-217, BYK-20869, Daliresp®, Daxas® | ||||
| roflupram |
|
10691 | FFPM, Zl-n-91 | ||||||
| rogaratinib | 9789 | BAY-1163877, BAY1163877, Example 1 [WO2013087578] | |||||||
| roginolisib | 12487 | compound 1 [WO2022207646A1], compound 339 [US9073940], IOA244, MSC-2360844, MSC2360844 | |||||||
| rogocekib | 13217 | CTX-712, CTX712 | |||||||
| rokitamycin |
|
12879 | Ricamycin®, TMS-19-Q | ||||||
| rolapitant |
|
5749 | SCH 619734, SCH-619734, Varubi®, Varuby® | ||||||
| rolipram |
|
5260 | (±)-rolipram, (R,S)-rolipram | ||||||
| [3H]rolipram |
|
|
5313 | [3H]-rolipram | |||||
| rolitetracycline |
|
12760 | pyrrolidinylmethyltetracycline, Reverin®, SQ 15,659, Syntetrin®, Velacycline® | ||||||
| rolofylline | 5604 | KW-3902, NAX | |||||||
| roluperidone |
|
13306 | Compound I [WO2020041504A1], CYR-101, CYR101, MIN-101, MIN101 | ||||||
| romaciclib | 13753 | RVU120, SEL120, SEL120-34A | |||||||
| ROMe |
|
6625 | (R)-FTY720 methyl ether, (R)-FTY720-OMe | ||||||
| romidepsin |
|
7006 | FK228, FR901228, Istodax® | ||||||
| ronacaleret | 9473 | SB-751689 | |||||||
| roniciclib | 7874 | BAY 10-00394, BAY 1000394, KB-145902 | |||||||
| ropinirole |
|
7295 | Requip®, SK&F-101468-A, SK&F-101468A | ||||||
| ropivacaine |
|
7602 | 1-propyl-2',6'-pipecoloxylidide, AL-381, LEA-103, Naropin®, ropivacaine hydrochloride | ||||||
| ropsacitinib | 11613 | compound 22 [PMID: 32787094], PF-06826647, PF06826647, Tyk2-IN-8 | |||||||
| RORC2 inverse agonist 66 [PMID: 30130103] |
|
10078 | example 5 [WO2016046755A1] | ||||||
| rose bengal (photoactivated) | 2393 | ||||||||
| rosiglitazone |
|
1056 | Avandia®, rosiglizole | ||||||
| rosiptor |
|
9249 | AQX-1125, AQX1125 | ||||||
| rosoxacin |
|
12474 | acrosoxacin, Eracine®, Eradacil®, Eradacin®, WIN 35213, Winuron® | ||||||
| rosuvastatin |
|
2954 | Crestor®, ZD4522 | ||||||
| rotigotine |
|
|
941 | Leganto®, N-0437, Neupro® | |||||
| rovadicitinib | 12384 | example 5 [US10561657B2] | |||||||
| rovazolac |
|
9625 | A-110, ALX-101, example 36 [WO2013130892] | ||||||
| roxadustat |
|
|
8454 | ASP-1517, ASP1517, Evrenzo®, FG-4592, FG4592 | |||||
| roxindole | 52 | ||||||||
| roxithromycin |
|
|
1465 | RU 28965 | |||||
| RP-001 | 10309 | RP001 | |||||||
| RP-101075 |
|
9889 | |||||||
| RP-1664 |
|
13841 | example 25 [WO2023159307A1], RP1664 | ||||||
| RP-52770 | 1839 | RP 52770 | |||||||
| RP-6685 | 12656 | RP-0006685, RP6685 | |||||||
| RP67580 | 3522 | RP 67580, RP-67580 | |||||||
| RP-69758 | 906 | RP 69758 | |||||||
| RP73870 | 3523 | RP 73870 | |||||||
| (S)-RP-6306 | 12072 | RP-6306, RP6306 | |||||||
| [3H]52770 RP |
|
|
1858 | ||||||
| RP60556A | 11006 | ||||||||
| Rp-8-Br-cGMPS | 10620 | ||||||||
| Rp-cAMPS |
|
5262 | adenosine- 3', 5'- cyclic monophosphorothioate, Rp- isomer | ||||||
| Rp-8-CPT-cGMPS | 5261 | Rp-8-[(4-chlorophenyl)thio]-guanosine-cyclic 3',5'-hydrogen phosphorothioate | |||||||
| Rp-5-OMe-UDPαB | 5910 | 5-OMe-uridine-5'-O-(α-boranodiphosphate), compound 18a [PMID: 22901672] | |||||||
| RPR121154 | 580 | RPR-121154 | |||||||
| RPR260243 | 7657 | RPR 260243, RPR-260243 | |||||||
| R-PSOP | 3524 | ||||||||
| (2R,3R)-APDC |
|
1392 | (2R,4R)-APDC, LY314593 | ||||||
| (2R,6R) 6-hydroxynorketamine | 9154 | (2R,6R)HNK | |||||||
| [18F](R,R)-quinuclidinyl-4-fluoromethyl-benzilate |
|
|
3275 | (R,R)-[18F]-FMeQNB, (R,R)-quinuclidinyl-4-[18F]-fluoromethyl-benzilate, (R,R)-quinuclidinyl-4-[18F]-fluoromethylbenzilate(PET ligand), [18F]-FMeQNB | |||||
| R,R-THC |
|
2822 | |||||||
| RS-1 | 13318 | Machaeriol 7 | |||||||
| RS 100235 | 250 | RS-100235, RS100235 | |||||||
| RS-100329 | 7381 | RS 100329, RS100329 | |||||||
| RS-102221 | 187 | RS-102,221, RS102221 | |||||||
| RS-102895 |
|
|
779 | abaucin, RS102895 | |||||
| RS 116 0086 | 251 | RO 116 0086, RO 116-0086, RS 116-0086 | |||||||
| RS-127445 | 188 | RS 127445 , RS-127445-190, RS127445 | |||||||
| RS-136270 | 780 | ||||||||
| RS-17053 | 495 | RS17053 | |||||||
| RS-2 | 13319 | Machaeriol 8 | |||||||
| RS-25344 |
|
6557 | RS 25344 | ||||||
| RS-30199 | 104 | ||||||||
| RS 39066 | 8567 | RS-39066, RS39066 | |||||||
| RS 39604 | 254 | RS-23597-190 , RS-39640 | |||||||
| RS-504393 |
|
781 | RS 504393, RS504393 | ||||||
| RS 57639 | 236 | RS-57639, RS57639 | |||||||
| RS 67333 | 237 | RS-67333, RS67, 333, RS67333 | |||||||
| RS67506 | 3230 | RS-67506 | |||||||
| RS79948 |
|
13128 | RS-79948 | ||||||
| RS 93520 | 1886 | RS 93427-007 , RS-93520 | |||||||
| [3H]RS 57639 |
|
|
239 | RS57639 | |||||
| (3R,4S)-293B | 2589 | chromanol 239B, LS-185874 | |||||||
| (RS)-5-diphosphomevalonate | 3055 | ||||||||
| (R/S) EF-1500 | 4583 | ||||||||
| (R,S)-PHPNECA | 369 | (R,S)-2-phenylhydroxypropynyl-NECA, 2-(3-hydroxy-3-phenyl)propyn-1-yladenosine-5'-N-ethyluronamide | |||||||
| (RS)-PPCC | 6676 | ||||||||
| (R,S)-4-PPG | 1406 | (R,S)-4-phosphonophenylglycine, (RS)PPG | |||||||
| (RS)-(tetrazol-5-yl)glycine | 4068 | ||||||||
| rT3 | 2636 | reverse T3, reverse triiodothyronine | |||||||
| RTI-118 | 7929 | ||||||||
| RTI-122 | 12395 | compound 30a [PMID: 36749855], RTI122 | |||||||
| RTI-13951-33 | 10031 | ||||||||
| RTI-19318-32 | 14176 | compound 32 [PMID: 37541631] | |||||||
| [125I]RTI55 |
|
|
5409 | [125I]-RTI55, [3H]β-CIT, [3H]iometopane | |||||
| 15R-TIC | 5864 | ||||||||
| RTOXA-43 | 12439 | Compound 40 [PMID: 34101446] | |||||||
| RU-0415529 | 13662 | ||||||||
| RU1968 | 10266 | ||||||||
| RU 24969 | 23 | RU-24,969, RU-24969 | |||||||
| Ru265 | 13350 | ||||||||
| RU26988 | 3446 | RU 26988, RU-26988 | |||||||
| RU28318 | 3451 | oxprenoate, RU 28318, RU-28318 | |||||||
| RU28362 | 3445 | RU-28362 | |||||||
| Ru360 | 13351 | ||||||||
| RU5135 | 2378 | RU 5135, RU-5135 | |||||||
| ruboxistaurin |
|
5263 | LY-333531 | ||||||
| rucaparib |
|
|
7736 | AG-014699, AG014699, AG14447, PF-01367338, Rubraca® | |||||
| rucaparib metabolite M324 | 13145 | ||||||||
| rufinamide |
|
7470 | Banzel®, CGP-33101, Inovelon®, RUF-331 | ||||||
| rufloxacin |
|
12473 | MF 934, Monos® | ||||||
| rugocrixan | 13739 | AZD-8797, AZD8797, compound 18a [PMID: 23516963], KAND-567, KAND567 | |||||||
| runcaciguat |
|
12359 | BAY 1101042, BAY-1101042, BAY1101042, compound 45 [PMID: 33872507] | ||||||
| rupatadine |
|
|
10103 | Rinialer®, Rupafin®, UR-12592, UR12592 | |||||
| rupitasertib |
|
12721 | M-2698, M2698, MSC-2363318A, MSC2363318A | ||||||
| ruserontinib | 12089 | SKLB-1028, SKLB1028 | |||||||
| ruxolitinib |
|
|
|
5688 | (R)-ruxolitinib, INC424, INCB 18424, INCB018424, Jakafi®, Jakavi® | ||||
| RV1729 |
|
10162 | RV-1729 | ||||||
| RV6153 |
|
10163 | RV-6153 | ||||||
| R-VK4-40 | 11288 | ||||||||
| RVT-1502 | 13314 | Compound 15 [WO2019160940A1], LGD-6972, LGD6972, RVT1502 | |||||||
| RWJ-351647 | 2198 | ||||||||
| RWJ-56110 | 3525 | RWJ56110 | |||||||
| RWJ-56423 |
|
|
9333 | (2S)-6 | |||||
| RX18 | 13155 | compound 22 [PMID: 24992070], RX-18 | |||||||
| RX821002 | 526 | 2-methoxyidazoxan, RX-821002 | |||||||
| [3H]RX821002 |
|
|
528 | [3H]2-methoxyidazoxan | |||||
| RXP-407 |
|
7894 | RXP 407 | ||||||
| RXP470.1 |
|
7812 | |||||||
| RY024 | 4301 | RY 024, RY-024 | |||||||
| RY764 | 1337 | RY 764, RY-764 | |||||||
| RY785 | 11478 | ||||||||
| RY796 | 7759 | RY 796, RY-796 | |||||||
| [3H]RY80 |
|
|
4364 | ||||||
| S | Back to top | ||||||||
| S136492 | 8620 | Cpd 3 (PMID 24990314) | |||||||
| (+)-S-14297 | 955 | (+)S14297 | |||||||
| S-14506 | 24 | S 14506, S-14,506 | |||||||
| S-14671 | 25 | S 14671, S-14,671 | |||||||
| S-15535 | 26 | S 15535 | |||||||
| S 16924 | 167 | S-16924 | |||||||
| S 17092 | 6565 | S-17092, S17092 | |||||||
| S18986 | 4304 | S 18986, S-18986 | |||||||
| (+)-S20 | 2772 | ||||||||
| S20 | 2773 | S20 (racemate), S20 racemic mixture | |||||||
| S20928 | 1360 | S 20928, S-20928 | |||||||
| S22153 | 1361 | S 22153, S-22153 | |||||||
| S24014 | 1353 | S 24014, S-24014 | |||||||
| S24773 | 1354 | S 24773, S-24773 | |||||||
| S26131 | 1362 | S 26131, S-26131 | |||||||
| S26284 | 1355 | S 26284 | |||||||
| S312 |
|
11163 | compound 19 [PMID: 26443076] | ||||||
| S33084 | 129 | S 33084 | |||||||
| S3969 | 4305 | S 3969 | |||||||
| S-4048 | 8845 | S 4048 | |||||||
| S4-1 |
|
12321 | |||||||
| S416 |
|
11164 | |||||||
| S-5751 | 1898 | S5751 | |||||||
| S6716 | 2163 | 3-amidinobenzylindole carboxamide 23 | |||||||
| S6821 | 12429 | ||||||||
| S7958 | 12430 | ||||||||
| S9947 | 2562 | S-9947 | |||||||
| [125I]S70254 |
|
|
7779 | ||||||
| [3H]S0139 |
|
|
3479 | [3H]-S0139, [3H]S-0139 | |||||
| [3H]S-145 |
|
|
1984 | ||||||
| [3H]S-15535 |
|
|
32 | ||||||
| S5A1 | 10116 | ||||||||
| SA-57 | 11815 | SA57 | |||||||
| sabcomeline | 306 | SB-202026 | |||||||
| sabizabulin |
|
11422 | VERU-111, VERU111 | ||||||
| sabutoclax | 7920 | BI 97C1, BI-97C1 | |||||||
| saccharin |
|
5432 | benzosulfimide, saccharimide | ||||||
| sacibertinib | 12090 | Example 161 [WO2011153942A1] | |||||||
| saclofen | 1078 | ||||||||
| sacubitril |
|
7857 | AHU377, Entresto®, Neparvis® | ||||||
| sacubitrilat |
|
7858 | LBQ-657, LBQ657 | ||||||
| safimaltib | 11883 | example 158 [WO2018119036A1] | |||||||
| safinamide |
|
8291 | EMD 1195686, EMD-1195686, Xadago® | ||||||
| SAFit1 |
|
11481 | compound 1 [PMID: 25436518] | ||||||
| SAFit2 | 11482 | compound 2 [PMID: 25436518] | |||||||
| safusidenib |
|
11884 | DS-1001B | ||||||
| SAG1.3 | 10327 | compound 22 [PMID: 12391318], SMO agonist (SAG), Smoothened agonist | |||||||
| SAGE-718 | 12050 | compound 5 [PMID: 35785990], SAGE718 | |||||||
| salbutamol |
|
|
558 | albuterol, SCH-13949W, Ventolin® | |||||
| salicylidene salicylhydrazide | 5465 | salicylaldehyde salicyloylhydrazone, salicylic salicylidenehydrazide, salicylidene-N'-salicylhydrazide | |||||||
| salinomycin | 11088 | Coxistac®, Procoxacin® | |||||||
| salirasib | 6281 | farnesylthiosalicylic acid, S-farnesylthiosalicylic acid | |||||||
| s-allylglycine |
|
5267 | (S)-2-Allylglycine, L-Allylglycine | ||||||
| salmeterol |
|
|
559 | GR 33343X, Serevent® | |||||
| samidorphan |
|
10651 | ALKS-33, ALKS33, compound 5 [PMID:15808478], Lybalvi® (olanzapine + samidorphan) | ||||||
| samotolisib | 8918 | example 1 [US8440829], LY-3023414, LY3023414 | |||||||
| samuraciclib |
|
9903 | CT7001, ICEC-0942, ICEC0942, PPDA-001 | ||||||
| sanfetrinem | 10856 | GV104326 | |||||||
| sanfetrinem cilexetil | 13812 | GV118819 | |||||||
| Sanofi-14h |
|
13067 | compound 14h [PMID: 25589934] | ||||||
| SANT-1 |
|
10330 | Shh signaling antagonist V | ||||||
| SANT-2 | 10331 | ||||||||
| santacruzamate A | 7916 | CAY10683 | |||||||
| [125I]SAP |
|
|
1982 | [125I]-SAP, I-SAP, Isap acid | |||||
| sapanisertib |
|
|
7933 | INK 128, INK-128, INK128, MLN0128, TAK-228 | |||||
| sapitinib | 7717 | AZD-8931, AZD8931 | |||||||
| S(+)-apomorphine |
|
8285 | S-apomorphine, S-(+)-apomorphine | ||||||
| saprisartan | 6899 | GR 138950, GR-138950, GR138950 | |||||||
| saquinavir |
|
|
4813 | Fortovase®, Invirase®, saquinavir mesilate | |||||
| SAR100842 | 11315 | Edg-2 receptor inhibitor 1, SAR-100842 | |||||||
| SAR-20347 |
|
9803 | |||||||
| SAR247799 |
|
10938 | |||||||
| SAR260301 |
|
8793 | compound 28 [PMID: 24387221], SAR-260301 | ||||||
| SAR296968 | 13934 | SAR-296968 | |||||||
| SAR405 | 9353 | SAR-405 | |||||||
| SAR407899 | 8910 | HY-15687A, SAR-407899 | |||||||
| SAR7334 |
|
10283 | SAR-7334 | ||||||
| saracatinib |
|
7731 | AZD-0530, AZD0530 | ||||||
| sarafloxacin |
|
10857 | A-56620, A56620 | ||||||
| sardomozide |
|
5268 | CGP 48664, CGP48664, SAM 486A, SAM486A | ||||||
| sarecycline |
|
|
12921 | P005672, Seysara® | |||||
| saredutant | 2111 | SR 48,968, SR 48968, SR-48,968, SR48968, SR48968C | |||||||
| [3H]saredutant |
|
|
3481 | [3H]-SR49868, [3H]SR48,968, [3H]SR48968 | |||||
| saridegib | 8198 | IPI 926, IPI-926 | |||||||
| sarpogrelate |
|
210 | Anplag®, LS-187,118, MCI-9042 | ||||||
| saruparib |
|
11526 | AZD-5305, AZD5305, example 4 [WO2021013735] | ||||||
| satavaptan | 2199 | SR 121463A, SR-121463B, SR-121463F, SR121463A | |||||||
| savolitinib |
|
|
9918 | AZD-6094, AZD6094, compound 28 [PMID: 25148209], HMPL-504, HMPL504, Orpathys®, volitinib | |||||
| saxagliptin |
|
6316 | BMS-477118, Onglyza® | ||||||
| SB202190 |
|
|
4307 | SB 202190, SB-202190 | |||||
| SB 202474 | 6036 | AG-J-84442 | |||||||
| SB 203186 | 255 | SB-203186 | |||||||
| SB203580 |
|
5269 | PB 203580, RWJ 64809, SB-203580 | ||||||
| SB 204070 | 256 | SB-204,070, SB-204070A, SB204070 | |||||||
| SB 204741 | 221 | SB-204,741, SB-204741 | |||||||
| SB 206553 | 189 | SB-206,553, SB-206553 | |||||||
| SB 207710 | 257 | SB207710 | |||||||
| SB209670 | 3528 | SB-209670 | |||||||
| SB 215505 | 190 | SB-215,505, SB-215505 | |||||||
| SB 216641 | 28 | SB-216,641, SB-216641 | |||||||
| SB 216763 | 8015 | SB-216763, SB216763 | |||||||
| SB 218078 | 6037 | SB-218078 | |||||||
| SB 218795 | 5764 | SB 218795 R, SB-218795 | |||||||
| SB-219993 | 2698 | ||||||||
| SB-219994 | 2697 | SB 219994, SB219994 | |||||||
| SB220025 |
|
6038 | 3erk, SB-220025 | ||||||
| SB 221284 | 191 | SB-221284, SB221284 | |||||||
| SB 222200 | 2131 | SB-222200 | |||||||
| SB 224289 | 130 | SB-224289, SB224289 | |||||||
| SB 225002 |
|
833 | SB-225002, SB225002 | ||||||
| SB 228357 | 192 | SB-228357, SB228357 | |||||||
| SB234551 | 1000 | SB 234551, SB-234551 | |||||||
| SB 235375 | 5772 | SB-235375 | |||||||
| SB236057 | 3231 | SB 236057, SB-236057 | |||||||
| SB 242084 | 193 | SB-242,084, SB242084 | |||||||
| SB 243213 | 194 | SB-243,213, SB-243213, SB243213A | |||||||
| SB251023 | 3468 | SB-251023 | |||||||
| SB258585 | 3232 | SB-258,585, SB-258585 | |||||||
| SB 258719 | 281 | SB-258,719, SB-258719, SB258719 | |||||||
| SB269652 | 7694 | SB-269,652, SB-269652 | |||||||
| SB269970 | 3233 | GR 125743, SB-269,970, SB-269970, SB-269970-A | |||||||
| SB 271046 | 276 | SB-271,046, SB-271046, SB271046 | |||||||
| SB 272183 | 75 | SB-272183 | |||||||
| SB-282241 | 782 | TCMDC-139245 | |||||||
| SB290157 |
|
3529 | SB-290157 | ||||||
| SB328437 |
|
3530 | SB 328437, SB-328437 | ||||||
| SB-334867 |
|
1703 | SB-334,867, SB334867, SB334867A | ||||||
| SB357134 | 3235 | SB 357134, SB-357,134, SB-357134 | |||||||
| SB366791 |
|
4309 | N-(3-methoxyphenyl)-4-chlorocinnamide, SB 366791, SB-366791 | ||||||
| SB399885 | 3241 | SB 399885, SB-399,885, SB-399885 | |||||||
| SB-408124 |
|
1704 | SB 408124, SB408124 | ||||||
| SB-410220 | 1705 | ||||||||
| SB 414240 | 5769 | SB-414240, SB414240 | |||||||
| SB-415286 | 8019 | SB 415286, SB415286 | |||||||
| SB-423562 | 9476 | NPSP795, SHP-635 | |||||||
| SB-431542 |
|
8216 | compound 14, SB431542 | ||||||
| SB-436811 | 2164 | ||||||||
| SB452533 | 4310 | SB 452533, SB-452533 | |||||||
| SB-568849 | 1312 | ||||||||
| SB590885 | 9389 | compound 33 [PMID: 16260133], SB 590885, SB-590885 | |||||||
| SB-611812 | 3531 | SB611812 | |||||||
| SB 612111 |
|
1693 | SB-612111, SB612111 | ||||||
| SB-633825 |
|
8642 | |||||||
| SB-649868 | 4461 | SB-649,868, SB649868 | |||||||
| SB 649915 | 76 | SB-649915 | |||||||
| SB656104 | 3237 | SB-656104, SB-656104-A | |||||||
| SB-674042 |
|
9136 | SB 674042, SB674042 | ||||||
| SB 699551 | 264 | SB-699,551, SB699551 | |||||||
| SB705498 | 4311 | SB 705498, SB-705498 | |||||||
| SB-706375 | 2165 | SB706375 | |||||||
| SB 714786 | 77 | SB-714786, SB714786 | |||||||
| [11C]SB207145 |
|
|
3244 | [11C] SB207145 (PET ligand) | |||||
| [123I]SB 207710 |
|
|
3243 | ||||||
| [125I]SB-236636 |
|
|
2710 | ||||||
| [125I]SB258585 |
|
|
3245 | ||||||
| [3H]SB269970 |
|
|
3247 | ||||||
| [3H]SB-674042 |
|
|
1706 | ||||||
| [3H]SB-733993 |
|
|
4491 | [3H]-(2R)-3-[(2R,6S)-2,6-dimethylpiperidin-1-yl]-2-hydroxy-S-(naphthalen-1-yl)propane-1-sulfonamido , [3H]-SB-733993 | |||||
| SB 277011-A | 143 | SB-277,011A, SB-277011, SB277011 | |||||||
| SB-747651A | 8130 | compound 26 | |||||||
| SBC-115,337 | 11539 | SBC-115337 | |||||||
| SB-3CT | 9509 | inhibitor 1 (Brown et al., 2000) | |||||||
| SBI-0206965 |
|
11339 | |||||||
| S-BMPA |
|
8676 | |||||||
| S-(2-boronoethyl)-L-cysteine | 5264 | BEC | |||||||
| SBP-3264 | 11811 | compound 20 [PMID: 34807584], SBP 3264, SBP3264 | |||||||
| SBP-7455 | 11340 | compound 26 [PMID: 33200929], SBP7455 | |||||||
| SC-19220 | 1922 | SC 19220, SC19220 | |||||||
| SC-22716 | 9102 | SC 22716 | |||||||
| SC-236 | 10242 | compound 1f [PMID: 9135032], SC236 | |||||||
| SC-41930 | 6156 | Biomed 101, CGS 24115, SC 41930 | |||||||
| SC-435 | 6530 | ||||||||
| SC46275 | 3331 | SC-46275 | |||||||
| SC-50998 | 883 | ||||||||
| SC-51089 |
|
1923 | SC 51089 | ||||||
| SC-51322 | 1924 | SC51322 | |||||||
| SC 53116 | 238 | SC-53116, SC53116 | |||||||
| SC-560 | 10240 | SC560 | |||||||
| SC-58125 | 11391 | SC 58125, SC58125 | |||||||
| SC-68376 | 6039 | SC68376 | |||||||
| SC83288 |
|
10175 | |||||||
| Sch 202596 | 6128 | ||||||||
| SCH 206272 | 2106 | SCH-206272 | |||||||
| SCH221510 | 8868 | SCH 221510, SCH-221510 | |||||||
| (+)-SCH-23390 | 956 | ||||||||
| SCH-23390 | 943 | SCH 23388, SCH23390 | |||||||
| Sch 29482 | 11031 | ||||||||
| Sch.336 |
|
9799 | analog 4j [PMID: 15664857], SCH-336, SCH336 | ||||||
| SCH 37370 | 1853 | respatadine, Sch-37370 | |||||||
| SCH 40338 | 1854 | ||||||||
| SCH442416 | 3283 | SCH 442416, SCH-442,416, SCH442,416 | |||||||
| SCH486757 | 8869 | ||||||||
| SCH50911 |
|
1075 | SCH 50911, SCH-50911 | ||||||
| SCH51866 | 5270 | SCH 51866, SCH-51866 | |||||||
| SCH 57790 | 350 | SCH-57790, SCH57790 | |||||||
| SCH 58261 | 403 | SCH-58261, SCH58261 | |||||||
| SCH772984 |
|
8056 | SCH-772984 | ||||||
| SCH-79797 | 10971 | SCH 79797, SCH79797 | |||||||
| SCH-900229 | 8848 | SCH 900229, SCH900229 | |||||||
| SCH 900271 |
|
8469 | SCH900271 | ||||||
| [125I]SCH23982 |
|
|
945 | [125I]-SCH23982 | |||||
| [3H]SCH-23390 |
|
|
946 | [3H]-SCH23390 | |||||
| [3H]SCH 58261 |
|
|
431 | ||||||
| SCO-267 | 11532 | SCO267 | |||||||
| S-(-)CPB | 4097 | ||||||||
| S-(-)CPP | 4098 | ||||||||
| scriptaid | 7505 | GNF-Pf-2024, scriptide | |||||||
| SD-208 |
|
8246 | SCI-208, SD 208 | ||||||
| SD-36 | 12915 | compound 14 [PMID: 31747516], SD36 | |||||||
| SD-91 | 11599 | ||||||||
| [125I]SD6 |
|
|
7770 | ||||||
| S-deschloroketamine | 11720 | S-DCK | |||||||
| S-26d [PMID: 37883692] |
|
12979 | |||||||
| SDZ 205557 | 258 | SDZ-205557 | |||||||
| SDZ-216525 | 78 | SDZ 216-525 | |||||||
| SDZ 64-412 | 1855 | SDZ-64412 | |||||||
| SDZ SER-082 | 195 | ||||||||
| SEA0400 |
|
4617 | SEA-0400 | ||||||
| sebetralstat |
|
11947 | compound 14w [PMID: 36251573], Ekterly®, KVD-900, KVD900 | ||||||
| secnidazole |
|
12925 | 14,539 RP, Solosec®, SYM-1219 | ||||||
| secobarbital |
|
7615 | Seconal® | ||||||
| β-secretase inhibitor IV |
|
11713 | compound 24 [PMID: 17432843] | ||||||
| secutrelvir | 13738 | compound I-077 [WO2023195530A1], S-892216, S892216 | |||||||
| segigratinib | 13218 | 3D-185, 3D185 | |||||||
| seladelpar |
|
|
11137 | compound 3r [PMID: 17524639], Livdelzi®, MBX-8025, MBX8025 | |||||
| selatinib | 9919 | ||||||||
| selatogrel |
|
14164 | ACT-246475, ACT246475, compound 30d [PMID: 26550844] | ||||||
| selegiline |
|
6639 | Eldepryl®, L-deprenalin, Otrasel®, Selegene®, Zelapar® | ||||||
| seletalisib |
|
9800 | UCB 5857, UCB-5857, UCB5857 | ||||||
| selexipag |
|
7552 | ACT-293987, NS-304, Uptravi® | ||||||
| selfotel | 4155 | CGS-19755, CGS19755 | |||||||
| selgantolimod |
|
10889 | compound (R)-7 [PMID: 32407112], GS-9688, GS9688 | ||||||
| seliciclib |
|
6035 | (R)-roscovitine, CYC-202, CYC202, R-roscovitine, roscovitine | ||||||
| selinexor |
|
|
10036 | compound 70 [WO2013019561A1], KPT-330, KPT330, Nexpovio®, Xpovio® | |||||
| selisistat | 8100 | EX 527, EX-527, EX527, SEN0014196 | |||||||
| selitrectinib | 10314 | BAY 2731954, BAY-2731954, example 28 [WO2017075107A1], LOXO-195, LOXO195 | |||||||
| selnoflast |
|
12173 | Example 6 [WO2019008025A1], RG-6418, RG6418 | ||||||
| selonabant | 13511 | ANEB-001, ANEB001 | |||||||
| selonsertib |
|
|
9040 | GS-4997 | |||||
| selpercatinib |
|
10318 | example 163 [WO2018071447A1], LOXO-292, LOXO292, LY3527723, Retevmo® | ||||||
| seltorexant | 9308 | JNJ-42847922, JNJ-922, JNJ42847922, MIN-202 | |||||||
| selumetinib |
|
|
5665 | ARRY-142886, ARRY-886, AZD6244, Koselugo®, NSC 741O78 | |||||
| semagacestat |
|
6978 | LY-450139 | ||||||
| semapimod | 9211 | CNI-1493 | |||||||
| semaxanib |
|
5056 | SU 5416, SU5416, VEGF receptor 2 kinase inhibitor III | ||||||
| S-EMCA |
|
|
7048 | 6α-ethyl-23(S)-methyl-cholic acid, INT-777, INT777 | |||||
| SEN177 |
|
13399 | SEN-177 | ||||||
| senaparib |
|
11199 | IMP-4297, IMP4297, Paishuning® (China) | ||||||
| senicapoc | 2331 | ICA-17043, ICA17043 | |||||||
| SENS-111 | 11072 | ||||||||
| seocalcitol |
|
2777 | EB 1089, EB1089 | ||||||
| SEQ-9 |
|
13159 | sequanamycin 9 | ||||||
| serabelisib | 8969 | INK 1117, INK-1117, INK1117, MLN 1117, MLN1117 | |||||||
| seralutinib | 10618 | GB-002, Gb002, PK-10571, PK10571, structure 2a [WO2014110200A1] | |||||||
| serdexmethylphenidate |
|
11450 | Azstarys® (serdexmethylphenidate + dexmethylphenidate), KP-484, KP484 | ||||||
| sergliflozin | 4587 | ||||||||
| sergolexole | 211 | ||||||||
| serlopitant |
|
9280 | compound 17 (Jiang et al. 2009), VPD-737 | ||||||
| sertindole |
|
98 | Serdolect®, Serlect®, sertindol | ||||||
| sertraline |
|
|
4798 | CP-51974-1, CP-519741, Lustral®, Zoloft® | |||||
| SET2 | 12547 | ||||||||
| setanaxib |
|
9932 | GKT-137831, GKT-831, GKT137831, GKT831 | ||||||
| setipiprant |
|
10180 | ACT-129968, ACT129968, compound 28 [PMID: 23721423] | ||||||
| setogepram |
|
10043 | 3-pentylbenzeneacetic acid, fezagepras, PBI-4050, PBI4050 | ||||||
| sevabertinib | 13491 | BAY 2927088, BAY-2927088, BAY2927088, Example 2 [WO2020216781] | |||||||
| sevasemten | 13704 | compound 6 [US11091464B2], EDG-5506, EDG5506 | |||||||
| seviteronel |
|
13855 | (S)-seviteronel, compound 6 [PMID: 24775307], INO-464, VT-464 | ||||||
| sevoflurane |
|
7296 | MR-6S4, MR6S4, Sojourn®, Ultane® | ||||||
| SEW2871 |
|
2926 | SEW 2871, SEW-2871 | ||||||
| SF-11 | 6404 | ||||||||
| SF1126 | 12619 | SF 1126, SF-1126 | |||||||
| SF-21 | 6405 | ||||||||
| SF-22 | 6389 | ||||||||
| SF-51 | 6387 | ||||||||
| SFI003 | 13644 | SFI-003 | |||||||
| SF-11 [PMID: 31267743] | 14159 | SF 11, SF11 | |||||||
| S1g-2 | 12929 | ||||||||
| SG-005 | 11855 | 7,12-O,O'dibenzyl-N-methylcoclaurine | |||||||
| SG-094 | 11856 | ||||||||
| SGC0946 |
|
7020 | |||||||
| SGC2085 | 9259 | compound 27 [PMID: 27390919] | |||||||
| SGC6870 |
|
11423 | (R)-2 | ||||||
| SGC707 |
|
8552 | |||||||
| SGC-CBP30 |
|
|
|
7529 | |||||
| SGI-1027 | 8891 | SGI 1027, SGI1027 | |||||||
| SGI-1776 | 8784 | SGI 1776, SGI1776 | |||||||
| SGI-1776-VHL-02 | 13039 | ||||||||
| SGR-1505 | 13295 | example 39 [WO2021134004A1], SGR1505 | |||||||
| SGX-523 |
|
5709 | SGX523 | ||||||
| SH045 | 9968 | compound 19 [PMID: 29522264] | |||||||
| SH-1028 |
|
13760 | oritinib, rilertinib, SH1028 | ||||||
| SHA 68 | 5813 | SHA-68, SHA68 | |||||||
| SHA 68R | 11707 | ||||||||
| 12S-[3H]HETE |
|
|
5508 | ||||||
| SI-10 | 13308 | compound 6p [PMID: 38551814] | |||||||
| SI306 | 10708 | ||||||||
| SIAIS164029 | 12246 | example 93 [WO2019114770A1], SIAIS 164029 | |||||||
| SIAIS178 |
|
10526 | compound 19 [PMID: 31539241], SIAIS-178 | ||||||
| SIB-1757 | 1431 | SIB1757 | |||||||
| SIB-1893 | 1432 | SIB1893 | |||||||
| sibutramine |
|
2586 | Meridia®, sibutramine hydrochloride | ||||||
| SID7969543 | 5423 | SID 7969543 | |||||||
| silahexocyclium | 331 | ||||||||
| sildenafil |
|
|
4743 | Viagra® | |||||
| silevertinib | 13371 | BDTX 1535, BDTX-1535, BDTX1535, Compound No. 37 [WO2021030711] | |||||||
| silmitasertib |
|
8126 | CX 4945, CX-4945, CX4945 | ||||||
| silodosin |
|
|
493 | KMD-3213, Rapaflo®, Silodyx® | |||||
| SIM1 | 11777 | compound 3 [PMID: 34675414] | |||||||
| simeprevir |
|
|
7367 | Olysio®, simeprevir sodium, TMC 435, TMC 435350, TMC-435, TMC435 | |||||
| simnotrelvir |
|
12960 | SIM-0417, SIM0417, SSD-8432, SSD8432 | ||||||
| simotinib |
|
7640 | AL 6802, AL6802, SIM 6802, SIM6802 | ||||||
| simurosertib |
|
10317 | example 108 [US9655900B2], TAK-931, TAK931 | ||||||
| simvastatin |
|
2955 | MK-733, Zocor® | ||||||
| siponimod |
|
|
|
9289 | BAF-312, BAF312, compound 32 [PMID: 24900670], Mayzent® | ||||
| SIR1-365 | 12244 | example 13 [US20210284598A1], SIR1365 | |||||||
| sirolimus |
|
|
|
6031 | AY-22989, Fyarro® (sirolimus albumin-bound particles), Rapamune®, rapamycin, WY-090217 | ||||
| SIRT1 activator 3 |
|
9514 | SA-3, SA3 | ||||||
| SIRT3 activator 5329973 | 13730 | ||||||||
| sitafloxacin |
|
11040 | compound 33 [PMID: 7932562], DU-6859, DU-6859a, DU6859a, Gracevit®, STX | ||||||
| sitagliptin |
|
|
6286 | Januvia®, MK-0431, Zituvio® | |||||
| sitaxsentan |
|
3950 | TBC11251 / TBC-11251, Thelin® | ||||||
| sitokiren | 12196 | compound 18 [PMID: 35939295], SPH-3127, SPH3127 | |||||||
| sitravatinib | 9920 | GCD-516, GCD516, MGCD516 | |||||||
| SITS | 4314 | 4'-isothiocyanostilbene-2,2'-disulphonic acid | |||||||
| sivelestat |
|
6441 | Elaspol®, LY544349, ONO-5046, Ono-EI-600 | ||||||
| sivopixant | 11756 | compound 28 [PMID: 34587541], S-600918 | |||||||
| (+)-SJ733 |
|
9723 | (+)-SJ000557733, (+)-SJ557733 | ||||||
| SJ988497 | 12310 | compound 7 [PMID: 34110416], SJ-988497 | |||||||
| SJ995973 | 11799 | compound 4c [PMID: 34614283], PG PROTAC 4c | |||||||
| SJB2-043 | 12225 | SJB2 043, SJB2043 | |||||||
| SKA-111 | 10554 | SKA 111, SKA111 | |||||||
| SKA-121 | 8492 | SKA 121, SKA121 | |||||||
| SKA-20 | 9312 | ||||||||
| SKA-31 | 2335 | 2-amino-beta-naphthothiazole, 2-aminonaphthiazole | |||||||
| SK&F 88070 | 11049 | Skf 88070 | |||||||
| (+)-SKF 10.047 | 6677 | (+)-SK&F10047 | |||||||
| SKF 105854 | 518 | SK&F 105854, SK-105854 | |||||||
| SKF-38393 | 935 | R(+)SKF38393, SKF 38393, SKF-38,393, SKF38393 | |||||||
| SKF-75670 | 936 | ||||||||
| SKF-76783 | 937 | ||||||||
| SKF-81297 | 938 | R(+)SKF81297, SKF 81297, SKF-81,297 | |||||||
| (+)-SKF-82526 | 933 | ||||||||
| (-)-SKF-82526 |
|
985 | |||||||
| SKF-82958 | 10742 | SKF 82958, SKF82958 | |||||||
| SKF-83566 | 944 | SK&F-83566, SK-83566, SK83566 | |||||||
| SKF-83959 | 8443 | SKF83959 | |||||||
| SKF-86002 |
|
6040 | SK&F 86002, SKF 86002 | ||||||
| SKF 89748 | 511 | SK&F 89748, SK&F 89748-A, SK&F-89748 | |||||||
| SKF96365 | 2441 | SK&F96365, SK-96365, SKF-96365 | |||||||
| SKF89976A | 4705 | SKF 89976A, SKF-89976A | |||||||
| SK1-I | 6622 | BML-258 | |||||||
| SKI II |
|
6041 | SKI 2, SKI-II | ||||||
| SKLB-03220 | 12353 | compound 12d [PMID: 36692394], SKLB03220 | |||||||
| SL-176 | 11104 | SL176 | |||||||
| SL422 | 8629 | analogue 55f [PMID: 11472217] | |||||||
| SLB1122168 | 12696 | compound 33p [PMID: 37010497], SLB-1122168 | |||||||
| SLB736 | 12572 | SLB 736, SLB-736 | |||||||
| SLC-0111 |
|
10149 | 4-fluorophenylureido-benzenesulfonamide, compound 7 [PMID: 21361354], SLC0111 | ||||||
| SLC-391 | 12320 | example 3.7 [WO2015081257A2], SLC391 | |||||||
| SLC4101431 | 10217 | compound 20dd [PMID: 28406646] | |||||||
| SLF |
|
11480 | Synthetic Ligand for FKBP, AP1510 monomer, compound 1a monomer [PMID: 12951089], ligand 2 [PMID: 22455398] | ||||||
| SLF1081851 |
|
12695 | compound 16d [PMID: 35609189], SLF-1081851 | ||||||
| SLF80821178 | 13436 | compound 11i [Foster et al., 2024], compound 35 [WO2022056045A1], SLF-80821178 | |||||||
| SLM6071469 |
|
10641 | compound 10 [PMID: 31895563] | ||||||
| SLR14 | 11795 | ||||||||
| SM-122 | 8855 | compound 1, Smac peptide mimetic 20 | |||||||
| SM-130,686 | 5866 | SM 130686 | |||||||
| SM19712 | 5272 | SM-19712 | |||||||
| SM 21 | 6682 | (±)-SM21, (RS)-SM21, SM-21 | |||||||
| SM-32504 | 6723 | ||||||||
| SM-337 | 7732 | ||||||||
| SMD-3040 | 12842 | compound 29 [PMID: 37523716], SMD3040 | |||||||
| SMP-797 | 6729 | compound 22b [PMID: 16242323] | |||||||
| SMT022357 | 11111 | (±)-4, (±)-SMT022357, compound 4 [Babbs et al., 2020] | |||||||
| SN-1 | 6401 | ||||||||
| SN-2 | 6402 | ||||||||
| SN-38 |
|
6925 | SN 38 lactone, SN38 | ||||||
| SN6 |
|
4666 | SN-6999, SN6999 | ||||||
| SNAP 37889 | 6126 | HT 2157, HT-2157 | |||||||
| SNAP 398299 | 6125 | SNAP-398299, SNAP398299 | |||||||
| SNAP5089 | 498 | (-)-SNAP-5089, SNAP 5089 | |||||||
| SNAP-5114 |
|
4677 | (S)-SNAP 5114 | ||||||
| SNAP-7941 | 1313 | SNAP7941 | |||||||
| [3H]SNAP-7941 |
|
|
1318 | ||||||
| SNC80 | 1611 | NSC707484 | |||||||
| S(+)-niguldipine | 487 | (+)-niguldipine | |||||||
| SNS-314 |
|
9397 | compound 21 [PMID: 18678489], SNS314 | ||||||
| SNX0723 |
|
|
9260 | ||||||
| SNX281 | 12011 | ||||||||
| sobetirome |
|
2639 | GC 1 compound, GC-1, QRX-431 | ||||||
| socrodeucitinib | 14067 | compound 1 [WO2022017494] | |||||||
| soficitinib | 14068 | compound 20 [WO2020259584] | |||||||
| sofnobrutinib |
|
10094 | compound 4b [PMID: 30216722] | ||||||
| sofosbuvir |
|
|
7368 | GI-7977, PSI 7977, Sovaldi® | |||||
| sofpironium |
|
13426 | BBI-4000 (sofpironium bromide), Ecclock®, Sofdra® | ||||||
| solabegron | 9512 | compound 38 [PMID: 16640337], GW427353 | |||||||
| solangepras |
|
11514 | compound 6i [PMID: 33861086], CVN-424, CVN424 | ||||||
| solcitinib |
|
9697 | compound 1 [WO2010149771], GLPG-0778, GLPG0778, GSK2586184 | ||||||
| solifenacin |
|
7483 | Vesicare®, YM-67905, YM-905 | ||||||
| solithromycin |
|
10859 | CEM-101, CEM101, compound 3 [PMID: 30258539], OP-1068, OP1068, Solithera, T-4288, T4288 | ||||||
| solriamfetol |
|
10342 | ADX-N05, ADXN05, JZP-110, JZP110, Sunosi® | ||||||
| sonepiprazole |
|
980 | PNU101,387G, U-101,387 | ||||||
| sonidegib |
|
8199 | erismodegib (deleted INN), LDE-225, LDE225, NVP-LDE225, Odomzo® | ||||||
| sonolisib | 7941 | PX-866, PX866 | |||||||
| sonrotoclax | 13354 | BGB-11417, BGB11417, compound 12e [PMID: 38695063] | |||||||
| sonvuterkib | 14074 | ||||||||
| S-OOPP | 6493 | ||||||||
| soquelitinib | 13190 | CPI-000818, CPI-818, CPI818, example 44 [WO2018089261] | |||||||
| 1-SORA-51 | 14062 | ||||||||
| sorafenib |
|
|
5711 | BAY 43-9006, BAY-439006, Nexavar® | |||||
| sorangicin A |
|
11038 | (+)-Sorangicin A | ||||||
| sorbinil |
|
7415 | CP-45634 | ||||||
| SOS1 PROTAC 23 | 13144 | compound 23 [PMID: 38316747] | |||||||
| SOS1 PROTAC 9d | 12069 | ||||||||
| sotagliflozin |
|
|
8312 | Inpefa®, LX-4211, LX4211, Zynquista® | |||||
| sotalol |
|
7297 | Betapace®, MJ-1999 | ||||||
| soticlestat |
|
11517 | OV935, TAK-935 | ||||||
| sotorasib |
|
10678 | AMG 510, AMG-510, AMG510, compound (R)-38 [PMID: 31820981], Lumakras®, Lumykras® | ||||||
| sotrastaurin |
|
|
7946 | AEB-071, AEB071 | |||||
| sotuletinib |
|
8250 | BLZ 945, BLZ-945, BLZ945 | ||||||
| sovesudil | 10695 | AMA 0076, AMA-0076, AMA0076, compound 18 [PMID: 24119557], PHP-201, PHP201 | |||||||
| sovleplenib | 11886 | compound 225 [WO2012167733A1], HMPL-523, HMPL523 | |||||||
| soxataltinib | 13492 | Example 114 [WO2020228756] | |||||||
| SP203 | 6434 | SP 203, SP-203 | |||||||
| SP-4206 |
|
|
9037 | compound 13 [PMID:12656598], SP4206 | |||||
| SP600125 |
|
|
5273 | 1,9-pyrazoloanthrone, JNK Inhibitor II, SP-600125 | |||||
| [32P]S1P |
|
|
5402 | [32P]-S1P | |||||
| sparfloxacin |
|
10860 | AT-4140, AT4140, CI-978, CI978, SPFX, Zagam ® | ||||||
| [18F]SPA-RQ |
|
|
3473 | [18F]-SPA-RQ | |||||
| sparsentan |
|
|
8448 | DARA-a (Dual Acting Receptor Antagonist of angiotension and endothelin receptors), BMS-346567, compound 7 [PMID 15634011], Filspari®, RE-021, retrophin | |||||
| Sp-cAMPS | 10623 | ||||||||
| S1P d20:1 | 11496 | D-erythro-sphingosine-1-phosphate (C20 base), S1P (d20:1), Sphingosine-1-Phosphate (d20:1) | |||||||
| spebrutinib |
|
7837 | AVL 292, AVL-292, cc-292 | ||||||
| SPG302 | 13262 | Phenylbenzothiazole-PEG4-OH, SPG-302 | |||||||
| sphingomyelin synthase 2 inhibitor 15w |
|
10054 | compound 15w [PMID: 30074791] | ||||||
| spiperone |
|
99 | R-5147, spiroperidol, spiropitan | ||||||
| [3H]spiperone |
|
|
|
3300 | [3H]-spiperone | ||||
| spiradoline | 1653 | U 62066, U-62066, U62066 | |||||||
| spiramide | 175 | AMI-193, R-5808 | |||||||
| spirapril |
|
6575 | Renormax®, SCH-33844 | ||||||
| spiraprilat |
|
6576 | SCH-33861 | ||||||
| spironolactone |
|
|
2875 | Aldactone®, Qaialdo®, spiractin, spirotone | |||||
| spiroxatrine | 53 | spiroxamide | |||||||
| splitomicin | 8101 | ||||||||
| SPM-354 | 9493 | ||||||||
| SPP1 | 10259 | spiropiperidine 1 | |||||||
| SPR719 | 13545 | SPR-719, VXc-486 | |||||||
| SPRi3 |
|
|
10130 | example 23 [WO2011047156], SPR inhibitor 3 | |||||
| SQ-109 |
|
7997 | MMV687273, SQ 109, SQ109 | ||||||
| SQ-24,798 | 8656 | compound 4, SQ 24798, SQ-24798 | |||||||
| SQ 26655 | 6070 | SQ-26,655, SQ-26655 | |||||||
| SQ-27986 | 1887 | SQ 27986, SQ27986 | |||||||
| SQ-29548 | 1980 | SQ-28053, SQ29548 | |||||||
| SQ-34919 | 3101 | ||||||||
| SQ641 | 13503 | ||||||||
| [125I]SQ-29548 |
|
|
1983 | ||||||
| [3H]SQ-29548 |
|
|
1985 | [3H]-SQ29548, [3H]SQ-28053, [3H]SQ29548 | |||||
| squalamine | 10861 | 7alpha-Hydroxy, 3beta-spermidine, MSI-1256F (squalamine lactate) | |||||||
| squarunkin A |
|
9966 | compound 3j [PMID: 28471079] | ||||||
| SR-0813 | 11541 | compound 10 [Garnar-Wortzel et al., 2021, SR0813 | |||||||
| SR1001 |
|
10143 | SR-1001 | ||||||
| SR101099 | 10886 | SAR 101099, SAR-101099 | |||||||
| SR-1114 | 11542 | compound 4 [Garnar-Wortzel et al., 2021] | |||||||
| SR11237 | 2809 | BMS 649 , SR-11237 | |||||||
| SR12813 |
|
2763 | SR 12813, SR-12813 | ||||||
| SR144528 |
|
751 | SR 144528, SR-144528 | ||||||
| SR146131 |
|
868 | SR 146131, SR-146131 | ||||||
| SR1555 |
|
10145 | SR-1555 | ||||||
| SR16835 | 8867 | AT-202 | |||||||
| SR2211 |
|
|
10144 | SR-2211 | |||||
| SR2640 |
|
3329 | SR 2640, SR-2640 | ||||||
| SR-4133 |
|
12692 | SR4133 | ||||||
| SR-419 | 13982 | example 11 [WO2019174577A1], SR 419, SR419 | |||||||
| SR48527 | 1581 | SR 48527, SR-48527 | |||||||
| SR7826 | 9840 | SR 7826 | |||||||
| SR8185 |
|
9578 | SR-8185 | ||||||
| SR8278 | 2904 | SR 8278, SR-8278 | |||||||
| SR9009 | 8901 | ||||||||
| SR9011 | 8900 | ||||||||
| SR9238 | 8692 | ||||||||
| SR120819A | 1530 | SR 120819A, SR-120819A | |||||||
| SR142948A | 1580 | SR-142948A | |||||||
| SR57227A | 4316 | ||||||||
| SR59230A | 547 | SR 59,230A, SR-59230A | |||||||
| SRA880 | 2030 | NVP-SRA880, obelin | |||||||
| [3H]SR 121463A |
|
|
2234 | [3H]-SR121463A | |||||
| (1S,3R)-ACPD |
|
1365 | (1S,3R)-1-ACPD, (1S,3S)-ACPD, 1S,3R-ACPD, trans-ACPD | ||||||
| 3S,4R-293B | 8610 | chromanol 239B | |||||||
| Src kinase inhibitor I |
|
6042 | |||||||
| SRI-20864 | 10986 | SRI20864 | |||||||
| SRI-20920 | 10987 | SRI 20920, SRI20920 | |||||||
| SRI22141 | 11694 | SRI 22141, SRI-22141 | |||||||
| SRI37892 | 10323 | ||||||||
| SRT1720 |
|
|
7703 | ||||||
| SRT2104 |
|
9515 | compound 4 [Ng et al., 2013], GSK2245840, SRT-2104 | ||||||
| SRTCX1003 | 7493 | ||||||||
| SRX246 | 12262 | compound 50 [PMID: 17234419], SRX 246, SRX-246 | |||||||
| SS148 | 13635 | SS-148 | |||||||
| SS-208 |
|
|
10490 | compound 7b [PMID: 31414801], SS208 | |||||
| (2S,4S)-ketoconazole |
|
8871 | |||||||
| SSR-103800 | 4778 | SSR103800 | |||||||
| SSR 146977 | 2133 | ||||||||
| SSR240612 | 662 | ||||||||
| SSR126768A | 2201 | SSR-126768A | |||||||
| SSR128129E |
|
7850 | SSR | ||||||
| SSYA10-001 | 13478 | ||||||||
| ST034307 | 10092 | ||||||||
| ST074946 | 6539 | ||||||||
| ST-1006 | 8983 | ||||||||
| ST-1478 | 12571 | ||||||||
| ST-1505 | 12570 | ||||||||
| ST-1535 | 5613 | ST 1535, ST1535 | |||||||
| ST-2191 | 12569 | ||||||||
| ST-2560 | 13286 | ||||||||
| St 587 | 513 | ||||||||
| STA2 | 1939 | 11α-carba-9α,11β-thia-Txa2, STA2 | |||||||
| stanozolol |
|
|
10369 | Stromba®, Tevabolin®, WIN-14833, WIN14833, Winstrol® | |||||
| STAT3 inhibitor 8q | 10139 | ||||||||
| stavudine |
|
12678 | BMY-27857, BMY27857, d4T, STV, Zerit® | ||||||
| STC-15 | 12894 | Example 2 [WO2021111124A1], STC15 | |||||||
| STING agonist 2 |
|
|
10127 | ||||||
| STING agonist 3 |
|
|
10128 | compound 3 [PMID: 30405246], diABZI, diABZI STING agonist-1 | |||||
| stiripentol |
|
5469 | BCX 2600, Diacomit ® | ||||||
| STK16-IN-1 | 9692 | ||||||||
| STM2457 |
|
11529 | STM-2457 | ||||||
| STO609 |
|
5274 | STO 609, STO-609 | ||||||
| streptomycin |
|
|
10923 | Gerox®, NSC-14083, Strepcen® | |||||
| [3H]strychnine |
|
|
|
2360 | |||||
| (R)-STU104 |
|
12006 | (R)-4e [PMID: 35442672] | ||||||
| STX-241 | 13828 | PFL-241, PFL241, STX241 | |||||||
| STX-721 |
|
13004 | STX721 | ||||||
| SU11274 |
|
5057 | Met kinase Inhibitor, SU-11274 | ||||||
| SU11652 |
|
6043 | SU-11652 | ||||||
| SU-14813 | 5712 | SU014813, SU14813 | |||||||
| SU-3327 | 10703 | compound 9 [PMID: 19271755], halicin, SU3327 | |||||||
| SU5402 |
|
11743 | compound 1 [PMID: 10602697], SU-5402 | ||||||
| SU6656 |
|
6044 | SU-6656 | ||||||
| SU9516 |
|
6045 | AC1NRD9P, SU-9516 | ||||||
| succinylcholine |
|
|
4004 | Quelicin®, suxamethonium | |||||
| sucralfate |
|
7055 | Antepsin®, Carafate® | ||||||
| sucunamostat | 11683 | SCO-792, SCO792 | |||||||
| sufentanil |
|
3534 | Sufenta®, sufentanil citrate, Zalviso® | ||||||
| sufinpyrazone |
|
|
5826 | Anturane®, Apo-sulfinpyrazone®, G 28315, NSC 75925, suphinpyrazone | |||||
| sufugolix | 1185 | TAK-013 | |||||||
| sulbactam |
|
|
10769 | Betamaze, CP-45,899, CP-45899 | |||||
| sulbenicillin | 12273 | SBPC | |||||||
| sulfabenzamide |
|
|
12632 | ||||||
| sulfacetamide |
|
12633 | Bleph-10®, Klaron®, sulphacetamide | ||||||
| sulfachlorpyridazine |
|
12634 | BA-10370, sulfachloropyridazine, sulphachlorpyridazine | ||||||
| sulfadiazine |
|
12635 | |||||||
| sulfadimethoxine |
|
12638 | Albon® (veterinary), sulfadimethoxydiazine, sulphadimethoxine | ||||||
| sulfadimidine |
|
12642 | sulfamethazine | ||||||
| sulfadoxine |
|
|
10173 | sulphadoxine | |||||
| sulfaguanidine |
|
|
12639 | sulfanilylguanidine, sulphaguanidine | |||||
| sulfalene |
|
10174 | Kelfizine®, sulfamethopyrazine, sulfamethoxypyrazine, sulfametopyrazine | ||||||
| sulfamazone |
|
13711 | Marespin®, sulphenazone | ||||||
| sulfamerazine |
|
12640 | 2-sulfanilamido-4-methylpyrimidine, sulfamethyldiazine, sulphamerazine | ||||||
| sulfamethizole |
|
12683 | Rufol®, sulphamethizole, Thiosulfil® | ||||||
| sulfamethoxazole |
|
|
10933 | Gantanol®, RO 4-2130, RO-42130, SMX, STX-608 | |||||
| sulfamethoxypyridazine |
|
12686 | Kynex®, sulphamethoxypyridazine | ||||||
| sulfametomidine | 12701 | methofadin, sulfamethomidine | |||||||
| sulfametoxydiazine |
|
12641 | sulfameter, sulfamethoxydiazine, Sulla® | ||||||
| sulfametrole |
|
12702 | |||||||
| sulfamonomethoxine |
|
|
12688 | Daimeton® | |||||
| sulfamoxole |
|
12744 | Nuprin®, sulfadimethyloxazole, Sulfuno®, sulphamoxole | ||||||
| sulfanegen | 9830 | ||||||||
| sulfanilamide |
|
|
12631 | AVC®, sulphanilamide | |||||
| sulfanitran | 13897 | ||||||||
| sulfaperin | 12742 | Sulfaperine | |||||||
| sulfaphenazole | 11352 | Sulfabid® | |||||||
| sulfapyridine |
|
|
12698 | Dagenan®, M&B 693, sulphapyridine | |||||
| sulfaquinoxaline | 13878 | ||||||||
| sulfasalazine |
|
|
4840 | Azulfidine®, Salazopyridin®, Salazopyrin®, SAS-500 | |||||
| sulfathiazole |
|
|
12699 | M&B 760, Thiazamide® | |||||
| sulfathiourea | 12745 | sulfathiocarbamide | |||||||
| sulfisoxazole |
|
12700 | Gantrisin®, NU-445, sulfafurazole, sulphafurazole | ||||||
| sulfonamide-01 | 4313 | SF-01 | |||||||
| sulfopin | 11540 | ||||||||
| sulindac |
|
|
5425 | Clinoril® | |||||
| sulopenem |
|
10862 | CP-70,429, CP-70429, CP70429, Orlynvah® (sulopenem etzadroxil and probenecid) | ||||||
| (+)-sulpiride | 960 | R-(+)-sulpiride | |||||||
| (-)-sulpiride |
|
|
958 | S-(-)-sulpiride | |||||
| sulpiride |
|
5501 | (±)-sulpiride, dl-sulpiride, Dolmatil®, RD 1403, Sulpor®, sulpyrid | ||||||
| sulprostone | 1919 | CP-34089, nalador, ZK-57671 | |||||||
| sultamicillin |
|
12290 | CP-49,952, Unasyn® | ||||||
| sulukast | 3327 | ||||||||
| sumanirole | 3949 | ||||||||
| sumatriptan |
|
54 | GR-43175C, Imigran®, Tosymra® (nasal spray) | ||||||
| [3H]sumatriptan |
|
|
119 | ||||||
| sunitinib |
|
|
5713 | SU11248, Sutent® | |||||
| sunobinop | 14125 | IMB-115, IMB115, S 117957, V117957 | |||||||
| sunvozertinib |
|
11672 | DZD-9008, DZD9008, Example 52 [WO2019149164A1] | ||||||
| super cinnamaldehyde | 6270 | ||||||||
| suprastat |
|
11220 | compound 6a [PMID: 32815366] | ||||||
| supratinib | 10015 | ||||||||
| suprofen |
|
|
7298 | Profenal®, R-25061 | |||||
| suramin |
|
|
1728 | CI-1003, suramine | |||||
| surinabant | 9233 | SR-147778 | |||||||
| surufatinib |
|
|
9769 | HMPL-012, HMPL012, KDR-IN-1, Sulanda®, VEGFR2 inhibitor [WO2011060746] | |||||
| sutezolid |
|
12772 | MMV688756, PF-02341272, PNU-100480, U-100480 | ||||||
| sutidiazine |
|
10024 | AZ13721412, MMV253, MMV674253, ZY19489 | ||||||
| suvadronabinol | 13225 | ||||||||
| suvecaltamide | 12648 | compound 1 [PMID: 27579577], compound 1 [PMID: 34582192], Cx-8998, JZP-385, JZP385, MK-8998, MK8998 | |||||||
| SUVN-911 | 10700 | compound 9h [PMID: 32026697] | |||||||
| SUVN-G3031 | 10232 | ||||||||
| suvorexant |
|
|
2890 | Belsomra®, MK 4305, MK-4305 | |||||
| suzetrigine |
|
12630 | Compound 7 [WO2021113627A1], Journavx®, VX-548, VX548 | ||||||
| SWE101 | 10494 | compound 22b [PMID: 31436984] | |||||||
| SX-517 | 8501 | ||||||||
| SX682 |
|
10165 | |||||||
| S‐Y048 | 11073 | S-Y048 | |||||||
| SY110 |
|
12654 | compound 3w [PMID: 36928316], SY-110 | ||||||
| SY-5609 |
|
11841 | SY-0005609, SY5609 | ||||||
| Syk inhibitor |
|
6046 | K00564a, spleen tyrosine kinase inhibitor | ||||||
| Syk inhibitor II |
|
6047 | K00592a | ||||||
| Syk inhibitor III | 6048 | NSC 10120, NSC 105303, NSC 170724, SBB007833 | |||||||
| [3H]SYM2081 |
|
|
4075 | [(3)H]4MG, [3H](2S,4R)-4-methylglutamate | |||||
| SYM2081 | 4317 | (2S,4R)-Me-Glu, compound 52 [PMID: 10821708], SYM 2081, SYM-2081 | |||||||
| synaptamide | 14141 | N-docosahexaenoylethanolamine | |||||||
| syn-BrP-LPA | 6986 | ||||||||
| SZ(+)-(S)-202-791 | 4318 | ||||||||
| SZM594 | 10388 | ||||||||
| SZM679 |
|
12311 | SZM-679 | ||||||
| SZUH280 | 12356 | compound 16e [PMID: 36516047], SZUH-280 | |||||||
| (2S)-2-[(6Z,15Z)-20-hydroxyicosa-6,15-dienamido]butanedioate | 11522 | 20-HETE receptor antagonist (AAA) | |||||||
| T | Back to top | ||||||||
| [3H]T-516 |
|
|
11449 | ||||||
| T0070907 |
|
3444 | T 0070907 | ||||||
| T-0080 | 14147 | T0080 | |||||||
| T0156 | 5275 | T-0156 | |||||||
| T-0509 | 533 | RP333 | |||||||
| T-0632 | 884 | 1H-Indole-3-propanoic acid, T0632 | |||||||
| T0901317 |
|
|
2755 | T 0901317, T-0901317 | |||||
| T1117 | 5560 | tocrifluor T1117 | |||||||
| T13 | 6984 | ||||||||
| T-226296 | 1314 | T 226296, T226296 | |||||||
| T2328 | 5746 | T 2328, T-2328 | |||||||
| T440 | 12304 | ||||||||
| T‐495 | 10711 | example 24 [WO2016208775], T495 | |||||||
| T-516 | 12605 | ||||||||
| T532 | 12303 | ||||||||
| T5-8 | 11323 | ||||||||
| T-690 | 11935 | ||||||||
| T863 |
|
7828 | |||||||
| T-98475 | 1184 | T 98475, T98475 | |||||||
| T2 | 6648 | 3,3'-diiodothyronine, T2 | |||||||
| tabernanthalog | 13551 | ||||||||
| tacaciclib | 12880 | ||||||||
| tacalcitol | 2780 | 1α,24(OH)2D3, 1,24-dihydroxyvitamin D3, TV-02H | |||||||
| tacapenem | 10863 | R-95867, R95867 | |||||||
| tacedinaline | 8367 | CI-994, CI994 | |||||||
| tacrine |
|
|
6687 | CI-970, Cognex®, tetrahydroaminoacridine | |||||
| tacrolimus |
|
|
6784 | FK506, fujimycin, Prograf®, Protopic® | |||||
| tadalafil |
|
|
7299 | Adcirca®, Cialis®, IC-351, IC351 | |||||
| tafamidis |
|
|
8378 | FX-1006, Vyndamax®, Vyndaqel® | |||||
| tafenoquine |
|
|
9722 | Arakoda®, etaquine, Krintafel®, WR238605 | |||||
| tafetinib | 9921 | SIM-010603, SIM010603 | |||||||
| tafluprost |
|
7451 | AFP-168, MK-2452, Taflotan® | ||||||
| tafluprost acid |
|
7452 | AFP-172 | ||||||
| tagtociclib | 11525 | compound 19 [PMID: 35485642], example 13 [WO2020157652], PF-07104091, PF07104091 | |||||||
| T16Ainh-A01 | 13563 | T16Ainh-01 | |||||||
| TAK-020 |
|
11730 | compound 3 [PMID: 34448571], TAK020 | ||||||
| TAK-070 | 6940 | ||||||||
| TAK-071 | 12302 | ||||||||
| TAK-220 | 800 | TAK 220, TAK220 | |||||||
| TAK-418 | 11516 | ||||||||
| TAK-441 | 8200 | ||||||||
| TAK-632 |
|
|
10387 | compound 8B [PMID: 23906342], TAK632 | |||||
| TAK-637 | 9329 | compound (aR,9R)-8b [PMID: 10508446], TAK 637, TAK637 | |||||||
| TAK-715 |
|
|
9328 | compound 8h [PMID: 16162000], TAK 715, TAK0715 | |||||
| TAK-733 |
|
9911 | compound 17 [PMID: 21310613], example 18 [US8470837], TAK733 | ||||||
| TAK-779 |
|
783 | TAK779 | ||||||
| TAK-981 |
|
11305 | Example 133 [WO2016004136A1], I-263a [WO2016004136A1], subasumstat (proposed INN), TAK981 | ||||||
| TAK-828F |
|
|
9867 | compound 10 [PMID: 29510038], TAK-828, TAK828F | |||||
| Takinib |
|
|
9655 | ||||||
| talabostat |
|
9892 | compound 1 [PMID: 18783201], PT-100, PT100, Val-boro-pro, Val-boroPro | ||||||
| taladegib |
|
10333 | LY-2940680, LY2940680 | ||||||
| talampanel | 8279 | GYKI 537773, LY-300164, LY300164 | |||||||
| talampicillin |
|
12289 | BRL 8988, Talpen® | ||||||
| talarozole | 11381 | R-115866, R115866, Rambazole® | |||||||
| talazoparib |
|
8313 | BMN-673, BMN673, Talzenna® | ||||||
| taletrectinib |
|
11198 | AB-106, AB106, DS-6051b, DS6051b, Ibtrozi® | ||||||
| talinolol | 4664 | ||||||||
| talipexole | 5442 | B-HT920, BHT920 | |||||||
| talmapimod |
|
|
7817 | SCIO 469 hydrochloride, SCIO-469 | |||||
| talnetant | 2132 | SB 223412, SB-223,412, SB-223412, SB223412 | |||||||
| taltirelin | 2143 | TA 0910 | |||||||
| TAM16 |
|
9645 | |||||||
| tamatinib |
|
|
5706 | R 406, R-406, R406 free base | |||||
| tambiciclib | 13219 | ||||||||
| tamibarotene |
|
|
2648 | AM-80, AM80, Amnolake®, retinobenzoic acid | |||||
| tamnorzatinib | 12091 | ONO-7475, ONO7475 | |||||||
| [3H]tamoxifen |
|
|
|
5384 | [3H]-tamoxifen | ||||
| tamoxifen |
|
|
1016 | ICI-46474, Nolvadex®, Soltamox® | |||||
| tamsulosin |
|
|
488 | (-)-YM617, Flomax®, LY-253351, Omnic®, tamsulosin hydrochloride | |||||
| TAN-67 | 9567 | (-)-TAN-67, SB-205,607, SB-213698 | |||||||
| tanaproget |
|
7416 | NSP-989 | ||||||
| tandospirone | 55 | ||||||||
| tandutinib | 5695 | CT53518, MLN-518, MLN518 | |||||||
| tanespimycin |
|
7751 | 17-AAG, 17-allylamino-17-demethoxygeldanamycin, 17-N-allylamino-17-demethoxygeldanamycin, 17AAG, compound 4 [PMID:15978816] | ||||||
| taniborbactam |
|
10774 | VNRX-5133, VNRX5133 | ||||||
| tanomastat | 6468 | BAY 12-9566, BAY-12-9566, BAY-129566 | |||||||
| tanuxiciclib | 11885 | example 24 [WO2016126085A2] | |||||||
| tanzisertib |
|
9836 | CC-930, CC930, compound 1 [PMID: 22244937] | ||||||
| tapentadol |
|
7477 | BN-200, CG-5503, Nucynta®, Palexia® | ||||||
| tapinarof |
|
|
|
9686 | benvitimod, GSK-2894512, GSK2894512, Vtama®, WB-1001, WBI 1001, WBI-1001 | ||||
| taprenepag |
|
5816 | CP 544326, CP-544326, PF 04217329, PF-04217329 | ||||||
| taprostene | 1968 | ||||||||
| taranabant |
|
9231 | MK 0364, MK-0364 | ||||||
| tariquidar |
|
11787 | compound 2 [PMID: 10098671], XR-9576, XR9576 | ||||||
| tarloxotinib | 9409 | PR610, tarloxotinib cation, TH-4000 | |||||||
| TAS05567 |
|
9941 | |||||||
| TAS1553 | 12113 | TAS-1553 | |||||||
| taselisib |
|
7794 | GDC-0032, GDC0032 | ||||||
| tasimelteon |
|
7393 | BMS-214778, Hetlioz®, VEC-162 | ||||||
| tasosartan | 6898 | ||||||||
| tasquinimod | 8098 | ABR-215050 | |||||||
| tasurgratinib |
|
|
11414 | E-7090, E7090, Example 22 [WO2014129477A1] | |||||
| [3H]taurocholic acid |
|
|
|
4546 | [3H]-taurocholate , [3H]-taurocholic acid | ||||
| taurolidine |
|
13030 | Defencath® (taurolidine + heparin), taurolin | ||||||
| tavapadon |
|
13372 | CVL-751, PF-06649751 | ||||||
| tazarotene |
|
6952 | AGN-190168, Tazorac®, Zorac® | ||||||
| tazemetostat |
|
7011 | E-7438, EPZ 6438, EPZ-6438, EPZ6438, Tazverik® | ||||||
| tazobactam |
|
10789 | CXA-201, CXA201, YTR 830, YTR 830H, Zerbaxa® (ceftolozane + tazobactam) | ||||||
| TBA-354 | 13546 | ||||||||
| TBA-7371 | 13133 | AZ-7371, compound 1 [PMID:24957839], TBA7371 | |||||||
| TBAJ-587 |
|
13060 | compound 8 [PMID: 30803745] | ||||||
| TBAJ-876 |
|
13132 | compound 46 [PMID: 30803745] | ||||||
| TBBt |
|
9372 | Casein Kinase II Inhibitor I, TBB | ||||||
| TBI-166 | 12961 | pyrifazimine | |||||||
| TBI-223 | 13029 | ||||||||
| TBK1 PROTAC 3i | 11661 | compound 3i [PMID: 28692295] | |||||||
| TBPB | 3258 | ||||||||
| (S)-TBPG | 3419 | S-TBPG | |||||||
| [35S]TBPS |
|
|
4369 | ||||||
| TBPS | 4320 | tert-butylbicyclophosphorothionate | |||||||
| [3H]TBZOH |
|
|
4766 | α-[O-methyl-3H]dihydrotetrabenazine, [3H]-TBZOH , [3H]dihydrotetrabenazine | |||||
| TC114 |
|
9576 | |||||||
| TC-2559 | 3987 | TC2559 | |||||||
| TCDD | 9642 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin, Dioxin | |||||||
| TC-E 5005 |
|
11625 | compound 1 [PMID: 21988093] | ||||||
| TCI15 | 6582 | ||||||||
| TCLPA5 | 9500 | compound 4 [PMID: 22801643], TC LPA5 4 | |||||||
| TCMDC-125163 |
|
10339 | |||||||
| TCMDC-135051 |
|
|
11109 | ||||||
| TCN-201 |
|
7846 | QCR-22, TCN 201, TCN201 | ||||||
| TCN-213 | 11700 | TCN 213, TCN213 | |||||||
| TCPA | 5590 | N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine | |||||||
| TCPOBOP |
|
2756 | 1,4-BDPOB | ||||||
| [3H]-TCS 1102 |
|
|
11527 | [3H]-BBAC, [3H]-compound 18 | |||||
| TCS 1102 | 9304 | BBAC, compound 18 [PMID: 18207395], TCS-1102 | |||||||
| TCS2314 | 6590 | TCS 2314, TCS-2314 | |||||||
| TCS 2510 | 5859 | TCS-2510 | |||||||
| TCS 5861528 | 6276 | ||||||||
| TCS-OX2-29 | 4038 | compound 29 [PMID: 14643355], KB-11822, TCS OX2 29 | |||||||
| TD-8954 | 8426 | compound 18 [PMID 23756062] | |||||||
| TDI-015051 |
|
13661 | YDT | ||||||
| TDI-11861 |
|
12309 | compound 33 [PMID: 36346696], TDI11861 | ||||||
| TDRL-551 | 12137 | compound 4 [PMID: 32550990], TDRL551 | |||||||
| [14C]TEA |
|
|
|
4575 | [14C]-TEA , tetraethylammonium | ||||
| tebanicline | 3989 | ABT-594, ABT594 | |||||||
| tebapivat |
|
13106 | AG-946, AG946, compound 27 [PMID: 38109501] | ||||||
| tebideutorexant | 12507 | JNJ-61393215, JNJ61393215 | |||||||
| tebipenem pivoxil |
|
10864 | L-084, LJC 11,084, LJC-11,084, LJC-11084, Orapenem®, TBPM-PI | ||||||
| tebuquine |
|
10392 | WR 228,258 | ||||||
| TEC4 | 13872 | ||||||||
| tecadenoson | 5592 | ||||||||
| tecalcet |
|
718 | NPS R-568, NPS R568, R 568 | ||||||
| tectorigenin |
|
9738 | |||||||
| 2-TEDC | 11394 | compound 24 [PMID: 2016727] | |||||||
| tedisamil | 2567 | KC-8857 | |||||||
| tedizolid |
|
|
10865 | DA-7157, previously torezolid, Sivextro®, TR-700, TR700 | |||||
| tegafur |
|
10513 | Florafur®, FT-207, FT207, Ftorafur® | ||||||
| tegaserod |
|
|
226 | HTF 919, SDZ HTF 919, Zelnorm® | |||||
| tegeprotafib | 12884 | compound 124 [US20230019236A1] | |||||||
| tegileridine |
|
13434 | Asut®, Embodiment 1 [US11111236B2], example 19 [US20200054594A1], SHR-8554, SHR8554 | ||||||
| teglicar |
|
12976 | compound 17 [Giannessi et al., 2003], ST-1326, ST1326 | ||||||
| tegoprazan |
|
|
12008 | CJ-12420, CJ12420, K-CAB® | |||||
| TEI-9063 | 1965 | TEI 9063 | |||||||
| TEI-9647 | 2788 | TEI9647 | |||||||
| teicoplanin |
|
10924 | Antibiotic 8327A, MDL-507, Targocid®, teichomycin, teicoplanin A2 | ||||||
| Teijin-lead_cmp_5 | 785 | ||||||||
| telacebec |
|
12953 | MMV687696, Q203 | ||||||
| telaglenastat |
|
9053 | CB-839, CB839 | ||||||
| telaprevir | 7871 | VX-950 | |||||||
| telatinib | 10476 | BAY 57-9352, Bay-57-9352, BAY-579352, BAY579352, example 14 [WO2001023375A2] | |||||||
| telavancin |
|
10925 | TD-6424, TD6424, Vibativ® | ||||||
| telcagepant |
|
703 | MK 0974 , MK-0974, MK0974 | ||||||
| [3H](+)telenzepine |
|
|
8594 | ||||||
| telithromycin |
|
10878 | HMR-3647, Ketek®, Levviax®, RU-66647, RU66647 | ||||||
| telmisartan |
|
|
592 | BIBR-277SE, Kinzalmono®, Micardis®, Pritor® | |||||
| telotristat ethyl |
|
|
9490 | LX-1606, LX1606, Xermelo® | |||||
| temafloxacin |
|
10866 | A-62254, A62254, Abbott 62254, Omniflox® | ||||||
| temazepam |
|
7300 | Restoril®, WY-3917 | ||||||
| temocapril |
|
11736 | CS-622, CS622 | ||||||
| temocaprilat | 11737 | compound 24c [PMID: 3669006], RNH 5139, RNH-5139, RNH5139, RS-5139, RS5139 | |||||||
| temocillin |
|
10926 | BRL-17421, BRL17421, Negaban® | ||||||
| temozolomide |
|
7301 | CCRG-81045, M-39831, Temodal®, Temodar® | ||||||
| 2,2,2-TEMPS | 6329 | ||||||||
| [3H]2,2,2-TEMPS |
|
|
6328 | [3H]-PAM | |||||
| temsirolimus |
|
|
5892 | CCI-779, Torisel® | |||||
| temuterkib |
|
9975 | LY-3214996, LY3214996 | ||||||
| TEN-010 | 9118 | (S)-JQ-35, (S)-JQ35, RG6146, Ro-6870810, RO-6870810, RO6870810, TEN010 | |||||||
| tenalisib |
|
9907 | RP-6530, RP6530 | ||||||
| tenapanor |
|
8449 | AZD-1722, AZD1722, Ibsrela®, RDX-5791 | ||||||
| teneligliptin |
|
|
|
9906 | compound 8g [PMID: 22959556], MP-513, MP513, Teneli | ||||
| tenidap |
|
2395 | |||||||
| teniposide |
|
|
6843 | isosulfan blue, VM-26, Vumon® | |||||
| tenivastatin |
|
3037 | |||||||
| tenofovir |
|
|
10948 | TDF, (R)-PMPA, PMPA, tenofovir (anhydrous) | |||||
| tenofovir alafenamide |
|
14054 | GS-7340, GS7340, Vemlidy® | ||||||
| tepilamide fumarate |
|
9770 | XP 23829, XP-23829, XP23829 | ||||||
| tepotinib |
|
|
8293 | compound 22 [PMID: 25736998], EMD 1214063, EMD-1214063, MSC2156119, MSC2156119J, Tepmetko® | |||||
| TEPP-46 |
|
10555 | compound 46 [PMID: 20451379], ML-265, ML265, TEPP46 | ||||||
| terazosin |
|
7302 | ABBOTT-45975, Hytrin® | ||||||
| terbutaline |
|
560 | Brethine®, Bricanyl®, KWD-2019, terbutalin | ||||||
| terevalefim | 11997 | ANG-3777, ANG3777, Refanalin | |||||||
| terfenadine |
|
|
2608 | RMI-9918, Seldane®, Triludan® | |||||
| terguride |
|
56 | dironyl | ||||||
| teriflunomide |
|
|
|
6844 | A77 1726, Aubagio®, flucyamide, HMR-1726 | ||||
| tersolisib |
|
12903 | STX-478, STX478 | ||||||
| (-)-tertatolol | 64 | ||||||||
| tertatolol | 571 | S-2395 | |||||||
| 6-tert-butyl-m-cresol | 4111 | ||||||||
| tert-butylphenoxycyclohexanol | 12607 | tBPC | |||||||
| terutroban | 6073 | S 18886, S18886, triplion | |||||||
| tesevatinib | 7944 | EXEL-7647, KD-019, XL-647, XL647 | |||||||
| testolactone |
|
7303 | SQ-9538, Teslac® | ||||||
| testosterone decanoate |
|
7630 | |||||||
| testosterone isocaproate |
|
7629 | testosterone 4-methylvalerate | ||||||
| testosterone phenylpropionate |
|
7628 | testosterone 17-phenylpropionate, testosterone hydrocinnamate | ||||||
| tetomilast |
|
9877 | compound 19f [PMID: 7830278], OPC-6535, OPC6535 | ||||||
| tetrabenazine |
|
4834 | TBZ, Nitoman®, Revocon®, Ro-19569 | ||||||
| tetracycline |
|
10927 | Achromycin®, Ala-Tet®, Brodspec®, NSC-108579, Panmycin®, Sumycin®, TCN | ||||||
| tetraethylammonium |
|
2343 | TEA | ||||||
| 5α-tetrahydrocorticosterone | 13001 | 5alpha-Tetrahydrocorticosterone, allotetrahydrocorticosterone | |||||||
| tetralin_urea analogue (7o) | 1319 | ||||||||
| 2,3',4,5'-Tetramethoxystilbene | 12963 | ||||||||
| tetroxoprim | 12328 | ||||||||
| tevenel | 12398 | ||||||||
| tezacaftor |
|
|
10199 | example 315 [US20090131492A1], VX-661, VX661 | |||||
| tezampanel | 4245 | LY-293,558, LY293558 | |||||||
| TFC007 | 11392 | TFC 007, TFC-007 | |||||||
| TFMPP | 115 | 3-trifluoromethylphenylpiperazine | |||||||
| TG-0203770 |
|
11107 | |||||||
| TG-100-115 |
|
5715 | TG 100-115, TG 100115, TG100-115 | ||||||
| TG11-77 |
|
10603 | compound 20o [PMID: 31904232] | ||||||
| TG4-155 | 5818 | ||||||||
| TG6-129 |
|
9283 | |||||||
| TG7-171 | 8546 | ||||||||
| TG8-260 |
|
12520 | compound 2f [PMID: 35187419], TG8260 | ||||||
| TGF-beta RI inhibitor III |
|
6049 | SB-505124, SB505124 | ||||||
| TGF-beta RI kinase inhibitor |
|
6050 | LY 364947, LY-364947, TbetaR-I inhibitor | ||||||
| TGN4 | 8822 | ||||||||
| TGX-221 | 8244 | TGX 221 | |||||||
| TH5487 |
|
|
10184 | TH-5487 | |||||
| thalidomide |
|
|
7327 | K-17 | |||||
| THAL-SNS-032 | 10547 | THAL-SNS032 | |||||||
| TH-4000E | 9410 | ||||||||
| THI | 6626 | 2-acetyl-5-tetrahydroxybutyl imidazole | |||||||
| thiabendazole |
|
|
7304 | E233, MK-360 | |||||
| thiamet-G |
|
10509 | thiamet G | ||||||
| [3H]thiamine |
|
|
|
4628 | [3H]-thiamine, [3H]vitamin B1 | ||||
| thiamphenicol |
|
12400 | |||||||
| thiamylal |
|
7305 | Surital® | ||||||
| 2-(2-thiazolyl)ethanamine | 1193 | 2-(2-aminoethyl)thiazole, 2-thiazoleethanamine, 2-thiazolylethylamine | |||||||
| Thiazomycin A | 10990 | compound 6 [PMID: 18804380] | |||||||
| thiethylperazine |
|
7306 | GS-95, Torecan® | ||||||
| THIIC | 6259 | ||||||||
| thio-BCTC | 2473 | ||||||||
| thiochrome | 348 | thiachrome | |||||||
| thioguanine |
|
|
6845 | 6-mercaptoguanine, 6-thioguanine, Lanvis®, Tabloid® | |||||
| thiopental |
|
2579 | Sodium Pentothal®, thiopental sodium, Trapanal® | ||||||
| thioperamide |
|
1267 | MR 12842 | ||||||
| thioridazine |
|
100 | Mellaril®, thioridazin, TP-21 | ||||||
| thiorphan |
|
5278 | |||||||
| thiotepa |
|
7622 | Tepadina®, Tepylute®, Thioplex® | ||||||
| Thio-THIP | 10907 | ||||||||
| thiothixene |
|
212 | Navane® | ||||||
| 2-thio-UDP | 6202 | ||||||||
| 2-thioUTP | 3398 | 2-thio-UTP | |||||||
| 4-thio-UTP | 1730 | 4-S-UTP, 4-thiouridine triphosphate | |||||||
| THIQ |
|
1338 | |||||||
| THPO | 4727 | 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridin-3-ol | |||||||
| threo-3-methylglutamate | 4573 | (±)-threo-3-methylglutamic acid | |||||||
| THRX160209 | 3255 | THRX 160209, THRX-160209 | |||||||
| [125I]thyroxine |
|
|
4627 | [125I]-T4, [125I]-thyroxine | |||||
| THZ1 | 8052 | HY-80013 | |||||||
| [3H]tiagabine |
|
|
|
4685 | |||||
| tiagabine |
|
|
4818 | ABBOTT-70569, ABT-569, Gabitril®, tiagabine hydrochloride | |||||
| tiamulin |
|
13651 | 81.723 hfu, Denagard® (veterinary), thiamutilin | ||||||
| tianeptine |
|
7558 | Stablon®, tianeptine sodium | ||||||
| tibolone |
|
9711 | Boltin, Livial, Org OD 14, Tibofem | ||||||
| tibremciclib | 12881 | ||||||||
| ticagrelor |
|
|
1765 | AR-C126532XX, AZD6140, Brilinta®, Brilique®, compound 17 [PMID: 17827008] | |||||
| ticarcillin |
|
10928 | BRL-2288, BRL2288, Ticar, Timentin® (ticarcillin + clavulanate) | ||||||
| ticlopidine |
|
|
7307 | 4-C-32, 53-32C, Ticlid® | |||||
| tideglusib | 6929 | NP-12, NP031112 | |||||||
| tifluadom | 1667 | ||||||||
| tigecycline |
|
10929 | GAR-936, GAR936, Tygacil®, WAY-GAR-936 | ||||||
| tigemocoxib |
|
|
13505 | 29b-(S) [PMID: 20709553], SC-75416, SC75416 | |||||
| tigemonam | 10867 | SQ-30213, SQ-30836 (tigemonam dicholate), SQ30213, SQ30836 (tigemonam dicholate) | |||||||
| tigozertinib | 11948 | BLU 945, BLU945, Compound 150 [WO2021133809A1] | |||||||
| tilarginine |
|
11467 | L-Monomethylarginine, L-NMA, N(G)-monomethyl L-arginine, targinine (deprecated INN) | ||||||
| tildacerfont | 14043 | Example 16 [WO2008036579A1], LY-2371712, LY2371712, SPR-001, SPR001 | |||||||
| tildipirosin | 13689 | Zuprevo® (veterinary) | |||||||
| tilfrinib | 9051 | compound 4f [PMID: 24650640] | |||||||
| tilmicosin | 13690 | EL-870, Micotil® (veterinary) | |||||||
| tilpisertib | 12094 | GS 4875, GS-4875 | |||||||
| tilpisertib fosmecarbil | 12081 | Example 1 [WO2020252151A1] | |||||||
| tiludronic acid |
|
7604 | CIPsMBP, Skelid®, SR-41319, tiludronate | ||||||
| TIM-38 | 11452 | TIM38 | |||||||
| timapiprant |
|
9277 | OC000459, OC459 | ||||||
| timcodar | 10868 | VX-853, VX853 | |||||||
| timolol |
|
|
565 | Timoptic® | |||||
| tinengotinib |
|
11887 | Example 6 [US10889586B2], TT-00420, TT00420 | ||||||
| tinidazole |
|
12341 | CP 12574, Fasigyn®, Tindamax® | ||||||
| tinlorafenib |
|
12096 | ARRY-461, ARRY461, PF-07284890, PF07284890 | ||||||
| tinodasertib |
|
12385 | AUM-001, AUM001, compound 48 [PMID: 29683667], ETC-1907206, ETC-206, ETC206 | ||||||
| tin protoporphyrin IX | 5279 | Sn protoporphyrin, Sn-heme | |||||||
| tinzaparin |
|
6846 | Innohep®, tinzaparin sodium | ||||||
| tioconazole |
|
13859 | |||||||
| tiospirone | 101 | BMY-13859, BMY-13859-1, tiospyrone | |||||||
| [3H]tiotidine |
|
|
3959 | [3H]-tiotidine | |||||
| tiotidine | 1235 | ICI 125,211, ICI-125211 | |||||||
| [3H]tiotropium |
|
|
8592 | ||||||
| tiotropium |
|
|
367 | BA-679-BR, Spiriva® | |||||
| tipifarnib |
|
8025 | R-115777, R115777 | ||||||
| tipiracil |
|
8696 | MA-1, TAS-1-462 | ||||||
| TIPPψ | 1637 | TIPP-psi | |||||||
| tipranavir |
|
|
12685 | Aptivus®, PNU-140690, TPV, U-140690 | |||||
| TIQ-15 | 9882 | ||||||||
| tirabrutinib |
|
|
|
9265 | GS-4059, ONO-4059, ONO4059, Velexbru® | ||||
| tirasemtiv |
|
8280 | CK-2017357 | ||||||
| tirbanibulin |
|
|
7957 | Klisyri®, KX 2-391, KX-01, KX-2-391, KX2-391 | |||||
| tirofiban |
|
|
6586 | Aggrastat®, L-700462, MK-383, tirofiban hydrochloride (monohydrate) | |||||
| tivantinib |
|
7948 | ARQ-197, ARQ197 | ||||||
| tivozanib |
|
|
6058 | AV-951, AV951, Fotivda®, KRN-951, KRN951, VEGFR tyrosine kinase inhibitor IV | |||||
| tizanidine |
|
7308 | AN-021, DS-103-282, Zanaflex® | ||||||
| tizaterkib |
|
11674 | ATG-017, AZD-0364, AZD0364 | ||||||
| TK05 |
|
9556 | |||||||
| TKB245 | 12589 | compound 5 [PMID: 37756225], TKB-245 | |||||||
| TL12-186 | 12147 | TL 12-186 | |||||||
| TL13-112 | 10529 | ||||||||
| TL-77 | 7834 | ||||||||
| [18F]TM30089 |
|
|
14137 | ||||||
| TM30089 |
|
1905 | CAY 10471, CAY-10471, CAY10471 | ||||||
| TM38837 | 8705 | TM-38837 | |||||||
| TM39875 | 13287 | TM-39875 | |||||||
| TMB-8 | 4323 | ||||||||
| TMinh-23 | 13561 | compound 10bm [PMID: 28493701], TMinh-23 | |||||||
| TMP269 |
|
7491 | compound 1 [PMID: 23524983], TMFO1, TMP 269, TMP-269 | ||||||
| TNG260 | 12628 | ||||||||
| TNG348 |
|
13296 | T-095 [US20240059689], TNG-348 | ||||||
| TNNI3K degrader | 11807 | compound 21 [WO2021053495A1] | |||||||
| TNP-ATP | 4324 | 2',3'-O-(2,4,6-trinitrophenyl)-ATP | |||||||
| TO507 |
|
11981 | compound 16 [PMID: 34152728], TO-507 | ||||||
| tocainide |
|
7309 | Tonocard®, W-36095 | ||||||
| toceranib |
|
11619 | compound 12f [PMID: 12646019], Palladiar®, PHA-291639, PHA291639, SU 11654, SU-11654, SU11654 | ||||||
| TOFA | 5280 | ||||||||
| tofacitinib |
|
|
|
5677 | CP-690,550, CP-690550, tasocitinib, Xeljanz® | ||||
| tofogliflozin |
|
9395 | Apleway®, compound 16d [PMID: 22889351], CSG-452, CSG452, Deberza® | ||||||
| tolazamide |
|
6847 | tolazolamide, Tolinase® | ||||||
| tolazoline |
|
7310 | TCMDC-125842 | ||||||
| tolbutamide |
|
6848 | Orinase®, tolbutamide sodium | ||||||
| tolcapone |
|
|
6646 | Ro 40-7592, Ro-407592, Tasmar® | |||||
| tolebrutinib |
|
10625 | BTK'168, example 3 [WO2016196840A1], PRN-2246, PRN2246, SAR442168 | ||||||
| tolfenamic acid |
|
|
8769 | Clotam® | |||||
| tolimidone | 9433 | CP-26154, MLR-1023 | |||||||
| tolinapant | 12704 | ASTX-660, ASTX660, compound 27 [PMID: 30091600] | |||||||
| tolmetin |
|
|
|
7311 | MCN-2559, McN-2559-21-98, Tolectin® | ||||
| tolrestat |
|
|
7404 | Alredase®, AY-27,773, AY-27773 | |||||
| tolterodine |
|
360 | Detrol®, Detrusitol®, KABI-2234 | ||||||
| toludesvenlafaxine |
|
12766 | ansofaxine, compound 71 [PMID: 28731336], LPM570065, LY-03005, Ruoxinlin® | ||||||
| toluene |
|
5481 | 1-methylbenzene, methylbenzol, phenylmethane | ||||||
| tolvaptan |
|
2226 | OPC-41061, Samsca® | ||||||
| tominostat | 12943 | compound 12m [PMID: 21711053] | |||||||
| tomivosertib |
|
|
10167 | compound 23 [PMID: 29526098], eFT-508, eFT508 | |||||
| tomopenem | 10869 | CS-023, CS023, R-115685, R115685, RO-4908463 | |||||||
| tonapofylline | 5605 | BG 9928, BG-9928 | |||||||
| topiramate |
|
|
6849 | epitomax, Eprontia® (liquid formulation), MCN-4853, RWJ-17021, Topamax® | |||||
| topiroxostat |
|
10592 | Topiloric, Uriadec | ||||||
| topotecan |
|
|
7101 | Hycamtin®, SK-S-104864-A | |||||
| toreforant |
|
9276 | JNJ-38518168 | ||||||
| toremifene |
|
|
4325 | Fareston®, Farestone®, FC-1157a | |||||
| torin 1 | 8004 | Torin-1, Torin1 | |||||||
| torin 2 |
|
8839 | compound 3, Torin-2, torin2 | ||||||
| torsemide |
|
|
7312 | AC-4464, AC4464, BM-02015, Demadex®, Soaanz® | |||||
| tosposertib | 13752 | example 9 [US10155763B2] | |||||||
| tosufloxacin |
|
12878 | Ozex®, T-3262 | ||||||
| tovorafenib |
|
|
9977 | BIIB024, DAY-101, DAY101, example 10Da [US20090036419], MLN-2480, MLN2480, Ojemda®, TAK-580, TAK580 | |||||
| toxaphene | 2830 | octachlorocamphene | |||||||
| tozadenant |
|
5611 | SYN-115, SYN115 | ||||||
| tozasertib |
|
5718 | MK 0457, VX 680, VX-680 | ||||||
| TP003 | 4326 | TP 003, TP-003 | |||||||
| TP0472993 | 12767 | compound 11c [PMID: 36318660] | |||||||
| TP-064 |
|
9528 | TP 064 | ||||||
| TP-10 | 13575 | TP10 | |||||||
| TP-271 | 11013 | TP271 | |||||||
| TP-472 |
|
9522 | |||||||
| TP-6076 |
|
13198 | |||||||
| TP-680 | 885 | TP 680 | |||||||
| TPA023 | 4327 | TPA 023, TPA-023 | |||||||
| TPC2-A1-N | 11848 | ||||||||
| TPC2-A1-P | 11849 | ||||||||
| TPG-25-1 | 13943 | Mpro inhibitor 20a, TPG-251 | |||||||
| TPI 1361-17 | 1315 | ||||||||
| Tpl2 kinase inhibitor | 6051 | ||||||||
| TPMPA |
|
4328 | (1,2,5,6-tetrahydropyridine-4-yl)methylphosphinic acid | ||||||
| TPN171 |
|
12781 | compound 15 [PMID: 31021628], TPN-171 | ||||||
| TPP+ |
|
4558 | tetraphenylphosphonium | ||||||
| TPT-004 |
|
12993 | compound 32 [Specker et al., 2023], TPT004 | ||||||
| TQB3804 | 12983 | compound 50 [PMID: 34323489], Example 34 [WO2019015655], TQB-3804 | |||||||
| tracazolate | 5467 | ICI-136,753, ICI-136753 | |||||||
| tradipitant |
|
9278 | LY-686017, LY686017, VLY-686 | ||||||
| TRAM-34 |
|
2336 | |||||||
| tramadol |
|
8286 | (1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclo-hexanol, Maxitram®, Tilodol®, Tramacet® | ||||||
| trametinib |
|
|
6495 | GSK1120212, GSK1120212B, GSK212, JTP 74057, Mekinist®, trametinib dimethyl sulfoxide | |||||
| trandolapril |
|
6453 | CI-907, indolapril, Mavik®, RU-44570 | ||||||
| trandolaprilat |
|
|
6455 | ||||||
| tranexamic acid |
|
|
6573 | CL-65336, Cyclo-F®, Cyklokapron®, Femstrual®, trans AMCHA | |||||
| tranilast |
|
|
|
6326 | MK-341, SB-252218 | ||||
| trans-3-ACPBPA | 4099 | ||||||||
| trans-flupenthixol | 968 | (E)-flupenthixol, beta-flupenthixol, flupentixol hydrochloride, trans-(E)-flupentixol | |||||||
| (+)-trans-H2-PAT | 1209 | ||||||||
| (-)-trans-H2-PAT | 1212 | H2-Pat | |||||||
| (±)-trans-H2-PAT | 1207 | ||||||||
| trans-JB253 | 7788 | ||||||||
| 7-trans-OH-PIPAT | 951 | 8-OH-PIPAT | |||||||
| tranylcypromine |
|
5281 | Parnate®, tranylcypromine sulphate | ||||||
| TRAP-101 | 10499 | Trap101 | |||||||
| travoprost |
|
7102 | AL-6221, Travatan® | ||||||
| traxoprodil | 4163 | CP-101,606, CP-101606, CP101606 | |||||||
| trazodone |
|
213 | AF-1161, Desyrel®, Molipaxin®, Oleptro® | ||||||
| treosulfan |
|
8281 | Grafapex®, Trecondi® | ||||||
| treprostinil |
|
|
5820 | LRX-15, Remodulin®, Tyvaso® | |||||
| trequinsin | 10436 | compound 56b [PMID: 6492077], HL 725 | |||||||
| triamcinolone |
|
|
2870 | fluoxiprednisolone, Kenalog®, Nasacort® | |||||
| triamcinolone acetonide |
|
|
|
2867 | Zilretta® | ||||
| triamterene |
|
|
4329 | Dyrenium®, Dytac®, SK-8542 | |||||
| triazine compound PC1 | 6064 | ||||||||
| triazine compound PC10 | 6433 | ||||||||
| triazine compound PC7 | 6431 | ||||||||
| triazolam |
|
7313 | Halcion®, U-33030 | ||||||
| trichlormethiazide |
|
7314 | Naqua® | ||||||
| 1-1-1-trichloroethane | 5482 | methylchloroform | |||||||
| trichloroethanol |
|
2293 | |||||||
| trichostatin A |
|
7005 | TSA | ||||||
| triciribine | 5920 | Akt inhibitor V, Akt/protein kinase B signaling inhibitor-2, API-2, NSC-154020, tricyclic nucleoside (TCN) | |||||||
| triethylcholine | 4760 | ||||||||
| trifarotene |
|
|
|
9962 | Aklief®, CD5789, compound 15b [PMID: 29706423] | ||||
| trifluoperazine |
|
|
214 | Eskazinyl®, Stelazine®, trifluoperazine hydrochloride | |||||
| triflupromazine |
|
4330 | triflupromazine hydrochloride, Vesprin® | ||||||
| trifluridine |
|
8697 | TFT, trifluorothymidine | ||||||
| triheptanoin |
|
11431 | Dojolvi®, UX-007, UX007 | ||||||
| trihexyphenidyl |
|
7315 | Artane®, benzhexol | ||||||
| trilaciclib |
|
|
9626 | Cosela®, G1T28 | |||||
| trilostane |
|
6850 | Vetoryl®, WIN 24,540, WIN-24540 | ||||||
| TRIM | 4331 | ||||||||
| trimethadione |
|
7316 | Tridione® | ||||||
| trimethobenzamide |
|
7614 | Tigan®, trimethobenzamide hydrochloride | ||||||
| trimethoprim |
|
|
10931 | BW-56-72, BW-5672, NSC-106568, Primsol®, Proloprim®, Trimpex® | |||||
| trimethylamine |
|
5521 | |||||||
| trimetrexate |
|
7613 | CI-898, Neutrexin®, trimetrexate glucuronate | ||||||
| trimipramine |
|
7317 | 7162 RP, IL-6001, Surmontil® | ||||||
| tripelennamine |
|
|
7318 | Pyribenzamine® | |||||
| tripitramine | 361 | ||||||||
| triple modulator 10 [PMID: 29878767] |
|
10002 | |||||||
| triprolidine |
|
1228 | Actidil® | ||||||
| troglitazone |
|
2693 | CS-045, Rezulin® | ||||||
| troleandomycin |
|
10209 | oleandocetin, Tao®, triacetyloleandomycin | ||||||
| tromethamine |
|
7328 | tris, trometamol | ||||||
| tropicamide |
|
7319 | Mydriacyl® | ||||||
| tropifexor |
|
9725 | compound 1 [PMID: 29148806], LJN452 | ||||||
| tropisetron |
|
|
260 | ICF 205-930, ICS 205930, Navoban®, tropisteron | |||||
| troriluzole | 11375 | BHV-4157, BHV-4157a, BHV4157, BHV4157a, FC-4157, trigriluzole | |||||||
| trospectomycin | 10870 | U-63,366F, U-63366F, U63366F | |||||||
| trospium |
|
7480 | Flotros®, IP-631, IP631, Regurin®, Sanctura® | ||||||
| trovafloxacin |
|
13476 | CP-99,219, Trovan®, Turvel® | ||||||
| TROX-1 | 7766 | ||||||||
| Trpvicin |
|
12551 | |||||||
| TRPV6 inhibitor cis-22 a |
|
12561 | |||||||
| TRULI | 12663 | TRULI; The Rockefeller University Lats Inhibitor | |||||||
| TrxR1 inhibitor 6a | 13699 | ||||||||
| TrxR1 prodrug 5u | 13698 | ||||||||
| tryptanthrin 5i |
|
10126 | compound 5i [PMID: 24099220] | ||||||
| TTA-A2 |
|
7724 | |||||||
| TTA-P2 |
|
7723 | |||||||
| TTFB | 12563 | ||||||||
| TTI-101 | 12268 | C188-9, TTI 101, TTI101 | |||||||
| TTK21 | 12197 | TTK-21 | |||||||
| TTNPB |
|
2646 | arotinoid acid | ||||||
| TTT-3002 | 11134 | TTT3002 | |||||||
| tubacin | 7374 | AC1O7Y2P | |||||||
| tubastatin A |
|
|
9702 | ||||||
| tubercidin |
|
4755 | sparsamycin A | ||||||
| tucatinib |
|
|
9922 | ARRY-380, Example 11 [WO2007059257A2], ONT-380, Tukysa® | |||||
| tucidinostat |
|
8305 | chidamide, CS-055, CS055, Epidaza® (China), HBI-8000 | ||||||
| TUG-1197 | 11195 | compound 34 [PMID: 27570890], TUG1197 | |||||||
| TUG-1375 |
|
10107 | compound 31 [PMID: 30247908], TUG1375 | ||||||
| TUG-2181 |
|
13892 | compound 40g [PMID: 40183744], compound I-319 [WO2022167445A1], TUG2181 | ||||||
| TUG-2304 | 12655 | compound 16l [Valentini et al., 2023], TUG2304 | |||||||
| TUG-424 | 3952 | TUG424 | |||||||
| TUG-770 | 6483 | TUG770 | |||||||
| TUG-891 |
|
6490 | TUG 891, TUG891 | ||||||
| TUG-905 | 9149 | agonist 13 [PMID: 22724451] | |||||||
| tulathromycin | 13691 | Draxxin® (veterinary), tulathromycin A | |||||||
| tulmimetostat | 12615 | compound 1 [US2022257577], CPI 0209, CPI-0209, CPI0209 | |||||||
| tunlametinib |
|
11675 | Example 9 [WO2013107283A1], HL-085, HL085, Kolupin® (China) | ||||||
| tunodafil | 12099 | yonkenafil (pseudo INN) | |||||||
| tuspetinib | 12010 | example 8 [US10870639B2], HM-43239, HM43239 | |||||||
| tuvusertib | 12082 | compound I-C-79 [WO2014089379A1] | |||||||
| tuxobertinib | 11676 | BDTX-189, BDTX189, example 8 [US11034672B1] | |||||||
| TWS119 | 5980 | GSK inhibitor XII, GSK-3beta inhibitor XII, TWS-119 | |||||||
| TX-16 | 13246 | compound 27 [PMID: 37683104] | |||||||
| TX1-85-1 | 9241 | TX-85-1 | |||||||
| TX2-121-1 | 9242 | conjugate 2e [PMID: 26094118] | |||||||
| TXA6101 |
|
13012 | |||||||
| TXA709 | 13160 | ||||||||
| TY-51469 |
|
9779 | |||||||
| TY-52156 | 10310 | TY 52156, TY52156 | |||||||
| TYA-018 | 13336 | TYA018 | |||||||
| TYD-68 |
|
13823 | TYK2 PROTAC 15t [PMID: 40116635] | ||||||
| TYK2 inhibitor 14l |
|
11425 | |||||||
| TYK2 inhibitor 18 [WO2023227946] | 13429 | Cpd No. 18 [WO2023227946A1] | |||||||
| tylvalosin | 13706 | acetylisovaleryltylosin, Aivlosin® (veterinary) | |||||||
| TYRA-200 | 14207 | example 181 [WO2022182972] | |||||||
| [3H]tyramine |
|
|
|
2148 | [3H]-Tyramine | ||||
| TZD18 | 2665 | TZD 18, TZD-18 | |||||||
| U | Back to top | ||||||||
| [3H]U46619 |
|
|
|
1974 | [3H]U 46619 | ||||
| [3H]U69593 |
|
|
1656 | [3H]-U69593 | |||||
| U0126 |
|
5282 | U 0126, U-0126 | ||||||
| U101958 | 5781 | U 101958, U-101958 | |||||||
| U46609 | 1972 | 9,11-epoxymethano-PGH2 | |||||||
| U46619 |
|
|
1888 | 11α,9α-epoxymethano-PGH2, U 46619, U-46619 | |||||
| U-47700 | 9282 | compound 1 [PMID: 2999404] | |||||||
| U50488 | 1652 | U 50488, U-50488, U-50488H, U50,488 | |||||||
| U69593 | 1655 | U-69,593, U-69593, U69-593 | |||||||
| U73122 | 5283 | U 73122, U-73122 | |||||||
| U75302 | 3325 | U 75302, U-75302 | |||||||
| U92016A | 30 | U-92,016-A, U-92016A | |||||||
| UAMC00039 | 6538 | ||||||||
| UAWJ248 | 12830 | PD-168803, PD168803, UAWJ-248, UAWJ2-48 | |||||||
| UAWJ9-36-3 |
|
11701 | |||||||
| ubavitinib |
|
12703 | AZD-3229, AZD3229 | ||||||
| [3H]UBP310 |
|
|
|
4092 | |||||
| UBP141 | 4332 | UBP 141, UBP-141 | |||||||
| UBP302 |
|
4333 | UBP 302, UBP-302 | ||||||
| UBP310 |
|
4334 | UBP 310, UBP-310 | ||||||
| ubrogepant |
|
10176 | MK-1602, MK1602, Ubrelvy® | ||||||
| UCB35625 | 3536 | UCB 35625, UCB-35625 | |||||||
| UCB-9260 |
|
13912 | UCB9260 | ||||||
| UCCF-029 | 4335 | ||||||||
| UCCF-339 | 4337 | ||||||||
| UCCF-853 | 4338 | ||||||||
| UCL1684 | 2320 | UCL-1684 | |||||||
| UCL1848 | 2321 | UCL-1848 | |||||||
| UCL-2138 | 1257 | UCL 2138, UCL2138 | |||||||
| UCM-05194 | 10587 | (S)-17 [PMID: 31790581], UCM05194 | |||||||
| UCM1014 | 9226 | Compound 8a [PMID 26334942] | |||||||
| UCM-1306 | 12170 | compound 26 [PMID: 36044544], UCM1306 | |||||||
| UCM1341 | 12324 | compound 29 [PMID: 30126274], UCM-1341 | |||||||
| UCM-14216 | 12522 | compound 54 [PMID: 35948083], GLXC-26113, UCM14216 | |||||||
| UCM 454 | 7783 | UCM-454, UCM454 | |||||||
| UCM 549 | 7772 | UCM-549, UCM549 | |||||||
| UCM 724 | 7773 | UCM-724, UCM724 | |||||||
| UCM 765 | 7923 | UCM-765, UCM765 | |||||||
| UCM 793 | 7777 | UCM-793, UCM793 | |||||||
| UCPH-101 | 4609 | UCPH101 | |||||||
| UCSF3384 | 10665 | Z1480758218, ZINC000157673384 | |||||||
| UCSF4226 | 10667 | Z1610979660, ZINC000128734226 | |||||||
| UCSF7447 | 10666 | Z1514261971, ZINC000555417447 | |||||||
| UCT943 |
|
10093 | |||||||
| udenafil |
|
11577 | DA-8159, DA8159, Zydena® | ||||||
| UDM-001651 | 10442 | compound 54 [PMID: 31246024] | |||||||
| UDP-β-S | 1750 | ||||||||
| UE2343 | 12037 | compound 4 [PMID: 28012176], UE-2343, Xanamem® | |||||||
| UFP-505 | 9838 | H-Dmt-Tic-Gly-NH-Bzl | |||||||
| UFP-512 | 9006 | H-Dmt-Tic-NH-CH(CH2-COOH)-Bid | |||||||
| (R)-UH 301 | 3218 | (+)-UH 301, 5-fluoro-8-hydroxy-2-(dipropylamino) tetralin | |||||||
| (S)-UH 301 | 61 | (-)-UH 301, (S)-UH301, UH301 | |||||||
| (+)-UH232 | 957 | ||||||||
| UH-AH 37 | 8583 | ||||||||
| UK-356202 | 6543 | compound 13j [PMID: 15149680], UK-356,202 | |||||||
| UK-356618 | 6528 | UK-356,618 | |||||||
| UK-396,082 |
|
8657 | compound 21 [PMID: 17990866], UK-396082 | ||||||
| UK-432,097 |
|
8420 | UK432,097, UK432097 | ||||||
| UK-5099 |
|
11302 | α-cyano-β-(1-phenylindol-3-yl)-acrylate, (E)-2-cyano-3-(1-phenyl-1H-indol-3-yl)acrylic acid, 2-CPIYA, 2-Cyano-3-(1-phenyl-1H-indol-3-yl)-acrylic acid, 2-Cyano-3-(1-phenylindol-3-yl)acrylate, UK5099 | ||||||
| ulecaciclib | 12079 | compound 116 [PMID: 28156111] | |||||||
| ulevostinag | 11972 | compound 26 [PMID: 35332774], MK-1454, MK1454 | |||||||
| ulimorelin | 3535 | TZP 101, TZP-101, TZP101 | |||||||
| ulipristal acetate |
|
|
7460 | CDB-2914, EllaOne®, VA2914 | |||||
| ulixacaltamide |
|
7718 | PRAX-944, PRAX944, Z 944, Z-944, Z944 | ||||||
| ulixertinib |
|
9210 | BVD-523, VRT-752271 | ||||||
| ulotaront |
|
10454 | example 129 [WO2011069063A2], SEP-363856 (parent molecule), SEP-856, SEP363856 | ||||||
| UM-9 | 11858 | 7,3'-Dihydroxy-2',4',8-trimethoxyisoflavan, Duartin, UM9 | |||||||
| umbralisib |
|
|
8916 | example A1 [US2014011819], RP-5264, RP5264, TGR-1202, TGR1202, Ukoniq® | |||||
| umeclidinium |
|
|
7354 | GSK573719A, Incruse Ellipta® | |||||
| UMI-77 | 8105 | ||||||||
| umibecestat |
|
12747 | CNP-520, CNP520, compound 15 [PMID: 34648711] | ||||||
| umifenovir |
|
|
11089 | AR-1I9514, Arbidol® | |||||
| UNC0006 | 7651 | ||||||||
| UNC0321 | 8389 | UNC 0321, UNC-0321 | |||||||
| UNC0638 |
|
7015 | |||||||
| UNC0642 | 7017 | ||||||||
| UNC1215 |
|
8232 | |||||||
| UNC1999 | 8237 | UNC 1999, UNC-1999 | |||||||
| UNC4203 |
|
10131 | MERTK inhibitor 19 [PMID: 30347155], UNC4203A [US20150291606A1] | ||||||
| UNC8969 | 13302 | compound 43 [PMID: 38556760], UNC-8969 | |||||||
| UNC9975 | 7650 | ||||||||
| UNC9994 | 7652 | ||||||||
| unecritinib |
|
12092 | compound 18 [WO2013041038A1] | ||||||
| unoprostone isopropyl |
|
8282 | Rescula® (proposed trade name), UF 021, UF-021 | ||||||
| upacicalcet |
|
12235 | Upasita® | ||||||
| upadacitinib |
|
|
9246 | ABT-494, Rinvoq® | |||||
| upamostat | 6497 | WX-671 | |||||||
| upidosin | 496 | Rec 15/2739, SB 216469 | |||||||
| uplarafenib | 12882 | Compound A [WO2022119905A2] | |||||||
| upleganan | 12797 | compound 44 [PMID: 31525992], EVER206, SPR206 | |||||||
| uproleselan | 11995 | ABI-701, ABI701, GMI-1271, GMI1271 | |||||||
| uprosertib | 7902 | GSK-2141795, GSK2141795 | |||||||
| uracil 20 |
|
9901 | |||||||
| uramustine |
|
7621 | U-8344, Uracil Mustard® | ||||||
| urapidil |
|
13357 | B 66256, B-66256, B66256, Ebrantil® | ||||||
| URB597 | 4339 | URB 597, URB-597 | |||||||
| URB937 | 11817 | URB-937 | |||||||
| URMC-099 | 8106 | compound 1 [PMID 24044867] | |||||||
| UR-PG146 | 1200 | ||||||||
| UR-PG153 | 1201 | ||||||||
| UR-PG131A | 1198 | ||||||||
| UR-PG55B | 1202 | ||||||||
| usmarapride | 12749 | SUVN-D4010, SUVND4010 | |||||||
| usnoflast |
|
12883 | Example-6 [WO2020148619A1], ZY-IL1, ZYIL-1, ZYIL1 | ||||||
| USP1 inhibitor 38-P2 | 13715 | ||||||||
| USP28 inhibitor 9p | 14187 | ||||||||
| USP7/USP47 inhibitor | 7895 | compound 14 [PMID: 24900381] | |||||||
| utatrectinib | 10360 | AZ12607092, AZD-7451, AZD7451, Example 6 [US8486966B2] | |||||||
| UTPγS | 1735 | UTPgammaS | |||||||
| utreloxastat | 13260 | compound C9 [WO2020081879A2], PTC-857, PTC857 | |||||||
| UVI3003 | 2816 | compound 10e [PMID: 19408900], UVI 3003 | |||||||
| uzansertib | 10626 | INCB-053914, INCB053914 | |||||||
| UZH2 |
|
13111 | compound 22 [PMID: 34431664] | ||||||
| V | Back to top | ||||||||
| V2043 | 12587 | 1-O-Octadecyl-2-O-benzyl-sn-glyceryl-3-phospho-GS-441524, compound 5c [PMID: 34310217], example 67 [WO2022081973A1], ODBG-P-RVn | |||||||
| vabametkib | 12391 | formula 17 [WO2015046653A1] | |||||||
| vaborbactam |
|
|
10871 | compound 9f [PMID: 25782055], RPX-7009, RPX7009, Vabomere (vaborbactam + meropenem) | |||||
| vacquinol-1 | 8373 | NSC13316 | |||||||
| vactosertib |
|
|
8107 | EW-7197, EW7197, NOV-1301, TEW-7197 | |||||
| vadadustat |
|
|
11831 | AKB-6548, AKB6548, Vafseo® | |||||
| valacyclovir |
|
|
4824 | 256U87 HCl, valacyclovir hydrochloride (monohydrate), Valtrex®, Zelitrex® | |||||
| valategrast |
|
11487 | R-411, RO-0272441 | ||||||
| valbenazine |
|
|
8694 | Ingrezza®, NBI 98854, NBI-98854 | |||||
| valdecoxib |
|
|
|
2894 | Bextra®, SC-65872 | ||||
| valemetostat |
|
12282 | (R)-OR-S2, DS-3201, DS3201, Ezharmia® | ||||||
| valerenic acid amide | 5470 | VA-A | |||||||
| valganciclovir |
|
4716 | Ro-1079070/194, RS-079070-194, Valcyte® | ||||||
| valnemulin | 13813 | Econor® (veterinary) | |||||||
| valproic acid |
|
|
7009 | A-44090, Depakote®, Epilim®, valproate sodium | |||||
| [3H]valsartan |
|
|
|
593 | |||||
| valsartan |
|
|
3937 | CGP-48933, Diovan®, Prexxartan® (oral solution) | |||||
| vamifeport |
|
11183 | VIT-2763, VIT2763 | ||||||
| vamorolone |
|
|
9247 | Agamree®, VBP-15, VBP15 | |||||
| vamotinib | 9792 | compound 1 (Table 1) [WO2012173521], PF-114, PF114 | |||||||
| vandetanib |
|
|
5717 | Caprelsa®, CH 331, ZD 6474, ZD-6474, ZD6474 | |||||
| vanin-1 inhibitor [PMID: 33196323] |
|
11718 | example 1 [WO2016193844A1] | ||||||
| vaniprevir |
|
|
11570 | analog 35b [PMID: 20163176], MK-7009, MK7009, Vanihep® | |||||
| vanoxerine |
|
9983 | GBR 12909, GBR-12909, GBR12909 | ||||||
| vanzacaftor |
|
13694 | VX-121, VX121 | ||||||
| vapiprost | 1976 | GR 32191, GR-32191, GR32191 | |||||||
| vardenafil |
|
|
7320 | Levitra®, Vivanza® | |||||
| varenicline |
|
|
5459 | Champix®, Chantix®, compound 9a [PMID: 16171993], CP 526555 | |||||
| varespladib |
|
|
9657 | compound 6m [PMID: 8978844], LY315920, S-5920, varespladib methyl (A-002), varespladib sodium (A-001) | |||||
| varlitinib | 7645 | ARRY-334543, ARRY334543 | |||||||
| varoglutamstat |
|
13397 | PQ-912, PQ912 | ||||||
| vatalanib | 5705 | CGP 79787, CGP-7978, PTK787, pynasunate, ZK-232934, ZK222584 | |||||||
| VBY-825 | 10746 | VBY825 | |||||||
| VCE-004.3 |
|
10030 | |||||||
| VE-821 | 8042 | VE 821 | |||||||
| vebreltinib |
|
|
11677 | APL-101, bozitinib, PLB1001 | |||||
| vecabrutinib |
|
10231 | BIIB-062, BIIB062, SNS-062, SNS062 | ||||||
| vecuronium |
|
4002 | Norcuron®, ORG NC 45 / ORG-NC 45 | ||||||
| VEGF receptor 2 kinase inhibitor I | 6053 | ||||||||
| VEGF receptor 2 kinase inhibitor II | 6054 | indolin-2-one deriv. 4b | |||||||
| VEGF receptor 2 kinase inhibitor IV | 6055 | KDR/Flk-1 kinase inhibitor IV, pyrazolo[1,5-a]pyrimidine 3g | |||||||
| VEGF receptor tyrosine kinase inhibitor II |
|
6056 | AG-E-85378 | ||||||
| VEGF receptor tyrosine kinase inhibitor III | 6057 | K00589a, KRN 633, KRN-633, KRN633 | |||||||
| veliparib |
|
7417 | ABT-888 | ||||||
| velpatasvir |
|
11269 | Epclusa® (sofosbuvir + velpatasvir), GS-5816, GS5816, Vosevi® (sofosbuvir + velpatasvir + voxilaprevi) | ||||||
| velsecorat |
|
|
9325 | AZ13189620, AZD7594, compound 15m [PMID: 28937774] | |||||
| veludacigib | 12625 | BAY 2965501, BAY-2965501, BAY2965501 | |||||||
| velusetrag | 8425 | compound 15 [PMID 22959244], TD-5108 | |||||||
| velzatinib |
|
11510 | compound 32 [PMID: 36728508], IDRX-42, IDRX42, M-4205, M4205 | ||||||
| vemurafenib |
|
|
|
5893 | PLX4032, RG7204, Zelboraf® | ||||
| venadaparib | 11184 | example 26 [WO2015037939A1], example I-26 [WO2015037939A1] | |||||||
| venetoclax |
|
|
|
8318 | ABT-199, GDC-0199, Venclexta®, Venclyxto® | ||||
| venglustat |
|
11550 | Genz-682452, GZ/SAR402671, ibiglustat, SAR402671 | ||||||
| venlafaxine |
|
7321 | Effexor®, WY-45030 | ||||||
| veonetinib | 13493 | Example 3 [WO2010021918] | |||||||
| vepafestinib | 11678 | example 85 [US20180009818A1] | |||||||
| vepdegrestrant | 11511 | ARV-471, ARV471, compound 341 [WO2018102725A1], PF-07850327, PF07850327 | |||||||
| VER-246608 |
|
9350 | |||||||
| VER-3323 | 168 | Lopac-V-1889 | |||||||
| verapamil |
|
2406 | Ansyr®, CP-165331 / CP-16533-1, Securon® | ||||||
| vercirnon |
|
|
9046 | CCX282-B, GSK'786, GSK1605786, GSK1605786A, Traficet-EN | |||||
| verdiperstat |
|
|
10052 | AZD-3241, AZD3241 | |||||
| vericiguat |
|
10010 | BAY-1021189, MK-1242, Verquvo® | ||||||
| verinurad |
|
9327 | RDEA-3170, RDEA3170 | ||||||
| verlukast |
|
6193 | MK-679, MK679 | ||||||
| verosudil | 8911 | AR 12286, AR-12286 | |||||||
| vertilmicin | 11018 | ||||||||
| verubecestat |
|
8699 | example 25 (US8940748), MK-8931 | ||||||
| verucerfont | 10378 | Compound (S)-8d [PMID: 21074436], GSK-561679, GSK561679, NBI-77860, NBI77860 | |||||||
| [3H]vesamicol |
|
|
4758 | [3H]-vesamicol | |||||
| vesamicol | 4759 | ||||||||
| vestipitant | 5757 | GW597588B | |||||||
| vevorisertib | 12613 | ARQ-751, GLXC-26917 | |||||||
| vibegron |
|
10100 | compound 7 [PMID: 26709102], Gemtesa®, KRP-114V, MK-4618, MK4618 | ||||||
| VIC 1911 | 12070 | example 1 [US10092556B2], TAS-119, TAS119, VIC1911 | |||||||
| vicadrostat | 13885 | compound 29 A [WO2016014736A1] | |||||||
| vicasinabin | 11890 | Example 151 [WO2013068306A1], RG-7774, RG7774 | |||||||
| vicriviroc | 807 | SCH 417690, SCH-417690, SCH-D690, SCH-DS | |||||||
| vidarabine |
|
|
4806 | CI-673, Vira-A® | |||||
| vidofludimus |
|
|
9860 | 4SC-101, IMU-838 (vidofludimus calcium), SC12267 | |||||
| vidupiprant |
|
10169 | AMG 853, AMG-853, AMG853, compound 2 [PMID: 24900313] | ||||||
| vigabatrin |
|
4821 | CPP-109, Kigabeq®, MDL-71754, Sabril®, Vigafyde® (oral solution) | ||||||
| vilagletistat | 12802 | TAK-227, ZED-1227, ZED1227 | |||||||
| vilanterol |
|
|
7353 | GW642444X | |||||
| vilazodone |
|
|
7427 | EMD-515259, EMD-68-843, SB-659746-A, Viibryd® | |||||
| vildagliptin |
|
6310 | Galvus®, LAF-237, NVP-LAF237 | ||||||
| viloxazine |
|
11502 | Emovit®, ICI-58,834, ICI-58834, Qelbree® | ||||||
| vilzemetkib | 13220 | Example 6 [US20120123126] | |||||||
| vimnerixin |
|
12100 | AZD-4721, AZD4721, compound 4 [WO2019055509A1], RIST4721 | ||||||
| vimseltinib |
|
|
11190 | compound 20 [PMID: 35961460], DCC-3014, DCC3014, example 10 [WO2014145025A2], Romvimza® | |||||
| vinblastine |
|
|
6851 | 29060-LE, Velban®, Velbe®, vincaleucoblastin, vincaleukoblastine | |||||
| vinburnine | 345 | eburnamonine | |||||||
| vinorelbine |
|
7105 | Navelbine® | ||||||
| vinpocetine |
|
|
5285 | ||||||
| VIP36 |
|
13816 | VIP-36 | ||||||
| vipadenant |
|
|
5612 | BIIB 014, BIIB014, V2006 | |||||
| vipivotide tetraxetan | 11982 | PSMA-617, PSMA617 | |||||||
| vipoglanstat |
|
12209 | BI 1029539, BI-1029539, BI1029539, GS-248, GS248 | ||||||
| viquidacin | 10872 | AVE-4221, AVE4221, compound 1 [PMID: 23968485], NXL-101, NXL101 | |||||||
| vismodegib |
|
|
6975 | Erivedge®, GDC-0449, HhAntag691 | |||||
| vistusertib | 7699 | AZD 2014, AZD-2014, AZD2014, cc-551 | |||||||
| vixotrigine |
|
12645 | BIIB-074, BIIB074, CNV-1014802, CNV1014802, compound 20 [PMID: 32945812], GSK1014802, raxatrigine (deleted INN) | ||||||
| vizenpistat | 14076 | SR-8541A, SR8541A | |||||||
| VK2809 | 12768 | compound 22c [PMID: 18975928], MB-07811, MB07811, VK-2809 | |||||||
| VK-II-86 | 10161 | compound 8 [PMID: 24124794] | |||||||
| VL-0395 | 886 | ||||||||
| VLX1570 | 9413 | VLX-1570 | |||||||
| VNA932 | 3537 | VNA 932, VNA-932 | |||||||
| vociprotafib | 12067 | compound A-290 [WO2018013597A1], RMC-4630, RMC4630, SAR-442720, SAR442720, SHP2-IN-7 | |||||||
| voderdeucitinib | 14066 | compound 51 [WO2022175752] | |||||||
| vodobatinib | 11191 | SCO-088, SCO088, SUN-K706, SUNK706 | |||||||
| vofopitant | 5752 | GR-205171, GR-205171A, GR205171 | |||||||
| volanesorsen |
|
8681 | APOC-III antisense inhibitor, ISIS 304801, ISIS-APOCIIIRx, Waylivra® | ||||||
| volasertib |
|
7947 | BI 6727, BI-6727 | ||||||
| [11C]volinanserin |
|
|
3249 | [11C]M100907 (PET ligand), [11C]MDL100907 | |||||
| volinanserin | 185 | MDL-100,907, MDL-100907, MDL100907 | |||||||
| vonafexor | 13935 | EYP-001, EYP001, PLX-007, PLX007 | |||||||
| vonoprazan |
|
|
11549 | compound 13e [PMID: 22512618], TAK-438, TAK438, TAKECAB®, Takecab®, Vocinti®, Voquezna® | |||||
| vopimetostat |
|
12902 | TNG-462, TNG462 | ||||||
| vorapaxar |
|
|
4047 | SCH 530348, SCH-530348, SCH530348, Zontivity® | |||||
| vorasidenib |
|
|
10663 | AG-881, AG881, Voranigo® | |||||
| vorinostat |
|
|
6852 | MK-0683, MK0683, SAHA, suberoylanilide hydroxamic acid, Zolinza® | |||||
| vorolanib | 11618 | CM-082, CM082, Example 8 [WO2008033562A2], EYP-1901, X-82 | |||||||
| vortioxetine |
|
|
|
7351 | Brintellix®, compound 5m [PMID: 21486038], Lu AA21004, Trintellix® | ||||
| voruciclib | 9923 | P1446A, P1446A-05 | |||||||
| voxelotor |
|
10559 | compound 36 [PMID: 28337324], GBT-440, GBT440, Oxbryta® | ||||||
| voxtalisib | 7964 | SAR-245409, SAR245409, XL765 | |||||||
| voxvoganan | 13759 | AMC-109, LTX 109, LTX-109, Lytixar® | |||||||
| VPC12249 | 2909 | VPC 12249, VPC-12249 | |||||||
| VPC171 | 8895 | ||||||||
| VPC23019 | 3324 | VPC 23019, VPC-23019 | |||||||
| VPC32179 | 5450 | VPC-32179 | |||||||
| VPC32183 | 2908 | compound 10t [PMID: 15125924] | |||||||
| VPC44116 | 2930 | VPC-44116 | |||||||
| VPC03090-P | 6992 | VPC 03090-P, VPC-03090-P | |||||||
| VPS34-IN-1 | 9378 | example 16a [US8685993], VPS34-IN1 | |||||||
| VRT-043198 |
|
|
9034 | ||||||
| VRT-532 | 4341 | VRT 532, VRT532 | |||||||
| VS-4718 | 8742 | PND-1186, PND1186 | |||||||
| VS-5584 | 8382 | SB 2343, SB2343, VS5584 | |||||||
| VT3989 | 13867 | compound 24 [WO2020214734A1], VT-3989 | |||||||
| VTX-11e |
|
9375 | 11e [PMID: 19827834], VX-11e | ||||||
| (S)-VU0637120 | 12608 | ||||||||
| VU0001171 | 6228 | ||||||||
| VU0010010 | 7633 | compound 14 [PMID: 19201489], VU10010 | |||||||
| VU0029767 | 3261 | ||||||||
| VU0080241 | 6227 | ||||||||
| VU0090157 | 3259 | ||||||||
| VU0092145 | 6229 | VU 0092145 | |||||||
| VU0092273 | 6421 | VU 0092273 | |||||||
| VU0119498 | 7632 | STK215777, VU 0119498, VU-0119498 | |||||||
| VU0134992 | 11821 | VU 0134992, VU-0134992, VU-992, VU992 | |||||||
| VU0152099 | 3256 | ||||||||
| VU0152100 | 3263 | VU 0152100, VU-0152100 | |||||||
| VU0155041 |
|
3323 | VU 0155041, VU-0155041 | ||||||
| VU0155094 | 10238 | ML 397, ML-397, ML397, VU 0155094, VU-0155094 | |||||||
| VU0238429 | 3257 | VU 0238429, VU-0238429 | |||||||
| VU0240382 | 6422 | ||||||||
| VU0240551 | 4665 | ||||||||
| VU0255035 | 3274 | ||||||||
| VU0285683 | 6398 | ||||||||
| VU0357121 | 6399 | VU 0357121 | |||||||
| VU0359516 | 6230 | ||||||||
| VU0360172 | 6400 | ||||||||
| VU0361737 | 3956 | compound 9b [PMID: 19469556], VU 0361737, VU-0361737 | |||||||
| VU0361747 | 6423 | ||||||||
| VU0364289 | 6424 | VU 0364289 | |||||||
| VU0364739 | 5287 | VU 0364739 | |||||||
| VU0364770 |
|
6234 | |||||||
| VU0366058 | 6438 | ||||||||
| VU0400195 | 6233 | ML182 | |||||||
| VU0404251 | 6410 | ||||||||
| VU0405601 | 7662 | VU 0405601, VU-0405601 | |||||||
| VU0409551 | 11437 | JNJ-46778212, JNJ46778212 | |||||||
| VU0422288 | 10239 | ML 396, ML-396, ML396, VU 0422288, VU-0422288 | |||||||
| VU0424465 |
|
6411 | ML273 | ||||||
| VU0463597 | 6225 | (R)-VU0463597, ML289 | |||||||
| VU0463841 | 6393 | ||||||||
| VU0467154 |
|
12301 | |||||||
| VU0467319 | 14056 | ||||||||
| VU0469650 | 6337 | ||||||||
| VU0483605 | 10009 | VU 0483605, VU-0483605 | |||||||
| VU0486846 | 12305 | compound 16 [PMID: 29701957] | |||||||
| VU0506013 | 14061 | ||||||||
| VU0546110 | 14041 | VU0546110-1 | |||||||
| VU0650786 | 10237 | VU 0650786, VU-0650786 | |||||||
| VU0810464 | 10260 | compound 8a [PMID: 28697302] | |||||||
| VU0948578 | 14037 | Analog 80 [PMID: 38893312], VU-0948578 | |||||||
| VU-1545 | 4059 | VU1545 | |||||||
| VU-29 |
|
6403 | VU 29 | ||||||
| VU2957 | 10135 | compound 7 (Panarese et al., 2018), valiglurax, VU0652957 | |||||||
| VU591 | 7696 | VU 591, VU-591 | |||||||
| VU6007678 |
|
14058 | |||||||
| VU6010608 | 9703 | compound 11a [Reed et al., 2017) | |||||||
| VU6012962 | 10196 | compound 7d [PMID: 30608678] | |||||||
| VU-71 | 6207 | VU71 | |||||||
| VUF14738 | 9873 | compound 28 [PMID: 29470065], VUF 14738, VUF-14738 | |||||||
| VUF14862 | 9874 | compound 33 [PMID: 29470065], VUF 14862, VUF-14862 | |||||||
| VUF15000 | 14155 | ||||||||
| VUF26063 | 14156 | compound 3f [PMID: 40568883] | |||||||
| VUF 4904 | 1263 | VUF-4904, VUF4904 | |||||||
| VUF 5207 | 1245 | VUF-5207, VUF5207 | |||||||
| VUF5574 | 3280 | VUF 5574, VUF-5574 | |||||||
| VUF 8328 | 1246 | ||||||||
| VUF 8430 | 1274 | VUF-8430, VUF8430 | |||||||
| VUF8504 | 475 | VUF 8504, VUF-8504 | |||||||
| VUF8507 | 476 | VUF 8507, VUF-8507 | |||||||
| vulolisib | 12075 | Example 22 [WO2021104146A1] | |||||||
| VVD-133214 | 13353 | RO-7589831, RO7589831, VVD-214, VVD133214 | |||||||
| VX-150 | 14016 | VX-150m, VX150 | |||||||
| VX-702 |
|
6059 | I14-1965, VX 702, VX702 | ||||||
| VX-993 |
|
13683 | VX993 | ||||||
| W | Back to top | ||||||||
| 1400W |
|
|
5102 | W 1400 | |||||
| 264W94 | 6529 | ||||||||
| W146 |
|
2931 | W 146, W-146, W146_02-01 | ||||||
| W54011 | 581 | W 54011, W-54011 | |||||||
| W-84 | 362 | Hdmppa, W84 | |||||||
| walrycin B | 11256 | ||||||||
| warfarin |
|
6853 | Coumadin®, Marevan®, panwarfin | ||||||
| [11C]WAY100635 |
|
|
3252 | [11C]WAY-100635, [11C]WAY100635 (PET ligand) | |||||
| [3H]WAY100635 |
|
|
3251 | ||||||
| (+)-WAY 100135 | 126 | ||||||||
| WAY-100135 | 79 | WAY 100135, WAY-100,135 | |||||||
| WAY-100635 | 80 | WAY 100635, WAY-100,635, WAY100635 | |||||||
| WAY-163909 | 229 | WAY163909 | |||||||
| WAY170523 | 5288 | WAY 170523, WAY-170523 | |||||||
| WAY-181187 | 3240 | WAY 181187, WAY-181,187 | |||||||
| WAY200070 | 4052 | WAY 200070, WAY-200070 | |||||||
| WAY-207024 | 5582 | WAY 207024 | |||||||
| WAY-208466 | 8429 | ||||||||
| WAY-213613 |
|
4531 | WAY-213,613 | ||||||
| WAY-255348 | 8664 | WAY 255348, WAY255348 | |||||||
| WAY-316606 | 9945 | compound 1 [PMID: 19072540] | |||||||
| WAY-855 | 5327 | WAY 855 | |||||||
| WB 4101 | 499 | WB-4101, WB4101 | |||||||
| WB4-24 | 8544 | ||||||||
| WD6305 | 13110 | compound 9 [PMID: 38194973], WD-6305 | |||||||
| WDuo3 | 363 | ||||||||
| WEHI-842 |
|
|
10616 | ||||||
| WEHI-P8 | 13904 | WEHIP8 | |||||||
| WF-47-JS03 | 10709 | compound 1 [Mathison et al., 2020], WF47JS03 | |||||||
| WH-4-023 |
|
8068 | |||||||
| [3H]WIN35428 |
|
|
|
4605 | [3H]-β-CFT, [3H]-2β-carboxymethy-3β-(4-fluorophenyl)tropane , [3H]-WIN35428 | ||||
| [3H]WIN55212-2 |
|
|
736 | ||||||
| WIN35428 |
|
4606 | β-CFT, 2β-carboxymethy-3β-(4-fluorophenyl)tropane , WIN 35,428, WIN 35428 | ||||||
| WIN 51,708 | 339 | WIN-51708, WIN51,708 | |||||||
| WIN55212-2 |
|
733 | Win 55,212, Win 55212-2, Win-55212-2, WIN55,212-2 | ||||||
| WIN 62,577 | 340 | WIN-62577, WIN62,577 | |||||||
| WIN 64338 | 677 | WIN-64338 | |||||||
| WJYK50 |
|
10639 | compound 1c [PMID: 29649738] | ||||||
| WLL-vs |
|
11321 | |||||||
| WM382 |
|
|
11162 | ||||||
| WN1703 |
|
13463 | compound 16c [PMID: 28918097], WN-1703, XOR inhibitor 16c | ||||||
| WNN0109-C011 | 11907 | ||||||||
| Wnt-C59 | 12020 | ||||||||
| WNY0824 | 12143 | compound 9b [PMID: 32088495], PLK1/BRD4-IN-1, WNY-0824 | |||||||
| WP1066 | 7972 | WP 1066, WP-1066 | |||||||
| WP814 | 8762 | ||||||||
| WRC-0571 | 8419 | ||||||||
| WS-23 | 2474 | WS 23 | |||||||
| WS-3 | 2475 | WS 3 | |||||||
| WS-5 | 6368 | ||||||||
| WS-898 | 11786 | compound 26 [PMID: 34723530], WS898 | |||||||
| WS-917 | 13577 | compound 40 [PMID: 39425773], WS917 | |||||||
| WU-04 |
|
12602 | WU04 | ||||||
| WWL0245 | 12142 | BRD4-PROTAC 12a, WWL-0245 | |||||||
| WWL123 | 9480 | ||||||||
| WWL70 | 5289 | WWL 70 | |||||||
| WXFL10203614 |
|
12621 | WX614, WXFL-10203614 | ||||||
| WX-UK1 | 6498 | compound 2r-L, UKI-1 | |||||||
| WYE-354 | 9361 | WYE354 | |||||||
| WZ4002 |
|
9176 | |||||||
| WZ4003 |
|
8047 | WZ-4003 | ||||||
| X | Back to top | ||||||||
| X14 | 13170 | ||||||||
| X-165 |
|
11115 | compound 1 [PMID: 32584034], X165 | ||||||
| [3H]XAC |
|
|
|
432 | [3H]xanthine amine congener | ||||
| XAC-BY630 | 3279 | ||||||||
| xamoterol | 538 | ICI-118587 | |||||||
| [11C]xanomeline |
|
|
3278 | [11C]xanomeline (PET ligand) | |||||
| xanomeline |
|
|
57 | Cobenfy®, KarXT, LY 246708 | |||||
| xanthine amine congener |
|
404 | XAC | ||||||
| XAP044 | 8545 | 7-hydroxy-3-(4-iodophenoxy)-4H-chromen-4-one | |||||||
| XCC | 451 | ||||||||
| XCT790 | 2832 | XCT 790, XCT-790 | |||||||
| XD1 |
|
7525 | colchicein, colchiceine, NSC33411 | ||||||
| XD14 |
|
7524 | |||||||
| XE991 | 2596 | LS-190926 | |||||||
| XEN907 | 5732 | XEN 907, XEN-907 | |||||||
| xeruborbactam |
|
13131 | QPX7728 | ||||||
| xeruborbactam isoboxil | 13241 | QPX-7831, QPX7831 | |||||||
| xevinapant | 7729 | AT 406, AT406, Debio-1143, Debio1143, QCR-136, SM 406 | |||||||
| xiliertinib | 9929 | HMPL-309, HMPL309, theliatinib | |||||||
| ximelagatran |
|
6381 | H 376-95, H 376/95 | ||||||
| xipamide |
|
7900 | BE-1293, Diurexan®, MJF-10938 | ||||||
| XL01126 | 12009 | ||||||||
| XL019 | 7971 | XL 019, XL-019 | |||||||
| XL388 | 7973 | XL-388 | |||||||
| XL413 |
|
8113 | BMS-863233, BMS863233, XL-413 | ||||||
| XL888 | 13794 | compound 12i [PMID: 22877636], XL-888 | |||||||
| XMD-12 |
|
11665 | compound 1 [PMID: 21992004], XMD12 | ||||||
| XMD17-109 |
|
9406 | compound 26 [PMID: 24239623], ERK5-IN-1 | ||||||
| XMD8-92 |
|
8057 | XMD 8-92 | ||||||
| XMT-1191 | 6486 | ||||||||
| XMU-MP-1 |
|
11812 | |||||||
| XNT [PMID: 18391097] | 7867 | ||||||||
| XP-102 |
|
13942 | BI 882370, BI-882370, BI882370, XP102 | ||||||
| XPC-4509 | 13386 | XPC4509 | |||||||
| XPC-5462 | 13387 | XPC5462 | |||||||
| XPC-6591 | 13388 | XPC6591 | |||||||
| XPC-7198 | 13389 | XPC7198 | |||||||
| XPC-7224 | 13390 | XPC7224 | |||||||
| XR8-23 | 11765 | compound 72 [PMID: 34665619] | |||||||
| XR8-24 |
|
11766 | compound 74 [PMID: 34665619] | ||||||
| XRD-0394 | 13457 | compound 569 [WO2021022078A1], XRD 0394, XRD0394 | |||||||
| (S)-XY-05 | 13117 | ||||||||
| XY-06-007 | 12141 | ||||||||
| XY101 |
|
10366 | compound 27 [PMID: 30964293], XY-101 | ||||||
| xylazine | 523 | BAY-VA-1470, Bayer 1470 | |||||||
| xylometazoline |
|
517 | Otrivine®, xylomethazoline | ||||||
| XYT528B | 11696 | ||||||||
| Y | Back to top | ||||||||
| Y134 | 5430 | Y-134 | |||||||
| Y27632 |
|
5290 | ROCK Inhibitor, Y-27632, Y-27632 | ||||||
| Yaddle1 | 14005 | compound 34 [PMID: 38716967] | |||||||
| YC-1 |
|
5291 | 3-(5′-hydroxymethyl-2′furyl)-1-benzyl-indazole, YC1 | ||||||
| YCT529 | 11954 | ||||||||
| YD-3 | 9458 | ||||||||
| YD54 | 13901 | ||||||||
| YF-476 | 887 | YF 476, YF476 | |||||||
| YH18968 | 10137 | YH-18968 | |||||||
| YH-53 |
|
11646 | compound 5h [PMID: 23994330], compound 5h [PMID: 33510133], GRL-2420 (compound 3 PMID: 34528437), YH53 | ||||||
| YH-6 | 12234 | compound 8a [PMID: 36229406] | |||||||
| YHJ1039 | 13032 | compound 26 [PMID: 34324343], YHJ-1039 | |||||||
| YIL781 | 3538 | YIL 781, YIL-781 | |||||||
| YJZ5118 | 13818 | compound 14k [PMID: 40080446] | |||||||
| YL-365 |
|
12947 | YL365 | ||||||
| YL5084 | 12484 | YL-5084 | |||||||
| (±)YM796 | 285 | ||||||||
| [3H]YM298198 |
|
|
5392 | [3H]-YM298198 | |||||
| YM-022 | 888 | YM022 | |||||||
| YM-202074 | 6361 | ||||||||
| YM 218 | 2204 | YM-218 | |||||||
| YM-244769 | 9484 | YM244769 | |||||||
| YM298198 | 1389 | YM-298198 | |||||||
| YM348 | 230 | YM-348 | |||||||
| YM-355179 | 793 | ||||||||
| YM44778 | 2120 | YM-44778 | |||||||
| YM44781 | 2121 | YM 44781, YM-44781 | |||||||
| YM 471 | 2205 | YM-471 | |||||||
| YM49598 | 2122 | YM-49598 | |||||||
| YM-75440 | 3137 | YM 75440, YM75440 | |||||||
| (-)-YM796 | 287 | ||||||||
| YM90709 |
|
5090 | YM 90709, YM-90709 | ||||||
| YM976 | 5292 | YM 976, YM-976 | |||||||
| (R)-YNT-3708 | 12606 | (R)-18 [PMID: 37043436] | |||||||
| YNT-185 | 10277 | compound 30 [PMID: 26267383], Nag 30 | |||||||
| Yoda1 | 9817 | Yoda 1 | |||||||
| Yoda2 | 14004 | KC289, Yoda 2 | |||||||
| Yoda2b | 14006 | CHR-1871-032, Yoda 2b | |||||||
| YS121 | 5293 | ||||||||
| YTHDC1 inhibitor 40 |
|
13394 | |||||||
| YTK-2205 | 12281 | example 2 [US20210163399A1], YTK 2205, YTK2205 | |||||||
| YT47R | 12816 | ||||||||
| YX862 | 13483 | compound 38 [PMID: 38949959], YX-862 | |||||||
| YXG-158 | 12801 | compound 23-h [PMID: 37458396], YXG158 | |||||||
| yzm18 | 8853 | ||||||||
| Z | Back to top | ||||||||
| Z-360 | 907 | Z 360, Z360 | |||||||
| Z55627844 | 14116 | ||||||||
| zabedosertib |
|
11415 | BAY-1834845, BAY1834845 | ||||||
| zabofloxacin | 10873 | DW-224a | |||||||
| (R)-zacopride | 2288 | ||||||||
| (S)-zacopride | 2289 | ||||||||
| [3H](S)-zacopride |
|
|
4074 | ||||||
| zacopride | 245 | AHR-11190-B, iodozacopride | |||||||
| zafirlukast |
|
|
|
3322 | Accolate®, ICI-204219 | ||||
| ZAK inhibitor 6p | 10402 | ||||||||
| zalcitabine |
|
4828 | dideoxycytidine (DDC), Hivid®, Ro-242027000/Ro-24-2027-000 | ||||||
| zaleplon |
|
4345 | CL-284846, LJC-10846, Sonata®, ZAL-846 | ||||||
| zaloblideg | 13460 | ARV-393, ARV393, compound 81 [WO2022221673A1] | |||||||
| zaloglanstat |
|
11406 | |||||||
| zalospirone | 58 | WY-47,846 | |||||||
| zalsupindole | 13552 | AAZ-A-154, AAZ-A154 | |||||||
| zanamivir |
|
|
12307 | Dectova®, GG-167, GG167, GR-121167, GR-121167X, ZMR | |||||
| zandatrigine | 11734 | NBI-921352, NBI921352, XEN-901, XEN901 | |||||||
| zandelisib |
|
10627 | A35 [WO2012135160A1], Example 51 [WO2012135160A1], ME-401, ME401, PWT-143, PWT143 | ||||||
| zanubrutinib |
|
|
9861 | BGB-3111, BGB3111, Brukinsa®, compound 27b [US9447106] | |||||
| zanzalintinib | 12093 | CL-092, compound 8 [WO2019148044A1], XL-092, XL092 | |||||||
| zapnometinib | 11679 | ATR-002, ATR002, PD-0184264, PD0184264 | |||||||
| zaprinast |
|
2919 | M&B-22948 | ||||||
| zasocitinib |
|
|
12155 | compound I-908 [US20190256519A1], NDI-034858, NDI034858, TAK-279, TAK279 | |||||
| zastaprazan |
|
13433 | JAQBO®, JP-1366, JP1366 | ||||||
| zatebradine | 2358 | UL-FS49 | |||||||
| zaurategrast |
|
11488 | CDP-323, CDP323 | ||||||
| zavabresib | 14065 | ||||||||
| zavegepant |
|
11513 | BHV-3500, BMS-742413, BMS742413, Zavzpret® | ||||||
| zavolosotine | 13224 | Compound 1 [WO2022177988] | |||||||
| zavondemstat | 12807 | Example 187 [WO2015200709A1] | |||||||
| (5Z)-5-[(5-bromothiophen-2-yl)methylidene]-1-methyl-2-sulfanylidene-1,3-diazinane-4,6-dione | 8729 | ||||||||
| ZCZ011 | 9239 | ZCZ 011, ZCZ-011 | |||||||
| ZD6021 | 2109 | ZD 6021, ZD-6021 | |||||||
| ZD-7155 |
|
8324 | ZD 7155, ZD7155 | ||||||
| ZD7288 | 2359 | ZD 7288, ZD-7288 | |||||||
| zebularine |
|
4729 | |||||||
| zegocractin |
|
10087 | Auxora, CM-4620, CM4620, compound I [WO2016138472A1] | ||||||
| zelasudil | 12386 | example 290 [EP3743420B1] | |||||||
| zelatriazin (TAK-041) | 11685 | compound 56 [PMID: 34260228], NBI-1065846, NBI1065846, TAK-041, TAK041 | |||||||
| zelebrudomide |
|
13490 | compound 28 [PMID: 38300987], NX-2127, NX2127 | ||||||
| zelenirstat |
|
13851 | example DDD86481 [US9156811B2], PCLX-001, PCLX001 | ||||||
| zelnecirnon |
|
12893 | example 37 [WO2019147862A1], RPT-193, RPT193 | ||||||
| zeltociclib | 13754 | Example 82 [WO2022134642A1], GTAEXS-617, GTAEXS617, REC-617, REC617 | |||||||
| zemirciclib |
|
11782 | AZD-4573, AZD4573, compound 24 [PMID: 33306391] | ||||||
| zemprocitinib |
|
13221 | compound 1 [US20220009927] | ||||||
| zenarestat |
|
7418 | FK-366, FR-74366 | ||||||
| zenuzolac |
|
11682 | (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, GIT-027, GIT-27, GIT27, GLS-1027, GLS1027, rac-[(5R)-3-phenyl-4,5-dihydro-1,2-oxazol-5-yl]acetic acid, VGX-1027, VGX1027 | ||||||
| zeprumetostat | 13512 | compound 2 [WO2017084494], compound Ia [WO2019091450] | |||||||
| zeteletinib | 11416 | BOS-172738, BOS172738, DS-5010, DS5010, Example 3 [WO2018060714A1] | |||||||
| zetomipzomib |
|
10409 | compound 12 [PMID: 30380863], KZR-616, KZR616 | ||||||
| (4Z)-1-(3-fluorophenyl)-4-(2-oxo-1H-indol-3-ylidene)pyrazolidine-3,5-dione | 8726 | ||||||||
| (5Z)-1-(2-fluorophenyl)-2-sulfanylidene-5-(thiophen-2-ylmethylidene)-1,3-diazinane-4,6-dione | 8727 | ||||||||
| zibotentan |
|
3539 | ZD 4054, ZD-4054, ZD4054 | ||||||
| zidebactam | 10874 | WCK-5107, WCK5107 | |||||||
| zidesamtinib |
|
12392 | Example 5 [US383715659], NVL-520, NVL520 | ||||||
| zidovudine |
|
|
4825 | AZT, 3'-azido-3'-deoxythymidine, Retrovir® | |||||
| zifanocycline | 12794 | KBP-7072 | |||||||
| zifaxaban | 10099 | TY-602, TY602 | |||||||
| ziftomenib |
|
11680 | compound 151 [US10781218B2], KO-539, KO539 | ||||||
| zileuton |
|
|
5297 | A-64077, ZYFLO® | |||||
| zilurgisertib | 11888 | Compound A [WO2021257532A1], example 34 [US20210155606A1], INCB-00928, INCB00928 | |||||||
| zimlovisertib |
|
|
9667 | compound 40 [PMID: 28498658], PF-06650833, PF06650833 | |||||
| (R)-ZINC-3573 |
|
|
9566 | ZINC-72453573 | |||||
| zinc protoporphyrin IX | 8903 | ZnPP, protoporphyrin IX containing Zn | |||||||
| zinc pyrithione | 2597 | ||||||||
| zinterol | 3466 | ||||||||
| zipalertinib |
|
11889 | CLN-081, CLN081, TAS-6417, TAS6417 | ||||||
| ziprasidone |
|
|
59 | CP-88059, CP-88059-27, CP-880591, CP-8805927, Geodon® | |||||
| ziritaxestat |
|
|
9561 | compound 11 [PMID: 28414242], GLPG-1690, GLPG1690 | |||||
| ZK110841 | 1889 | ZK 110841, ZK-110841 | |||||||
| ZK112993 | 3448 | 11β-(4-acetylphenyl)-17β-hydroxyl-17α-(1-propinyl)-4,8-estradiene-3-one, ZK 112,993, ZK 112993 | |||||||
| ZK118182 | 1890 | ZK 118182, ZK-118182 | |||||||
| ZK-158252 | 6162 | ZK 158252, ZK158252 | |||||||
| ZK159222 | 2789 | C410228, ZK 159222 | |||||||
| ZK216348 | 8643 | ZK 216348, ZK-216348 | |||||||
| ZK 756326 |
|
|
813 | ZK-756326, ZK756326 | |||||
| ZK93423 | 4346 | ZK 93423, ZK-93423 | |||||||
| ZK93426 | 4347 | ZK 93426, ZK-93426 | |||||||
| ZLN005 |
|
13255 | ZLN 005, ZLN-005 | ||||||
| [125I]ZM-241385 |
|
|
430 | ||||||
| [3H]ZM 241385 |
|
|
455 | [3H]-ZM241385 | |||||
| ZM-241385 |
|
405 | ZM-241,385, ZM241385 | ||||||
| ZM 253270 | 5771 | ZM-253270, ZM253270 | |||||||
| ZM-274773 | 5778 | M-274773 | |||||||
| ZM-306416 | 8245 | CB-676475, ZM 306416, ZM306416 | |||||||
| ZM336372 | 9130 | compound 1 [PMID: 15454231], ZM 336372, ZM-336372 | |||||||
| ZM447439 |
|
8353 | ZM 447439, ZM-447439 | ||||||
| ZN-c5 | 13967 | compound F [WO2021216671A1], example 5A [US20210330651A1], ZNc5 | |||||||
| zofenopril |
|
6462 | SO-26991, SQ-26900 | ||||||
| zofenoprilat |
|
|
6463 | ||||||
| zoledronic acid |
|
|
3177 | Aclasta®, CGP-42446, CGP-42446A, Reclast®, zoledronate, Zometa® | |||||
| zoliflodacin |
|
10875 | AZD-0914, AZD0914, EXT-0914, EXT0914 | ||||||
| zoligratinib |
|
9787 | CH5183284, DEBIO-1347, DEBIO1347 | ||||||
| zolmitriptan |
|
60 | 311C90, Zomig® | ||||||
| [3H]zolpidem |
|
|
|
4362 | |||||
| zolpidem |
|
|
4348 | Ambien®, SL 80.0750-23N, SL-80.0750-23N, Stilnoct® | |||||
| zomiradomide |
|
11904 | compound A [WO2022027058A1] | ||||||
| zongertinib |
|
12387 | BI 1810631, BI-1810631, BI1810631, example I-01 [WO2021213800A1], Hernexeos® | ||||||
| zonisamide |
|
|
7047 | AD-810, CI-912, PD-110843, Zonegran® | |||||
| zopiclone |
|
7430 | compound 3 [PMID: 8863805], RP-27267, Zimovane® | ||||||
| zopolrestat |
|
7419 | CP-73850 | ||||||
| zorifertinib |
|
10456 | AZD-3759, AZD3759, compound 1m [PMID: 26313252] | ||||||
| zosuquidar | 11788 | LY 335979, LY-335979, LY335979 | |||||||
| zosurabalpin |
|
12950 | Abx MCP, RG6006, RO7223280 | ||||||
| zotarolimus | 7974 | ABT 578, ABT-578, ABT578 | |||||||
| zotepine |
|
|
103 | Zoleptil® | |||||
| zotiraciclib | 9095 | compound 26h [PMID: 22148278], SB-1317, SB1317, TG-02, TG02 | |||||||
| zotizalkib | 12388 | TPX-0131, TPX0131 | |||||||
| zovegalisib |
|
13065 | RLY-2608, RLY2608 | ||||||
| zoxazolamine |
|
2327 | |||||||
| 5Z-7-oxozeaenol |
|
8077 | (5Z)-7-oxozeaenol, FR-148083, LL-Z1640-2 | ||||||
| ZQ-16 | 11211 | ||||||||
| ZSA-215 |
|
13969 | compound 2dr [PMID: 40442142], ZSA215 | ||||||
| ZSTK474 |
|
7965 | TCMDC-137004, ZSTK 474, ZSTK-474 | ||||||
| ztz240 |
|
7668 | |||||||
| zucapsaicin |
|
11576 | Civanex®, Zuacta® | ||||||
| zuclopenthixol |
|
7559 | Acuphase®, cis(Z)-cloflupentixol, Cisordinol®, Clopixol®, NSC 64087, NSC169185 | ||||||
| zunsemetinib | 11681 | ATI-450, ATI450, CDD-450, CDD450 | |||||||
| zuranolone |
|
12858 | compound 3 [PMID: 28753313], SAGE-217, SAGE217, Zurzuvae® | ||||||
| zurletrectinib | 12389 | Example 1 [US20210147445A1], ICP-723, ICP723 | |||||||
| ZY15557 | 9627 | ||||||||
| ZYBT1 | 11193 | example 13 [WO2015132799A2] | |||||||
| ZYDG2 | 13925 | ||||||||
| Others | Back to top | ||||||||
| '1988 | 12741 | Z795161988 | |||||||
| '2882 | 12740 | Z793205438, ZINC000061142882 | |||||||
| '9213 | 12739 | Z1723430981, ZINC000475239213 | |||||||
| (S)-41 | 13156 | ||||||||